| Outgoing Relation(s) |
| antineoplastic agent (CHEBI:35610) is a drug (CHEBI:23888) |
| Incoming Relation(s) |
| .alpha.-pyrrolidinononanophenone (CHEBI:756908) has role antineoplastic agent (CHEBI:35610) |
| (+)-albicanol (CHEBI:155904) has role antineoplastic agent (CHEBI:35610) |
| (+)-aplysinillin (CHEBI:65417) has role antineoplastic agent (CHEBI:35610) |
| (+)-dexrazoxane (CHEBI:50223) has role antineoplastic agent (CHEBI:35610) |
| (+)-dihydromyricetin (CHEBI:28429) has role antineoplastic agent (CHEBI:35610) |
| (+)-flavipucine (CHEBI:156436) has role antineoplastic agent (CHEBI:35610) |
| (+)-halomon (CHEBI:147399) has role antineoplastic agent (CHEBI:35610) |
| (+)-jasplakinolide V (CHEBI:68278) has role antineoplastic agent (CHEBI:35610) |
| (+)-jasplakinolide W (CHEBI:68279) has role antineoplastic agent (CHEBI:35610) |
| (+)-jasplakinolide Z1 (CHEBI:68274) has role antineoplastic agent (CHEBI:35610) |
| (+)-jasplakinolide Z2 (CHEBI:68275) has role antineoplastic agent (CHEBI:35610) |
| (+)-jasplakinolide Z5 (CHEBI:68280) has role antineoplastic agent (CHEBI:35610) |
| (+)-jasplakinolide Z3 (CHEBI:68276) has role antineoplastic agent (CHEBI:35610) |
| (+)-lyoniresinol (CHEBI:68168) has role antineoplastic agent (CHEBI:35610) |
| (+)-sesamin (CHEBI:66470) has role antineoplastic agent (CHEBI:35610) |
| (+)-syringaresinol (CHEBI:47) has role antineoplastic agent (CHEBI:35610) |
| (+)-tephrorin A (CHEBI:66199) has role antineoplastic agent (CHEBI:35610) |
| (+)-tephrorin B (CHEBI:66200) has role antineoplastic agent (CHEBI:35610) |
| (+)-tephrosone (CHEBI:66201) has role antineoplastic agent (CHEBI:35610) |
| (+)-δ-cadinol (CHEBI:184119) has role antineoplastic agent (CHEBI:35610) |
| (E,E)-germacrone (CHEBI:80830) has role antineoplastic agent (CHEBI:35610) |
| (E)-trans-miyabenol C (CHEBI:76193) has role antineoplastic agent (CHEBI:35610) |
| (E)-2-[[[4-(2-chlorophenyl)-1,3-thiazol-2-yl]hydrazinylidene]methyl]benzoic acid (CHEBI:167669) has role antineoplastic agent (CHEBI:35610) |
| (R,R,S)-lobaplatin (CHEBI:194425) has role antineoplastic agent (CHEBI:35610) |
| (R)-adrenaline (CHEBI:28918) has role antineoplastic agent (CHEBI:35610) |
| (R)-amygdalin (CHEBI:17019) has role antineoplastic agent (CHEBI:35610) |
| (R)-bicalutamide (CHEBI:39589) has role antineoplastic agent (CHEBI:35610) |
| (R)-carnitine (CHEBI:16347) has role antineoplastic agent (CHEBI:35610) |
| (R)-etodolac (CHEBI:60370) has role antineoplastic agent (CHEBI:35610) |
| (R)-flurbiprofen (CHEBI:38666) has role antineoplastic agent (CHEBI:35610) |
| (R)-homocamptothecin (CHEBI:144047) has role antineoplastic agent (CHEBI:35610) |
| (S,S,S)-lobaplatin (CHEBI:194426) has role antineoplastic agent (CHEBI:35610) |
| (S)-amphetamine (CHEBI:4469) has role antineoplastic agent (CHEBI:35610) |
| (S)-glaucine (CHEBI:5373) has role antineoplastic agent (CHEBI:35610) |
| (S)-timolol maleate (CHEBI:9600) has role antineoplastic agent (CHEBI:35610) |
| (−)-(S)-chlorizidine A (CHEBI:156431) has role antineoplastic agent (CHEBI:35610) |
| (−)-anisomycin (CHEBI:338412) has role antineoplastic agent (CHEBI:35610) |
| (−)-annonaine (CHEBI:76) has role antineoplastic agent (CHEBI:35610) |
| (−)-antofine (CHEBI:143911) has role antineoplastic agent (CHEBI:35610) |
| (−)-coronaridine (CHEBI:3887) has role antineoplastic agent (CHEBI:35610) |
| (−)-demecolcine (CHEBI:4393) has role antineoplastic agent (CHEBI:35610) |
| (−)-duryne (CHEBI:67754) has role antineoplastic agent (CHEBI:35610) |
| (−)-duryne B (CHEBI:67755) has role antineoplastic agent (CHEBI:35610) |
| (−)-duryne C (CHEBI:67756) has role antineoplastic agent (CHEBI:35610) |
| (−)-duryne D (CHEBI:67757) has role antineoplastic agent (CHEBI:35610) |
| (−)-duryne E (CHEBI:67758) has role antineoplastic agent (CHEBI:35610) |
| (−)-duryne F (CHEBI:67759) has role antineoplastic agent (CHEBI:35610) |
| (−)-epigallocatechin 3-gallate (CHEBI:4806) has role antineoplastic agent (CHEBI:35610) |
| (−)-flavipucine (CHEBI:156437) has role antineoplastic agent (CHEBI:35610) |
| (−)-gallocatechin gallate (CHEBI:156271) has role antineoplastic agent (CHEBI:35610) |
| (−)-jasplakinolide Z4 (CHEBI:68277) has role antineoplastic agent (CHEBI:35610) |
| (−)-marinopyrrole A (CHEBI:66678) has role antineoplastic agent (CHEBI:35610) |
| (−)-noscapine (CHEBI:73237) has role antineoplastic agent (CHEBI:35610) |
| (−)-phenylahistin (CHEBI:192360) has role antineoplastic agent (CHEBI:35610) |
| (−)-voacangine (CHEBI:141966) has role antineoplastic agent (CHEBI:35610) |
| (−)-β-elemene (CHEBI:62855) has role antineoplastic agent (CHEBI:35610) |
| (1,2-diaminocyclohexane)PtCl2 (CHEBI:90269) has role antineoplastic agent (CHEBI:35610) |
| (1R,2R,4S,5S,6R,7S)4,5-epoxygermacra-9Z-en-1,2,6-triol (CHEBI:66168) has role antineoplastic agent (CHEBI:35610) |
| (13R)-13-dihydrocarminomycin (CHEBI:31058) has role antineoplastic agent (CHEBI:35610) |
| (2→6)-β-D-fructan (CHEBI:16703) has role antineoplastic agent (CHEBI:35610) |
| (2S)-(−)-kurarinone (CHEBI:66150) has role antineoplastic agent (CHEBI:35610) |
| (2S)-1-O-(7Z,10Z,13Z)-hexadecatrienoyl-2-O-(7Z,10Z)-hexadecadienoyl-3-O-β-D-galactopyranosyl-sn-glycerol (CHEBI:83004) has role antineoplastic agent (CHEBI:35610) |
| (2S)-1-O-(7Z,10Z)-hexadecadienoyl-2-O-(7Z,10Z)-hexadecadienoyl-3-O-β-D-galactopyranosyl-sn-glycerol (CHEBI:83005) has role antineoplastic agent (CHEBI:35610) |
| (2S)-1-O-(7Z,10Z)-hexadecadienoyl-2-O-linoleoyl-3-O-β-D-galactopyranosyl-sn-glycerol (CHEBI:83006) has role antineoplastic agent (CHEBI:35610) |
| (2S)-1-O-(9Z,12Z)-octadecadienoyl-2-O-(7Z,10Z)-hexadecadienoyl-3-O-(α-D-galactopyranosyl(1→6)-β-D-galactopyranosyl)-sn-glycerol (CHEBI:83007) has role antineoplastic agent (CHEBI:35610) |
| (2S)-2'-hydroxy-7,8,3',4',5'-pentamethoxyflavan (CHEBI:66036) has role antineoplastic agent (CHEBI:35610) |
| (2S)-2'-methoxykurarinone (CHEBI:66151) has role antineoplastic agent (CHEBI:35610) |
| (2S)-5-Hydroxy-7-methoxy-8-[(E)-3-oxo-1-butenyl]flavanone (CHEBI:66031) has role antineoplastic agent (CHEBI:35610) |
| (2S)-5,7-dimethoxy-8-(2S-hydroxy-3-methyl-3-butenyl)-3',4'-methylenedioxyflavanone (CHEBI:65796) has role antineoplastic agent (CHEBI:35610) |
| (2S)-5,7-dimethoxy-8-formylflavanone (CHEBI:65795) has role antineoplastic agent (CHEBI:35610) |
| (2S),(2''S)-8,8''-5'-trihydroxy-7,7''-3,3''-4,4''-5''-heptamethoxy-5,5''-biflavan (CHEBI:66413) has role antineoplastic agent (CHEBI:35610) |
| (2S),(2''S)-8,8''-5',5''-tetrahydroxy-7,7''-3,3''-4,4''-hexamethoxy-5,5''-biflavan (CHEBI:66414) has role antineoplastic agent (CHEBI:35610) |
| (20S)-ginsenoside Rg3 (CHEBI:67991) has role antineoplastic agent (CHEBI:35610) |
| (20S)-ginsenoside Rh2 (CHEBI:77147) has role antineoplastic agent (CHEBI:35610) |
| (22E,24R)-5α,8α-epidioxyergosta-6,9,22-triene-3β-ol-3-O-β-D-glucopyranoside (CHEBI:65852) has role antineoplastic agent (CHEBI:35610) |
| (25R)-5β-spirostan-3β-ol (CHEBI:28933) has role antineoplastic agent (CHEBI:35610) |
| (2R,3S,4S,5R)-2-(6-amino-2-fluoro-9-purinyl)-5-(hydroxymethyl)oxolane-3,4-diol (CHEBI:94701) has role antineoplastic agent (CHEBI:35610) |
| (2S,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide (CHEBI:131164) has role antineoplastic agent (CHEBI:35610) |
| (2S)-2-(4-chlorophenyl)-1-[4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]-1-piperazinyl]-3-(propan-2-ylamino)-1-propanone (CHEBI:95089) has role antineoplastic agent (CHEBI:35610) |
| (2S)-2-[[(2R)-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl]-4-methyl-1-oxopentyl]amino]-2-phenylacetic acid cyclopentyl ester (CHEBI:95044) has role antineoplastic agent (CHEBI:35610) |
| (2S)-2-[[(2S)-4-carboxy-2-[[(2R)-2-[[2-[[(2S)-3-carboxy-2-[[(2S)-2-formamido-4-(methylthio)-1-oxobutyl]amino]-1-oxopropyl]amino]-1-oxoethyl]amino]-3-mercapto-1-oxopropyl]amino]-1-oxobutyl]amino]-4-methylpentanoic acid (CHEBI:125492) has role antineoplastic agent (CHEBI:35610) |
| (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(dimethylarsinothio)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid (CHEBI:94295) has role antineoplastic agent (CHEBI:35610) |
| (3S)-3-{[3',4'-difluoro-5-({4'-fluoro-6-[(3S)-pyrrolidinium-3-yloxy][biphenyl]-3-yl}carbamoyl)[biphenyl]-2-yl]oxy}pyrrolidinium dichloride (CHEBI:146308) has role antineoplastic agent (CHEBI:35610) |
| (3β,16α)-16-hydroxy-13,28-epoxyoleanan-3-yl α-L-Rhap-(1→2)-β-D-Glcp-(1→4)-[β-D-Glcp-(1→2)]-α-L-arabinopyranoside (CHEBI:66425) has role antineoplastic agent (CHEBI:35610) |
| (4,6-dimethyl-5-pyrimidinyl)-[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methyl-1-piperidinyl]methanone (CHEBI:94843) has role antineoplastic agent (CHEBI:35610) |
| (4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid (CHEBI:140238) has role antineoplastic agent (CHEBI:35610) |
| (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid (CHEBI:94618) has role antineoplastic agent (CHEBI:35610) |
| (4βH)-5α-hydroxy-8α-(2-methylbut-2-enoyloxy)-2-oxo-1(10),11(13)-guaiadien-12,6α-olide (CHEBI:65832) has role antineoplastic agent (CHEBI:35610) |
| (4βH)-8α-(2-methylbut-2-enoyloxy)-2-oxo-1(5),10(14),11(13)-guaiatrien-12,6α-olide (CHEBI:65833) has role antineoplastic agent (CHEBI:35610) |
| (5,6-dimethyl-1,10-phenanthroline)(1S,2S-diaminocyclohexane)platinum(II)(2+) (CHEBI:83153) has role antineoplastic agent (CHEBI:35610) |
| (5Z,9Z,12Z)-octadecatrienoic acid (CHEBI:86136) has role antineoplastic agent (CHEBI:35610) |
| (6R)-5,10-methylenetetrahydrofolic acid (CHEBI:1989) has role antineoplastic agent (CHEBI:35610) |
| (6S)-5-formyltetrahydrofolic acid (CHEBI:63606) has role antineoplastic agent (CHEBI:35610) |
| (9E,11E)-octadecadienoic acid (CHEBI:88464) has role antineoplastic agent (CHEBI:35610) |
| (9Z,11E,13Z)-octadecatrienoic acid (CHEBI:8638) has role antineoplastic agent (CHEBI:35610) |
| [18f]fluoromisonidazole (CHEBI:750393) has role antineoplastic agent (CHEBI:35610) |
| {4-[(E)-2-(3,5-difluorophenyl)ethenyl]phenoxy}methyl dihydrogen phosphate (CHEBI:747874) has role antineoplastic agent (CHEBI:35610) |
| all-trans-4-oxoretinol (CHEBI:44597) has role antineoplastic agent (CHEBI:35610) |
| ent-kaur-16-en-19-oic acid (CHEBI:15417) has role antineoplastic agent (CHEBI:35610) |
| epi-silvestrol (CHEBI:66485) has role antineoplastic agent (CHEBI:35610) |
| epi-tulipinolide (CHEBI:10552) has role antineoplastic agent (CHEBI:35610) |
| meso-tetrakis(N-methyl-4-pyridyl)porphine tetrakis(p-toluenesulfonate) (CHEBI:78039) has role antineoplastic agent (CHEBI:35610) |
| meso-tetrakis(N-methyl-4-pyridyl)porphine(4+) (CHEBI:37447) has role antineoplastic agent (CHEBI:35610) |
| N-(2-[(2-aminoethyl)(methyl)amino]-5-{[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino}phenyl)acetamide (CHEBI:143115) has role antineoplastic agent (CHEBI:35610) |
| N-(2-methoxyethyl)-4-{[6-(pyridin-4-yl)quinazolin-2-yl]amino}benzamide (CHEBI:143119) has role antineoplastic agent (CHEBI:35610) |
| N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide (CHEBI:91399) has role antineoplastic agent (CHEBI:35610) |
| N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}but-2-ynamide (CHEBI:90180) has role antineoplastic agent (CHEBI:35610) |
| N-desmethylenzalutamide (CHEBI:68538) has role antineoplastic agent (CHEBI:35610) |
| N-ethyl-5'-carboxamidoadenosine (CHEBI:73284) has role antineoplastic agent (CHEBI:35610) |
| N-hydroxy-7-(naphthalen-2-ylthio)heptanamide (CHEBI:94741) has role antineoplastic agent (CHEBI:35610) |
| N-hydroxyguanidine (CHEBI:43089) has role antineoplastic agent (CHEBI:35610) |
| N-methylpyrrolidin-2-one (CHEBI:7307) has role antineoplastic agent (CHEBI:35610) |
| N-oleoyltaurine (CHEBI:146206) has role antineoplastic agent (CHEBI:35610) |
| N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys (CHEBI:134411) has role antineoplastic agent (CHEBI:35610) |
| N1,N12-diethylspermine (CHEBI:90282) has role antineoplastic agent (CHEBI:35610) |
| N2-([biphenyl]-4-ylsulfonyl)-N-hydroxy-N2-isopropoxy-D-valinamide (CHEBI:93296) has role antineoplastic agent (CHEBI:35610) |
| N6-(Δ2-isopentenyl)adenosine (CHEBI:62881) has role antineoplastic agent (CHEBI:35610) |
| Nγ-nitro-L-arginine (CHEBI:27960) has role antineoplastic agent (CHEBI:35610) |
| Nω-methyl-L-arginine (CHEBI:28229) has role antineoplastic agent (CHEBI:35610) |
| O-(2-aminoethyl)-L-serine (CHEBI:72341) has role antineoplastic agent (CHEBI:35610) |
| O-(chloroacetylcarbamoyl)fumagillol (CHEBI:90748) has role antineoplastic agent (CHEBI:35610) |
| O-acetyl-L-carnitine (CHEBI:57589) has role antineoplastic agent (CHEBI:35610) |
| O-phosphoethanolamine (CHEBI:17553) has role antineoplastic agent (CHEBI:35610) |
| p-N,N-bis(2-chloroethyl)amino-D-phenylalanine (CHEBI:25814) has role antineoplastic agent (CHEBI:35610) |
| rac-crizotinib (CHEBI:77563) has role antineoplastic agent (CHEBI:35610) |
| S-allylcysteine (CHEBI:74077) has role antineoplastic agent (CHEBI:35610) |
| Se-methyl-L-selenocysteine (CHEBI:27812) has role antineoplastic agent (CHEBI:35610) |
| Se-methylselenocysteine (CHEBI:9068) has role antineoplastic agent (CHEBI:35610) |
| all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) has role antineoplastic agent (CHEBI:35610) |
| all-cis-docosa-4,7,10,13,16,19-hexaenoic acid (CHEBI:28125) has role antineoplastic agent (CHEBI:35610) |
| all-trans-retinoic acid (CHEBI:15367) has role antineoplastic agent (CHEBI:35610) |
| cis-9-nonadecenoic acid (CHEBI:78443) has role antineoplastic agent (CHEBI:35610) |
| myo-inositol hexakisphosphate (CHEBI:17401) has role antineoplastic agent (CHEBI:35610) |
| trans-2-hydroxyisoxypropyl-3-hydroxy-7-isopentene-2,3-dihydrobenzofuran-5-carboxylic acid (CHEBI:66044) has role antineoplastic agent (CHEBI:35610) |
| trans-astringin (CHEBI:2899) has role antineoplastic agent (CHEBI:35610) |
| trans-rhaponticin (CHEBI:8824) has role antineoplastic agent (CHEBI:35610) |
| 11C-choline chloride (CHEBI:72321) has role antineoplastic agent (CHEBI:35610) |
| 223RaCl2 (CHEBI:74895) has role antineoplastic agent (CHEBI:35610) |
| D-glucaric acid (CHEBI:16002) has role antineoplastic agent (CHEBI:35610) |
| D-glucitol (CHEBI:17924) has role antineoplastic agent (CHEBI:35610) |
| D-glucopyranose (CHEBI:4167) has role antineoplastic agent (CHEBI:35610) |
| L-canaline (CHEBI:41401) has role antineoplastic agent (CHEBI:35610) |
| L-citrulline (CHEBI:16349) has role antineoplastic agent (CHEBI:35610) |
| 1-(2-hydroxy-4-methoxyphenyl)-3-(4-hydroxy-3-methoxyphenyl)propane (CHEBI:69704) has role antineoplastic agent (CHEBI:35610) |
| 1-(3-chlorophenyl)-3-[5-[2-(4-thieno[3,2-d]pyrimidinylamino)ethyl]-2-thiazolyl]urea (CHEBI:94720) has role antineoplastic agent (CHEBI:35610) |
| 1-(4'-hydroxy-3'-methoxyphenyl)-7-phenyl-3-heptanone (CHEBI:66033) has role antineoplastic agent (CHEBI:35610) |
| 1-[5-bromo-4-methyl-2-[[(2S)-2-morpholinyl]methoxy]phenyl]-3-(5-methyl-2-pyrazinyl)urea (CHEBI:124917) has role antineoplastic agent (CHEBI:35610) |
| 1-O-(α-D-galactosyl)-N-hexacosanoylphytosphingosine (CHEBI:466659) has role antineoplastic agent (CHEBI:35610) |
| 1-O-caffeoylquinic acid (CHEBI:136555) has role antineoplastic agent (CHEBI:35610) |
| 1-behenoylglycerol (CHEBI:142497) has role antineoplastic agent (CHEBI:35610) |
| 1-deoxysphinganine (CHEBI:67106) has role antineoplastic agent (CHEBI:35610) |
| 1-ethyl-3-[2-methoxy-4-[5-methyl-4-[[(1S)-1-(3-pyridinyl)butyl]amino]-2-pyrimidinyl]phenyl]urea (CHEBI:95005) has role antineoplastic agent (CHEBI:35610) |
| 1-isothiocyanato-6-(methylsulfanyl)hexane (CHEBI:136921) has role antineoplastic agent (CHEBI:35610) |
| 1-methyltryptophan (CHEBI:72821) has role antineoplastic agent (CHEBI:35610) |
| 1,2,3,4,6-pentakis-O-galloyl-β-D-glucose (CHEBI:18082) has role antineoplastic agent (CHEBI:35610) |
| 1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-(6'-O-acetyl)-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside (CHEBI:69521) has role antineoplastic agent (CHEBI:35610) |
| 1,3,6,8-tetraazatricyclo[6.2.1.13,6]dodecane (CHEBI:63487) has role antineoplastic agent (CHEBI:35610) |
| 1,5,6-trihydroxy-6',6'-dimethyl-2H-pyrano(2',3':3,4)-2-(3-methylbut-2-enyl)xanthone (CHEBI:66792) has role antineoplastic agent (CHEBI:35610) |
| 1,6,7-trihydroxy-6',6'-dimethyl-2H-pyrano(2',3':3,2)-4-(3-methylbut-2-enyl)xanthone (CHEBI:66793) has role antineoplastic agent (CHEBI:35610) |
| 1'-acetoxychavicol acetate (CHEBI:469) has role antineoplastic agent (CHEBI:35610) |
| 1R,4S,6R-1,4-endoperoxy-bisabola-2,10-diene (CHEBI:65845) has role antineoplastic agent (CHEBI:35610) |
| 1S,4R,6R-1,4-endoperoxy-bisabola-2,10-diene (CHEBI:65844) has role antineoplastic agent (CHEBI:35610) |
| 1S,6R-di(2-)methylbutanoyloxy-4S-hydroxy-8S-benzoyloxy-9R-(3-)furancarbonyloxy-13-acetyloxy-β-dihydroagarofuran (CHEBI:65878) has role antineoplastic agent (CHEBI:35610) |
| 10-Hydroxycamptothecin (CHEBI:81395) has role antineoplastic agent (CHEBI:35610) |
| 10-hydroxycanthin-6-one (CHEBI:66064) has role antineoplastic agent (CHEBI:35610) |
| 10058-F4 (CHEBI:149696) has role antineoplastic agent (CHEBI:35610) |
| 1018 iss (CHEBI:757138) has role antineoplastic agent (CHEBI:35610) |
| 12-O-acetyl-16-O-deacetyl-16-epi-scalarobutenolide (CHEBI:65366) has role antineoplastic agent (CHEBI:35610) |
| 12-deacetoxy-21-acetoxyscalarin (CHEBI:66063) has role antineoplastic agent (CHEBI:35610) |
| 12-ketomethymycin (CHEBI:188461) has role antineoplastic agent (CHEBI:35610) |
| 13-deoxycarminomycin (CHEBI:31056) has role antineoplastic agent (CHEBI:35610) |
| 13-deoxydoxorubicin (CHEBI:755236) has role antineoplastic agent (CHEBI:35610) |
| 13,14-dihydro-Δ12-prostaglandin J2 (CHEBI:28130) has role antineoplastic agent (CHEBI:35610) |
| 13(S)-HODE (CHEBI:34154) has role antineoplastic agent (CHEBI:35610) |
| 14-norpseurotin A (CHEBI:66636) has role antineoplastic agent (CHEBI:35610) |
| 14g2a (CHEBI:754222) has role antineoplastic agent (CHEBI:35610) |
| 15-O-deacetylnimbolidin B (CHEBI:65725) has role antineoplastic agent (CHEBI:35610) |
| 16-O-deacetyl-16-epi-scalarolbutenolide (CHEBI:66061) has role antineoplastic agent (CHEBI:35610) |
| 16,23-epoxy-5β-cholestane triglycoside (CHEBI:65855) has role antineoplastic agent (CHEBI:35610) |
| 16β-[(O-(2-O-(E)-cinnamoyl-β-D-xylopyranosyl)-(1→2)-2-O-acetyl-α-L-arabinopyranosyl)oxy]-3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxycholest-5-en-22-one (CHEBI:65629) has role antineoplastic agent (CHEBI:35610) |
| 16β-[(α-L-arabinopyranosyl)oxy]-3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxycholest-5-en-22-one (CHEBI:65628) has role antineoplastic agent (CHEBI:35610) |
| 17-epi-17-hydroxyazadiradione (CHEBI:67288) has role antineoplastic agent (CHEBI:35610) |
| 17α-ethynylestradiol (CHEBI:4903) has role antineoplastic agent (CHEBI:35610) |
| 17α-ethynylestradiol 3-sulfate (CHEBI:136600) has role antineoplastic agent (CHEBI:35610) |
| 17α-hydroxywithanolide D (CHEBI:66329) has role antineoplastic agent (CHEBI:35610) |
| 18-oxotryprostatin A (CHEBI:66842) has role antineoplastic agent (CHEBI:35610) |
| 2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide (CHEBI:91353) has role antineoplastic agent (CHEBI:35610) |
| 2-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-3-pyridinecarboxamide (CHEBI:91424) has role antineoplastic agent (CHEBI:35610) |
| 2-(2,4-dihydroxy-5-prenylphenyl)-5,6-methylenedioxybenzofuran (CHEBI:65785) has role antineoplastic agent (CHEBI:35610) |
| 2-(6-methoxy-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-N-[4-(piperazin-1-yl)pyridin-3-yl]-1,3-thiazole-4-carboxamide (CHEBI:90627) has role antineoplastic agent (CHEBI:35610) |
| 2-(7-aminoheptyl)guanidine (CHEBI:133366) has role antineoplastic agent (CHEBI:35610) |
| 2-[[[1-(7-chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)-3-pyrazolyl]-oxomethyl]amino]-2-adamantanecarboxylic acid (CHEBI:125516) has role antineoplastic agent (CHEBI:35610) |
| 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid (CHEBI:94559) has role antineoplastic agent (CHEBI:35610) |
| 2-[4-(piperidin-3-yl)phenyl]-2H-indazole-7-carboxamide (CHEBI:177298) has role antineoplastic agent (CHEBI:35610) |
| 2-[4-[3-(6-quinolinylmethyl)-5-triazolo[4,5-b]pyrazinyl]-1-pyrazolyl]ethanol (CHEBI:91425) has role antineoplastic agent (CHEBI:35610) |
| 2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID (CHEBI:45377) has role antineoplastic agent (CHEBI:35610) |
| 2-{4-[(3R)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (CHEBI:177299) has role antineoplastic agent (CHEBI:35610) |
| 2-acetamidophenol (CHEBI:143107) has role antineoplastic agent (CHEBI:35610) |
| 2-amino-3-cyano-7-(dimethylamino)-4-(2-methoxyphenyl)-4H-chromene (CHEBI:194427) has role antineoplastic agent (CHEBI:35610) |
| 2-amino-4-(3-nitrophenyl)-3-cyano-7-(dimethylamino)-4H-chromene (CHEBI:192743) has role antineoplastic agent (CHEBI:35610) |
| 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoic acid (CHEBI:73307) has role antineoplastic agent (CHEBI:35610) |
| 2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-5-yl)-7-pyrido[2,3-d]pyrimidinone (CHEBI:124914) has role antineoplastic agent (CHEBI:35610) |
| 2-Cl-IB-MECA (CHEBI:747623) has role antineoplastic agent (CHEBI:35610) |
| 2-deoxy-2-fluoro-D-glucopyranose (CHEBI:49126) has role antineoplastic agent (CHEBI:35610) |
| 2-fluoroadenine (CHEBI:72457) has role antineoplastic agent (CHEBI:35610) |
| 2-heptylfuran (CHEBI:167091) has role antineoplastic agent (CHEBI:35610) |
| 2-hydroxylinoleic acid (CHEBI:136927) has role antineoplastic agent (CHEBI:35610) |
| 2-hydroxymelatonin (CHEBI:145792) has role antineoplastic agent (CHEBI:35610) |
| 2-hydroxyoleic acid (CHEBI:143096) has role antineoplastic agent (CHEBI:35610) |
| 2-methoxy-17β-estradiol (CHEBI:28955) has role antineoplastic agent (CHEBI:35610) |
| 2,2,2-tetramine (CHEBI:39501) has role antineoplastic agent (CHEBI:35610) |
| 2,3-dihydro-3β-O-sulfate withaferin A (CHEBI:69123) has role antineoplastic agent (CHEBI:35610) |
| 2,4,4',6-tetrahydroxydibenzoylmethane (CHEBI:75418) has role antineoplastic agent (CHEBI:35610) |
| 2,5-bis(2-hydroxyethylamino)-3,6-diaziridinylbenzoquinone (CHEBI:90193) has role antineoplastic agent (CHEBI:35610) |
| 2,5-epoxy-2β-hydroxy-8α-(2-methylbut-2-enoyloxy)-4(15),10(14),11(13)-germacratrien-12,6α-olide (CHEBI:65834) has role antineoplastic agent (CHEBI:35610) |
| 2'-deoxycytidine (CHEBI:15698) has role antineoplastic agent (CHEBI:35610) |
| 2',4'-dihydroxy-3'-(2-hydroxy benzyl)-6'-methoxy chalcone (CHEBI:65777) has role antineoplastic agent (CHEBI:35610) |
| 20-epi-bryonolic acid (CHEBI:65846) has role antineoplastic agent (CHEBI:35610) |
| 20-hydroxytubocapsanolide A (CHEBI:66326) has role antineoplastic agent (CHEBI:35610) |
| 20(R),22(ξ),24(S)-dammar-25(26)-ene-3β,6α,12β,20,22,24-hexanol (CHEBI:65722) has role antineoplastic agent (CHEBI:35610) |
| 23-hydroxytubocapsanolide A (CHEBI:66327) has role antineoplastic agent (CHEBI:35610) |
| 23,24-dimethylcholest-16(17)-E-en-3β,5α,6β,20(S)-tetrol (CHEBI:66175) has role antineoplastic agent (CHEBI:35610) |
| 25-O-methoxycimigenol 3-O-α-L-arabinopyranoside (CHEBI:66702) has role antineoplastic agent (CHEBI:35610) |
| 28-deoxonimbolide (CHEBI:67307) has role antineoplastic agent (CHEBI:35610) |
| 2x-121 (CHEBI:755671) has role antineoplastic agent (CHEBI:35610) |
| 2α-(2'-pyrrolyl)-4α-methoxycarbonyl-5β-[(2''-methyl)-heptyl]-1,3-oxazacyclohexane (CHEBI:65617) has role antineoplastic agent (CHEBI:35610) |
| 2α-(3-hydroxypropyl)-1α,25-dihydroxy-19-norvitamin D3 (CHEBI:91006) has role antineoplastic agent (CHEBI:35610) |
| 2β-methoxy-2-deethoxy-8-O-deacylphantomolin-8-O-tiglinate (CHEBI:65836) has role antineoplastic agent (CHEBI:35610) |
| 2β-methoxy-2-deethoxyphantomolin (CHEBI:65835) has role antineoplastic agent (CHEBI:35610) |
| 3-(1-methyl-3-indolyl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-3-indolyl]pyrrole-2,5-dione (CHEBI:91368) has role antineoplastic agent (CHEBI:35610) |
| 3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)-1-adamantanecarboxamide (CHEBI:124965) has role antineoplastic agent (CHEBI:35610) |
| 3-(4-quinolinylmethylamino)-N-[4-(trifluoromethoxy)phenyl]-2-thiophenecarboxamide (CHEBI:91433) has role antineoplastic agent (CHEBI:35610) |
| 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid (CHEBI:75390) has role antineoplastic agent (CHEBI:35610) |
| 3-[3-[2-(1-piperidinyl)ethoxy]phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole (CHEBI:91437) has role antineoplastic agent (CHEBI:35610) |
| 3-[3-[4-(methylaminomethyl)phenyl]-5-isoxazolyl]-5-(4-propan-2-ylsulfonylphenyl)-2-pyrazinamine (CHEBI:131166) has role antineoplastic agent (CHEBI:35610) |
| 3-[4-[4-[2-[3-[(dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethyl-3-pyrazolyl]phenyl]-1,1-dimethylurea (CHEBI:91362) has role antineoplastic agent (CHEBI:35610) |
| 3-epi-heliangin (CHEBI:65881) has role antineoplastic agent (CHEBI:35610) |
| 3-O-feruloylcycloartenol (CHEBI:69436) has role antineoplastic agent (CHEBI:35610) |
| 3-acetamino-6-isobutyl-2,5-dioxopiperazine (CHEBI:65362) has role antineoplastic agent (CHEBI:35610) |
| 3-bromopyruvic acid (CHEBI:131461) has role antineoplastic agent (CHEBI:35610) |
| 3-guanidinopropanoic acid (CHEBI:15968) has role antineoplastic agent (CHEBI:35610) |
| 3-hydroxy-2-hydroxymethyl-9,10-anthraquinone (CHEBI:69520) has role antineoplastic agent (CHEBI:35610) |
| 3-iodo-L-phenylalanine (CHEBI:233132) has role antineoplastic agent (CHEBI:35610) |
| 3-β-O-(E)-coumaroyl-D:C-friedooleana-7,9(11)-dien-29-oic acid (CHEBI:65663) has role antineoplastic agent (CHEBI:35610) |
| 3,3'-diindolylmethane (CHEBI:50182) has role antineoplastic agent (CHEBI:35610) |
| 3,3'-dimethylquercetin (CHEBI:146138) has role antineoplastic agent (CHEBI:35610) |
| 3,3',5-triiodo-L-thyronine (CHEBI:18258) has role antineoplastic agent (CHEBI:35610) |
| 3,4-dihydroxybenzoic acid (CHEBI:36062) has role antineoplastic agent (CHEBI:35610) |
| 3,4'-dimethylkaempferol (CHEBI:146142) has role antineoplastic agent (CHEBI:35610) |
| 3,5-di-O-caffeoyl quinic acid (CHEBI:65751) has role antineoplastic agent (CHEBI:35610) |
| 3,5-dihydroxy-2-(1'-oxo-3'-hexadecenyl)-2-cyclohexene-1-one (CHEBI:65773) has role antineoplastic agent (CHEBI:35610) |
| 3,5-dimethoxy-4-hydroxybenzyl alcohol-4-O-β-D-glucopyranoside (CHEBI:68338) has role antineoplastic agent (CHEBI:35610) |
| 3,6-diaminoacridine (CHEBI:8452) has role antineoplastic agent (CHEBI:35610) |
| 3,7-dihydroxytropolone (CHEBI:156362) has role antineoplastic agent (CHEBI:35610) |
| 3'-C-Ethynylcytidine (CHEBI:231178) has role antineoplastic agent (CHEBI:35610) |
| 3'-deamino-3'-(3-cyanomorpholin-4-yl)doxorubicin (CHEBI:41576) has role antineoplastic agent (CHEBI:35610) |
| 3',4'-difluoro-N-{4'-fluoro-6-[(3S)-pyrrolidin-3-yloxy][biphenyl]-3-yl}-6-[(3S)-pyrrolidin-3-yloxy][biphenyl]-3-carboxamide (CHEBI:147294) has role antineoplastic agent (CHEBI:35610) |
| 3',4',5-trihydroxy-3,6,7-trimethoxyflavone (CHEBI:18016) has role antineoplastic agent (CHEBI:35610) |
| 3',4',7-trihydroxyisoflavone (CHEBI:50399) has role antineoplastic agent (CHEBI:35610) |
| 3PO (CHEBI:144367) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(O-β-D-glucopyranosyl-(1→3)-4,6-dideoxy-2-O-methyl-β-D-gulopyranosyl)]-5β,14β-dihydroxy-19-oxocard-20(22)enolide (CHEBI:65677) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-(2-O-3,4-dimethoxybenzoyl-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one (CHEBI:65625) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-(2-O-3,4,5-trimethoxybenzoyl-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one (CHEBI:65626) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]-17αhydroxy-16β-[(O-(3-O-3,4-dimethoxybenzoyl-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one (CHEBI:65627) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-(2-O-3,4-dimethoxybenzoyl-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one (CHEBI:65623) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-(2-O-3,4,5-trimethoxybenzoyl-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one (CHEBI:65624) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-(2-O-3,4-dimethoxybenzoyl-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one (CHEBI:65621) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-(2-O-3,4,5-trimethoxybenzoyl-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one (CHEBI:65620) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyloxy]cholest-5-en-22-one (CHEBI:65622) has role antineoplastic agent (CHEBI:35610) |
| 3β-O-{α-L-Rhap-(1→2)-β-D-Glcp-(1→4)-[β-D-Glcp-(1→2)]-α-L-Arap}primulagenin A (CHEBI:65424) has role antineoplastic agent (CHEBI:35610) |
| 3β,12-dihydroxy-13-methyl-5,8,11,13-podocarpatetraene-7-one (CHEBI:65781) has role antineoplastic agent (CHEBI:35610) |
| 3β,12-dihydroxy-13-methyl-6,8,11,13-podocarpatetraene (CHEBI:65782) has role antineoplastic agent (CHEBI:35610) |
| 4-(2-methyl-3-propan-2-yl-4-imidazolyl)-N-(4-methylsulfonylphenyl)-2-pyrimidinamine (CHEBI:91419) has role antineoplastic agent (CHEBI:35610) |
| 4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-pyrazole-3-carboxamide (CHEBI:91326) has role antineoplastic agent (CHEBI:35610) |
| 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide (CHEBI:125562) has role antineoplastic agent (CHEBI:35610) |
| 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]quinazoline (CHEBI:94782) has role antineoplastic agent (CHEBI:35610) |
| 4-[[9-chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid (CHEBI:91366) has role antineoplastic agent (CHEBI:35610) |
| 4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid (CHEBI:64210) has role antineoplastic agent (CHEBI:35610) |
| 4-amino-TEMPO (CHEBI:180672) has role antineoplastic agent (CHEBI:35610) |
| 4-aminofolic acid (CHEBI:22526) has role antineoplastic agent (CHEBI:35610) |
| 4-demethyl-4-cholesteryloxycarbonylpenclomedine (CHEBI:756758) has role antineoplastic agent (CHEBI:35610) |
| 4-hydroperoxycyclophosphamide (CHEBI:196991) has role antineoplastic agent (CHEBI:35610) |
| 4-Hydroxy-N-desmethyltamoxifen (CHEBI:80555) has role antineoplastic agent (CHEBI:35610) |
| 4-hydroxy-N,1-dimethyl-2-oxo-N-phenyl-3-quinolinecarboxamide (CHEBI:92056) has role antineoplastic agent (CHEBI:35610) |
| 4-hydroxy-TEMPO (CHEBI:180664) has role antineoplastic agent (CHEBI:35610) |
| 4-hydroxyphenyl retinamide (CHEBI:42588) has role antineoplastic agent (CHEBI:35610) |
| 4-iodo-3-nitrobenzamide (CHEBI:95067) has role antineoplastic agent (CHEBI:35610) |
| 4-iodo-6-phenylpyrimidine (CHEBI:91213) has role antineoplastic agent (CHEBI:35610) |
| 4-isothioureidobutyronitrile (CHEBI:757016) has role antineoplastic agent (CHEBI:35610) |
| 4-methoxymagnaldehyde B (CHEBI:66705) has role antineoplastic agent (CHEBI:35610) |
| 4-methyl-5-pentylbenzene-1,3-diol (CHEBI:61089) has role antineoplastic agent (CHEBI:35610) |
| 4-methylaeruginoic acid (CHEBI:66368) has role antineoplastic agent (CHEBI:35610) |
| 4-methylumbelliferone (CHEBI:17224) has role antineoplastic agent (CHEBI:35610) |
| 4-methylumbelliferone β-D-glucuronide (CHEBI:1904) has role antineoplastic agent (CHEBI:35610) |
| 4-phenylbutyric acid (CHEBI:41500) has role antineoplastic agent (CHEBI:35610) |
| 4-terpineol (CHEBI:78884) has role antineoplastic agent (CHEBI:35610) |
| 4,5,4'-trihydroxy-3,3'-dimethoxybibenzyl (CHEBI:193138) has role antineoplastic agent (CHEBI:35610) |
| 4'-demethyldeoxypodophyllotoxin (CHEBI:1729) has role antineoplastic agent (CHEBI:35610) |
| 4'-demethylepipodophyllotoxin (CHEBI:74422) has role antineoplastic agent (CHEBI:35610) |
| 4'-epidoxorubicin (CHEBI:47898) has role antineoplastic agent (CHEBI:35610) |
| 4'-hydroxychalcone (CHEBI:34360) has role antineoplastic agent (CHEBI:35610) |
| 4'-thio-2'-deoxycytidine (CHEBI:749173) has role antineoplastic agent (CHEBI:35610) |
| 4',5,7-trihydroxy-3'-methoxyflavone (CHEBI:16514) has role antineoplastic agent (CHEBI:35610) |
| 4',5'-dihydro-11,5'-dihydroxy-4'-methoxytephrosin (CHEBI:65772) has role antineoplastic agent (CHEBI:35610) |
| 4''-dehydro-3-hydroxyterphenyllin (CHEBI:67529) has role antineoplastic agent (CHEBI:35610) |
| 4b5 (CHEBI:754221) has role antineoplastic agent (CHEBI:35610) |
| 4g7xh22 (CHEBI:754376) has role antineoplastic agent (CHEBI:35610) |
| 4sc-203 (CHEBI:759119) has role antineoplastic agent (CHEBI:35610) |
| 5-(N,N-hexamethylene)amiloride (CHEBI:76400) has role antineoplastic agent (CHEBI:35610) |
| 5-(2,2-diferuloylethen-1-yl)thalidomide (CHEBI:74775) has role antineoplastic agent (CHEBI:35610) |
| 5-(tetradecyloxy)-2-furoic acid (CHEBI:77936) has role antineoplastic agent (CHEBI:35610) |
| 5-[2-(feruloyl)ethen-1-yl]thalidomide (CHEBI:74774) has role antineoplastic agent (CHEBI:35610) |
| 5-O-ethyl embelin (CHEBI:65843) has role antineoplastic agent (CHEBI:35610) |
| 5-O-methyl embelin (CHEBI:65842) has role antineoplastic agent (CHEBI:35610) |
| 5-amino-2-[2-(dimethylamino)ethyl]benzo[de]isoquinoline-1,3-dione (CHEBI:94661) has role antineoplastic agent (CHEBI:35610) |
| 5-aminolevulinic acid (CHEBI:17549) has role antineoplastic agent (CHEBI:35610) |
| 5-aminolevulinic acid hydrochloride (CHEBI:132969) has role antineoplastic agent (CHEBI:35610) |
| 5-azacytidine (CHEBI:2038) has role antineoplastic agent (CHEBI:35610) |
| 5-azaorotic acid (CHEBI:30863) has role antineoplastic agent (CHEBI:35610) |
| 5-bromo-2'-deoxyuridine (CHEBI:472552) has role antineoplastic agent (CHEBI:35610) |
| 5-bromo-8-methoxy-1-methyl-β-carboline (CHEBI:65524) has role antineoplastic agent (CHEBI:35610) |
| 5-chloro-7-iodoquinolin-8-ol (CHEBI:74460) has role antineoplastic agent (CHEBI:35610) |
| 5-fluoronicotinic acid (CHEBI:748816) has role antineoplastic agent (CHEBI:35610) |
| 5-fluorouracil (CHEBI:46345) has role antineoplastic agent (CHEBI:35610) |
| 5-fluorouridine (CHEBI:40154) has role antineoplastic agent (CHEBI:35610) |
| 5-heptadecylresorcinol (CHEBI:145967) has role antineoplastic agent (CHEBI:35610) |
| 5-hydroxy-2-(1'-hydroxyethyl)naphtho[2,3-b]furan-4,9-dione (CHEBI:66028) has role antineoplastic agent (CHEBI:35610) |
| 5-hydroxy-2-methylchromone-7-O-rutinoside (CHEBI:66371) has role antineoplastic agent (CHEBI:35610) |
| 5-hydroxy-6-methoxy-2-methylchromone-7-O-rutinoside (CHEBI:66370) has role antineoplastic agent (CHEBI:35610) |
| 5-hydroxy-7-prop-2-en-(E)-ylidene-7,7a-dihydro- 2H-cyclopenta[b]pyran-6-one (CHEBI:65800) has role antineoplastic agent (CHEBI:35610) |
| 5-hydroxy-7-prop-2-en-(Z)-ylidene-7,7a-dihydro- 2H-cyclopenta[b]pyran-6-one (CHEBI:65801) has role antineoplastic agent (CHEBI:35610) |
| 5-hydroxyimidazole-4-carboxamide (CHEBI:88290) has role antineoplastic agent (CHEBI:35610) |
| 5-iodo-2'-deoxyuridine (CHEBI:147675) has role antineoplastic agent (CHEBI:35610) |
| 5-methyl-2'-fluoroarauracil f-18 (CHEBI:756833) has role antineoplastic agent (CHEBI:35610) |
| 5,6-dichloro-1-β-D-ribofuranosyl-1H-benzimidazole (CHEBI:49852) has role antineoplastic agent (CHEBI:35610) |
| 5,6-epoxyretinoic acid (CHEBI:80658) has role antineoplastic agent (CHEBI:35610) |
| 5,7,3'-trihydroxy-4'-methoxy-8,2'-di(3-methyl-2-butenyl)-(2S)-flavanone (CHEBI:66264) has role antineoplastic agent (CHEBI:35610) |
| 5E-7-oxozeaenol (CHEBI:67558) has role antineoplastic agent (CHEBI:35610) |
| 5Z-7-oxozeaenol (CHEBI:67559) has role antineoplastic agent (CHEBI:35610) |
| 5α,8α-epidioxycholest-6-en-3β-ol (CHEBI:65851) has role antineoplastic agent (CHEBI:35610) |
| 5α,8α-epidioxysterol (CHEBI:65853) has role antineoplastic agent (CHEBI:35610) |
| 6-(18F)fluoro-L-dopa (CHEBI:49166) has role antineoplastic agent (CHEBI:35610) |
| 6-[1'-oxo-3'(R)-hydroxy-butyl]-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (CHEBI:66660) has role antineoplastic agent (CHEBI:35610) |
| 6-[1'-oxo-3'(R)-methoxy-butyl]-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (CHEBI:66661) has role antineoplastic agent (CHEBI:35610) |
| 6-[difluoro-[6-(1-methyl-4-pyrazolyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline (CHEBI:91417) has role antineoplastic agent (CHEBI:35610) |
| 6-anilino-5,8-quinolinedione (CHEBI:78677) has role antineoplastic agent (CHEBI:35610) |
| 6-azauridine (CHEBI:35668) has role antineoplastic agent (CHEBI:35610) |
| 6-azauridine 5'-monophosphate (CHEBI:46319) has role antineoplastic agent (CHEBI:35610) |
| 6-azauridine 5'-monophosphate(2−) (CHEBI:147401) has role antineoplastic agent (CHEBI:35610) |
| 6-chloro-7-[2-(4-morpholinyl)ethylamino]quinoline-5,8-dione (CHEBI:92053) has role antineoplastic agent (CHEBI:35610) |
| 6-diazo-5-oxo-L-norleucine (CHEBI:138889) has role antineoplastic agent (CHEBI:35610) |
| 6-hydroxypaclitaxel (CHEBI:63859) has role antineoplastic agent (CHEBI:35610) |
| 6-methoxyspirotryprostatin B (CHEBI:66707) has role antineoplastic agent (CHEBI:35610) |
| 6-o-benzylguanine (CHEBI:748866) has role antineoplastic agent (CHEBI:35610) |
| 6'-O-galloylalbiflorin (CHEBI:132816) has role antineoplastic agent (CHEBI:35610) |
| 6α-methylprednisolone (CHEBI:6888) has role antineoplastic agent (CHEBI:35610) |
| 7-(4''-hydroxy-3''-methoxyphenyl)-1-phenyl-4E-heptene-3-one (CHEBI:66034) has role antineoplastic agent (CHEBI:35610) |
| 7-(4''-hydroxy-3''-methoxyphenyl)-5-methoxy-1-phenyl-3-heptanone (CHEBI:66032) has role antineoplastic agent (CHEBI:35610) |
| 7-deacetyl-7-benzoylgedunin (CHEBI:67297) has role antineoplastic agent (CHEBI:35610) |
| 7-methoxydeoxymorellin (CHEBI:66704) has role antineoplastic agent (CHEBI:35610) |
| 7-nor-ergosterolide (CHEBI:70332) has role antineoplastic agent (CHEBI:35610) |
| 7-oxo-3,8,9-trihydroxy staurosporine (CHEBI:66839) has role antineoplastic agent (CHEBI:35610) |
| 7-oxo-8,9-dihydroxy-4'-N-demethyl staurosporine (CHEBI:66840) has role antineoplastic agent (CHEBI:35610) |
| 7,3',4'-trihydroxy-3,8-dimethoxyflavone (CHEBI:69452) has role antineoplastic agent (CHEBI:35610) |
| 7,8-dehydrocerberin (CHEBI:65734) has role antineoplastic agent (CHEBI:35610) |
| 7,8-dihydroxyflavanone (CHEBI:65787) has role antineoplastic agent (CHEBI:35610) |
| 7,8-dihydroxyflavone (CHEBI:140464) has role antineoplastic agent (CHEBI:35610) |
| 7α-hydroperoxy manool (CHEBI:66025) has role antineoplastic agent (CHEBI:35610) |
| 8-(2-chloro-3,4,5-trimethoxybenzyl)-2-fluoro-9-pent-4-yn-1-yl-9H-purin-6-amine (CHEBI:47628) has role antineoplastic agent (CHEBI:35610) |
| 8-[(6-IODO-1,3-BENZODIOXOL-5-YL)THIO]-9-[3-(ISOPROPYLAMINO)PROPYL]-9H-PURIN-6-AMINE (CHEBI:42928) has role antineoplastic agent (CHEBI:35610) |
| 8-acetoxy-4,10-dihydroxy-2,11(13)-guaiadiene-12,6-olide (CHEBI:65363) has role antineoplastic agent (CHEBI:35610) |
| 8-azaguanine (CHEBI:63486) has role antineoplastic agent (CHEBI:35610) |
| 8-chloro-2-phenyl-3-[(1S)-1-(7H-purin-6-ylamino)ethyl]-1-isoquinolinone (CHEBI:131169) has role antineoplastic agent (CHEBI:35610) |
| 8-chloroadenosine (CHEBI:757885) has role antineoplastic agent (CHEBI:35610) |
| 8-hydroxy-2-(1'-hydroxyethyl)naphtho-[2,3-b]-furan-4,9-dione (CHEBI:66029) has role antineoplastic agent (CHEBI:35610) |
| 8-PIP-cAMP (CHEBI:145730) has role antineoplastic agent (CHEBI:35610) |
| 8,8a-epoxymorellic acid (CHEBI:66402) has role antineoplastic agent (CHEBI:35610) |
| 8h9 131i (CHEBI:754153) has role antineoplastic agent (CHEBI:35610) |
| 9-cis-retinoate (CHEBI:78630) has role antineoplastic agent (CHEBI:35610) |
| 9-cis-retinoic acid (CHEBI:50648) has role antineoplastic agent (CHEBI:35610) |
| 9-Aminocamptothecin (CHEBI:80755) has role antineoplastic agent (CHEBI:35610) |
| 9-deacetoxyfumigaclavine C (CHEBI:65724) has role antineoplastic agent (CHEBI:35610) |
| 9-hydroxy hedychenone (CHEBI:66010) has role antineoplastic agent (CHEBI:35610) |
| 9-hydroxycanthin-6-one (CHEBI:66041) has role antineoplastic agent (CHEBI:35610) |
| 9-hydroxyellipticine (CHEBI:88297) has role antineoplastic agent (CHEBI:35610) |
| 9-methoxycanthin-6-one (CHEBI:66699) has role antineoplastic agent (CHEBI:35610) |
| 9-β-D-arabinofuranosylguanine (CHEBI:73141) has role antineoplastic agent (CHEBI:35610) |
| 9(11)-dehydroaxinysterol (CHEBI:65733) has role antineoplastic agent (CHEBI:35610) |
| 9H-purine-2,6-diamine (CHEBI:40235) has role antineoplastic agent (CHEBI:35610) |
| 9α,11α-dihydroxyergosta-4,6,8(14),22-tetraen-3-one (CHEBI:68054) has role antineoplastic agent (CHEBI:35610) |
| A2-32-01 (CHEBI:86341) has role antineoplastic agent (CHEBI:35610) |
| A2-58-06 (CHEBI:86342) has role antineoplastic agent (CHEBI:35610) |
| a27.15 (CHEBI:754277) has role antineoplastic agent (CHEBI:35610) |
| a33 131i (CHEBI:754377) has role antineoplastic agent (CHEBI:35610) |
| ab-101 (CHEBI:757139) has role antineoplastic agent (CHEBI:35610) |
| abacavir (CHEBI:421707) has role antineoplastic agent (CHEBI:35610) |
| abagovomab (CHEBI:750061) has role antineoplastic agent (CHEBI:35610) |
| abarelix (CHEBI:337298) has role antineoplastic agent (CHEBI:35610) |
| abatacept (CHEBI:749599) has role antineoplastic agent (CHEBI:35610) |
| abbv-744 (CHEBI:756940) has role antineoplastic agent (CHEBI:35610) |
| abefolastat tesaroxetan (CHEBI:759205) has role antineoplastic agent (CHEBI:35610) |
| Abemaciclib (CHEBI:233362) has role antineoplastic agent (CHEBI:35610) |
| abequolixron (CHEBI:749077) has role antineoplastic agent (CHEBI:35610) |
| abequolixron zinc (CHEBI:758972) has role antineoplastic agent (CHEBI:35610) |
| abexinostat (CHEBI:92223) has role antineoplastic agent (CHEBI:35610) |
| abipapogene suvaplasmid (CHEBI:760113) has role antineoplastic agent (CHEBI:35610) |
| abiraterone (CHEBI:68642) has role antineoplastic agent (CHEBI:35610) |
| abiraterone acetate (CHEBI:68639) has role antineoplastic agent (CHEBI:35610) |
| abiraterone decanoate (CHEBI:759655) has role antineoplastic agent (CHEBI:35610) |
| abituzumab (CHEBI:754362) has role antineoplastic agent (CHEBI:35610) |
| abivertinib (CHEBI:757305) has role antineoplastic agent (CHEBI:35610) |
| abivertinib maleate (CHEBI:757306) has role antineoplastic agent (CHEBI:35610) |
| abm-1310 (CHEBI:760473) has role antineoplastic agent (CHEBI:35610) |
| abt-510 (CHEBI:748709) has role antineoplastic agent (CHEBI:35610) |
| ABT-737 (CHEBI:47575) has role antineoplastic agent (CHEBI:35610) |
| abx-196 (CHEBI:757915) has role antineoplastic agent (CHEBI:35610) |
| abyssinone A (CHEBI:65358) has role antineoplastic agent (CHEBI:35610) |
| abyssinone C (CHEBI:65359) has role antineoplastic agent (CHEBI:35610) |
| abyssinone D (CHEBI:65360) has role antineoplastic agent (CHEBI:35610) |
| ac-480 (CHEBI:749942) has role antineoplastic agent (CHEBI:35610) |
| acadesine (CHEBI:28498) has role antineoplastic agent (CHEBI:35610) |
| acalabrutinib (CHEBI:167707) has role antineoplastic agent (CHEBI:35610) |
| acalabrutinib maleate (CHEBI:757795) has role antineoplastic agent (CHEBI:35610) |
| acalisib (CHEBI:757655) has role antineoplastic agent (CHEBI:35610) |
| acapatamab (CHEBI:758565) has role antineoplastic agent (CHEBI:35610) |
| acasunlimab (CHEBI:758906) has role antineoplastic agent (CHEBI:35610) |
| acebutolol (CHEBI:2379) has role antineoplastic agent (CHEBI:35610) |
| acenocoumarol (CHEBI:53766) has role antineoplastic agent (CHEBI:35610) |
| acetazolamide (CHEBI:27690) has role antineoplastic agent (CHEBI:35610) |
| acetic acid c-11 (CHEBI:756831) has role antineoplastic agent (CHEBI:35610) |
| acetyl aleuritolic acid (CHEBI:70418) has role antineoplastic agent (CHEBI:35610) |
| acetylsalicylic acid (CHEBI:15365) has role antineoplastic agent (CHEBI:35610) |
| acimtamig (CHEBI:759698) has role antineoplastic agent (CHEBI:35610) |
| acivicin (CHEBI:74545) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin A (CHEBI:74619) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin A zwitterion (CHEBI:77980) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin N (CHEBI:75091) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin S (CHEBI:79176) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin S zwitterion (CHEBI:78303) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin T (CHEBI:74351) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin T hydrochloride (CHEBI:74758) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin T zwitterion (CHEBI:77979) has role antineoplastic agent (CHEBI:35610) |
| acolbifene hydrochloride (CHEBI:751718) has role antineoplastic agent (CHEBI:35610) |
| acridine (CHEBI:36420) has role antineoplastic agent (CHEBI:35610) |
| acriflavinium chloride (CHEBI:74728) has role antineoplastic agent (CHEBI:35610) |
| acrixolimab (CHEBI:758690) has role antineoplastic agent (CHEBI:35610) |
| acronycine (CHEBI:2437) has role antineoplastic agent (CHEBI:35610) |
| act-001 (CHEBI:754922) has role antineoplastic agent (CHEBI:35610) |
| actinium ac 225 dotatate (CHEBI:760328) has role antineoplastic agent (CHEBI:35610) |
| actinodaphnine (CHEBI:2444) has role antineoplastic agent (CHEBI:35610) |
| actinomycin D (CHEBI:27666) has role antineoplastic agent (CHEBI:35610) |
| aculeatol E (CHEBI:65368) has role antineoplastic agent (CHEBI:35610) |
| acumitin (CHEBI:65369) has role antineoplastic agent (CHEBI:35610) |
| acyclovir sodium (CHEBI:749231) has role antineoplastic agent (CHEBI:35610) |
| ada-011 (CHEBI:760474) has role antineoplastic agent (CHEBI:35610) |
| adagloxad simolenin (CHEBI:755770) has role antineoplastic agent (CHEBI:35610) |
| adakitug (CHEBI:759251) has role antineoplastic agent (CHEBI:35610) |
| adalimumab (CHEBI:749494) has role antineoplastic agent (CHEBI:35610) |
| adargiminase (CHEBI:760114) has role antineoplastic agent (CHEBI:35610) |
| adavosertib (CHEBI:91414) has role antineoplastic agent (CHEBI:35610) |
| adebrelimab (CHEBI:757272) has role antineoplastic agent (CHEBI:35610) |
| adecatumumab (CHEBI:753036) has role antineoplastic agent (CHEBI:35610) |
| adenine arabinoside (CHEBI:45327) has role antineoplastic agent (CHEBI:35610) |
| adenosine (CHEBI:16335) has role antineoplastic agent (CHEBI:35610) |
| aderbasib (CHEBI:750464) has role antineoplastic agent (CHEBI:35610) |
| adg-106 (CHEBI:757993) has role antineoplastic agent (CHEBI:35610) |
| adh-1 (CHEBI:755894) has role antineoplastic agent (CHEBI:35610) |
| adonixanthin (CHEBI:80217) has role antineoplastic agent (CHEBI:35610) |
| adrixetinib (CHEBI:759159) has role antineoplastic agent (CHEBI:35610) |
| adu-s100 (CHEBI:757145) has role antineoplastic agent (CHEBI:35610) |
| AEE788 (CHEBI:40629) has role antineoplastic agent (CHEBI:35610) |
| aeg-35156 (CHEBI:760504) has role antineoplastic agent (CHEBI:35610) |
| afamitresgene autoleucel (CHEBI:758561) has role antineoplastic agent (CHEBI:35610) |
| afatinib (CHEBI:61390) has role antineoplastic agent (CHEBI:35610) |
| afatinib dimaleate (CHEBI:76003) has role antineoplastic agent (CHEBI:35610) |
| afeletecan hydrochloride (CHEBI:757126) has role antineoplastic agent (CHEBI:35610) |
| afimoxifene (CHEBI:44616) has role antineoplastic agent (CHEBI:35610) |
| aflibercept (CHEBI:750062) has role antineoplastic agent (CHEBI:35610) |
| afm-11 (CHEBI:757313) has role antineoplastic agent (CHEBI:35610) |
| afp-464 (CHEBI:759129) has role antineoplastic agent (CHEBI:35610) |
| afuresertib (CHEBI:754906) has role antineoplastic agent (CHEBI:35610) |
| ag-24322 (CHEBI:755632) has role antineoplastic agent (CHEBI:35610) |
| ag-270 (CHEBI:758485) has role antineoplastic agent (CHEBI:35610) |
| agathisflavone (CHEBI:2512) has role antineoplastic agent (CHEBI:35610) |
| agatolimod sodium (CHEBI:750467) has role antineoplastic agent (CHEBI:35610) |
| ageladine A (CHEBI:65373) has role antineoplastic agent (CHEBI:35610) |
| agi-134 (CHEBI:758201) has role antineoplastic agent (CHEBI:35610) |
| agigenin (CHEBI:72849) has role antineoplastic agent (CHEBI:35610) |
| aglaiabbreviatin F (CHEBI:70267) has role antineoplastic agent (CHEBI:35610) |
| aglatimagene besadenovec (CHEBI:755409) has role antineoplastic agent (CHEBI:35610) |
| ags-16c3f (CHEBI:757936) has role antineoplastic agent (CHEBI:35610) |
| ags62p1 (CHEBI:757331) has role antineoplastic agent (CHEBI:35610) |
| ahn-12 (CHEBI:754266) has role antineoplastic agent (CHEBI:35610) |
| ak-01 (CHEBI:757859) has role antineoplastic agent (CHEBI:35610) |
| akebia saponin D (CHEBI:194124) has role antineoplastic agent (CHEBI:35610) |
| AKI00000020a (CHEBI:169940) has role antineoplastic agent (CHEBI:35610) |
| aklavinone (CHEBI:31181) has role antineoplastic agent (CHEBI:35610) |
| akn-028 (CHEBI:758446) has role antineoplastic agent (CHEBI:35610) |
| alanosine (CHEBI:748911) has role antineoplastic agent (CHEBI:35610) |
| alantolactone (CHEBI:2540) has role antineoplastic agent (CHEBI:35610) |
| alatolide (CHEBI:2542) has role antineoplastic agent (CHEBI:35610) |
| albinterferon alfa-2b (CHEBI:752889) has role antineoplastic agent (CHEBI:35610) |
| albizoside A (CHEBI:65379) has role antineoplastic agent (CHEBI:35610) |
| albizoside B (CHEBI:65380) has role antineoplastic agent (CHEBI:35610) |
| albizoside C (CHEBI:65381) has role antineoplastic agent (CHEBI:35610) |
| albumin human (CHEBI:749447) has role antineoplastic agent (CHEBI:35610) |
| alcestobart (CHEBI:760116) has role antineoplastic agent (CHEBI:35610) |
| alclometasone dipropionate (CHEBI:31184) has role antineoplastic agent (CHEBI:35610) |
| aldastotug (CHEBI:760004) has role antineoplastic agent (CHEBI:35610) |
| aldesleukin (CHEBI:749478) has role antineoplastic agent (CHEBI:35610) |
| aldoxorubicin hydrochloride (CHEBI:752883) has role antineoplastic agent (CHEBI:35610) |
| alectinib (CHEBI:90936) has role antineoplastic agent (CHEBI:35610) |
| alectinib hydrochloride (CHEBI:62268) has role antineoplastic agent (CHEBI:35610) |
| alefacept (CHEBI:749492) has role antineoplastic agent (CHEBI:35610) |
| alemtuzumab (CHEBI:749551) has role antineoplastic agent (CHEBI:35610) |
| alemtuzumab beta (CHEBI:759417) has role antineoplastic agent (CHEBI:35610) |
| alendronate sodium (CHEBI:748035) has role antineoplastic agent (CHEBI:35610) |
| alendronic acid (CHEBI:2567) has role antineoplastic agent (CHEBI:35610) |
| alethine (CHEBI:749189) has role antineoplastic agent (CHEBI:35610) |
| alextatug (CHEBI:759501) has role antineoplastic agent (CHEBI:35610) |
| alfadex (CHEBI:749654) has role antineoplastic agent (CHEBI:35610) |
| alfuzosin (CHEBI:51141) has role antineoplastic agent (CHEBI:35610) |
| algenpantucel-l (CHEBI:753657) has role antineoplastic agent (CHEBI:35610) |
| alintegimod (CHEBI:759160) has role antineoplastic agent (CHEBI:35610) |
| alisertib (CHEBI:125628) has role antineoplastic agent (CHEBI:35610) |
| allanxanthone C (CHEBI:65387) has role antineoplastic agent (CHEBI:35610) |
| allicin (CHEBI:28411) has role antineoplastic agent (CHEBI:35610) |
| allopurinol (CHEBI:40279) has role antineoplastic agent (CHEBI:35610) |
| allyl isothiocyanate (CHEBI:73224) has role antineoplastic agent (CHEBI:35610) |
| alnuctamab (CHEBI:760476) has role antineoplastic agent (CHEBI:35610) |
| alobresib (CHEBI:756024) has role antineoplastic agent (CHEBI:35610) |
| Aloe emodin (CHEBI:2607) has role antineoplastic agent (CHEBI:35610) |
| alofanib (CHEBI:757923) has role antineoplastic agent (CHEBI:35610) |
| alovudine f-18 (CHEBI:759631) has role antineoplastic agent (CHEBI:35610) |
| alrizomadlin (CHEBI:756595) has role antineoplastic agent (CHEBI:35610) |
| alsevalimab (CHEBI:758018) has role antineoplastic agent (CHEBI:35610) |
| alsterpaullone (CHEBI:138488) has role antineoplastic agent (CHEBI:35610) |
| alteminostat (CHEBI:759645) has role antineoplastic agent (CHEBI:35610) |
| alteplase (CHEBI:749459) has role antineoplastic agent (CHEBI:35610) |
| altiratinib (CHEBI:755597) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin E (CHEBI:65390) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin F (CHEBI:65391) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin G (CHEBI:65392) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin H (CHEBI:65393) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin I (CHEBI:65394) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin J (CHEBI:65395) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin K (CHEBI:65396) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin L (CHEBI:65397) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin M (CHEBI:65398) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin N (CHEBI:65399) has role antineoplastic agent (CHEBI:35610) |
| alvelestat (CHEBI:755658) has role antineoplastic agent (CHEBI:35610) |
| alvespimycin (CHEBI:65324) has role antineoplastic agent (CHEBI:35610) |
| alvespimycin hydrochloride (CHEBI:751533) has role antineoplastic agent (CHEBI:35610) |
| alvimopan (CHEBI:135686) has role antineoplastic agent (CHEBI:35610) |
| alvocidib (CHEBI:47344) has role antineoplastic agent (CHEBI:35610) |
| alvocidib hydrochloride (CHEBI:90998) has role antineoplastic agent (CHEBI:35610) |
| AM-251 (CHEBI:90724) has role antineoplastic agent (CHEBI:35610) |
| amatuximab (CHEBI:750064) has role antineoplastic agent (CHEBI:35610) |
| amcasertib (CHEBI:755816) has role antineoplastic agent (CHEBI:35610) |
| amcenestrant (CHEBI:757695) has role antineoplastic agent (CHEBI:35610) |
| AMD 070 (CHEBI:138865) has role antineoplastic agent (CHEBI:35610) |
| amdizalisib (CHEBI:757670) has role antineoplastic agent (CHEBI:35610) |
| AMG-208 (CHEBI:90626) has role antineoplastic agent (CHEBI:35610) |
| amg-224 (CHEBI:757994) has role antineoplastic agent (CHEBI:35610) |
| amg-319 (CHEBI:757662) has role antineoplastic agent (CHEBI:35610) |
| amg-337 (CHEBI:755883) has role antineoplastic agent (CHEBI:35610) |
| amg-404 (CHEBI:757996) has role antineoplastic agent (CHEBI:35610) |
| amg-780 (CHEBI:754343) has role antineoplastic agent (CHEBI:35610) |
| amg-820 (CHEBI:754158) has role antineoplastic agent (CHEBI:35610) |
| amg-888 (CHEBI:754208) has role antineoplastic agent (CHEBI:35610) |
| amg-900 (CHEBI:754774) has role antineoplastic agent (CHEBI:35610) |
| AMG-925 (CHEBI:145537) has role antineoplastic agent (CHEBI:35610) |
| amg553 (CHEBI:758197) has role antineoplastic agent (CHEBI:35610) |
| amifampridine phosphate (CHEBI:755293) has role antineoplastic agent (CHEBI:35610) |
| amifostine (CHEBI:2636) has role antineoplastic agent (CHEBI:35610) |
| amino acids (CHEBI:749563) has role antineoplastic agent (CHEBI:35610) |
| aminoglutethimide (CHEBI:2654) has role antineoplastic agent (CHEBI:35610) |
| aminophylline (CHEBI:2659) has role antineoplastic agent (CHEBI:35610) |
| amitriptyline (CHEBI:2666) has role antineoplastic agent (CHEBI:35610) |
| amivantamab (CHEBI:757222) has role antineoplastic agent (CHEBI:35610) |
| amlodipine (CHEBI:2668) has role antineoplastic agent (CHEBI:35610) |
| ammonium trichlorotellurate (CHEBI:757729) has role antineoplastic agent (CHEBI:35610) |
| amomol A (CHEBI:65404) has role antineoplastic agent (CHEBI:35610) |
| amostomig (CHEBI:760005) has role antineoplastic agent (CHEBI:35610) |
| amoxicillin (CHEBI:2676) has role antineoplastic agent (CHEBI:35610) |
| amp-224 (CHEBI:757045) has role antineoplastic agent (CHEBI:35610) |
| amphotericin B (CHEBI:2682) has role antineoplastic agent (CHEBI:35610) |
| amredobresib (CHEBI:755986) has role antineoplastic agent (CHEBI:35610) |
| amrubicin (CHEBI:135779) has role antineoplastic agent (CHEBI:35610) |
| amrubicin hydrochloride (CHEBI:748929) has role antineoplastic agent (CHEBI:35610) |
| amrubicinol (CHEBI:156204) has role antineoplastic agent (CHEBI:35610) |
| amsacrine (CHEBI:2687) has role antineoplastic agent (CHEBI:35610) |
| amsilarotene (CHEBI:748112) has role antineoplastic agent (CHEBI:35610) |
| amulirafusp alfa (CHEBI:760006) has role antineoplastic agent (CHEBI:35610) |
| amv-564 (CHEBI:757027) has role antineoplastic agent (CHEBI:35610) |
| amxt-1501 (CHEBI:748948) has role antineoplastic agent (CHEBI:35610) |
| an-9 (CHEBI:748430) has role antineoplastic agent (CHEBI:35610) |
| anagrelide (CHEBI:142290) has role antineoplastic agent (CHEBI:35610) |
| anagrelide hydrochloride (CHEBI:55345) has role antineoplastic agent (CHEBI:35610) |
| Anakinra (CHEBI:231683) has role antineoplastic agent (CHEBI:35610) |
| anamorelin (CHEBI:754417) has role antineoplastic agent (CHEBI:35610) |
| anamorelin hydrochloride (CHEBI:750468) has role antineoplastic agent (CHEBI:35610) |
| anastrozole (CHEBI:2704) has role antineoplastic agent (CHEBI:35610) |
| anbalcabtagene autoleucel (CHEBI:759350) has role antineoplastic agent (CHEBI:35610) |
| ancestim (CHEBI:753882) has role antineoplastic agent (CHEBI:35610) |
| ancitabine (CHEBI:74838) has role antineoplastic agent (CHEBI:35610) |
| ancitabine hydrochloride (CHEBI:74843) has role antineoplastic agent (CHEBI:35610) |
| andecaliximab (CHEBI:755953) has role antineoplastic agent (CHEBI:35610) |
| andrographolide (CHEBI:65408) has role antineoplastic agent (CHEBI:35610) |
| anetumab ravtansine (CHEBI:754368) has role antineoplastic agent (CHEBI:35610) |
| ang1005 (CHEBI:749136) has role antineoplastic agent (CHEBI:35610) |
| anitocabtagene autoleucel (CHEBI:759418) has role antineoplastic agent (CHEBI:35610) |
| anizatrectinib (CHEBI:758672) has role antineoplastic agent (CHEBI:35610) |
| anpocogin (CHEBI:757501) has role antineoplastic agent (CHEBI:35610) |
| ansamitocin P3 (CHEBI:29515) has role antineoplastic agent (CHEBI:35610) |
| ansipastobart (CHEBI:760007) has role antineoplastic agent (CHEBI:35610) |
| anthra[1,9-cd]pyrazol-6(2H)-one (CHEBI:90695) has role antineoplastic agent (CHEBI:35610) |
| anthramycin (CHEBI:40699) has role antineoplastic agent (CHEBI:35610) |
| anti-gd2 monoclonal antibody 3f8 (CHEBI:754219) has role antineoplastic agent (CHEBI:35610) |
| anti-tac 90 y-hat (CHEBI:754189) has role antineoplastic agent (CHEBI:35610) |
| antilymphocyte immunoglobulin (horse) (CHEBI:753888) has role antineoplastic agent (CHEBI:35610) |
| antineoplaston a10 (CHEBI:750341) has role antineoplastic agent (CHEBI:35610) |
| antroquinonol (CHEBI:65415) has role antineoplastic agent (CHEBI:35610) |
| anvatabart opadotin (CHEBI:757330) has role antineoplastic agent (CHEBI:35610) |
| anvatabart pactil (CHEBI:759313) has role antineoplastic agent (CHEBI:35610) |
| anzurstobart (CHEBI:758893) has role antineoplastic agent (CHEBI:35610) |
| AOH1996 (CHEBI:195529) has role antineoplastic agent (CHEBI:35610) |
| apalutamide (CHEBI:755199) has role antineoplastic agent (CHEBI:35610) |
| apatorsen (CHEBI:755090) has role antineoplastic agent (CHEBI:35610) |
| Apaziquone (CHEBI:177558) has role antineoplastic agent (CHEBI:35610) |
| apc-100 (CHEBI:748145) has role antineoplastic agent (CHEBI:35610) |
| apg-1387 (CHEBI:757940) has role antineoplastic agent (CHEBI:35610) |
| apg-2575 (CHEBI:758266) has role antineoplastic agent (CHEBI:35610) |
| aphidicolin (CHEBI:2766) has role antineoplastic agent (CHEBI:35610) |
| apigenin (CHEBI:18388) has role antineoplastic agent (CHEBI:35610) |
| apitolisib (CHEBI:750288) has role antineoplastic agent (CHEBI:35610) |
| apixaban (CHEBI:72296) has role antineoplastic agent (CHEBI:35610) |
| apl-501 (CHEBI:757850) has role antineoplastic agent (CHEBI:35610) |
| aplitabart (CHEBI:760008) has role antineoplastic agent (CHEBI:35610) |
| aplysinoplide A (CHEBI:65418) has role antineoplastic agent (CHEBI:35610) |
| aplysinoplide B (CHEBI:65419) has role antineoplastic agent (CHEBI:35610) |
| aplysinoplide C (CHEBI:65420) has role antineoplastic agent (CHEBI:35610) |
| apolizumab (CHEBI:753250) has role antineoplastic agent (CHEBI:35610) |
| apomine (CHEBI:758112) has role antineoplastic agent (CHEBI:35610) |
| apratoxin A (CHEBI:35212) has role antineoplastic agent (CHEBI:35610) |
| apratoxin D (CHEBI:65421) has role antineoplastic agent (CHEBI:35610) |
| apratoxin E (CHEBI:65422) has role antineoplastic agent (CHEBI:35610) |
| aprepitant (CHEBI:499361) has role antineoplastic agent (CHEBI:35610) |
| apricoxib (CHEBI:750219) has role antineoplastic agent (CHEBI:35610) |
| aprinocarsen (CHEBI:753279) has role antineoplastic agent (CHEBI:35610) |
| aprotinin (CHEBI:749537) has role antineoplastic agent (CHEBI:35610) |
| aprutumab ixadotin (CHEBI:758195) has role antineoplastic agent (CHEBI:35610) |
| apto-253 (CHEBI:756766) has role antineoplastic agent (CHEBI:35610) |
| apvo-414 (CHEBI:758014) has role antineoplastic agent (CHEBI:35610) |
| apvo-436 (CHEBI:757999) has role antineoplastic agent (CHEBI:35610) |
| apx-3330 (CHEBI:749088) has role antineoplastic agent (CHEBI:35610) |
| aquacobalamin (CHEBI:758087) has role antineoplastic agent (CHEBI:35610) |
| AR-42 (CHEBI:188197) has role antineoplastic agent (CHEBI:35610) |
| ar-67 (CHEBI:748532) has role antineoplastic agent (CHEBI:35610) |
| archexin (CHEBI:757513) has role antineoplastic agent (CHEBI:35610) |
| arcitumomab (CHEBI:753251) has role antineoplastic agent (CHEBI:35610) |
| ardisianoside A (CHEBI:65425) has role antineoplastic agent (CHEBI:35610) |
| ardisianoside B (CHEBI:65426) has role antineoplastic agent (CHEBI:35610) |
| ardisianoside C (CHEBI:65427) has role antineoplastic agent (CHEBI:35610) |
| ardisianoside D (CHEBI:65428) has role antineoplastic agent (CHEBI:35610) |
| ardisianoside E (CHEBI:65429) has role antineoplastic agent (CHEBI:35610) |
| ardisiphenol A (CHEBI:65430) has role antineoplastic agent (CHEBI:35610) |
| ardisiphenol B (CHEBI:65431) has role antineoplastic agent (CHEBI:35610) |
| ardisiphenol C (CHEBI:65432) has role antineoplastic agent (CHEBI:35610) |
| arenamide A (CHEBI:65433) has role antineoplastic agent (CHEBI:35610) |
| arenamide B (CHEBI:65434) has role antineoplastic agent (CHEBI:35610) |
| arginine butyrate (CHEBI:759914) has role antineoplastic agent (CHEBI:35610) |
| Arginine hydrochloride (CHEBI:31235) has role antineoplastic agent (CHEBI:35610) |
| arglabin (CHEBI:73228) has role antineoplastic agent (CHEBI:35610) |
| arlocabtagene autoleucel (CHEBI:760346) has role antineoplastic agent (CHEBI:35610) |
| aroplatin (CHEBI:756768) has role antineoplastic agent (CHEBI:35610) |
| arotinoid acid (CHEBI:75261) has role antineoplastic agent (CHEBI:35610) |
| arq-621 (CHEBI:757660) has role antineoplastic agent (CHEBI:35610) |
| arq-736 (CHEBI:759120) has role antineoplastic agent (CHEBI:35610) |
| arry-382 (CHEBI:755670) has role antineoplastic agent (CHEBI:35610) |
| ARS-1620 (CHEBI:193597) has role antineoplastic agent (CHEBI:35610) |
| arsenic trioxide (CHEBI:759843) has role antineoplastic agent (CHEBI:35610) |
| artemether (CHEBI:195280) has role antineoplastic agent (CHEBI:35610) |
| artesunate (CHEBI:63918) has role antineoplastic agent (CHEBI:35610) |
| artocarpin (CHEBI:65439) has role antineoplastic agent (CHEBI:35610) |
| artochamin C (CHEBI:65440) has role antineoplastic agent (CHEBI:35610) |
| artoindonesianin E1 (CHEBI:65441) has role antineoplastic agent (CHEBI:35610) |
| artoindonesianin P (CHEBI:65442) has role antineoplastic agent (CHEBI:35610) |
| arzoxifene (CHEBI:748781) has role antineoplastic agent (CHEBI:35610) |
| arzoxifene hydrochloride (CHEBI:751710) has role antineoplastic agent (CHEBI:35610) |
| as-1409 (CHEBI:754216) has role antineoplastic agent (CHEBI:35610) |
| as-703988 (CHEBI:755536) has role antineoplastic agent (CHEBI:35610) |
| AS-I-145 (CHEBI:82669) has role antineoplastic agent (CHEBI:35610) |
| AS1842856 (CHEBI:145800) has role antineoplastic agent (CHEBI:35610) |
| asandeutertinib (CHEBI:759926) has role antineoplastic agent (CHEBI:35610) |
| asaretoclax (CHEBI:759859) has role antineoplastic agent (CHEBI:35610) |
| asciminib (CHEBI:756638) has role antineoplastic agent (CHEBI:35610) |
| asciminib hydrochloride (CHEBI:756726) has role antineoplastic agent (CHEBI:35610) |
| ascochlorin (CHEBI:156219) has role antineoplastic agent (CHEBI:35610) |
| ascofuranone (CHEBI:156148) has role antineoplastic agent (CHEBI:35610) |
| ascrinvacumab (CHEBI:754143) has role antineoplastic agent (CHEBI:35610) |
| asg-5me (CHEBI:754334) has role antineoplastic agent (CHEBI:35610) |
| asiaticoside (CHEBI:79928) has role antineoplastic agent (CHEBI:35610) |
| ask-120067 (CHEBI:760444) has role antineoplastic agent (CHEBI:35610) |
| aslan-003 (CHEBI:754932) has role antineoplastic agent (CHEBI:35610) |
| asoprisnil (CHEBI:748849) has role antineoplastic agent (CHEBI:35610) |
| asp-1948 (CHEBI:758330) has role antineoplastic agent (CHEBI:35610) |
| asp-1951 (CHEBI:758331) has role antineoplastic agent (CHEBI:35610) |
| ASP-3026 (CHEBI:167650) has role antineoplastic agent (CHEBI:35610) |
| asp-5878 (CHEBI:757916) has role antineoplastic agent (CHEBI:35610) |
| asp-8374 (CHEBI:757332) has role antineoplastic agent (CHEBI:35610) |
| asp-9521 (CHEBI:757698) has role antineoplastic agent (CHEBI:35610) |
| aspacytarabine (CHEBI:757073) has role antineoplastic agent (CHEBI:35610) |
| aspacytarabine hydrochloride (CHEBI:758557) has role antineoplastic agent (CHEBI:35610) |
| asparaginase (CHEBI:753896) has role antineoplastic agent (CHEBI:35610) |
| asparaginase erwinia chrysanthemi (CHEBI:750222) has role antineoplastic agent (CHEBI:35610) |
| asperfuranone (CHEBI:64397) has role antineoplastic agent (CHEBI:35610) |
| aspergillide A (CHEBI:65450) has role antineoplastic agent (CHEBI:35610) |
| aspergillide B (CHEBI:65451) has role antineoplastic agent (CHEBI:35610) |
| aspergillide C (CHEBI:65452) has role antineoplastic agent (CHEBI:35610) |
| asperphenamate (CHEBI:145105) has role antineoplastic agent (CHEBI:35610) |
| asprellic acid A (CHEBI:65455) has role antineoplastic agent (CHEBI:35610) |
| asprellic acid C (CHEBI:65456) has role antineoplastic agent (CHEBI:35610) |
| astuprotimut-r (CHEBI:753649) has role antineoplastic agent (CHEBI:35610) |
| astx-660 (CHEBI:756626) has role antineoplastic agent (CHEBI:35610) |
| asukamycin (CHEBI:73481) has role antineoplastic agent (CHEBI:35610) |
| asunercept (CHEBI:757324) has role antineoplastic agent (CHEBI:35610) |
| at-13148 (CHEBI:755391) has role antineoplastic agent (CHEBI:35610) |
| AT7867 (CHEBI:82708) has role antineoplastic agent (CHEBI:35610) |
| AT9283 (CHEBI:125514) has role antineoplastic agent (CHEBI:35610) |
| atamestane (CHEBI:751732) has role antineoplastic agent (CHEBI:35610) |
| atamparib (CHEBI:758629) has role antineoplastic agent (CHEBI:35610) |
| atazanavir (CHEBI:37924) has role antineoplastic agent (CHEBI:35610) |
| ateganosine (CHEBI:755237) has role antineoplastic agent (CHEBI:35610) |
| atenastobart (CHEBI:760124) has role antineoplastic agent (CHEBI:35610) |
| atenolol (CHEBI:2904) has role antineoplastic agent (CHEBI:35610) |
| atezolizumab (CHEBI:755740) has role antineoplastic agent (CHEBI:35610) |
| atigotatug (CHEBI:760009) has role antineoplastic agent (CHEBI:35610) |
| atiprimod (CHEBI:748431) has role antineoplastic agent (CHEBI:35610) |
| atirmociclib (CHEBI:747454) has role antineoplastic agent (CHEBI:35610) |
| atn-161 (CHEBI:756942) has role antineoplastic agent (CHEBI:35610) |
| atomoxetine (CHEBI:127342) has role antineoplastic agent (CHEBI:35610) |
| atorvastatin (CHEBI:39548) has role antineoplastic agent (CHEBI:35610) |
| atorvastatin calcium (CHEBI:50686) has role antineoplastic agent (CHEBI:35610) |
| atovaquone (CHEBI:575568) has role antineoplastic agent (CHEBI:35610) |
| atrasentan hydrochloride (CHEBI:751785) has role antineoplastic agent (CHEBI:35610) |
| atromentin (CHEBI:149660) has role antineoplastic agent (CHEBI:35610) |
| atropine (CHEBI:16684) has role antineoplastic agent (CHEBI:35610) |
| atsm copper (ii) (CHEBI:756864) has role antineoplastic agent (CHEBI:35610) |
| atu-027 (CHEBI:757333) has role antineoplastic agent (CHEBI:35610) |
| atuveciclib (CHEBI:757673) has role antineoplastic agent (CHEBI:35610) |
| aumolertinib (CHEBI:758431) has role antineoplastic agent (CHEBI:35610) |
| aumolertinib mesylate (CHEBI:759052) has role antineoplastic agent (CHEBI:35610) |
| auranofin (CHEBI:2922) has role antineoplastic agent (CHEBI:35610) |
| auraptene (CHEBI:134355) has role antineoplastic agent (CHEBI:35610) |
| aureothin (CHEBI:80024) has role antineoplastic agent (CHEBI:35610) |
| aus-131 (CHEBI:748719) has role antineoplastic agent (CHEBI:35610) |
| austocystin D (CHEBI:67827) has role antineoplastic agent (CHEBI:35610) |
| autogene cevumeran (CHEBI:758268) has role antineoplastic agent (CHEBI:35610) |
| autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous cd54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (CHEBI:759750) has role antineoplastic agent (CHEBI:35610) |
| av-203 (CHEBI:754210) has role antineoplastic agent (CHEBI:35610) |
| av-412 (CHEBI:759906) has role antineoplastic agent (CHEBI:35610) |
| avadomide (CHEBI:756423) has role antineoplastic agent (CHEBI:35610) |
| avanbulin (CHEBI:755358) has role antineoplastic agent (CHEBI:35610) |
| avapritinib (CHEBI:756628) has role antineoplastic agent (CHEBI:35610) |
| avasopasem manganese (CHEBI:757387) has role antineoplastic agent (CHEBI:35610) |
| avdoralimab (CHEBI:757944) has role antineoplastic agent (CHEBI:35610) |
| ave-9633 (CHEBI:754130) has role antineoplastic agent (CHEBI:35610) |
| avelumab (CHEBI:755952) has role antineoplastic agent (CHEBI:35610) |
| avenanthramide B (CHEBI:167489) has role antineoplastic agent (CHEBI:35610) |
| avid-200 (CHEBI:758001) has role antineoplastic agent (CHEBI:35610) |
| aviscumine (CHEBI:753179) has role antineoplastic agent (CHEBI:35610) |
| avitotamig (CHEBI:760347) has role antineoplastic agent (CHEBI:35610) |
| avn-944 (CHEBI:755334) has role antineoplastic agent (CHEBI:35610) |
| avobenzone (CHEBI:134751) has role antineoplastic agent (CHEBI:35610) |
| avotaciclib (CHEBI:758226) has role antineoplastic agent (CHEBI:35610) |
| avutometinib potassium (CHEBI:755244) has role antineoplastic agent (CHEBI:35610) |
| axatilimab (CHEBI:758080) has role antineoplastic agent (CHEBI:35610) |
| axicabtagene ciloleucel (CHEBI:756472) has role antineoplastic agent (CHEBI:35610) |
| axitinib (CHEBI:66910) has role antineoplastic agent (CHEBI:35610) |
| axp-107-11 (CHEBI:755520) has role antineoplastic agent (CHEBI:35610) |
| AZ505 (CHEBI:228259) has role antineoplastic agent (CHEBI:35610) |
| azadirone (CHEBI:76293) has role antineoplastic agent (CHEBI:35610) |
| azaserine (CHEBI:74846) has role antineoplastic agent (CHEBI:35610) |
| azathioprine (CHEBI:2948) has role antineoplastic agent (CHEBI:35610) |
| azd-0156 (CHEBI:757336) has role antineoplastic agent (CHEBI:35610) |
| azd-0424 (CHEBI:759121) has role antineoplastic agent (CHEBI:35610) |
| AZD-1152 (CHEBI:91367) has role antineoplastic agent (CHEBI:35610) |
| azd-1208 (CHEBI:755633) has role antineoplastic agent (CHEBI:35610) |
| azd-1390 (CHEBI:757917) has role antineoplastic agent (CHEBI:35610) |
| azd-1480 (CHEBI:749656) has role antineoplastic agent (CHEBI:35610) |
| azd-3759 (CHEBI:755663) has role antineoplastic agent (CHEBI:35610) |
| azd-4877 (CHEBI:750217) has role antineoplastic agent (CHEBI:35610) |
| azd-5312 (CHEBI:757338) has role antineoplastic agent (CHEBI:35610) |
| azd-5991 (CHEBI:756968) has role antineoplastic agent (CHEBI:35610) |
| azd-6918 (CHEBI:755559) has role antineoplastic agent (CHEBI:35610) |
| azd-7451 (CHEBI:755686) has role antineoplastic agent (CHEBI:35610) |
| azd-7648 (CHEBI:757672) has role antineoplastic agent (CHEBI:35610) |
| AZD-8055 (CHEBI:91329) has role antineoplastic agent (CHEBI:35610) |
| AZD-8835 (CHEBI:234357) has role antineoplastic agent (CHEBI:35610) |
| azd-9496 (CHEBI:755662) has role antineoplastic agent (CHEBI:35610) |
| azd-9574 (CHEBI:758800) has role antineoplastic agent (CHEBI:35610) |
| AZD1080 (CHEBI:167651) has role antineoplastic agent (CHEBI:35610) |
| azd2461 (CHEBI:756600) has role antineoplastic agent (CHEBI:35610) |
| AZD2858 (CHEBI:167652) has role antineoplastic agent (CHEBI:35610) |
| AZD3463 (CHEBI:167653) has role antineoplastic agent (CHEBI:35610) |
| azd3514 (CHEBI:754955) has role antineoplastic agent (CHEBI:35610) |
| AZD3965 (CHEBI:234329) has role antineoplastic agent (CHEBI:35610) |
| AZD4547 (CHEBI:63453) has role antineoplastic agent (CHEBI:35610) |
| AZD4573 (CHEBI:233359) has role antineoplastic agent (CHEBI:35610) |
| AZD5153 (CHEBI:231674) has role antineoplastic agent (CHEBI:35610) |
| AZD7762 (CHEBI:131156) has role antineoplastic agent (CHEBI:35610) |
| AZD8186 (CHEBI:234358) has role antineoplastic agent (CHEBI:35610) |
| azeliragon (CHEBI:756419) has role antineoplastic agent (CHEBI:35610) |
| azenosertib (CHEBI:758622) has role antineoplastic agent (CHEBI:35610) |
| azercabtagene zapreleucel (CHEBI:759034) has role antineoplastic agent (CHEBI:35610) |
| azerutamig (CHEBI:760125) has role antineoplastic agent (CHEBI:35610) |
| azintuxizumab vedotin (CHEBI:757300) has role antineoplastic agent (CHEBI:35610) |
| azirkitug (CHEBI:760010) has role antineoplastic agent (CHEBI:35610) |
| azithromycin (CHEBI:2955) has role antineoplastic agent (CHEBI:35610) |
| AZT-1152 (CHEBI:167636) has role antineoplastic agent (CHEBI:35610) |
| b-AP15 (CHEBI:229606) has role antineoplastic agent (CHEBI:35610) |
| baclofen (CHEBI:2972) has role antineoplastic agent (CHEBI:35610) |
| Bafetinib (CHEBI:197107) has role antineoplastic agent (CHEBI:35610) |
| bafisontamab (CHEBI:757952) has role antineoplastic agent (CHEBI:35610) |
| baicalein (CHEBI:2979) has role antineoplastic agent (CHEBI:35610) |
| baicalin (CHEBI:2981) has role antineoplastic agent (CHEBI:35610) |
| balixafortide (CHEBI:758453) has role antineoplastic agent (CHEBI:35610) |
| baloramotide (CHEBI:757502) has role antineoplastic agent (CHEBI:35610) |
| balstilimab (CHEBI:757315) has role antineoplastic agent (CHEBI:35610) |
| baltaleucel-t (CHEBI:756485) has role antineoplastic agent (CHEBI:35610) |
| balugrastim (CHEBI:753526) has role antineoplastic agent (CHEBI:35610) |
| BAM15 (CHEBI:233585) has role antineoplastic agent (CHEBI:35610) |
| Bardoxolone methyl (CHEBI:177406) has role antineoplastic agent (CHEBI:35610) |
| barecetamab (CHEBI:758362) has role antineoplastic agent (CHEBI:35610) |
| basiliximab (CHEBI:63583) has role antineoplastic agent (CHEBI:35610) |
| basiliximab sarotalocan (CHEBI:759419) has role antineoplastic agent (CHEBI:35610) |
| basroparib (CHEBI:758675) has role antineoplastic agent (CHEBI:35610) |
| bassianolide (CHEBI:145108) has role antineoplastic agent (CHEBI:35610) |
| batabulin (CHEBI:748359) has role antineoplastic agent (CHEBI:35610) |
| batabulin sodium (CHEBI:751679) has role antineoplastic agent (CHEBI:35610) |
| batimastat (CHEBI:195398) has role antineoplastic agent (CHEBI:35610) |
| batiraxcept (CHEBI:757943) has role antineoplastic agent (CHEBI:35610) |
| batoprotafib (CHEBI:758398) has role antineoplastic agent (CHEBI:35610) |
| bavdegalutamide (CHEBI:758590) has role antineoplastic agent (CHEBI:35610) |
| bavituximab (CHEBI:750069) has role antineoplastic agent (CHEBI:35610) |
| bavunalimab (CHEBI:759014) has role antineoplastic agent (CHEBI:35610) |
| bay-1082439 (CHEBI:755672) has role antineoplastic agent (CHEBI:35610) |
| bay-1125976 (CHEBI:758424) has role antineoplastic agent (CHEBI:35610) |
| bay-1161909 (CHEBI:757653) has role antineoplastic agent (CHEBI:35610) |
| bay-1217389 (CHEBI:757679) has role antineoplastic agent (CHEBI:35610) |
| BAY-826 (CHEBI:192483) has role antineoplastic agent (CHEBI:35610) |
| BAY11-7085 (CHEBI:176500) has role antineoplastic agent (CHEBI:35610) |
| bay1436032 (CHEBI:756632) has role antineoplastic agent (CHEBI:35610) |
| bazedoxifene (CHEBI:135947) has role antineoplastic agent (CHEBI:35610) |
| bazlitoran (CHEBI:757422) has role antineoplastic agent (CHEBI:35610) |
| bb-1701 (CHEBI:759668) has role antineoplastic agent (CHEBI:35610) |
| bbp-398 (CHEBI:759860) has role antineoplastic agent (CHEBI:35610) |
| bcg vaccine (CHEBI:753821) has role antineoplastic agent (CHEBI:35610) |
| BCI-215 (CHEBI:143128) has role antineoplastic agent (CHEBI:35610) |
| BDA-366 (CHEBI:86325) has role antineoplastic agent (CHEBI:35610) |
| BE-54238A (CHEBI:65475) has role antineoplastic agent (CHEBI:35610) |
| BE-54238B (CHEBI:65476) has role antineoplastic agent (CHEBI:35610) |
| beauvericin (CHEBI:3000) has role antineoplastic agent (CHEBI:35610) |
| becatecarin (CHEBI:752560) has role antineoplastic agent (CHEBI:35610) |
| beclanorsen (CHEBI:760529) has role antineoplastic agent (CHEBI:35610) |
| beclomethasone dipropionate (CHEBI:3002) has role antineoplastic agent (CHEBI:35610) |
| becotatug (CHEBI:758363) has role antineoplastic agent (CHEBI:35610) |
| becotatug vedotin (CHEBI:760127) has role antineoplastic agent (CHEBI:35610) |
| befotertinib (CHEBI:758750) has role antineoplastic agent (CHEBI:35610) |
| belacabnagene franleucel (CHEBI:760011) has role antineoplastic agent (CHEBI:35610) |
| belagenpumatucel-l (CHEBI:753531) has role antineoplastic agent (CHEBI:35610) |
| belantamab (CHEBI:757614) has role antineoplastic agent (CHEBI:35610) |
| belantamab mafodotin (CHEBI:757615) has role antineoplastic agent (CHEBI:35610) |
| belapectin (CHEBI:757052) has role antineoplastic agent (CHEBI:35610) |
| belimumab (CHEBI:750192) has role antineoplastic agent (CHEBI:35610) |
| belinostat (CHEBI:61076) has role antineoplastic agent (CHEBI:35610) |
| belladonna (CHEBI:753822) has role antineoplastic agent (CHEBI:35610) |
| belotecan (CHEBI:135702) has role antineoplastic agent (CHEBI:35610) |
| belotecan hydrochloride (CHEBI:752561) has role antineoplastic agent (CHEBI:35610) |
| belrestotug (CHEBI:758518) has role antineoplastic agent (CHEBI:35610) |
| belumosudil (CHEBI:750359) has role antineoplastic agent (CHEBI:35610) |
| belvarafenib (CHEBI:756021) has role antineoplastic agent (CHEBI:35610) |
| belzupacap sarotalocan (CHEBI:758507) has role antineoplastic agent (CHEBI:35610) |
| belzutifan (CHEBI:757730) has role antineoplastic agent (CHEBI:35610) |
| bemarituzumab (CHEBI:758486) has role antineoplastic agent (CHEBI:35610) |
| bemcentinib (CHEBI:755891) has role antineoplastic agent (CHEBI:35610) |
| bemiparin (CHEBI:755829) has role antineoplastic agent (CHEBI:35610) |
| bempegaldesleukin (CHEBI:757481) has role antineoplastic agent (CHEBI:35610) |
| bendamustine (CHEBI:135515) has role antineoplastic agent (CHEBI:35610) |
| bendamustine dodecyl ester (CHEBI:756913) has role antineoplastic agent (CHEBI:35610) |
| bendamustine hydrochloride (CHEBI:749587) has role antineoplastic agent (CHEBI:35610) |
| benmelstobart (CHEBI:759730) has role antineoplastic agent (CHEBI:35610) |
| benralizumab (CHEBI:750071) has role antineoplastic agent (CHEBI:35610) |
| benzylpenicillin potassium (CHEBI:7963) has role antineoplastic agent (CHEBI:35610) |
| berberine (CHEBI:16118) has role antineoplastic agent (CHEBI:35610) |
| berkeleydione (CHEBI:69021) has role antineoplastic agent (CHEBI:35610) |
| bermekimab (CHEBI:754385) has role antineoplastic agent (CHEBI:35610) |
| beroterkib (CHEBI:759911) has role antineoplastic agent (CHEBI:35610) |
| berubicin (CHEBI:754418) has role antineoplastic agent (CHEBI:35610) |
| berubicin hydrochloride (CHEBI:750469) has role antineoplastic agent (CHEBI:35610) |
| bestatin (CHEBI:3070) has role antineoplastic agent (CHEBI:35610) |
| bestatin hydrochloride (CHEBI:180575) has role antineoplastic agent (CHEBI:35610) |
| besvatresgene autoleucel (CHEBI:759421) has role antineoplastic agent (CHEBI:35610) |
| betamethasone (CHEBI:3077) has role antineoplastic agent (CHEBI:35610) |
| betfisolimab (CHEBI:758692) has role antineoplastic agent (CHEBI:35610) |
| bethanechol (CHEBI:3084) has role antineoplastic agent (CHEBI:35610) |
| betulin (CHEBI:3086) has role antineoplastic agent (CHEBI:35610) |
| betulinic acid (CHEBI:3087) has role antineoplastic agent (CHEBI:35610) |
| bevacizumab (CHEBI:749495) has role antineoplastic agent (CHEBI:35610) |
| bexarotene (CHEBI:50859) has role antineoplastic agent (CHEBI:35610) |
| bexatamig (CHEBI:760013) has role antineoplastic agent (CHEBI:35610) |
| bexirestrant (CHEBI:758642) has role antineoplastic agent (CHEBI:35610) |
| bexmarilimab (CHEBI:758017) has role antineoplastic agent (CHEBI:35610) |
| bezafibrate (CHEBI:47612) has role antineoplastic agent (CHEBI:35610) |
| bezetabart (CHEBI:759504) has role antineoplastic agent (CHEBI:35610) |
| bezetabart debotansine (CHEBI:759505) has role antineoplastic agent (CHEBI:35610) |
| bezuclastinib (CHEBI:758806) has role antineoplastic agent (CHEBI:35610) |
| BF 4 (CHEBI:65488) has role antineoplastic agent (CHEBI:35610) |
| BF 5 (CHEBI:65489) has role antineoplastic agent (CHEBI:35610) |
| BF 6 (CHEBI:65490) has role antineoplastic agent (CHEBI:35610) |
| BGC 945 (CHEBI:190251) has role antineoplastic agent (CHEBI:35610) |
| BGJ-398 (CHEBI:63451) has role antineoplastic agent (CHEBI:35610) |
| BGT226 (CHEBI:71953) has role antineoplastic agent (CHEBI:35610) |
| BGT226 free base (CHEBI:71967) has role antineoplastic agent (CHEBI:35610) |
| bhq-880 (CHEBI:754198) has role antineoplastic agent (CHEBI:35610) |
| bi-1206 (CHEBI:757946) has role antineoplastic agent (CHEBI:35610) |
| BI-2536 (CHEBI:49868) has role antineoplastic agent (CHEBI:35610) |
| BI-3406 (CHEBI:746963) has role antineoplastic agent (CHEBI:35610) |
| BI-4020 (CHEBI:232716) has role antineoplastic agent (CHEBI:35610) |
| bi-505 (CHEBI:754268) has role antineoplastic agent (CHEBI:35610) |
| bi-811283 (CHEBI:755617) has role antineoplastic agent (CHEBI:35610) |
| bi-836826 (CHEBI:758005) has role antineoplastic agent (CHEBI:35610) |
| bianfugenine (CHEBI:132719) has role antineoplastic agent (CHEBI:35610) |
| bicalutamide (CHEBI:3090) has role antineoplastic agent (CHEBI:35610) |
| bielschowskysin (CHEBI:65497) has role antineoplastic agent (CHEBI:35610) |
| bifidobacterium spp. (CHEBI:757348) has role antineoplastic agent (CHEBI:35610) |
| bigelovin (CHEBI:69337) has role antineoplastic agent (CHEBI:35610) |
| biib-015 (CHEBI:754335) has role antineoplastic agent (CHEBI:35610) |
| biib-022 (CHEBI:754181) has role antineoplastic agent (CHEBI:35610) |
| biib-028 (CHEBI:756852) has role antineoplastic agent (CHEBI:35610) |
| BIIB021 (CHEBI:90687) has role antineoplastic agent (CHEBI:35610) |
| bimiralisib (CHEBI:756587) has role antineoplastic agent (CHEBI:35610) |
| binimetinib (CHEBI:145371) has role antineoplastic agent (CHEBI:35610) |
| bintrafusp alfa (CHEBI:757448) has role antineoplastic agent (CHEBI:35610) |
| bio-11006 (CHEBI:757156) has role antineoplastic agent (CHEBI:35610) |
| biochanin A (CHEBI:17574) has role antineoplastic agent (CHEBI:35610) |
| biphenyl-4-ylacetic acid (CHEBI:31597) has role antineoplastic agent (CHEBI:35610) |
| biricodar dicitrate (CHEBI:750820) has role antineoplastic agent (CHEBI:35610) |
| Birinapant (CHEBI:177705) has role antineoplastic agent (CHEBI:35610) |
| biropepimut-s (CHEBI:756486) has role antineoplastic agent (CHEBI:35610) |
| bis(S-citronellalthiosemicarbazonato)nickel(II) (CHEBI:156433) has role antineoplastic agent (CHEBI:35610) |
| bisantrene (CHEBI:88337) has role antineoplastic agent (CHEBI:35610) |
| bismuth subcitrate (CHEBI:750171) has role antineoplastic agent (CHEBI:35610) |
| bismuth subsalicylate (CHEBI:261649) has role antineoplastic agent (CHEBI:35610) |
| bisoprolol (CHEBI:3127) has role antineoplastic agent (CHEBI:35610) |
| bisthianostat (CHEBI:755250) has role antineoplastic agent (CHEBI:35610) |
| bistratamide E (CHEBI:65504) has role antineoplastic agent (CHEBI:35610) |
| bistratamide F (CHEBI:65505) has role antineoplastic agent (CHEBI:35610) |
| bistratamide G (CHEBI:65506) has role antineoplastic agent (CHEBI:35610) |
| bistratamide H (CHEBI:65507) has role antineoplastic agent (CHEBI:35610) |
| bistratamide I (CHEBI:65508) has role antineoplastic agent (CHEBI:35610) |
| bistratamide J (CHEBI:65509) has role antineoplastic agent (CHEBI:35610) |
| bivatuzumab (CHEBI:753386) has role antineoplastic agent (CHEBI:35610) |
| biw-8962 (CHEBI:754223) has role antineoplastic agent (CHEBI:35610) |
| bizalimogene ralaplasmid (CHEBI:756753) has role antineoplastic agent (CHEBI:35610) |
| bizaxofusp (CHEBI:757451) has role antineoplastic agent (CHEBI:35610) |
| BKM120 (CHEBI:71954) has role antineoplastic agent (CHEBI:35610) |
| bl22 (CHEBI:754178) has role antineoplastic agent (CHEBI:35610) |
| bleomycin (CHEBI:22907) has role antineoplastic agent (CHEBI:35610) |
| bleomycin A2 (CHEBI:3139) has role antineoplastic agent (CHEBI:35610) |
| bleomycin A5 (CHEBI:78160) has role antineoplastic agent (CHEBI:35610) |
| bleomycin a6 (CHEBI:749657) has role antineoplastic agent (CHEBI:35610) |
| bleomycin B2 (CHEBI:28641) has role antineoplastic agent (CHEBI:35610) |
| bleomycin hydrochloride (CHEBI:78353) has role antineoplastic agent (CHEBI:35610) |
| bleomycin sulfate (CHEBI:34582) has role antineoplastic agent (CHEBI:35610) |
| blinatumomab (CHEBI:750072) has role antineoplastic agent (CHEBI:35610) |
| BML-210 (CHEBI:61077) has role antineoplastic agent (CHEBI:35610) |
| bms-184476 (CHEBI:756771) has role antineoplastic agent (CHEBI:35610) |
| bms-188797 (CHEBI:749144) has role antineoplastic agent (CHEBI:35610) |
| BMS-214662 (CHEBI:167655) has role antineoplastic agent (CHEBI:35610) |
| bms-275183 (CHEBI:756772) has role antineoplastic agent (CHEBI:35610) |
| bms-690514 (CHEBI:755618) has role antineoplastic agent (CHEBI:35610) |
| BMS-754807 (CHEBI:88339) has role antineoplastic agent (CHEBI:35610) |
| bms-813160 (CHEBI:757907) has role antineoplastic agent (CHEBI:35610) |
| bms-817378 (CHEBI:755434) has role antineoplastic agent (CHEBI:35610) |
| bms-833923 (CHEBI:755623) has role antineoplastic agent (CHEBI:35610) |
| bms-911543 (CHEBI:755521) has role antineoplastic agent (CHEBI:35610) |
| bms-986148 (CHEBI:760480) has role antineoplastic agent (CHEBI:35610) |
| bms-986156 (CHEBI:757043) has role antineoplastic agent (CHEBI:35610) |
| bms-986178 (CHEBI:757159) has role antineoplastic agent (CHEBI:35610) |
| bms-986179 (CHEBI:757160) has role antineoplastic agent (CHEBI:35610) |
| bms-986258 (CHEBI:757162) has role antineoplastic agent (CHEBI:35610) |
| bms-986299 (CHEBI:758753) has role antineoplastic agent (CHEBI:35610) |
| bms-986310 (CHEBI:759603) has role antineoplastic agent (CHEBI:35610) |
| BMX-001 (CHEBI:232540) has role antineoplastic agent (CHEBI:35610) |
| BMY-25067 (CHEBI:195316) has role antineoplastic agent (CHEBI:35610) |
| bn-104 (CHEBI:760453) has role antineoplastic agent (CHEBI:35610) |
| bnc-105p (CHEBI:757352) has role antineoplastic agent (CHEBI:35610) |
| bnt-152 mrna (CHEBI:759703) has role antineoplastic agent (CHEBI:35610) |
| bnt-153 mrna (CHEBI:759704) has role antineoplastic agent (CHEBI:35610) |
| bocodepsin (CHEBI:759279) has role antineoplastic agent (CHEBI:35610) |
| bocodepsin besylate (CHEBI:759280) has role antineoplastic agent (CHEBI:35610) |
| boditrectinib (CHEBI:759161) has role antineoplastic agent (CHEBI:35610) |
| bomedemstat (CHEBI:756789) has role antineoplastic agent (CHEBI:35610) |
| bomedemstat tosylate (CHEBI:758969) has role antineoplastic agent (CHEBI:35610) |
| borrelidin (CHEBI:78661) has role antineoplastic agent (CHEBI:35610) |
| bortezomib (CHEBI:52717) has role antineoplastic agent (CHEBI:35610) |
| bortezomib d-mannitol (CHEBI:759801) has role antineoplastic agent (CHEBI:35610) |
| bos-172722 (CHEBI:755987) has role antineoplastic agent (CHEBI:35610) |
| bosentan (CHEBI:51450) has role antineoplastic agent (CHEBI:35610) |
| boserolimab (CHEBI:758931) has role antineoplastic agent (CHEBI:35610) |
| bosmolisib (CHEBI:759962) has role antineoplastic agent (CHEBI:35610) |
| bosutinib (CHEBI:39112) has role antineoplastic agent (CHEBI:35610) |
| bosutinib hydrate (CHEBI:68533) has role antineoplastic agent (CHEBI:35610) |
| botensilimab (CHEBI:758321) has role antineoplastic agent (CHEBI:35610) |
| bouvardin (CHEBI:233285) has role antineoplastic agent (CHEBI:35610) |
| bowdichione (CHEBI:3162) has role antineoplastic agent (CHEBI:35610) |
| BPDZ 711 (CHEBI:138512) has role antineoplastic agent (CHEBI:35610) |
| bpi-9016 (CHEBI:755531) has role antineoplastic agent (CHEBI:35610) |
| branebrutinib (CHEBI:757132) has role antineoplastic agent (CHEBI:35610) |
| brasilicardin A (CHEBI:65513) has role antineoplastic agent (CHEBI:35610) |
| brasiliquinone A (CHEBI:65516) has role antineoplastic agent (CHEBI:35610) |
| brasiliquinone B (CHEBI:65517) has role antineoplastic agent (CHEBI:35610) |
| brasiliquinone C (CHEBI:65518) has role antineoplastic agent (CHEBI:35610) |
| brasixanthone B (CHEBI:65519) has role antineoplastic agent (CHEBI:35610) |
| brasixanthone C (CHEBI:65520) has role antineoplastic agent (CHEBI:35610) |
| brasixanthone D (CHEBI:65521) has role antineoplastic agent (CHEBI:35610) |
| brazilein (CHEBI:69196) has role antineoplastic agent (CHEBI:35610) |
| brazilin (CHEBI:3170) has role antineoplastic agent (CHEBI:35610) |
| brenetafusp (CHEBI:759424) has role antineoplastic agent (CHEBI:35610) |
| brentuximab vedotin (CHEBI:750074) has role antineoplastic agent (CHEBI:35610) |
| brequinar (CHEBI:177387) has role antineoplastic agent (CHEBI:35610) |
| brequinar sodium (CHEBI:177871) has role antineoplastic agent (CHEBI:35610) |
| brevipolide A (CHEBI:65522) has role antineoplastic agent (CHEBI:35610) |
| brevipolide B (CHEBI:65523) has role antineoplastic agent (CHEBI:35610) |
| brexucabtagene autoleucel (CHEBI:758090) has role antineoplastic agent (CHEBI:35610) |
| breynceanothanolic acid (CHEBI:67583) has role antineoplastic agent (CHEBI:35610) |
| briciclib (CHEBI:749626) has role antineoplastic agent (CHEBI:35610) |
| briciclib sodium (CHEBI:755138) has role antineoplastic agent (CHEBI:35610) |
| brigatinib (CHEBI:232810) has role antineoplastic agent (CHEBI:35610) |
| brigimadlin (CHEBI:759162) has role antineoplastic agent (CHEBI:35610) |
| brilanestrant (CHEBI:755644) has role antineoplastic agent (CHEBI:35610) |
| brimarafenib (CHEBI:759861) has role antineoplastic agent (CHEBI:35610) |
| briquilimab (CHEBI:758693) has role antineoplastic agent (CHEBI:35610) |
| brivanib (CHEBI:167686) has role antineoplastic agent (CHEBI:35610) |
| brivanib alaninate (CHEBI:167656) has role antineoplastic agent (CHEBI:35610) |
| brivaracetam (CHEBI:133013) has role antineoplastic agent (CHEBI:35610) |
| brivestobart (CHEBI:760131) has role antineoplastic agent (CHEBI:35610) |
| brivudine (CHEBI:47278) has role antineoplastic agent (CHEBI:35610) |
| bromelains (CHEBI:753928) has role antineoplastic agent (CHEBI:35610) |
| bromocriptine methanesulfonate (CHEBI:3182) has role antineoplastic agent (CHEBI:35610) |
| bromophycolide A (CHEBI:65525) has role antineoplastic agent (CHEBI:35610) |
| bromotopsentin (CHEBI:144088) has role antineoplastic agent (CHEBI:35610) |
| brontictuzumab (CHEBI:755546) has role antineoplastic agent (CHEBI:35610) |
| brostallicin (CHEBI:749200) has role antineoplastic agent (CHEBI:35610) |
| bruceanol D (CHEBI:65526) has role antineoplastic agent (CHEBI:35610) |
| bruceanol E (CHEBI:65527) has role antineoplastic agent (CHEBI:35610) |
| bruceanol F (CHEBI:65528) has role antineoplastic agent (CHEBI:35610) |
| bruceine D (CHEBI:68931) has role antineoplastic agent (CHEBI:35610) |
| bruceolide (CHEBI:65529) has role antineoplastic agent (CHEBI:35610) |
| bryostatin 1 (CHEBI:88353) has role antineoplastic agent (CHEBI:35610) |
| bryostatin 2 (CHEBI:139177) has role antineoplastic agent (CHEBI:35610) |
| bt-5528 (CHEBI:759644) has role antineoplastic agent (CHEBI:35610) |
| btx-a51 (CHEBI:758427) has role antineoplastic agent (CHEBI:35610) |
| budesonide (CHEBI:3207) has role antineoplastic agent (CHEBI:35610) |
| budigalimab (CHEBI:757299) has role antineoplastic agent (CHEBI:35610) |
| bufalin (CHEBI:517248) has role antineoplastic agent (CHEBI:35610) |
| buformin (CHEBI:3209) has role antineoplastic agent (CHEBI:35610) |
| bumetanide (CHEBI:3213) has role antineoplastic agent (CHEBI:35610) |
| bupivacaine (CHEBI:3215) has role antineoplastic agent (CHEBI:35610) |
| bupivacaine hydrochloride (CHEBI:749236) has role antineoplastic agent (CHEBI:35610) |
| bupropion (CHEBI:3219) has role antineoplastic agent (CHEBI:35610) |
| Bupropion hydrochloride (CHEBI:3220) has role antineoplastic agent (CHEBI:35610) |
| burixafor (CHEBI:755526) has role antineoplastic agent (CHEBI:35610) |
| burseran (CHEBI:3222) has role antineoplastic agent (CHEBI:35610) |
| buserelin (CHEBI:135907) has role antineoplastic agent (CHEBI:35610) |
| Buserelin acetate (CHEBI:31324) has role antineoplastic agent (CHEBI:35610) |
| busulfan (CHEBI:28901) has role antineoplastic agent (CHEBI:35610) |
| butein (CHEBI:3237) has role antineoplastic agent (CHEBI:35610) |
| buthionine sulfoximine (CHEBI:749712) has role antineoplastic agent (CHEBI:35610) |
| C-1027 chromophore (CHEBI:3252) has role antineoplastic agent (CHEBI:35610) |
| c-188-9 (CHEBI:755346) has role antineoplastic agent (CHEBI:35610) |
| C75 (CHEBI:189865) has role antineoplastic agent (CHEBI:35610) |
| cabazitaxel (CHEBI:63584) has role antineoplastic agent (CHEBI:35610) |
| cabergoline (CHEBI:3286) has role antineoplastic agent (CHEBI:35610) |
| cabiralizumab (CHEBI:757166) has role antineoplastic agent (CHEBI:35610) |
| cabotamig (CHEBI:759508) has role antineoplastic agent (CHEBI:35610) |
| cabozantinib (CHEBI:72317) has role antineoplastic agent (CHEBI:35610) |
| cabozantinib malate (CHEBI:72319) has role antineoplastic agent (CHEBI:35610) |
| cadiyenol (CHEBI:65538) has role antineoplastic agent (CHEBI:35610) |
| cadonilimab (CHEBI:757937) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin A (CHEBI:69231) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin C (CHEBI:69232) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin F (CHEBI:69225) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin G (CHEBI:69226) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin H (CHEBI:69227) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin I (CHEBI:69228) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin J (CHEBI:69229) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin K (CHEBI:69230) has role antineoplastic agent (CHEBI:35610) |
| caerulomycinamide (CHEBI:69233) has role antineoplastic agent (CHEBI:35610) |
| caerulomycinonitrile (CHEBI:69234) has role antineoplastic agent (CHEBI:35610) |
| cafelkibart (CHEBI:760016) has role antineoplastic agent (CHEBI:35610) |
| cafestol (CHEBI:3291) has role antineoplastic agent (CHEBI:35610) |
| caffeine (CHEBI:27732) has role antineoplastic agent (CHEBI:35610) |
| cafusertib (CHEBI:755591) has role antineoplastic agent (CHEBI:35610) |
| cal (CHEBI:754324) has role antineoplastic agent (CHEBI:35610) |
| calaspargase pegol (CHEBI:753666) has role antineoplastic agent (CHEBI:35610) |
| calciol (CHEBI:28940) has role antineoplastic agent (CHEBI:35610) |
| calcipotriol (CHEBI:50749) has role antineoplastic agent (CHEBI:35610) |
| calcitriol (CHEBI:17823) has role antineoplastic agent (CHEBI:35610) |
| calcium carbonate (CHEBI:3311) has role antineoplastic agent (CHEBI:35610) |
| calcium dichloride (CHEBI:3312) has role antineoplastic agent (CHEBI:35610) |
| calcium gluconate (CHEBI:3309) has role antineoplastic agent (CHEBI:35610) |
| calcium(0) (CHEBI:29320) has role antineoplastic agent (CHEBI:35610) |
| calicheamicin γ1I (CHEBI:3319) has role antineoplastic agent (CHEBI:35610) |
| callophycoic acid A (CHEBI:65557) has role antineoplastic agent (CHEBI:35610) |
| callophycoic acid C (CHEBI:65559) has role antineoplastic agent (CHEBI:35610) |
| callophycoic acid D (CHEBI:65560) has role antineoplastic agent (CHEBI:35610) |
| callophycoic acid E (CHEBI:65561) has role antineoplastic agent (CHEBI:35610) |
| callophycoic acid F (CHEBI:65562) has role antineoplastic agent (CHEBI:35610) |
| callophycoic acid G (CHEBI:65563) has role antineoplastic agent (CHEBI:35610) |
| callophycoic acid H (CHEBI:65564) has role antineoplastic agent (CHEBI:35610) |
| callophycol A (CHEBI:65565) has role antineoplastic agent (CHEBI:35610) |
| callophycol B (CHEBI:65566) has role antineoplastic agent (CHEBI:35610) |
| calotatug (CHEBI:760017) has role antineoplastic agent (CHEBI:35610) |
| calotatug ginistinag (CHEBI:760018) has role antineoplastic agent (CHEBI:35610) |
| calotropone (CHEBI:65568) has role antineoplastic agent (CHEBI:35610) |
| cambritaxestat (CHEBI:755985) has role antineoplastic agent (CHEBI:35610) |
| camidanlumab tesirine (CHEBI:757310) has role antineoplastic agent (CHEBI:35610) |
| camonsertib (CHEBI:229722) has role antineoplastic agent (CHEBI:35610) |
| camostat (CHEBI:135632) has role antineoplastic agent (CHEBI:35610) |
| camostat mesylate (CHEBI:31347) has role antineoplastic agent (CHEBI:35610) |
| camoteskimab (CHEBI:754354) has role antineoplastic agent (CHEBI:35610) |
| camptothecin (CHEBI:27656) has role antineoplastic agent (CHEBI:35610) |
| camptothecin-20-o-propionate (CHEBI:748508) has role antineoplastic agent (CHEBI:35610) |
| camrelizumab (CHEBI:757168) has role antineoplastic agent (CHEBI:35610) |
| camsirubicin (CHEBI:758756) has role antineoplastic agent (CHEBI:35610) |
| CAN-508 (CHEBI:42356) has role antineoplastic agent (CHEBI:35610) |
| canakinumab (CHEBI:749608) has role antineoplastic agent (CHEBI:35610) |
| Candesartan cilexetil (CHEBI:3348) has role antineoplastic agent (CHEBI:35610) |
| canerpaturev (CHEBI:756732) has role antineoplastic agent (CHEBI:35610) |
| canertinib (CHEBI:61399) has role antineoplastic agent (CHEBI:35610) |
| canertinib dihydrochloride (CHEBI:749032) has role antineoplastic agent (CHEBI:35610) |
| canfosfamide hydrochloride (CHEBI:752564) has role antineoplastic agent (CHEBI:35610) |
| canlitinib (CHEBI:759214) has role antineoplastic agent (CHEBI:35610) |
| Cannabinol (CHEBI:3360) has role antineoplastic agent (CHEBI:35610) |
| cantuzumab ravtansine (CHEBI:750078) has role antineoplastic agent (CHEBI:35610) |
| capecitabine (CHEBI:31348) has role antineoplastic agent (CHEBI:35610) |
| capilliposide B (CHEBI:65574) has role antineoplastic agent (CHEBI:35610) |
| capivasertib (CHEBI:229222) has role antineoplastic agent (CHEBI:35610) |
| capmatinib (CHEBI:231693) has role antineoplastic agent (CHEBI:35610) |
| capmatinib hydrochloride (CHEBI:756426) has role antineoplastic agent (CHEBI:35610) |
| capsaicin (CHEBI:3374) has role antineoplastic agent (CHEBI:35610) |
| captopril (CHEBI:3380) has role antineoplastic agent (CHEBI:35610) |
| carbendazim (CHEBI:3392) has role antineoplastic agent (CHEBI:35610) |
| carbetocin (CHEBI:59204) has role antineoplastic agent (CHEBI:35610) |
| carbogen (CHEBI:757169) has role antineoplastic agent (CHEBI:35610) |
| carbon atom (CHEBI:27594) has role antineoplastic agent (CHEBI:35610) |
| carbonarone A (CHEBI:69403) has role antineoplastic agent (CHEBI:35610) |
| carbonic acid (CHEBI:28976) has role antineoplastic agent (CHEBI:35610) |
| carboplatin (CHEBI:31355) has role antineoplastic agent (CHEBI:35610) |
| Carboquone (CHEBI:31356) has role antineoplastic agent (CHEBI:35610) |
| carboxyamidotriazole (CHEBI:748414) has role antineoplastic agent (CHEBI:35610) |
| cardivin A (CHEBI:65576) has role antineoplastic agent (CHEBI:35610) |
| cardivin B (CHEBI:65577) has role antineoplastic agent (CHEBI:35610) |
| cardivin C (CHEBI:65578) has role antineoplastic agent (CHEBI:35610) |
| cardivin D (CHEBI:65579) has role antineoplastic agent (CHEBI:35610) |
| carfilzomib (CHEBI:65347) has role antineoplastic agent (CHEBI:35610) |
| caricotamide (CHEBI:750355) has role antineoplastic agent (CHEBI:35610) |
| carlecortemcel-l (CHEBI:752892) has role antineoplastic agent (CHEBI:35610) |
| carlumab (CHEBI:750079) has role antineoplastic agent (CHEBI:35610) |
| carminomycin (CHEBI:31359) has role antineoplastic agent (CHEBI:35610) |
| Carmofur (CHEBI:31360) has role antineoplastic agent (CHEBI:35610) |
| carmustine (CHEBI:3423) has role antineoplastic agent (CHEBI:35610) |
| carnosic acid (CHEBI:65585) has role antineoplastic agent (CHEBI:35610) |
| carnosine (CHEBI:15727) has role antineoplastic agent (CHEBI:35610) |
| carotuximab (CHEBI:754157) has role antineoplastic agent (CHEBI:35610) |
| carrimycin (CHEBI:758276) has role antineoplastic agent (CHEBI:35610) |
| carvedilol (CHEBI:3441) has role antineoplastic agent (CHEBI:35610) |
| casdatifan (CHEBI:760136) has role antineoplastic agent (CHEBI:35610) |
| casdozokitug (CHEBI:759356) has role antineoplastic agent (CHEBI:35610) |
| caseamemebrol A (CHEBI:65586) has role antineoplastic agent (CHEBI:35610) |
| caseamemebrol B (CHEBI:65587) has role antineoplastic agent (CHEBI:35610) |
| caseanigrescen A (CHEBI:65588) has role antineoplastic agent (CHEBI:35610) |
| caseanigrescen B (CHEBI:65589) has role antineoplastic agent (CHEBI:35610) |
| caseanigrescen C (CHEBI:65590) has role antineoplastic agent (CHEBI:35610) |
| caseanigrescen D (CHEBI:65591) has role antineoplastic agent (CHEBI:35610) |
| Casiopeina II-gly (CHEBI:232493) has role antineoplastic agent (CHEBI:35610) |
| catequentinib (CHEBI:757650) has role antineoplastic agent (CHEBI:35610) |
| catequentinib hydrochloride (CHEBI:759268) has role antineoplastic agent (CHEBI:35610) |
| catumaxomab (CHEBI:753535) has role antineoplastic agent (CHEBI:35610) |
| caudatin-3-O-β-cymaropyranoside (CHEBI:65603) has role antineoplastic agent (CHEBI:35610) |
| caxmotabart (CHEBI:760137) has role antineoplastic agent (CHEBI:35610) |
| caxmotabart entudotin (CHEBI:760138) has role antineoplastic agent (CHEBI:35610) |
| CB-103 (CHEBI:232592) has role antineoplastic agent (CHEBI:35610) |
| CBL0137 (CHEBI:138650) has role antineoplastic agent (CHEBI:35610) |
| cbp-501 (CHEBI:756855) has role antineoplastic agent (CHEBI:35610) |
| cbs-9106 (CHEBI:757523) has role antineoplastic agent (CHEBI:35610) |
| cc-11006 (CHEBI:756945) has role antineoplastic agent (CHEBI:35610) |
| cc-115 (CHEBI:755646) has role antineoplastic agent (CHEBI:35610) |
| cc-94676 (CHEBI:758846) has role antineoplastic agent (CHEBI:35610) |
| CCT-018159 (CHEBI:41656) has role antineoplastic agent (CHEBI:35610) |
| CCT251545 (CHEBI:143114) has role antineoplastic agent (CHEBI:35610) |
| cd24fc (CHEBI:757170) has role antineoplastic agent (CHEBI:35610) |
| cd40 ligand (CHEBI:757171) has role antineoplastic agent (CHEBI:35610) |
| CD532 (CHEBI:83432) has role antineoplastic agent (CHEBI:35610) |
| cdc-801 (CHEBI:748393) has role antineoplastic agent (CHEBI:35610) |
| cdx-014 (CHEBI:757172) has role antineoplastic agent (CHEBI:35610) |
| cdx-1140 (CHEBI:757174) has role antineoplastic agent (CHEBI:35610) |
| cdx-301 (CHEBI:758278) has role antineoplastic agent (CHEBI:35610) |
| cdx-3379 (CHEBI:758194) has role antineoplastic agent (CHEBI:35610) |
| cebsulfase alfa (CHEBI:758912) has role antineoplastic agent (CHEBI:35610) |
| cedazuridine (CHEBI:755235) has role antineoplastic agent (CHEBI:35610) |
| cediranib maleate (CHEBI:750471) has role antineoplastic agent (CHEBI:35610) |
| cefazolin (CHEBI:474053) has role antineoplastic agent (CHEBI:35610) |
| cefazolin sodium (CHEBI:3483) has role antineoplastic agent (CHEBI:35610) |
| cefepime (CHEBI:478164) has role antineoplastic agent (CHEBI:35610) |
| cefixime (CHEBI:472657) has role antineoplastic agent (CHEBI:35610) |
| cefmetazole (CHEBI:3489) has role antineoplastic agent (CHEBI:35610) |
| ceftobiprole medocaril sodium (CHEBI:756687) has role antineoplastic agent (CHEBI:35610) |
| ceftriaxone sodium (CHEBI:759887) has role antineoplastic agent (CHEBI:35610) |
| celastrol (CHEBI:63959) has role antineoplastic agent (CHEBI:35610) |
| celebixanthone (CHEBI:65606) has role antineoplastic agent (CHEBI:35610) |
| celecoxib (CHEBI:41423) has role antineoplastic agent (CHEBI:35610) |
| cemacabtagene ansegedleucel (CHEBI:759509) has role antineoplastic agent (CHEBI:35610) |
| cemavafusp (CHEBI:759425) has role antineoplastic agent (CHEBI:35610) |
| cembra-2,7,11-triene-4,6-diol (CHEBI:525464) has role antineoplastic agent (CHEBI:35610) |
| cemiplimab (CHEBI:757176) has role antineoplastic agent (CHEBI:35610) |
| cemsidomide (CHEBI:758804) has role antineoplastic agent (CHEBI:35610) |
| cenersen (CHEBI:753273) has role antineoplastic agent (CHEBI:35610) |
| cenersen sodium (CHEBI:754920) has role antineoplastic agent (CHEBI:35610) |
| cenisertib (CHEBI:750327) has role antineoplastic agent (CHEBI:35610) |
| centaureidin (CHEBI:69356) has role antineoplastic agent (CHEBI:35610) |
| cep-11981 (CHEBI:750369) has role antineoplastic agent (CHEBI:35610) |
| cep-32496 (CHEBI:750385) has role antineoplastic agent (CHEBI:35610) |
| cep-37440 (CHEBI:756008) has role antineoplastic agent (CHEBI:35610) |
| cep-40783 (CHEBI:758392) has role antineoplastic agent (CHEBI:35610) |
| cep-9722 (CHEBI:756947) has role antineoplastic agent (CHEBI:35610) |
| cepeginterferon alfa-2b (CHEBI:753080) has role antineoplastic agent (CHEBI:35610) |
| cerberin (CHEBI:75049) has role antineoplastic agent (CHEBI:35610) |
| cerdulatinib (CHEBI:756610) has role antineoplastic agent (CHEBI:35610) |
| cergutuzumab amunaleukin (CHEBI:756500) has role antineoplastic agent (CHEBI:35610) |
| ceritinib (CHEBI:78432) has role antineoplastic agent (CHEBI:35610) |
| certepetide (CHEBI:759716) has role antineoplastic agent (CHEBI:35610) |
| certociclib (CHEBI:760335) has role antineoplastic agent (CHEBI:35610) |
| certolizumab (CHEBI:757040) has role antineoplastic agent (CHEBI:35610) |
| cesium cs-131 (CHEBI:756857) has role antineoplastic agent (CHEBI:35610) |
| cesnicabtagene autoleucel (CHEBI:760020) has role antineoplastic agent (CHEBI:35610) |
| cetrelimab (CHEBI:757427) has role antineoplastic agent (CHEBI:35610) |
| cetrorelix (CHEBI:59224) has role antineoplastic agent (CHEBI:35610) |
| cetrorelix acetate (CHEBI:31387) has role antineoplastic agent (CHEBI:35610) |
| cetuximab (CHEBI:749550) has role antineoplastic agent (CHEBI:35610) |
| cetuximab beta (CHEBI:760139) has role antineoplastic agent (CHEBI:35610) |
| cetuximab sarotalocan (CHEBI:757507) has role antineoplastic agent (CHEBI:35610) |
| cevipabulin (CHEBI:749185) has role antineoplastic agent (CHEBI:35610) |
| cevostamab (CHEBI:757345) has role antineoplastic agent (CHEBI:35610) |
| cfg-920 (CHEBI:756971) has role antineoplastic agent (CHEBI:35610) |
| cfi-400945 (CHEBI:756948) has role antineoplastic agent (CHEBI:35610) |
| CG-1521 (CHEBI:156510) has role antineoplastic agent (CHEBI:35610) |
| cg-200745 (CHEBI:756858) has role antineoplastic agent (CHEBI:35610) |
| cg250 111in (CHEBI:755771) has role antineoplastic agent (CHEBI:35610) |
| cg250 177lu (CHEBI:755783) has role antineoplastic agent (CHEBI:35610) |
| cgc-11047 (CHEBI:748573) has role antineoplastic agent (CHEBI:35610) |
| cgm-097 (CHEBI:755655) has role antineoplastic agent (CHEBI:35610) |
| CGP-42112A (CHEBI:147302) has role antineoplastic agent (CHEBI:35610) |
| CGS 15943 (CHEBI:131351) has role antineoplastic agent (CHEBI:35610) |
| CH5126766 (CHEBI:78825) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin B (CHEBI:68734) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin D (CHEBI:68807) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin E (CHEBI:68731) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin F (CHEBI:68732) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin G (CHEBI:68813) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin J (CHEBI:68735) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin L (CHEBI:68775) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin Q (CHEBI:68736) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin T (CHEBI:68738) has role antineoplastic agent (CHEBI:35610) |
| chelerythrine (CHEBI:78373) has role antineoplastic agent (CHEBI:35610) |
| chidamide (CHEBI:135918) has role antineoplastic agent (CHEBI:35610) |
| CHIR-265 (CHEBI:91451) has role antineoplastic agent (CHEBI:35610) |
| CHIR-98014 (CHEBI:167657) has role antineoplastic agent (CHEBI:35610) |
| chlorambucil (CHEBI:28830) has role antineoplastic agent (CHEBI:35610) |
| chlorhexidine (CHEBI:3614) has role antineoplastic agent (CHEBI:35610) |
| chlorhexidine gluconate (CHEBI:28312) has role antineoplastic agent (CHEBI:35610) |
| chlorine dioxide (CHEBI:52357) has role antineoplastic agent (CHEBI:35610) |
| chlorogenic acid (CHEBI:16112) has role antineoplastic agent (CHEBI:35610) |
| chlorophyllin copper complex (CHEBI:753834) has role antineoplastic agent (CHEBI:35610) |
| chloroquine (CHEBI:3638) has role antineoplastic agent (CHEBI:35610) |
| chlorotoxin (CHEBI:757536) has role antineoplastic agent (CHEBI:35610) |
| chlorotrianisene (CHEBI:3641) has role antineoplastic agent (CHEBI:35610) |
| chlorphenesin carbamate (CHEBI:3643) has role antineoplastic agent (CHEBI:35610) |
| chlorpromazine (CHEBI:3647) has role antineoplastic agent (CHEBI:35610) |
| chlorsulfaquinoxaline (CHEBI:750252) has role antineoplastic agent (CHEBI:35610) |
| cho-h01 (CHEBI:757178) has role antineoplastic agent (CHEBI:35610) |
| cholesterol (CHEBI:16113) has role antineoplastic agent (CHEBI:35610) |
| cholestyramine (CHEBI:749501) has role antineoplastic agent (CHEBI:35610) |
| choline magnesium trisalicylate (CHEBI:757179) has role antineoplastic agent (CHEBI:35610) |
| chondramide A (CHEBI:84380) has role antineoplastic agent (CHEBI:35610) |
| chondramide B (CHEBI:84381) has role antineoplastic agent (CHEBI:35610) |
| chondramide C (CHEBI:84382) has role antineoplastic agent (CHEBI:35610) |
| chondramide D (CHEBI:84383) has role antineoplastic agent (CHEBI:35610) |
| chondroitin sulfate sodium (CHEBI:753835) has role antineoplastic agent (CHEBI:35610) |
| chrysin (CHEBI:75095) has role antineoplastic agent (CHEBI:35610) |
| chrysosplenol C (CHEBI:3690) has role antineoplastic agent (CHEBI:35610) |
| chs-114 (CHEBI:760482) has role antineoplastic agent (CHEBI:35610) |
| chs-828 (CHEBI:747991) has role antineoplastic agent (CHEBI:35610) |
| chtnt-1 131i (CHEBI:754202) has role antineoplastic agent (CHEBI:35610) |
| CHZ868 (CHEBI:90828) has role antineoplastic agent (CHEBI:35610) |
| cibisatamab (CHEBI:757510) has role antineoplastic agent (CHEBI:35610) |
| cibrigirsen (CHEBI:759512) has role antineoplastic agent (CHEBI:35610) |
| cidofovir anhydrous (CHEBI:3696) has role antineoplastic agent (CHEBI:35610) |
| cidofovir dihydrate (CHEBI:59495) has role antineoplastic agent (CHEBI:35610) |
| ciduvectamig (CHEBI:759358) has role antineoplastic agent (CHEBI:35610) |
| ciforadenant (CHEBI:756704) has role antineoplastic agent (CHEBI:35610) |
| cifurtilimab (CHEBI:758695) has role antineoplastic agent (CHEBI:35610) |
| CIGB-300 (CHEBI:83696) has role antineoplastic agent (CHEBI:35610) |
| ciglitazone (CHEBI:64227) has role antineoplastic agent (CHEBI:35610) |
| cilastatin (CHEBI:3697) has role antineoplastic agent (CHEBI:35610) |
| ciletatug (CHEBI:760140) has role antineoplastic agent (CHEBI:35610) |
| ciletatug vedotin (CHEBI:760141) has role antineoplastic agent (CHEBI:35610) |
| ciliatamide B (CHEBI:65631) has role antineoplastic agent (CHEBI:35610) |
| ciltacabtagene autoleucel (CHEBI:758570) has role antineoplastic agent (CHEBI:35610) |
| cinacalcet hydrochloride (CHEBI:48391) has role antineoplastic agent (CHEBI:35610) |
| cinrebafusp alfa (CHEBI:757260) has role antineoplastic agent (CHEBI:35610) |
| cinsebrutinib (CHEBI:759215) has role antineoplastic agent (CHEBI:35610) |
| cintirorgon (CHEBI:757693) has role antineoplastic agent (CHEBI:35610) |
| cintredekin besudotox (CHEBI:753537) has role antineoplastic agent (CHEBI:35610) |
| ciprofloxacin (CHEBI:100241) has role antineoplastic agent (CHEBI:35610) |
| ciprofloxacin hydrochloride (anhydrous) (CHEBI:310388) has role antineoplastic agent (CHEBI:35610) |
| cirmtuzumab (CHEBI:757180) has role antineoplastic agent (CHEBI:35610) |
| cirsilineol (CHEBI:3718) has role antineoplastic agent (CHEBI:35610) |
| cirtuvivint (CHEBI:758438) has role antineoplastic agent (CHEBI:35610) |
| cisplatin (CHEBI:27899) has role antineoplastic agent (CHEBI:35610) |
| citarinostat (CHEBI:755707) has role antineoplastic agent (CHEBI:35610) |
| citatuzumab bogatox (CHEBI:750080) has role antineoplastic agent (CHEBI:35610) |
| civorebrutinib (CHEBI:759216) has role antineoplastic agent (CHEBI:35610) |
| cixutumumab (CHEBI:750081) has role antineoplastic agent (CHEBI:35610) |
| cizutamig (CHEBI:760142) has role antineoplastic agent (CHEBI:35610) |
| cjm-112 (CHEBI:757360) has role antineoplastic agent (CHEBI:35610) |
| cladoniamide G (CHEBI:65639) has role antineoplastic agent (CHEBI:35610) |
| cladribine (CHEBI:567361) has role antineoplastic agent (CHEBI:35610) |
| claturafenib (CHEBI:760336) has role antineoplastic agent (CHEBI:35610) |
| clavulanic acid (CHEBI:48947) has role antineoplastic agent (CHEBI:35610) |
| clavulone II (CHEBI:34643) has role antineoplastic agent (CHEBI:35610) |
| clemizole (CHEBI:52140) has role antineoplastic agent (CHEBI:35610) |
| clesitamig (CHEBI:760143) has role antineoplastic agent (CHEBI:35610) |
| clethroidoside C (CHEBI:69603) has role antineoplastic agent (CHEBI:35610) |
| clethroidoside D (CHEBI:69604) has role antineoplastic agent (CHEBI:35610) |
| clethroidoside F (CHEBI:69606) has role antineoplastic agent (CHEBI:35610) |
| clionastatin A (CHEBI:65644) has role antineoplastic agent (CHEBI:35610) |
| clionastatin B (CHEBI:65645) has role antineoplastic agent (CHEBI:35610) |
| clivatuzumab tetraxetan (CHEBI:755269) has role antineoplastic agent (CHEBI:35610) |
| clobetasol propionate (CHEBI:31414) has role antineoplastic agent (CHEBI:35610) |
| clodronic acid (CHEBI:110423) has role antineoplastic agent (CHEBI:35610) |
| clodronic acid disodium salt (CHEBI:59586) has role antineoplastic agent (CHEBI:35610) |
| clofarabine (CHEBI:681569) has role antineoplastic agent (CHEBI:35610) |
| clofibric acid (CHEBI:34648) has role antineoplastic agent (CHEBI:35610) |
| clopidogrel (CHEBI:37941) has role antineoplastic agent (CHEBI:35610) |
| clopidogrel bisulfate (CHEBI:749151) has role antineoplastic agent (CHEBI:35610) |
| cm-082 (CHEBI:755634) has role antineoplastic agent (CHEBI:35610) |
| CM-272 (CHEBI:229970) has role antineoplastic agent (CHEBI:35610) |
| cm-4307 (CHEBI:756976) has role antineoplastic agent (CHEBI:35610) |
| cmd-193 (CHEBI:754285) has role antineoplastic agent (CHEBI:35610) |
| CNDAC (CHEBI:145435) has role antineoplastic agent (CHEBI:35610) |
| cobalamin (CHEBI:30411) has role antineoplastic agent (CHEBI:35610) |
| cobicistat (CHEBI:72291) has role antineoplastic agent (CHEBI:35610) |
| cobimetinib (CHEBI:90851) has role antineoplastic agent (CHEBI:35610) |
| cobimetinib fumarate (CHEBI:90853) has role antineoplastic agent (CHEBI:35610) |
| cobolimab (CHEBI:757537) has role antineoplastic agent (CHEBI:35610) |
| cobomarsen (CHEBI:756476) has role antineoplastic agent (CHEBI:35610) |
| cochinchinone A (CHEBI:65646) has role antineoplastic agent (CHEBI:35610) |
| cochinchinoxanthone (CHEBI:67545) has role antineoplastic agent (CHEBI:35610) |
| codrituzumab (CHEBI:757508) has role antineoplastic agent (CHEBI:35610) |
| coenzyme A (CHEBI:15346) has role antineoplastic agent (CHEBI:35610) |
| coenzyme Q10 (CHEBI:46245) has role antineoplastic agent (CHEBI:35610) |
| cofetuzumab pelidotin (CHEBI:756466) has role antineoplastic agent (CHEBI:35610) |
| coformycin (CHEBI:16213) has role antineoplastic agent (CHEBI:35610) |
| coh-29 (CHEBI:756910) has role antineoplastic agent (CHEBI:35610) |
| colesevelam hydrochloride (CHEBI:59599) has role antineoplastic agent (CHEBI:35610) |
| colestipol hydrochloride (CHEBI:59602) has role antineoplastic agent (CHEBI:35610) |
| colistin (CHEBI:37943) has role antineoplastic agent (CHEBI:35610) |
| collagenase clostridium histolyticum (CHEBI:753652) has role antineoplastic agent (CHEBI:35610) |
| colpol (CHEBI:65652) has role antineoplastic agent (CHEBI:35610) |
| coltuximab ravtansine (CHEBI:754139) has role antineoplastic agent (CHEBI:35610) |
| columbianadin (CHEBI:132624) has role antineoplastic agent (CHEBI:35610) |
| comazaphilone D (CHEBI:70013) has role antineoplastic agent (CHEBI:35610) |
| comazaphilone E (CHEBI:70014) has role antineoplastic agent (CHEBI:35610) |
| comazaphilone F (CHEBI:70015) has role antineoplastic agent (CHEBI:35610) |
| combretastatin (CHEBI:748818) has role antineoplastic agent (CHEBI:35610) |
| combretastatin a-1 (CHEBI:748123) has role antineoplastic agent (CHEBI:35610) |
| comsaleucel (CHEBI:760144) has role antineoplastic agent (CHEBI:35610) |
| conatumumab (CHEBI:750082) has role antineoplastic agent (CHEBI:35610) |
| conbercept (CHEBI:753301) has role antineoplastic agent (CHEBI:35610) |
| conteltinib (CHEBI:755967) has role antineoplastic agent (CHEBI:35610) |
| contusugene ladenovec (CHEBI:753539) has role antineoplastic agent (CHEBI:35610) |
| copanlisib (CHEBI:173077) has role antineoplastic agent (CHEBI:35610) |
| copanlisib dihydrochloride (CHEBI:173081) has role antineoplastic agent (CHEBI:35610) |
| copper (CHEBI:748257) has role antineoplastic agent (CHEBI:35610) |
| Copper gluconate (CHEBI:31431) has role antineoplastic agent (CHEBI:35610) |
| copper oxodotreotide cu-64 (CHEBI:756834) has role antineoplastic agent (CHEBI:35610) |
| cordycepin (CHEBI:29014) has role antineoplastic agent (CHEBI:35610) |
| cordycepin triphosphate (CHEBI:52316) has role antineoplastic agent (CHEBI:35610) |
| cordyol C (CHEBI:64518) has role antineoplastic agent (CHEBI:35610) |
| corticorelin ovine triflutate (CHEBI:749441) has role antineoplastic agent (CHEBI:35610) |
| cortisol (CHEBI:17650) has role antineoplastic agent (CHEBI:35610) |
| Cortisone acetate (CHEBI:3897) has role antineoplastic agent (CHEBI:35610) |
| corynoline (CHEBI:65660) has role antineoplastic agent (CHEBI:35610) |
| cosibelimab (CHEBI:757181) has role antineoplastic agent (CHEBI:35610) |
| costunolide (CHEBI:3900) has role antineoplastic agent (CHEBI:35610) |
| coumermycin A1 (CHEBI:3907) has role antineoplastic agent (CHEBI:35610) |
| cp-461 (CHEBI:756655) has role antineoplastic agent (CHEBI:35610) |
| cp-506 (CHEBI:759835) has role antineoplastic agent (CHEBI:35610) |
| cp-609754 (CHEBI:756859) has role antineoplastic agent (CHEBI:35610) |
| CP-724714 (CHEBI:167658) has role antineoplastic agent (CHEBI:35610) |
| CP681301 (CHEBI:232980) has role antineoplastic agent (CHEBI:35610) |
| cpg-52852 (CHEBI:749068) has role antineoplastic agent (CHEBI:35610) |
| cpi 613 (CHEBI:755210) has role antineoplastic agent (CHEBI:35610) |
| cpi-1205 (CHEBI:756949) has role antineoplastic agent (CHEBI:35610) |
| crassolide (CHEBI:65669) has role antineoplastic agent (CHEBI:35610) |
| crassumolide A (CHEBI:65670) has role antineoplastic agent (CHEBI:35610) |
| cratoxyarborenone A (CHEBI:65671) has role antineoplastic agent (CHEBI:35610) |
| cratoxyarborenone B (CHEBI:65672) has role antineoplastic agent (CHEBI:35610) |
| cratoxyarborenone C (CHEBI:65673) has role antineoplastic agent (CHEBI:35610) |
| cratoxyarborenone D (CHEBI:65674) has role antineoplastic agent (CHEBI:35610) |
| cratoxyarborenone E (CHEBI:65675) has role antineoplastic agent (CHEBI:35610) |
| cratoxyarborenone F (CHEBI:65676) has role antineoplastic agent (CHEBI:35610) |
| cratoxylumxanthone C (CHEBI:195283) has role antineoplastic agent (CHEBI:35610) |
| creatine (CHEBI:16919) has role antineoplastic agent (CHEBI:35610) |
| creatinolfosfate (CHEBI:134856) has role antineoplastic agent (CHEBI:35610) |
| crefmirlimab (CHEBI:758574) has role antineoplastic agent (CHEBI:35610) |
| crelosidenib (CHEBI:759876) has role antineoplastic agent (CHEBI:35610) |
| crelosidenib gentisate (CHEBI:760303) has role antineoplastic agent (CHEBI:35610) |
| cremeomycin (CHEBI:184373) has role antineoplastic agent (CHEBI:35610) |
| Crenigacestat (CHEBI:232469) has role antineoplastic agent (CHEBI:35610) |
| crenolanib (CHEBI:145365) has role antineoplastic agent (CHEBI:35610) |
| crenolanib besylate (CHEBI:754783) has role antineoplastic agent (CHEBI:35610) |
| cretostimogene grenadenorepvec (CHEBI:759015) has role antineoplastic agent (CHEBI:35610) |
| cridanimod (CHEBI:136036) has role antineoplastic agent (CHEBI:35610) |
| crisantaspase (CHEBI:753844) has role antineoplastic agent (CHEBI:35610) |
| crizotinib (CHEBI:64310) has role antineoplastic agent (CHEBI:35610) |
| crocetin (CHEBI:3918) has role antineoplastic agent (CHEBI:35610) |
| crofelemer (CHEBI:753192) has role antineoplastic agent (CHEBI:35610) |
| Crolibulin (CHEBI:177518) has role antineoplastic agent (CHEBI:35610) |
| crozbaciclib (CHEBI:756657) has role antineoplastic agent (CHEBI:35610) |
| cryptolepine (CHEBI:3930) has role antineoplastic agent (CHEBI:35610) |
| cryptopleurine (CHEBI:3932) has role antineoplastic agent (CHEBI:35610) |
| cs-1003 (CHEBI:758010) has role antineoplastic agent (CHEBI:35610) |
| csl-360 (CHEBI:754161) has role antineoplastic agent (CHEBI:35610) |
| CT-179 (CHEBI:234076) has role antineoplastic agent (CHEBI:35610) |
| ct-2584 (CHEBI:756775) has role antineoplastic agent (CHEBI:35610) |
| ct-7001 (CHEBI:756974) has role antineoplastic agent (CHEBI:35610) |
| ctt-1057 (CHEBI:755360) has role antineoplastic agent (CHEBI:35610) |
| cucurbitacin E 2-O-β-D-glucopyranoside (CHEBI:68916) has role antineoplastic agent (CHEBI:35610) |
| cucurbitacin I (CHEBI:3947) has role antineoplastic agent (CHEBI:35610) |
| cudarolimab (CHEBI:758025) has role antineoplastic agent (CHEBI:35610) |
| cudraflavone C (CHEBI:68023) has role antineoplastic agent (CHEBI:35610) |
| cudratricusxanthone A (CHEBI:65686) has role antineoplastic agent (CHEBI:35610) |
| cugrastomig (CHEBI:760025) has role antineoplastic agent (CHEBI:35610) |
| culmerciclib (CHEBI:758677) has role antineoplastic agent (CHEBI:35610) |
| cumingianoside A (CHEBI:65689) has role antineoplastic agent (CHEBI:35610) |
| cumingianoside B (CHEBI:65690) has role antineoplastic agent (CHEBI:35610) |
| cumingianoside C (CHEBI:65691) has role antineoplastic agent (CHEBI:35610) |
| cumingianoside D (CHEBI:65692) has role antineoplastic agent (CHEBI:35610) |
| cumingianoside E (CHEBI:65693) has role antineoplastic agent (CHEBI:35610) |
| cumingianoside F (CHEBI:65694) has role antineoplastic agent (CHEBI:35610) |
| curacozole (CHEBI:156428) has role antineoplastic agent (CHEBI:35610) |
| curcumin (CHEBI:3962) has role antineoplastic agent (CHEBI:35610) |
| cusatuzumab (CHEBI:757329) has role antineoplastic agent (CHEBI:35610) |
| custirsen (CHEBI:753297) has role antineoplastic agent (CHEBI:35610) |
| custirsen sodium (CHEBI:754917) has role antineoplastic agent (CHEBI:35610) |
| cv-8102 (CHEBI:758515) has role antineoplastic agent (CHEBI:35610) |
| cvx-060 (CHEBI:757950) has role antineoplastic agent (CHEBI:35610) |
| cvx-241 (CHEBI:758279) has role antineoplastic agent (CHEBI:35610) |
| CX-5461 (CHEBI:156287) has role antineoplastic agent (CHEBI:35610) |
| cyanocobalamin (CHEBI:754405) has role antineoplastic agent (CHEBI:35610) |
| cyc-065 (CHEBI:755683) has role antineoplastic agent (CHEBI:35610) |
| cyclodepsipeptide 2 (CHEBI:66300) has role antineoplastic agent (CHEBI:35610) |
| cyclophosphamide (CHEBI:4027) has role antineoplastic agent (CHEBI:35610) |
| cyclophosphamide hydrate (CHEBI:4026) has role antineoplastic agent (CHEBI:35610) |
| cyclosporine (CHEBI:748220) has role antineoplastic agent (CHEBI:35610) |
| cyproheptadine hydrochloride (anhydrous) (CHEBI:59695) has role antineoplastic agent (CHEBI:35610) |
| cyproterone acetate (CHEBI:50743) has role antineoplastic agent (CHEBI:35610) |
| cystodytin D (CHEBI:65710) has role antineoplastic agent (CHEBI:35610) |
| cystodytin E (CHEBI:65711) has role antineoplastic agent (CHEBI:35610) |
| cystodytin F (CHEBI:65712) has role antineoplastic agent (CHEBI:35610) |
| cystodytin G (CHEBI:65713) has role antineoplastic agent (CHEBI:35610) |
| cystodytin H (CHEBI:65714) has role antineoplastic agent (CHEBI:35610) |
| cystodytin I (CHEBI:65715) has role antineoplastic agent (CHEBI:35610) |
| cystothiazole A (CHEBI:65716) has role antineoplastic agent (CHEBI:35610) |
| cyt-500 177lu (CHEBI:754318) has role antineoplastic agent (CHEBI:35610) |
| cytarabine (CHEBI:28680) has role antineoplastic agent (CHEBI:35610) |
| cytarabine 5'-phosphate (CHEBI:749103) has role antineoplastic agent (CHEBI:35610) |
| cytarabine hydrochloride (CHEBI:749710) has role antineoplastic agent (CHEBI:35610) |
| cytidine (CHEBI:17562) has role antineoplastic agent (CHEBI:35610) |
| cytochalasin D (CHEBI:529996) has role antineoplastic agent (CHEBI:35610) |
| cytochlor (CHEBI:756776) has role antineoplastic agent (CHEBI:35610) |
| cytoglobosin C (CHEBI:68761) has role antineoplastic agent (CHEBI:35610) |
| cytoglobosin D (CHEBI:68762) has role antineoplastic agent (CHEBI:35610) |
| cytosine (CHEBI:16040) has role antineoplastic agent (CHEBI:35610) |
| cytotrienin A (CHEBI:65720) has role antineoplastic agent (CHEBI:35610) |
| d-3263 (CHEBI:755793) has role antineoplastic agent (CHEBI:35610) |
| dabrafenib (CHEBI:75045) has role antineoplastic agent (CHEBI:35610) |
| dabrafenib mesylate (CHEBI:75048) has role antineoplastic agent (CHEBI:35610) |
| dacarbazine (CHEBI:4305) has role antineoplastic agent (CHEBI:35610) |
| dacetuzumab (CHEBI:750084) has role antineoplastic agent (CHEBI:35610) |
| daclizumab (CHEBI:749553) has role antineoplastic agent (CHEBI:35610) |
| dacomitinib (CHEBI:132268) has role antineoplastic agent (CHEBI:35610) |
| dactolisib (CHEBI:71952) has role antineoplastic agent (CHEBI:35610) |
| daidzein (CHEBI:28197) has role antineoplastic agent (CHEBI:35610) |
| daidzein(1−) (CHEBI:77764) has role antineoplastic agent (CHEBI:35610) |
| dalantercept (CHEBI:754386) has role antineoplastic agent (CHEBI:35610) |
| dalmelitinib (CHEBI:755896) has role antineoplastic agent (CHEBI:35610) |
| dalmitamig (CHEBI:760348) has role antineoplastic agent (CHEBI:35610) |
| dalnicastobart (CHEBI:759360) has role antineoplastic agent (CHEBI:35610) |
| dalotuzumab (CHEBI:750085) has role antineoplastic agent (CHEBI:35610) |
| dalpiciclib (CHEBI:747469) has role antineoplastic agent (CHEBI:35610) |
| dalteparin sodium (CHEBI:749547) has role antineoplastic agent (CHEBI:35610) |
| dalucabtagene autoleucel (CHEBI:758697) has role antineoplastic agent (CHEBI:35610) |
| dalutrafusp alfa (CHEBI:758848) has role antineoplastic agent (CHEBI:35610) |
| danazol (CHEBI:4315) has role antineoplastic agent (CHEBI:35610) |
| danburstotug (CHEBI:758311) has role antineoplastic agent (CHEBI:35610) |
| daniquidone (CHEBI:748479) has role antineoplastic agent (CHEBI:35610) |
| danusertib (CHEBI:94490) has role antineoplastic agent (CHEBI:35610) |
| danvatirsen (CHEBI:757190) has role antineoplastic agent (CHEBI:35610) |
| danvilostomig (CHEBI:759361) has role antineoplastic agent (CHEBI:35610) |
| dapagliflozin (CHEBI:85078) has role antineoplastic agent (CHEBI:35610) |
| dapansutrile (CHEBI:756431) has role antineoplastic agent (CHEBI:35610) |
| daphnoretin (CHEBI:4324) has role antineoplastic agent (CHEBI:35610) |
| dapolsertib (CHEBI:757687) has role antineoplastic agent (CHEBI:35610) |
| dapsone (CHEBI:4325) has role antineoplastic agent (CHEBI:35610) |
| daratumumab (CHEBI:750086) has role antineoplastic agent (CHEBI:35610) |
| daraxonrasib (CHEBI:746946) has role antineoplastic agent (CHEBI:35610) |
| darbepoetin alfa (CHEBI:749503) has role antineoplastic agent (CHEBI:35610) |
| dargistotug (CHEBI:759362) has role antineoplastic agent (CHEBI:35610) |
| darleukin (CHEBI:757191) has role antineoplastic agent (CHEBI:35610) |
| darolutamide (CHEBI:747353) has role antineoplastic agent (CHEBI:35610) |
| Darovasertib (CHEBI:233324) has role antineoplastic agent (CHEBI:35610) |
| dasatinib (anhydrous) (CHEBI:49375) has role antineoplastic agent (CHEBI:35610) |
| dasatinib laurylsulfate (CHEBI:759298) has role antineoplastic agent (CHEBI:35610) |
| dasatinib monohydrate (CHEBI:70839) has role antineoplastic agent (CHEBI:35610) |
| dasiprotimut-t (CHEBI:754994) has role antineoplastic agent (CHEBI:35610) |
| datopotamab (CHEBI:759324) has role antineoplastic agent (CHEBI:35610) |
| datopotamab deruxtecan (CHEBI:757370) has role antineoplastic agent (CHEBI:35610) |
| daunorubicin (CHEBI:41977) has role antineoplastic agent (CHEBI:35610) |
| daunorubicin citrate (CHEBI:749256) has role antineoplastic agent (CHEBI:35610) |
| Daunorubicin hydrochloride (CHEBI:31456) has role antineoplastic agent (CHEBI:35610) |
| davamotecan pegadexamer (CHEBI:758514) has role antineoplastic agent (CHEBI:35610) |
| davanat (CHEBI:757390) has role antineoplastic agent (CHEBI:35610) |
| davelizomib (CHEBI:759219) has role antineoplastic agent (CHEBI:35610) |
| davoceticept (CHEBI:758878) has role antineoplastic agent (CHEBI:35610) |
| davutamig (CHEBI:759041) has role antineoplastic agent (CHEBI:35610) |
| dazostinag (CHEBI:759892) has role antineoplastic agent (CHEBI:35610) |
| dazostinag sodium (CHEBI:760331) has role antineoplastic agent (CHEBI:35610) |
| DC_517 (CHEBI:229971) has role antineoplastic agent (CHEBI:35610) |
| DCC-2036 (CHEBI:62166) has role antineoplastic agent (CHEBI:35610) |
| dcll-9718s (CHEBI:759708) has role antineoplastic agent (CHEBI:35610) |
| deacetyltanghinin (CHEBI:66193) has role antineoplastic agent (CHEBI:35610) |
| decitabine (CHEBI:749378) has role antineoplastic agent (CHEBI:35610) |
| decursinol (CHEBI:4354) has role antineoplastic agent (CHEBI:35610) |
| defactinib (CHEBI:755159) has role antineoplastic agent (CHEBI:35610) |
| defactinib hydrochloride (CHEBI:755140) has role antineoplastic agent (CHEBI:35610) |
| Defencath (CHEBI:230518) has role antineoplastic agent (CHEBI:35610) |
| deferasirox (CHEBI:49005) has role antineoplastic agent (CHEBI:35610) |
| defibrotide (CHEBI:753370) has role antineoplastic agent (CHEBI:35610) |
| defoslimod (CHEBI:748754) has role antineoplastic agent (CHEBI:35610) |
| degarelix acetate (CHEBI:750382) has role antineoplastic agent (CHEBI:35610) |
| deguelin (CHEBI:4357) has role antineoplastic agent (CHEBI:35610) |
| dehydrocostus lactone (CHEBI:244418) has role antineoplastic agent (CHEBI:35610) |
| dehydroepiandrosterone (CHEBI:28689) has role antineoplastic agent (CHEBI:35610) |
| DEL-22379 (CHEBI:90905) has role antineoplastic agent (CHEBI:35610) |
| delanzomib (CHEBI:141530) has role antineoplastic agent (CHEBI:35610) |
| delphinidin (CHEBI:28436) has role antineoplastic agent (CHEBI:35610) |
| delphinidin(1−) (CHEBI:144775) has role antineoplastic agent (CHEBI:35610) |
| delta8-THC (CHEBI:183415) has role antineoplastic agent (CHEBI:35610) |
| demcizumab (CHEBI:754200) has role antineoplastic agent (CHEBI:35610) |
| demethoxycurcumin (CHEBI:65737) has role antineoplastic agent (CHEBI:35610) |
| demplatin pegraglumer (CHEBI:757475) has role antineoplastic agent (CHEBI:35610) |
| denenicokin (CHEBI:752898) has role antineoplastic agent (CHEBI:35610) |
| denfivontinib (CHEBI:757708) has role antineoplastic agent (CHEBI:35610) |
| Denifanstat (CHEBI:233413) has role antineoplastic agent (CHEBI:35610) |
| denikitug (CHEBI:760026) has role antineoplastic agent (CHEBI:35610) |
| denileukin diftitox (CHEBI:749427) has role antineoplastic agent (CHEBI:35610) |
| denintuzumab mafodotin (CHEBI:755601) has role antineoplastic agent (CHEBI:35610) |
| denosumab (CHEBI:749681) has role antineoplastic agent (CHEBI:35610) |
| deoxyandrographolide (CHEBI:748684) has role antineoplastic agent (CHEBI:35610) |
| deoxycholic acid (CHEBI:28834) has role antineoplastic agent (CHEBI:35610) |
| deoxylapachol (CHEBI:4414) has role antineoplastic agent (CHEBI:35610) |
| deoxypodophyllotoxin (CHEBI:4429) has role antineoplastic agent (CHEBI:35610) |
| depatuxizumab (CHEBI:755780) has role antineoplastic agent (CHEBI:35610) |
| depatuxizumab mafodotin (CHEBI:755768) has role antineoplastic agent (CHEBI:35610) |
| dequalinium (CHEBI:41872) has role antineoplastic agent (CHEBI:35610) |
| dequalinium chloride (CHEBI:31466) has role antineoplastic agent (CHEBI:35610) |
| derazantinib (CHEBI:756705) has role antineoplastic agent (CHEBI:35610) |
| derazantinib hydrochloride (CHEBI:757565) has role antineoplastic agent (CHEBI:35610) |
| deruxtecan (CHEBI:757771) has role antineoplastic agent (CHEBI:35610) |
| desferrioxamine B (CHEBI:4356) has role antineoplastic agent (CHEBI:35610) |
| desferrioxamine E (CHEBI:50437) has role antineoplastic agent (CHEBI:35610) |
| desipramine (CHEBI:47781) has role antineoplastic agent (CHEBI:35610) |
| desloratadine (CHEBI:291342) has role antineoplastic agent (CHEBI:35610) |
| desmopressin (CHEBI:4450) has role antineoplastic agent (CHEBI:35610) |
| detalimogene voraplasmid (CHEBI:759042) has role antineoplastic agent (CHEBI:35610) |
| detumomab (CHEBI:753980) has role antineoplastic agent (CHEBI:35610) |
| deulorlatinib (CHEBI:759965) has role antineoplastic agent (CHEBI:35610) |
| deutenzalutamide (CHEBI:757909) has role antineoplastic agent (CHEBI:35610) |
| devazepide (CHEBI:4460) has role antineoplastic agent (CHEBI:35610) |
| devimistat (CHEBI:233197) has role antineoplastic agent (CHEBI:35610) |
| dexamethasone (CHEBI:41879) has role antineoplastic agent (CHEBI:35610) |
| Dexamethasone acetate (CHEBI:4463) has role antineoplastic agent (CHEBI:35610) |
| dexamethasone sodium phosphate (CHEBI:4462) has role antineoplastic agent (CHEBI:35610) |
| dexmedetomidine (CHEBI:4466) has role antineoplastic agent (CHEBI:35610) |
| dexmedetomidine hydrochloride (CHEBI:31472) has role antineoplastic agent (CHEBI:35610) |
| dexormaplatin (CHEBI:85605) has role antineoplastic agent (CHEBI:35610) |
| dexrazoxane hydrochloride (CHEBI:50224) has role antineoplastic agent (CHEBI:35610) |
| dextrin (CHEBI:28675) has role antineoplastic agent (CHEBI:35610) |
| df-1001 (CHEBI:759709) has role antineoplastic agent (CHEBI:35610) |
| dfo-atezolizumab zr-89 (CHEBI:760501) has role antineoplastic agent (CHEBI:35610) |
| dfp-13318 (CHEBI:758936) has role antineoplastic agent (CHEBI:35610) |
| DH334 (CHEBI:82662) has role antineoplastic agent (CHEBI:35610) |
| DH334(1+) (CHEBI:82666) has role antineoplastic agent (CHEBI:35610) |
| dhes-0815a (CHEBI:757364) has role antineoplastic agent (CHEBI:35610) |
| di-leu16-il2 (CHEBI:758282) has role antineoplastic agent (CHEBI:35610) |
| diallyl disulfide (CHEBI:4488) has role antineoplastic agent (CHEBI:35610) |
| diallyl trisulfide (CHEBI:78492) has role antineoplastic agent (CHEBI:35610) |
| dianhydrogalactitol (CHEBI:755152) has role antineoplastic agent (CHEBI:35610) |
| dianversicoside A (CHEBI:65755) has role antineoplastic agent (CHEBI:35610) |
| dianversicoside B (CHEBI:65756) has role antineoplastic agent (CHEBI:35610) |
| dianversicoside C (CHEBI:65757) has role antineoplastic agent (CHEBI:35610) |
| dianversicoside D (CHEBI:65758) has role antineoplastic agent (CHEBI:35610) |
| dianversicoside E (CHEBI:65759) has role antineoplastic agent (CHEBI:35610) |
| dianversicoside F (CHEBI:65760) has role antineoplastic agent (CHEBI:35610) |
| dianversicoside G (CHEBI:65761) has role antineoplastic agent (CHEBI:35610) |
| diarsenic trioxide (CHEBI:30621) has role antineoplastic agent (CHEBI:35610) |
| diazepinomicin (CHEBI:156321) has role antineoplastic agent (CHEBI:35610) |
| diaziquone (CHEBI:90185) has role antineoplastic agent (CHEBI:35610) |
| diazomethane (CHEBI:73716) has role antineoplastic agent (CHEBI:35610) |
| diazoxide choline (CHEBI:756777) has role antineoplastic agent (CHEBI:35610) |
| dibenzoylmethane (CHEBI:75417) has role antineoplastic agent (CHEBI:35610) |
| dibotatug (CHEBI:760027) has role antineoplastic agent (CHEBI:35610) |
| dicerandrol A (CHEBI:65764) has role antineoplastic agent (CHEBI:35610) |
| dicerandrol B (CHEBI:65765) has role antineoplastic agent (CHEBI:35610) |
| dicerandrol C (CHEBI:65766) has role antineoplastic agent (CHEBI:35610) |
| dichloroacetic acid (CHEBI:36386) has role antineoplastic agent (CHEBI:35610) |
| diclofenac (CHEBI:47381) has role antineoplastic agent (CHEBI:35610) |
| diclofenac sodium (CHEBI:4509) has role antineoplastic agent (CHEBI:35610) |
| didanosine (CHEBI:490877) has role antineoplastic agent (CHEBI:35610) |
| dienogest (CHEBI:70708) has role antineoplastic agent (CHEBI:35610) |
| diethylstilbestrol (CHEBI:41922) has role antineoplastic agent (CHEBI:35610) |
| diethylstilbestrol diphosphate (CHEBI:4532) has role antineoplastic agent (CHEBI:35610) |
| diflomotecan (CHEBI:144046) has role antineoplastic agent (CHEBI:35610) |
| digoxin (CHEBI:4551) has role antineoplastic agent (CHEBI:35610) |
| dihydromotuporamine C (CHEBI:82642) has role antineoplastic agent (CHEBI:35610) |
| diiodine (CHEBI:17606) has role antineoplastic agent (CHEBI:35610) |
| dilanubicel (CHEBI:756745) has role antineoplastic agent (CHEBI:35610) |
| dilopholide (CHEBI:65794) has role antineoplastic agent (CHEBI:35610) |
| dilpacimab (CHEBI:757806) has role antineoplastic agent (CHEBI:35610) |
| diltiazem (CHEBI:101278) has role antineoplastic agent (CHEBI:35610) |
| diltiazem hydrochloride (CHEBI:645509) has role antineoplastic agent (CHEBI:35610) |
| dimesna (CHEBI:750766) has role antineoplastic agent (CHEBI:35610) |
| dimethicone (CHEBI:753206) has role antineoplastic agent (CHEBI:35610) |
| dimethyl fumarate (CHEBI:76004) has role antineoplastic agent (CHEBI:35610) |
| dinaciclib (CHEBI:95060) has role antineoplastic agent (CHEBI:35610) |
| dinitrogen (CHEBI:17997) has role antineoplastic agent (CHEBI:35610) |
| dinochrome A (CHEBI:65797) has role antineoplastic agent (CHEBI:35610) |
| dinutuximab (CHEBI:755169) has role antineoplastic agent (CHEBI:35610) |
| dinutuximab beta (CHEBI:759751) has role antineoplastic agent (CHEBI:35610) |
| dioscin (CHEBI:74023) has role antineoplastic agent (CHEBI:35610) |
| diosgenin (CHEBI:4629) has role antineoplastic agent (CHEBI:35610) |
| diosmetin (CHEBI:4630) has role antineoplastic agent (CHEBI:35610) |
| diphenhydramine (CHEBI:4636) has role antineoplastic agent (CHEBI:35610) |
| diphtheria toxoid (CHEBI:754013) has role antineoplastic agent (CHEBI:35610) |
| diplotrin B (CHEBI:69448) has role antineoplastic agent (CHEBI:35610) |
| dipyridamole (CHEBI:4653) has role antineoplastic agent (CHEBI:35610) |
| disaccharide tripeptide glycerol dipalmitoyl (CHEBI:756882) has role antineoplastic agent (CHEBI:35610) |
| disitamab (CHEBI:760396) has role antineoplastic agent (CHEBI:35610) |
| disitamab vedotin (CHEBI:758849) has role antineoplastic agent (CHEBI:35610) |
| disodium cromoglycate (CHEBI:128458) has role antineoplastic agent (CHEBI:35610) |
| disodium selenite (CHEBI:48843) has role antineoplastic agent (CHEBI:35610) |
| disomotide (CHEBI:748502) has role antineoplastic agent (CHEBI:35610) |
| disulfiram (CHEBI:4659) has role antineoplastic agent (CHEBI:35610) |
| diuvaretin (CHEBI:65802) has role antineoplastic agent (CHEBI:35610) |
| divarasib (CHEBI:758813) has role antineoplastic agent (CHEBI:35610) |
| divarasib adipate (CHEBI:759301) has role antineoplastic agent (CHEBI:35610) |
| divaricoside (CHEBI:4668) has role antineoplastic agent (CHEBI:35610) |
| dkn-01 (CHEBI:757037) has role antineoplastic agent (CHEBI:35610) |
| DMH1 (CHEBI:86289) has role antineoplastic agent (CHEBI:35610) |
| DMH4 (CHEBI:229963) has role antineoplastic agent (CHEBI:35610) |
| docetaxel (CHEBI:755540) has role antineoplastic agent (CHEBI:35610) |
| docetaxel anhydrous (CHEBI:4672) has role antineoplastic agent (CHEBI:35610) |
| docetaxel trihydrate (CHEBI:59809) has role antineoplastic agent (CHEBI:35610) |
| dociparstat sodium (CHEBI:756488) has role antineoplastic agent (CHEBI:35610) |
| dofequidar (CHEBI:748291) has role antineoplastic agent (CHEBI:35610) |
| dolasetron mesylate (CHEBI:755015) has role antineoplastic agent (CHEBI:35610) |
| dolastatin 10 (CHEBI:67357) has role antineoplastic agent (CHEBI:35610) |
| dolastatin-10 (CHEBI:748154) has role antineoplastic agent (CHEBI:35610) |
| dolcanatide (CHEBI:755469) has role antineoplastic agent (CHEBI:35610) |
| domatinostat (CHEBI:756661) has role antineoplastic agent (CHEBI:35610) |
| domvanalimab (CHEBI:758283) has role antineoplastic agent (CHEBI:35610) |
| donepezil (CHEBI:53289) has role antineoplastic agent (CHEBI:35610) |
| donepezil hydrochloride (CHEBI:4696) has role antineoplastic agent (CHEBI:35610) |
| donitabart (CHEBI:760028) has role antineoplastic agent (CHEBI:35610) |
| dordaviprone (CHEBI:232328) has role antineoplastic agent (CHEBI:35610) |
| dordaviprone hydrochloride (CHEBI:760311) has role antineoplastic agent (CHEBI:35610) |
| dorgenmeltucel-l (CHEBI:755257) has role antineoplastic agent (CHEBI:35610) |
| dornase alfa (CHEBI:749545) has role antineoplastic agent (CHEBI:35610) |
| dostarlimab (CHEBI:757538) has role antineoplastic agent (CHEBI:35610) |
| DOTA (CHEBI:61028) has role antineoplastic agent (CHEBI:35610) |
| dotamtate pb-212 (CHEBI:756841) has role antineoplastic agent (CHEBI:35610) |
| dovitinib (CHEBI:748972) has role antineoplastic agent (CHEBI:35610) |
| dovitinib lactate (CHEBI:756669) has role antineoplastic agent (CHEBI:35610) |
| doxazosin (CHEBI:4708) has role antineoplastic agent (CHEBI:35610) |
| doxercalciferol (CHEBI:4712) has role antineoplastic agent (CHEBI:35610) |
| doxifluridine (CHEBI:31521) has role antineoplastic agent (CHEBI:35610) |
| dromostanolone propionate (CHEBI:31523) has role antineoplastic agent (CHEBI:35610) |
| drozitumab (CHEBI:750087) has role antineoplastic agent (CHEBI:35610) |
| DS-1-38 (CHEBI:231606) has role antineoplastic agent (CHEBI:35610) |
| ds-2248 (CHEBI:758760) has role antineoplastic agent (CHEBI:35610) |
| ds-3078a (CHEBI:755392) has role antineoplastic agent (CHEBI:35610) |
| ds-7423 (CHEBI:755538) has role antineoplastic agent (CHEBI:35610) |
| ds-8273a (CHEBI:757851) has role antineoplastic agent (CHEBI:35610) |
| dsp-0390 (CHEBI:759606) has role antineoplastic agent (CHEBI:35610) |
| dubermatinib (CHEBI:750377) has role antineoplastic agent (CHEBI:35610) |
| dubermatinib tartrate (CHEBI:757784) has role antineoplastic agent (CHEBI:35610) |
| dulanermin (CHEBI:752893) has role antineoplastic agent (CHEBI:35610) |
| duligotuzumab (CHEBI:755171) has role antineoplastic agent (CHEBI:35610) |
| duocarmazine (CHEBI:757553) has role antineoplastic agent (CHEBI:35610) |
| dupilumab (CHEBI:753623) has role antineoplastic agent (CHEBI:35610) |
| durcabtagene autoleucel (CHEBI:759427) has role antineoplastic agent (CHEBI:35610) |
| durvalumab (CHEBI:755270) has role antineoplastic agent (CHEBI:35610) |
| dusigitumab (CHEBI:754180) has role antineoplastic agent (CHEBI:35610) |
| dutomycin (CHEBI:171673) has role antineoplastic agent (CHEBI:35610) |
| duvelisib monohydrate (CHEBI:759803) has role antineoplastic agent (CHEBI:35610) |
| dv-281 (CHEBI:758012) has role antineoplastic agent (CHEBI:35610) |
| E-3810 (CHEBI:65138) has role antineoplastic agent (CHEBI:35610) |
| E-3810 free base (CHEBI:65209) has role antineoplastic agent (CHEBI:35610) |
| e-6201 (CHEBI:749146) has role antineoplastic agent (CHEBI:35610) |
| e-7016 (CHEBI:755363) has role antineoplastic agent (CHEBI:35610) |
| e-7090 (CHEBI:755704) has role antineoplastic agent (CHEBI:35610) |
| e-7130 (CHEBI:758470) has role antineoplastic agent (CHEBI:35610) |
| e-7386 (CHEBI:756977) has role antineoplastic agent (CHEBI:35610) |
| e-7766 (CHEBI:758810) has role antineoplastic agent (CHEBI:35610) |
| e-7820 (CHEBI:756868) has role antineoplastic agent (CHEBI:35610) |
| e-7974 (CHEBI:758347) has role antineoplastic agent (CHEBI:35610) |
| e2.3 (CHEBI:754278) has role antineoplastic agent (CHEBI:35610) |
| e7107 (CHEBI:756779) has role antineoplastic agent (CHEBI:35610) |
| ebselen (CHEBI:77543) has role antineoplastic agent (CHEBI:35610) |
| ebvaciclib (CHEBI:757676) has role antineoplastic agent (CHEBI:35610) |
| ec-17 (CHEBI:756780) has role antineoplastic agent (CHEBI:35610) |
| eciruciclib (CHEBI:758645) has role antineoplastic agent (CHEBI:35610) |
| eciskafusp alfa (CHEBI:759672) has role antineoplastic agent (CHEBI:35610) |
| eclutatug (CHEBI:760151) has role antineoplastic agent (CHEBI:35610) |
| ecromeximab (CHEBI:753954) has role antineoplastic agent (CHEBI:35610) |
| eculizumab (CHEBI:749604) has role antineoplastic agent (CHEBI:35610) |
| edelfosine (CHEBI:78649) has role antineoplastic agent (CHEBI:35610) |
| ederimotide (CHEBI:759429) has role antineoplastic agent (CHEBI:35610) |
| edicotinib (CHEBI:755695) has role antineoplastic agent (CHEBI:35610) |
| edodekin alfa (CHEBI:753956) has role antineoplastic agent (CHEBI:35610) |
| edotecarin (CHEBI:748547) has role antineoplastic agent (CHEBI:35610) |
| edotreotide gallium ga-68 (CHEBI:756835) has role antineoplastic agent (CHEBI:35610) |
| edralbrutinib (CHEBI:758235) has role antineoplastic agent (CHEBI:35610) |
| edrecolomab (CHEBI:753866) has role antineoplastic agent (CHEBI:35610) |
| EDTA monocalcium diisodium salt (CHEBI:4757) has role antineoplastic agent (CHEBI:35610) |
| efarindodekin alfa (CHEBI:760152) has role antineoplastic agent (CHEBI:35610) |
| efatutazone (CHEBI:755555) has role antineoplastic agent (CHEBI:35610) |
| efavirenz (CHEBI:119486) has role antineoplastic agent (CHEBI:35610) |
| efbemalenograstim alfa (CHEBI:757380) has role antineoplastic agent (CHEBI:35610) |
| efdelikofusp alfa (CHEBI:760153) has role antineoplastic agent (CHEBI:35610) |
| efercoleukin alfa (CHEBI:759519) has role antineoplastic agent (CHEBI:35610) |
| efgitasialase alfa (CHEBI:760155) has role antineoplastic agent (CHEBI:35610) |
| efgivanermin alfa (CHEBI:757454) has role antineoplastic agent (CHEBI:35610) |
| efineptakin alfa (CHEBI:758062) has role antineoplastic agent (CHEBI:35610) |
| efizonerimod alfa (CHEBI:756511) has role antineoplastic agent (CHEBI:35610) |
| eflapegrastim (CHEBI:755956) has role antineoplastic agent (CHEBI:35610) |
| eflornithine (CHEBI:41948) has role antineoplastic agent (CHEBI:35610) |
| eflornithine hydrochloride (CHEBI:749357) has role antineoplastic agent (CHEBI:35610) |
| efpegerglucagon (CHEBI:759520) has role antineoplastic agent (CHEBI:35610) |
| eftilagimod alfa (CHEBI:758030) has role antineoplastic agent (CHEBI:35610) |
| eftozanermin alfa (CHEBI:757821) has role antineoplastic agent (CHEBI:35610) |
| efungumab (CHEBI:750088) has role antineoplastic agent (CHEBI:35610) |
| efzilonkofusp alfa (CHEBI:760159) has role antineoplastic agent (CHEBI:35610) |
| EG00229 (CHEBI:166820) has role antineoplastic agent (CHEBI:35610) |
| eganelisib (CHEBI:756025) has role antineoplastic agent (CHEBI:35610) |
| ekatetrone (CHEBI:141382) has role antineoplastic agent (CHEBI:35610) |
| elacestrant (CHEBI:229213) has role antineoplastic agent (CHEBI:35610) |
| elacestrant hydrochloride (CHEBI:757776) has role antineoplastic agent (CHEBI:35610) |
| Elacytarabine (CHEBI:177700) has role antineoplastic agent (CHEBI:35610) |
| elaeodendroside B (CHEBI:65825) has role antineoplastic agent (CHEBI:35610) |
| elaeodendroside F (CHEBI:65826) has role antineoplastic agent (CHEBI:35610) |
| elaeodendroside G (CHEBI:65827) has role antineoplastic agent (CHEBI:35610) |
| elaeodendroside T (CHEBI:65828) has role antineoplastic agent (CHEBI:35610) |
| elaeodendroside U (CHEBI:65829) has role antineoplastic agent (CHEBI:35610) |
| elaeodendroside W (CHEBI:65831) has role antineoplastic agent (CHEBI:35610) |
| elaidylphosphocholine (CHEBI:75487) has role antineoplastic agent (CHEBI:35610) |
| elapegademase (CHEBI:756508) has role antineoplastic agent (CHEBI:35610) |
| eldocasiran (CHEBI:759367) has role antineoplastic agent (CHEBI:35610) |
| elephantin (CHEBI:520527) has role antineoplastic agent (CHEBI:35610) |
| elesclomol (CHEBI:79369) has role antineoplastic agent (CHEBI:35610) |
| elesclomol-Cu(II) (CHEBI:79377) has role antineoplastic agent (CHEBI:35610) |
| elgemtumab (CHEBI:757438) has role antineoplastic agent (CHEBI:35610) |
| eliglustat (CHEBI:82752) has role antineoplastic agent (CHEBI:35610) |
| elimusertib (CHEBI:758117) has role antineoplastic agent (CHEBI:35610) |
| elisidepsin (CHEBI:83152) has role antineoplastic agent (CHEBI:35610) |
| ellagic acid (CHEBI:4775) has role antineoplastic agent (CHEBI:35610) |
| ellipticine (CHEBI:4776) has role antineoplastic agent (CHEBI:35610) |
| elongatol A (CHEBI:65837) has role antineoplastic agent (CHEBI:35610) |
| elongatol E (CHEBI:65838) has role antineoplastic agent (CHEBI:35610) |
| elotuzumab (CHEBI:750089) has role antineoplastic agent (CHEBI:35610) |
| elpamotide (CHEBI:177637) has role antineoplastic agent (CHEBI:35610) |
| elraglusib (CHEBI:748981) has role antineoplastic agent (CHEBI:35610) |
| elranatamab (CHEBI:757254) has role antineoplastic agent (CHEBI:35610) |
| elritercept (CHEBI:759432) has role antineoplastic agent (CHEBI:35610) |
| eltanexor (CHEBI:229762) has role antineoplastic agent (CHEBI:35610) |
| eltivutabart (CHEBI:760160) has role antineoplastic agent (CHEBI:35610) |
| eltrombopag (CHEBI:85010) has role antineoplastic agent (CHEBI:35610) |
| eluvixtamab (CHEBI:757995) has role antineoplastic agent (CHEBI:35610) |
| elzocabtagene autoleucel (CHEBI:760035) has role antineoplastic agent (CHEBI:35610) |
| elzovantinib (CHEBI:758646) has role antineoplastic agent (CHEBI:35610) |
| emactuzumab (CHEBI:755600) has role antineoplastic agent (CHEBI:35610) |
| emarginatine B (CHEBI:65839) has role antineoplastic agent (CHEBI:35610) |
| emarginatine F (CHEBI:65840) has role antineoplastic agent (CHEBI:35610) |
| emavusertib (CHEBI:758436) has role antineoplastic agent (CHEBI:35610) |
| emavusertib hydrochloride (CHEBI:758983) has role antineoplastic agent (CHEBI:35610) |
| emavusertib maleate (CHEBI:759269) has role antineoplastic agent (CHEBI:35610) |
| emavusertib mesylate (CHEBI:759270) has role antineoplastic agent (CHEBI:35610) |
| emavusertib phosphate (CHEBI:759271) has role antineoplastic agent (CHEBI:35610) |
| emavusertib tosylate (CHEBI:759272) has role antineoplastic agent (CHEBI:35610) |
| embelin (CHEBI:4778) has role antineoplastic agent (CHEBI:35610) |
| emd-1201081 (CHEBI:757420) has role antineoplastic agent (CHEBI:35610) |
| emd-1204831 (CHEBI:756011) has role antineoplastic agent (CHEBI:35610) |
| emd-273063 (CHEBI:754218) has role antineoplastic agent (CHEBI:35610) |
| emerfetamab (CHEBI:758571) has role antineoplastic agent (CHEBI:35610) |
| emetine (CHEBI:4781) has role antineoplastic agent (CHEBI:35610) |
| emetine dihydrochloride (CHEBI:149551) has role antineoplastic agent (CHEBI:35610) |
| emetine dihydrochloride hydrate (CHEBI:146000) has role antineoplastic agent (CHEBI:35610) |
| emibetuzumab (CHEBI:755262) has role antineoplastic agent (CHEBI:35610) |
| emiltatug (CHEBI:760036) has role antineoplastic agent (CHEBI:35610) |
| emiltatug ledadotin (CHEBI:760037) has role antineoplastic agent (CHEBI:35610) |
| emilumenib (CHEBI:759221) has role antineoplastic agent (CHEBI:35610) |
| emirodatamab (CHEBI:757319) has role antineoplastic agent (CHEBI:35610) |
| emodin (CHEBI:42223) has role antineoplastic agent (CHEBI:35610) |
| emodin(1−) (CHEBI:77659) has role antineoplastic agent (CHEBI:35610) |
| empagliflozin (CHEBI:82720) has role antineoplastic agent (CHEBI:35610) |
| empegfilgrastim (CHEBI:759999) has role antineoplastic agent (CHEBI:35610) |
| emunkitug (CHEBI:760162) has role antineoplastic agent (CHEBI:35610) |
| emvododstat (CHEBI:758234) has role antineoplastic agent (CHEBI:35610) |
| emzadirib (CHEBI:759326) has role antineoplastic agent (CHEBI:35610) |
| emzeltrectinib (CHEBI:759164) has role antineoplastic agent (CHEBI:35610) |
| enadenotucirev (CHEBI:757197) has role antineoplastic agent (CHEBI:35610) |
| enalapril (CHEBI:4784) has role antineoplastic agent (CHEBI:35610) |
| enasidenib (CHEBI:145374) has role antineoplastic agent (CHEBI:35610) |
| enasidenib mesylate (CHEBI:756421) has role antineoplastic agent (CHEBI:35610) |
| enavermotide (CHEBI:759521) has role antineoplastic agent (CHEBI:35610) |
| enbezotinib (CHEBI:758647) has role antineoplastic agent (CHEBI:35610) |
| encequidar (CHEBI:757800) has role antineoplastic agent (CHEBI:35610) |
| encequidar mesylate (CHEBI:757801) has role antineoplastic agent (CHEBI:35610) |
| encorafenib (CHEBI:755294) has role antineoplastic agent (CHEBI:35610) |
| endostatin (CHEBI:757198) has role antineoplastic agent (CHEBI:35610) |
| endostatin, n-terminal-mggshhhhh (CHEBI:757377) has role antineoplastic agent (CHEBI:35610) |
| enfortumab vedotin (CHEBI:755272) has role antineoplastic agent (CHEBI:35610) |
| englerin A (CHEBI:72441) has role antineoplastic agent (CHEBI:35610) |
| englumafusp alfa (CHEBI:758944) has role antineoplastic agent (CHEBI:35610) |
| eniluracil (CHEBI:177783) has role antineoplastic agent (CHEBI:35610) |
| enitociclib (CHEBI:231682) has role antineoplastic agent (CHEBI:35610) |
| enlonstobart (CHEBI:759728) has role antineoplastic agent (CHEBI:35610) |
| enmd-2076 (CHEBI:749008) has role antineoplastic agent (CHEBI:35610) |
| enmd-981693 (CHEBI:748247) has role antineoplastic agent (CHEBI:35610) |
| enoblituzumab (CHEBI:755603) has role antineoplastic agent (CHEBI:35610) |
| enobosarm (CHEBI:749997) has role antineoplastic agent (CHEBI:35610) |
| enomimeran (CHEBI:759044) has role antineoplastic agent (CHEBI:35610) |
| enoticumab (CHEBI:754201) has role antineoplastic agent (CHEBI:35610) |
| enoxaparin sodium (CHEBI:749476) has role antineoplastic agent (CHEBI:35610) |
| enristomig (CHEBI:759327) has role antineoplastic agent (CHEBI:35610) |
| enrofloxacin (CHEBI:35720) has role antineoplastic agent (CHEBI:35610) |
| enrupatinib (CHEBI:759869) has role antineoplastic agent (CHEBI:35610) |
| ensartinib (CHEBI:756608) has role antineoplastic agent (CHEBI:35610) |
| ensituximab (CHEBI:750092) has role antineoplastic agent (CHEBI:35610) |
| entacapone (CHEBI:4798) has role antineoplastic agent (CHEBI:35610) |
| entecavir hydrate (CHEBI:59902) has role antineoplastic agent (CHEBI:35610) |
| entinostat (CHEBI:132082) has role antineoplastic agent (CHEBI:35610) |
| entolimod (CHEBI:753631) has role antineoplastic agent (CHEBI:35610) |
| entospletinib (CHEBI:755246) has role antineoplastic agent (CHEBI:35610) |
| entrectinib (CHEBI:195558) has role antineoplastic agent (CHEBI:35610) |
| envafolimab (CHEBI:757431) has role antineoplastic agent (CHEBI:35610) |
| envonalkib (CHEBI:758648) has role antineoplastic agent (CHEBI:35610) |
| enzalutamide (CHEBI:68534) has role antineoplastic agent (CHEBI:35610) |
| enzastaurin hydrochloride (CHEBI:752576) has role antineoplastic agent (CHEBI:35610) |
| enzomenib (CHEBI:759607) has role antineoplastic agent (CHEBI:35610) |
| epacadostat (CHEBI:755599) has role antineoplastic agent (CHEBI:35610) |
| epacmarstobart (CHEBI:758909) has role antineoplastic agent (CHEBI:35610) |
| epalrestat (CHEBI:31539) has role antineoplastic agent (CHEBI:35610) |
| epcoritamab (CHEBI:758284) has role antineoplastic agent (CHEBI:35610) |
| epirubicin hydrochloride (CHEBI:232543) has role antineoplastic agent (CHEBI:35610) |
| epitinib (CHEBI:759124) has role antineoplastic agent (CHEBI:35610) |
| eplerenone (CHEBI:31547) has role antineoplastic agent (CHEBI:35610) |
| epoetin alfa (CHEBI:749425) has role antineoplastic agent (CHEBI:35610) |
| epoetin beta (CHEBI:753987) has role antineoplastic agent (CHEBI:35610) |
| epofolate (CHEBI:757200) has role antineoplastic agent (CHEBI:35610) |
| epothilone A (CHEBI:31549) has role antineoplastic agent (CHEBI:35610) |
| epothilone B (CHEBI:31550) has role antineoplastic agent (CHEBI:35610) |
| epratuzumab (CHEBI:753378) has role antineoplastic agent (CHEBI:35610) |
| epratuzumab 90y (CHEBI:753335) has role antineoplastic agent (CHEBI:35610) |
| eprenetapopt (CHEBI:755208) has role antineoplastic agent (CHEBI:35610) |
| epsametostat (CHEBI:760038) has role antineoplastic agent (CHEBI:35610) |
| equecabtagene autoleucel (CHEBI:759369) has role antineoplastic agent (CHEBI:35610) |
| eragidomide (CHEBI:758510) has role antineoplastic agent (CHEBI:35610) |
| eras-801 (CHEBI:760485) has role antineoplastic agent (CHEBI:35610) |
| erastin (CHEBI:94287) has role antineoplastic agent (CHEBI:35610) |
| Erdafitinib (CHEBI:232556) has role antineoplastic agent (CHEBI:35610) |
| erdasporine A (CHEBI:156313) has role antineoplastic agent (CHEBI:35610) |
| erdasporine B (CHEBI:156314) has role antineoplastic agent (CHEBI:35610) |
| erdasporine C (CHEBI:156315) has role antineoplastic agent (CHEBI:35610) |
| erfonrilimab (CHEBI:758365) has role antineoplastic agent (CHEBI:35610) |
| ergolide (CHEBI:69340) has role antineoplastic agent (CHEBI:35610) |
| ergosterol peroxide (CHEBI:65858) has role antineoplastic agent (CHEBI:35610) |
| erianin (CHEBI:233659) has role antineoplastic agent (CHEBI:35610) |
| eribulin (CHEBI:63587) has role antineoplastic agent (CHEBI:35610) |
| eribulin mesylate (CHEBI:70710) has role antineoplastic agent (CHEBI:35610) |
| eritoran tetrasodium (CHEBI:46692) has role antineoplastic agent (CHEBI:35610) |
| erlotinib (CHEBI:114785) has role antineoplastic agent (CHEBI:35610) |
| erlotinib hydrochloride (CHEBI:53509) has role antineoplastic agent (CHEBI:35610) |
| erteberel (CHEBI:231600) has role antineoplastic agent (CHEBI:35610) |
| ertumaxomab (CHEBI:753046) has role antineoplastic agent (CHEBI:35610) |
| ery-974 (CHEBI:757378) has role antineoplastic agent (CHEBI:35610) |
| erybraedin A (CHEBI:65862) has role antineoplastic agent (CHEBI:35610) |
| erzotabart (CHEBI:759711) has role antineoplastic agent (CHEBI:35610) |
| escitalopram (CHEBI:36791) has role antineoplastic agent (CHEBI:35610) |
| esculeoside A (CHEBI:65866) has role antineoplastic agent (CHEBI:35610) |
| esepapogene zalarnarepvec (CHEBI:759371) has role antineoplastic agent (CHEBI:35610) |
| esmolol (CHEBI:4856) has role antineoplastic agent (CHEBI:35610) |
| esperamicin A1 (CHEBI:53273) has role antineoplastic agent (CHEBI:35610) |
| estramustine (CHEBI:4868) has role antineoplastic agent (CHEBI:35610) |
| estramustine phosphate (CHEBI:68643) has role antineoplastic agent (CHEBI:35610) |
| estramustine sodium phosphate (CHEBI:31562) has role antineoplastic agent (CHEBI:35610) |
| estrogens, conjugated (CHEBI:749574) has role antineoplastic agent (CHEBI:35610) |
| estrogens, esterified (CHEBI:749546) has role antineoplastic agent (CHEBI:35610) |
| estrone (CHEBI:17263) has role antineoplastic agent (CHEBI:35610) |
| etaconazole (CHEBI:4874) has role antineoplastic agent (CHEBI:35610) |
| etacrynic acid (CHEBI:4876) has role antineoplastic agent (CHEBI:35610) |
| etakafusp alfa (CHEBI:760039) has role antineoplastic agent (CHEBI:35610) |
| etanercept (CHEBI:4875) has role antineoplastic agent (CHEBI:35610) |
| etanidazole (CHEBI:75473) has role antineoplastic agent (CHEBI:35610) |
| etaracizumab (CHEBI:759087) has role antineoplastic agent (CHEBI:35610) |
| etarfolatide (CHEBI:756781) has role antineoplastic agent (CHEBI:35610) |
| etavopivat (CHEBI:758230) has role antineoplastic agent (CHEBI:35610) |
| etc-159 (CHEBI:755665) has role antineoplastic agent (CHEBI:35610) |
| etentamig (CHEBI:759663) has role antineoplastic agent (CHEBI:35610) |
| ethane (CHEBI:42266) has role antineoplastic agent (CHEBI:35610) |
| ethane dimethane sulfonate (CHEBI:748666) has role antineoplastic agent (CHEBI:35610) |
| ethaselen (CHEBI:750390) has role antineoplastic agent (CHEBI:35610) |
| ethiodized oil (CHEBI:749453) has role antineoplastic agent (CHEBI:35610) |
| ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate (CHEBI:84883) has role antineoplastic agent (CHEBI:35610) |
| ethyl trans-caffeate (CHEBI:132714) has role antineoplastic agent (CHEBI:35610) |
| ethyl isothiocyanate (CHEBI:85098) has role antineoplastic agent (CHEBI:35610) |
| ethyl methanesulfonate (CHEBI:23994) has role antineoplastic agent (CHEBI:35610) |
| ethylenediamine (CHEBI:30347) has role antineoplastic agent (CHEBI:35610) |
| etidronate disodium (CHEBI:4906) has role antineoplastic agent (CHEBI:35610) |
| etidronic acid (CHEBI:4907) has role antineoplastic agent (CHEBI:35610) |
| etigilimab (CHEBI:757612) has role antineoplastic agent (CHEBI:35610) |
| etimumotide (CHEBI:759435) has role antineoplastic agent (CHEBI:35610) |
| etimupepimut (CHEBI:760312) has role antineoplastic agent (CHEBI:35610) |
| etirinotecan pegol (CHEBI:755091) has role antineoplastic agent (CHEBI:35610) |
| etivelcabtagene erigedleucel (CHEBI:760163) has role antineoplastic agent (CHEBI:35610) |
| etodolac (CHEBI:4909) has role antineoplastic agent (CHEBI:35610) |
| etoglucid (CHEBI:748896) has role antineoplastic agent (CHEBI:35610) |
| etoposide (CHEBI:4911) has role antineoplastic agent (CHEBI:35610) |
| etoricoxib (CHEBI:6339) has role antineoplastic agent (CHEBI:35610) |
| etrumadenant (CHEBI:758418) has role antineoplastic agent (CHEBI:35610) |
| eucalyptal A (CHEBI:65869) has role antineoplastic agent (CHEBI:35610) |
| eucalyptal B (CHEBI:65870) has role antineoplastic agent (CHEBI:35610) |
| eucalyptal C (CHEBI:65871) has role antineoplastic agent (CHEBI:35610) |
| eudistomin C (CHEBI:80955) has role antineoplastic agent (CHEBI:35610) |
| eugeniin (CHEBI:4916) has role antineoplastic agent (CHEBI:35610) |
| eugenol (CHEBI:4917) has role antineoplastic agent (CHEBI:35610) |
| eupaheliangolide A (CHEBI:65879) has role antineoplastic agent (CHEBI:35610) |
| eupatilin (CHEBI:4932) has role antineoplastic agent (CHEBI:35610) |
| eupatolide (CHEBI:4935) has role antineoplastic agent (CHEBI:35610) |
| eupatorin (CHEBI:136666) has role antineoplastic agent (CHEBI:35610) |
| euphornin L (CHEBI:65886) has role antineoplastic agent (CHEBI:35610) |
| eurestobart (CHEBI:759436) has role antineoplastic agent (CHEBI:35610) |
| eurycomanone (CHEBI:65887) has role antineoplastic agent (CHEBI:35610) |
| eurysterol A (CHEBI:65888) has role antineoplastic agent (CHEBI:35610) |
| eurysterol A sulfonic acid (CHEBI:68591) has role antineoplastic agent (CHEBI:35610) |
| eurysterol B (CHEBI:65889) has role antineoplastic agent (CHEBI:35610) |
| eurysterol B sulfonic acid (CHEBI:68594) has role antineoplastic agent (CHEBI:35610) |
| evalstotug (CHEBI:759523) has role antineoplastic agent (CHEBI:35610) |
| evencaleucel (CHEBI:758703) has role antineoplastic agent (CHEBI:35610) |
| everolimus (CHEBI:68478) has role antineoplastic agent (CHEBI:35610) |
| evexomostat (CHEBI:758528) has role antineoplastic agent (CHEBI:35610) |
| evixapodlin (CHEBI:758814) has role antineoplastic agent (CHEBI:35610) |
| evofosfamide (CHEBI:231678) has role antineoplastic agent (CHEBI:35610) |
| evolocumab (CHEBI:755001) has role antineoplastic agent (CHEBI:35610) |
| evorpacept (CHEBI:757318) has role antineoplastic agent (CHEBI:35610) |
| EVP4593 (CHEBI:232358) has role antineoplastic agent (CHEBI:35610) |
| evunzekibart (CHEBI:758881) has role antineoplastic agent (CHEBI:35610) |
| exarafenib (CHEBI:758682) has role antineoplastic agent (CHEBI:35610) |
| Exatecan mesilate hydrate (CHEBI:31587) has role antineoplastic agent (CHEBI:35610) |
| exemestane (CHEBI:4953) has role antineoplastic agent (CHEBI:35610) |
| exicorilant (CHEBI:756591) has role antineoplastic agent (CHEBI:35610) |
| exlinkibart (CHEBI:759372) has role antineoplastic agent (CHEBI:35610) |
| ezabenlimab (CHEBI:758492) has role antineoplastic agent (CHEBI:35610) |
| ezatiostat (CHEBI:754420) has role antineoplastic agent (CHEBI:35610) |
| ezatiostat hydrochloride (CHEBI:750475) has role antineoplastic agent (CHEBI:35610) |
| ezobresib (CHEBI:756944) has role antineoplastic agent (CHEBI:35610) |
| ezurpimtrostat (CHEBI:758762) has role antineoplastic agent (CHEBI:35610) |
| F-14512 (CHEBI:232860) has role antineoplastic agent (CHEBI:35610) |
| f-arag f-18 (CHEBI:759630) has role antineoplastic agent (CHEBI:35610) |
| f16il2 (CHEBI:754340) has role antineoplastic agent (CHEBI:35610) |
| f16sip 131i (CHEBI:754341) has role antineoplastic agent (CHEBI:35610) |
| f19 131i (CHEBI:754378) has role antineoplastic agent (CHEBI:35610) |
| F390B (CHEBI:65893) has role antineoplastic agent (CHEBI:35610) |
| F390C (CHEBI:65894) has role antineoplastic agent (CHEBI:35610) |
| falbikitug (CHEBI:759700) has role antineoplastic agent (CHEBI:35610) |
| famitinib (CHEBI:749753) has role antineoplastic agent (CHEBI:35610) |
| fanastomig (CHEBI:759524) has role antineoplastic agent (CHEBI:35610) |
| fangchinoline (CHEBI:132893) has role antineoplastic agent (CHEBI:35610) |
| fanregratinib (CHEBI:759970) has role antineoplastic agent (CHEBI:35610) |
| fapi ga-68 (CHEBI:758251) has role antineoplastic agent (CHEBI:35610) |
| fapi-46 ga-68 (CHEBI:758904) has role antineoplastic agent (CHEBI:35610) |
| farletuzumab (CHEBI:750094) has role antineoplastic agent (CHEBI:35610) |
| farletuzumab ecteribulin (CHEBI:758523) has role antineoplastic agent (CHEBI:35610) |
| favezelimab (CHEBI:757230) has role antineoplastic agent (CHEBI:35610) |
| fazarabine (CHEBI:141077) has role antineoplastic agent (CHEBI:35610) |
| FB23-2 (CHEBI:746967) has role antineoplastic agent (CHEBI:35610) |
| FD-211 (CHEBI:65896) has role antineoplastic agent (CHEBI:35610) |
| fedratinib hydrochloride (CHEBI:756722) has role antineoplastic agent (CHEBI:35610) |
| feladilimab (CHEBI:757399) has role antineoplastic agent (CHEBI:35610) |
| felmetatug (CHEBI:760164) has role antineoplastic agent (CHEBI:35610) |
| felmetatug vedotin (CHEBI:760165) has role antineoplastic agent (CHEBI:35610) |
| felzartamab (CHEBI:758052) has role antineoplastic agent (CHEBI:35610) |
| fenamic acid (CHEBI:34756) has role antineoplastic agent (CHEBI:35610) |
| fencabtagene autoleucel (CHEBI:759525) has role antineoplastic agent (CHEBI:35610) |
| fenofibrate (CHEBI:5001) has role antineoplastic agent (CHEBI:35610) |
| fenofibric acid (CHEBI:83469) has role antineoplastic agent (CHEBI:35610) |
| fentanyl (CHEBI:119915) has role antineoplastic agent (CHEBI:35610) |
| fentanyl citrate (CHEBI:31602) has role antineoplastic agent (CHEBI:35610) |
| ferric carboxymaltose (CHEBI:753551) has role antineoplastic agent (CHEBI:35610) |
| ferric hydroxide (CHEBI:135985) has role antineoplastic agent (CHEBI:35610) |
| ferroptocide (CHEBI:173106) has role antineoplastic agent (CHEBI:35610) |
| ferruginol (CHEBI:78274) has role antineoplastic agent (CHEBI:35610) |
| ferumoxytol (CHEBI:749612) has role antineoplastic agent (CHEBI:35610) |
| fexapotide triflutate (CHEBI:755790) has role antineoplastic agent (CHEBI:35610) |
| fexofenadine (CHEBI:5050) has role antineoplastic agent (CHEBI:35610) |
| ff-10101 (CHEBI:758188) has role antineoplastic agent (CHEBI:35610) |
| fgf401 (CHEBI:755973) has role antineoplastic agent (CHEBI:35610) |
| fgfr inhibitor debio 1347 (CHEBI:755972) has role antineoplastic agent (CHEBI:35610) |
| FHD-286 (CHEBI:233318) has role antineoplastic agent (CHEBI:35610) |
| fianlimab (CHEBI:757504) has role antineoplastic agent (CHEBI:35610) |
| fianlimab dfo zr-89 (CHEBI:760502) has role antineoplastic agent (CHEBI:35610) |
| Fibrin (CHEBI:5054) has role antineoplastic agent (CHEBI:35610) |
| ficerafusp alfa (CHEBI:758887) has role antineoplastic agent (CHEBI:35610) |
| ficlatuzumab (CHEBI:750096) has role antineoplastic agent (CHEBI:35610) |
| ficonalkib (CHEBI:759167) has role antineoplastic agent (CHEBI:35610) |
| figitumumab (CHEBI:750097) has role antineoplastic agent (CHEBI:35610) |
| filanesib (CHEBI:754957) has role antineoplastic agent (CHEBI:35610) |
| filgrastim (CHEBI:749461) has role antineoplastic agent (CHEBI:35610) |
| fimaporfin (CHEBI:757320) has role antineoplastic agent (CHEBI:35610) |
| fingolimod (CHEBI:63115) has role antineoplastic agent (CHEBI:35610) |
| fingolimod hydrochloride (CHEBI:63112) has role antineoplastic agent (CHEBI:35610) |
| fingolimod phosphate (CHEBI:73420) has role antineoplastic agent (CHEBI:35610) |
| FINO2 (CHEBI:176420) has role antineoplastic agent (CHEBI:35610) |
| finotonlimab (CHEBI:758393) has role antineoplastic agent (CHEBI:35610) |
| firastotug (CHEBI:759697) has role antineoplastic agent (CHEBI:35610) |
| firicabtagene autoleucel (CHEBI:759526) has role antineoplastic agent (CHEBI:35610) |
| firmonertinib (CHEBI:756763) has role antineoplastic agent (CHEBI:35610) |
| firmonertinib mesylate (CHEBI:760387) has role antineoplastic agent (CHEBI:35610) |
| firocoxib (CHEBI:76136) has role antineoplastic agent (CHEBI:35610) |
| firtecan pegol (CHEBI:757748) has role antineoplastic agent (CHEBI:35610) |
| fisetin (CHEBI:42567) has role antineoplastic agent (CHEBI:35610) |
| fish oil (CHEBI:755949) has role antineoplastic agent (CHEBI:35610) |
| fish oil triglycerides (CHEBI:757013) has role antineoplastic agent (CHEBI:35610) |
| fisogatinib (CHEBI:757699) has role antineoplastic agent (CHEBI:35610) |
| FK-866 (CHEBI:187413) has role antineoplastic agent (CHEBI:35610) |
| flanvotumab (CHEBI:753671) has role antineoplastic agent (CHEBI:35610) |
| flavokawain B (CHEBI:65899) has role antineoplastic agent (CHEBI:35610) |
| flavone (CHEBI:42491) has role antineoplastic agent (CHEBI:35610) |
| flezurafenib (CHEBI:759928) has role antineoplastic agent (CHEBI:35610) |
| flibanserin (CHEBI:90865) has role antineoplastic agent (CHEBI:35610) |
| florbenguane f18 (CHEBI:758249) has role antineoplastic agent (CHEBI:35610) |
| florbetapir F-18 (CHEBI:66880) has role antineoplastic agent (CHEBI:35610) |
| floretyrosine f18 (CHEBI:748989) has role antineoplastic agent (CHEBI:35610) |
| florilglutamic acid f-18 (CHEBI:759632) has role antineoplastic agent (CHEBI:35610) |
| flotetuzumab (CHEBI:756518) has role antineoplastic agent (CHEBI:35610) |
| flotufolastat F-18 (CHEBI:229648) has role antineoplastic agent (CHEBI:35610) |
| flotufolastat F-18 gallium (CHEBI:229675) has role antineoplastic agent (CHEBI:35610) |
| floxuridine (CHEBI:60761) has role antineoplastic agent (CHEBI:35610) |
| fluciclovine (18F) (CHEBI:134703) has role antineoplastic agent (CHEBI:35610) |
| fluconazole (CHEBI:46081) has role antineoplastic agent (CHEBI:35610) |
| flucytosine (CHEBI:5100) has role antineoplastic agent (CHEBI:35610) |
| fludarabine phosphate (CHEBI:63599) has role antineoplastic agent (CHEBI:35610) |
| fludeoxyglucose f 18 (CHEBI:750387) has role antineoplastic agent (CHEBI:35610) |
| fludrocortisone acetate (CHEBI:5102) has role antineoplastic agent (CHEBI:35610) |
| flumatinib (CHEBI:233593) has role antineoplastic agent (CHEBI:35610) |
| fluopsin C (CHEBI:222417) has role antineoplastic agent (CHEBI:35610) |
| fluorescein (lactone form) (CHEBI:31624) has role antineoplastic agent (CHEBI:35610) |
| fluorescein sodium (CHEBI:749924) has role antineoplastic agent (CHEBI:35610) |
| fluoride ion f-18 (CHEBI:748569) has role antineoplastic agent (CHEBI:35610) |
| fluoroestradiol (CHEBI:749923) has role antineoplastic agent (CHEBI:35610) |
| fluoroestradiol f-18 (CHEBI:757767) has role antineoplastic agent (CHEBI:35610) |
| fluorofuranylnorprogesterone (CHEBI:748749) has role antineoplastic agent (CHEBI:35610) |
| fluorofuranylnorprogesterone f-18 (CHEBI:756870) has role antineoplastic agent (CHEBI:35610) |
| fluoromisonidazole (CHEBI:750421) has role antineoplastic agent (CHEBI:35610) |
| fluoxetine (CHEBI:5118) has role antineoplastic agent (CHEBI:35610) |
| fluoxymesterone (CHEBI:5120) has role antineoplastic agent (CHEBI:35610) |
| Fluphenazine hydrochloride (CHEBI:5126) has role antineoplastic agent (CHEBI:35610) |
| flutamide (CHEBI:5132) has role antineoplastic agent (CHEBI:35610) |
| flutemetamol (CHEBI:749082) has role antineoplastic agent (CHEBI:35610) |
| fluticasone propionate (CHEBI:31441) has role antineoplastic agent (CHEBI:35610) |
| fluvastatin (CHEBI:38561) has role antineoplastic agent (CHEBI:35610) |
| fluvastatin sodium (CHEBI:5137) has role antineoplastic agent (CHEBI:35610) |
| fluvoxamine (CHEBI:5138) has role antineoplastic agent (CHEBI:35610) |
| fluzoparib (CHEBI:755990) has role antineoplastic agent (CHEBI:35610) |
| flysyn (CHEBI:758191) has role antineoplastic agent (CHEBI:35610) |
| fn-1501 (CHEBI:757954) has role antineoplastic agent (CHEBI:35610) |
| folic acid (CHEBI:27470) has role antineoplastic agent (CHEBI:35610) |
| folitixorin calcium (CHEBI:750476) has role antineoplastic agent (CHEBI:35610) |
| fondaparinux (CHEBI:61033) has role antineoplastic agent (CHEBI:35610) |
| foretinib (CHEBI:91418) has role antineoplastic agent (CHEBI:35610) |
| forimtamig (CHEBI:759375) has role antineoplastic agent (CHEBI:35610) |
| formestane (CHEBI:75172) has role antineoplastic agent (CHEBI:35610) |
| formoterol fumarate (CHEBI:31633) has role antineoplastic agent (CHEBI:35610) |
| formycin A (CHEBI:42452) has role antineoplastic agent (CHEBI:35610) |
| forodesine hydrochloride (CHEBI:749070) has role antineoplastic agent (CHEBI:35610) |
| fosaprepitant (CHEBI:64321) has role antineoplastic agent (CHEBI:35610) |
| fosaprepitant dimeglumine (CHEBI:64311) has role antineoplastic agent (CHEBI:35610) |
| fosbretabulin (CHEBI:749625) has role antineoplastic agent (CHEBI:35610) |
| fosbretabulin disodium (CHEBI:748146) has role antineoplastic agent (CHEBI:35610) |
| fosbretabulin tromethamine (CHEBI:751546) has role antineoplastic agent (CHEBI:35610) |
| fosciclopirox (CHEBI:758471) has role antineoplastic agent (CHEBI:35610) |
| fosdesdenosine sipalabenamide (CHEBI:759079) has role antineoplastic agent (CHEBI:35610) |
| foselutoclax (CHEBI:759929) has role antineoplastic agent (CHEBI:35610) |
| fosfomycin (CHEBI:28915) has role antineoplastic agent (CHEBI:35610) |
| fosgemcitabine palabenamide (CHEBI:755134) has role antineoplastic agent (CHEBI:35610) |
| fosifloxuridine nafalbenamide (CHEBI:754840) has role antineoplastic agent (CHEBI:35610) |
| foslinanib (CHEBI:749906) has role antineoplastic agent (CHEBI:35610) |
| fosmanogepix (CHEBI:757066) has role antineoplastic agent (CHEBI:35610) |
| fospropofol (CHEBI:135193) has role antineoplastic agent (CHEBI:35610) |
| fostamatinib (CHEBI:750486) has role antineoplastic agent (CHEBI:35610) |
| fostamatinib disodium (CHEBI:756118) has role antineoplastic agent (CHEBI:35610) |
| fostriecin (CHEBI:167004) has role antineoplastic agent (CHEBI:35610) |
| fostroxacitabine bralpamide (CHEBI:759127) has role antineoplastic agent (CHEBI:35610) |
| fostroxacitabine bralpamide hydrochloride (CHEBI:759253) has role antineoplastic agent (CHEBI:35610) |
| fotemustine (CHEBI:131848) has role antineoplastic agent (CHEBI:35610) |
| fovinaciclib (CHEBI:759930) has role antineoplastic agent (CHEBI:35610) |
| fp-1039 (CHEBI:757205) has role antineoplastic agent (CHEBI:35610) |
| fpt-155 (CHEBI:757857) has role antineoplastic agent (CHEBI:35610) |
| FR901463 (CHEBI:65914) has role antineoplastic agent (CHEBI:35610) |
| FR901464 (CHEBI:65915) has role antineoplastic agent (CHEBI:35610) |
| FR901465 (CHEBI:65916) has role antineoplastic agent (CHEBI:35610) |
| frenlosirsen (CHEBI:758167) has role antineoplastic agent (CHEBI:35610) |
| frenlosirsen sodium (CHEBI:758359) has role antineoplastic agent (CHEBI:35610) |
| fresolimumab (CHEBI:750100) has role antineoplastic agent (CHEBI:35610) |
| froniglutide (CHEBI:759673) has role antineoplastic agent (CHEBI:35610) |
| fruquintinib (CHEBI:229221) has role antineoplastic agent (CHEBI:35610) |
| fruticoside A (CHEBI:67584) has role antineoplastic agent (CHEBI:35610) |
| fs-102 (CHEBI:757386) has role antineoplastic agent (CHEBI:35610) |
| fucoidan (CHEBI:5181) has role antineoplastic agent (CHEBI:35610) |
| fulvestrant (CHEBI:31638) has role antineoplastic agent (CHEBI:35610) |
| fulzerasib (CHEBI:759169) has role antineoplastic agent (CHEBI:35610) |
| furosemide (CHEBI:47426) has role antineoplastic agent (CHEBI:35610) |
| fusarithioamide A (CHEBI:141359) has role antineoplastic agent (CHEBI:35610) |
| fusidic acid (CHEBI:29013) has role antineoplastic agent (CHEBI:35610) |
| futibatinib (CHEBI:755715) has role antineoplastic agent (CHEBI:35610) |
| futuximab (CHEBI:754204) has role antineoplastic agent (CHEBI:35610) |
| fuzanin D (CHEBI:65939) has role antineoplastic agent (CHEBI:35610) |
| fx-909 (CHEBI:760421) has role antineoplastic agent (CHEBI:35610) |
| FX1 (CHEBI:133537) has role antineoplastic agent (CHEBI:35610) |
| G-1 (CHEBI:156296) has role antineoplastic agent (CHEBI:35610) |
| G-15 (CHEBI:156295) has role antineoplastic agent (CHEBI:35610) |
| G-573 (CHEBI:83404) has role antineoplastic agent (CHEBI:35610) |
| g17dt immunogen (CHEBI:758853) has role antineoplastic agent (CHEBI:35610) |
| gabapentin (CHEBI:42797) has role antineoplastic agent (CHEBI:35610) |
| gadobenate dimeglumine (CHEBI:749279) has role antineoplastic agent (CHEBI:35610) |
| gadobutrol (CHEBI:68841) has role antineoplastic agent (CHEBI:35610) |
| gadofosveset (CHEBI:750267) has role antineoplastic agent (CHEBI:35610) |
| gadolinium (CHEBI:749665) has role antineoplastic agent (CHEBI:35610) |
| gadopentetate dimeglumine (CHEBI:31797) has role antineoplastic agent (CHEBI:35610) |
| gadopiclenol (CHEBI:757103) has role antineoplastic agent (CHEBI:35610) |
| gadoterate meglumine (CHEBI:73727) has role antineoplastic agent (CHEBI:35610) |
| gadoteridol (CHEBI:31643) has role antineoplastic agent (CHEBI:35610) |
| Galeterone (CHEBI:177536) has role antineoplastic agent (CHEBI:35610) |
| galgenprostucel-l (CHEBI:753048) has role antineoplastic agent (CHEBI:35610) |
| galinpepimut-s (CHEBI:755957) has role antineoplastic agent (CHEBI:35610) |
| galiximab (CHEBI:754080) has role antineoplastic agent (CHEBI:35610) |
| gallic acid (CHEBI:30778) has role antineoplastic agent (CHEBI:35610) |
| gallium citrate ga 67 (CHEBI:749353) has role antineoplastic agent (CHEBI:35610) |
| gallium ga 68 gozetotide (CHEBI:758625) has role antineoplastic agent (CHEBI:35610) |
| gallium nitrate (CHEBI:231505) has role antineoplastic agent (CHEBI:35610) |
| gamitrinib (CHEBI:758116) has role antineoplastic agent (CHEBI:35610) |
| ganciclovir (CHEBI:465284) has role antineoplastic agent (CHEBI:35610) |
| ganciclovir sodium (CHEBI:749328) has role antineoplastic agent (CHEBI:35610) |
| gancotamab (CHEBI:755935) has role antineoplastic agent (CHEBI:35610) |
| Gandotinib (CHEBI:188757) has role antineoplastic agent (CHEBI:35610) |
| Ganetespib (CHEBI:177770) has role antineoplastic agent (CHEBI:35610) |
| ganitumab (CHEBI:750102) has role antineoplastic agent (CHEBI:35610) |
| GANT61 (CHEBI:140908) has role antineoplastic agent (CHEBI:35610) |
| gardiquimod (CHEBI:234430) has role antineoplastic agent (CHEBI:35610) |
| garivulimab (CHEBI:758333) has role antineoplastic agent (CHEBI:35610) |
| garlic (CHEBI:753431) has role antineoplastic agent (CHEBI:35610) |
| garsorasib (CHEBI:758650) has role antineoplastic agent (CHEBI:35610) |
| gartanin (CHEBI:5279) has role antineoplastic agent (CHEBI:35610) |
| gartisertib (CHEBI:231616) has role antineoplastic agent (CHEBI:35610) |
| gastrin-17 (CHEBI:75441) has role antineoplastic agent (CHEBI:35610) |
| gataparsen (CHEBI:754918) has role antineoplastic agent (CHEBI:35610) |
| gatipotuzumab (CHEBI:757035) has role antineoplastic agent (CHEBI:35610) |
| gaudichaudiic acid F (CHEBI:65950) has role antineoplastic agent (CHEBI:35610) |
| gaudichaudiic acid G (CHEBI:65951) has role antineoplastic agent (CHEBI:35610) |
| gaudichaudiic acid H (CHEBI:65952) has role antineoplastic agent (CHEBI:35610) |
| gaudichaudiic acid I (CHEBI:65953) has role antineoplastic agent (CHEBI:35610) |
| gavocabtagene autoleucel (CHEBI:758566) has role antineoplastic agent (CHEBI:35610) |
| gc1118 (CHEBI:758193) has role antineoplastic agent (CHEBI:35610) |
| gdc-0152 (CHEBI:750414) has role antineoplastic agent (CHEBI:35610) |
| GDC-0326 (CHEBI:229938) has role antineoplastic agent (CHEBI:35610) |
| GDC-0623 (CHEBI:167659) has role antineoplastic agent (CHEBI:35610) |
| GDC-0879 (CHEBI:83405) has role antineoplastic agent (CHEBI:35610) |
| gdc-0917 (CHEBI:756782) has role antineoplastic agent (CHEBI:35610) |
| gdc-0927 (CHEBI:757207) has role antineoplastic agent (CHEBI:35610) |
| gebasaxturev (CHEBI:759001) has role antineoplastic agent (CHEBI:35610) |
| Gedatolisib (CHEBI:747853) has role antineoplastic agent (CHEBI:35610) |
| gedunin (CHEBI:65954) has role antineoplastic agent (CHEBI:35610) |
| gefitinib (CHEBI:49668) has role antineoplastic agent (CHEBI:35610) |
| gelatin (CHEBI:5291) has role antineoplastic agent (CHEBI:35610) |
| geldanamycin (CHEBI:5292) has role antineoplastic agent (CHEBI:35610) |
| gelomulide K (CHEBI:65955) has role antineoplastic agent (CHEBI:35610) |
| gelomulide M (CHEBI:65956) has role antineoplastic agent (CHEBI:35610) |
| gemcitabine (CHEBI:175901) has role antineoplastic agent (CHEBI:35610) |
| Gemcitabine elaidate (CHEBI:177710) has role antineoplastic agent (CHEBI:35610) |
| gemcitabine hydrochloride (CHEBI:31647) has role antineoplastic agent (CHEBI:35610) |
| gemfibrozil (CHEBI:5296) has role antineoplastic agent (CHEBI:35610) |
| gemigliptin (CHEBI:134731) has role antineoplastic agent (CHEBI:35610) |
| gemini-0072 (CHEBI:139243) has role antineoplastic agent (CHEBI:35610) |
| gemini-0097 (CHEBI:139244) has role antineoplastic agent (CHEBI:35610) |
| gemtuzumab (CHEBI:753322) has role antineoplastic agent (CHEBI:35610) |
| gemtuzumab ozogamicin (CHEBI:749520) has role antineoplastic agent (CHEBI:35610) |
| gen-1053 (CHEBI:760513) has role antineoplastic agent (CHEBI:35610) |
| gengleucel (CHEBI:759529) has role antineoplastic agent (CHEBI:35610) |
| genistein (CHEBI:28088) has role antineoplastic agent (CHEBI:35610) |
| gentamicin (CHEBI:759884) has role antineoplastic agent (CHEBI:35610) |
| gentisyl alcohol (CHEBI:5325) has role antineoplastic agent (CHEBI:35610) |
| gentulizumab (CHEBI:759674) has role antineoplastic agent (CHEBI:35610) |
| genz-644282 (CHEBI:748717) has role antineoplastic agent (CHEBI:35610) |
| gevokizumab (CHEBI:750104) has role antineoplastic agent (CHEBI:35610) |
| ggti-2418 (CHEBI:755223) has role antineoplastic agent (CHEBI:35610) |
| ghrelin (CHEBI:75431) has role antineoplastic agent (CHEBI:35610) |
| GI254023X (CHEBI:143102) has role antineoplastic agent (CHEBI:35610) |
| gibberosin K (CHEBI:65960) has role antineoplastic agent (CHEBI:35610) |
| gibberosin L (CHEBI:65961) has role antineoplastic agent (CHEBI:35610) |
| gigantetronenin (CHEBI:65962) has role antineoplastic agent (CHEBI:35610) |
| gigantrionenin (CHEBI:65963) has role antineoplastic agent (CHEBI:35610) |
| gilmelisib (CHEBI:758651) has role antineoplastic agent (CHEBI:35610) |
| giloralimab (CHEBI:757991) has role antineoplastic agent (CHEBI:35610) |
| gilteritinib (CHEBI:145372) has role antineoplastic agent (CHEBI:35610) |
| gilteritinib fumarate (CHEBI:755286) has role antineoplastic agent (CHEBI:35610) |
| gilvusmycin (CHEBI:65964) has role antineoplastic agent (CHEBI:35610) |
| gimatecan (CHEBI:748458) has role antineoplastic agent (CHEBI:35610) |
| gimistotug (CHEBI:760040) has role antineoplastic agent (CHEBI:35610) |
| gindameran (CHEBI:759309) has role antineoplastic agent (CHEBI:35610) |
| ginger (CHEBI:753433) has role antineoplastic agent (CHEBI:35610) |
| gingerol (CHEBI:10136) has role antineoplastic agent (CHEBI:35610) |
| ginkgetin (CHEBI:5353) has role antineoplastic agent (CHEBI:35610) |
| ginkgolide B (CHEBI:5356) has role antineoplastic agent (CHEBI:35610) |
| ginseng, american (CHEBI:754085) has role antineoplastic agent (CHEBI:35610) |
| ginseng, asian (CHEBI:753435) has role antineoplastic agent (CHEBI:35610) |
| ginsenoside C-K (CHEBI:77146) has role antineoplastic agent (CHEBI:35610) |
| ginsenoside F2 (CHEBI:77145) has role antineoplastic agent (CHEBI:35610) |
| ginsenoside Mc (CHEBI:77491) has role antineoplastic agent (CHEBI:35610) |
| ginsenoside Mx (CHEBI:77490) has role antineoplastic agent (CHEBI:35610) |
| ginsenoside Re (CHEBI:77148) has role antineoplastic agent (CHEBI:35610) |
| ginsenoside Rf (CHEBI:67986) has role antineoplastic agent (CHEBI:35610) |
| giredestrant (CHEBI:758216) has role antineoplastic agent (CHEBI:35610) |
| girentuximab (CHEBI:750105) has role antineoplastic agent (CHEBI:35610) |
| givastomig (CHEBI:759530) has role antineoplastic agent (CHEBI:35610) |
| givinostat (CHEBI:94187) has role antineoplastic agent (CHEBI:35610) |
| givinostat hydrochloride (CHEBI:231333) has role antineoplastic agent (CHEBI:35610) |
| givinostat hydrochloride monohydrate (CHEBI:231335) has role antineoplastic agent (CHEBI:35610) |
| glasdegib (CHEBI:145428) has role antineoplastic agent (CHEBI:35610) |
| glasdegib maleate (CHEBI:757012) has role antineoplastic agent (CHEBI:35610) |
| glatiramer acetate (CHEBI:749565) has role antineoplastic agent (CHEBI:35610) |
| glaucarubinone (CHEBI:5371) has role antineoplastic agent (CHEBI:35610) |
| glecirasib (CHEBI:759222) has role antineoplastic agent (CHEBI:35610) |
| glembatumumab (CHEBI:753650) has role antineoplastic agent (CHEBI:35610) |
| glembatumumab vedotin (CHEBI:750106) has role antineoplastic agent (CHEBI:35610) |
| glesatinib (CHEBI:756408) has role antineoplastic agent (CHEBI:35610) |
| glionitrin A (CHEBI:65967) has role antineoplastic agent (CHEBI:35610) |
| glipizide (CHEBI:5384) has role antineoplastic agent (CHEBI:35610) |
| globostellatic acid A (CHEBI:72301) has role antineoplastic agent (CHEBI:35610) |
| globostellatic acid B (CHEBI:72304) has role antineoplastic agent (CHEBI:35610) |
| globostellatic acid C (CHEBI:72308) has role antineoplastic agent (CHEBI:35610) |
| globostellatic acid D (CHEBI:72310) has role antineoplastic agent (CHEBI:35610) |
| globosumone A (CHEBI:68705) has role antineoplastic agent (CHEBI:35610) |
| globosumone B (CHEBI:68706) has role antineoplastic agent (CHEBI:35610) |
| globosuxanthone A (CHEBI:68712) has role antineoplastic agent (CHEBI:35610) |
| glochierioside A (CHEBI:65973) has role antineoplastic agent (CHEBI:35610) |
| glochierioside B (CHEBI:65974) has role antineoplastic agent (CHEBI:35610) |
| glofitamab (CHEBI:757511) has role antineoplastic agent (CHEBI:35610) |
| glpg-0187 (CHEBI:755320) has role antineoplastic agent (CHEBI:35610) |
| Glu-Trp (CHEBI:73512) has role antineoplastic agent (CHEBI:35610) |
| glucarpidase (CHEBI:750223) has role antineoplastic agent (CHEBI:35610) |
| glufosfamide (CHEBI:752456) has role antineoplastic agent (CHEBI:35610) |
| glutathione disulfide (CHEBI:17858) has role antineoplastic agent (CHEBI:35610) |
| glycerol (CHEBI:17754) has role antineoplastic agent (CHEBI:35610) |
| glycyrol (CHEBI:80832) has role antineoplastic agent (CHEBI:35610) |
| glycyrrhizinic acid (CHEBI:15939) has role antineoplastic agent (CHEBI:35610) |
| gnidilatimonoein (CHEBI:65978) has role antineoplastic agent (CHEBI:35610) |
| gnkg-168 (CHEBI:757392) has role antineoplastic agent (CHEBI:35610) |
| go-203-2c (CHEBI:756952) has role antineoplastic agent (CHEBI:35610) |
| gocatamig (CHEBI:760041) has role antineoplastic agent (CHEBI:35610) |
| golcadomide (CHEBI:758803) has role antineoplastic agent (CHEBI:35610) |
| golcadomide hydrochloride (CHEBI:760317) has role antineoplastic agent (CHEBI:35610) |
| gold (CHEBI:755184) has role antineoplastic agent (CHEBI:35610) |
| gold sodium thiomalate (CHEBI:748324) has role antineoplastic agent (CHEBI:35610) |
| golidocitinib (CHEBI:757725) has role antineoplastic agent (CHEBI:35610) |
| golimumab (CHEBI:749607) has role antineoplastic agent (CHEBI:35610) |
| Golvatinib (CHEBI:177746) has role antineoplastic agent (CHEBI:35610) |
| gonadorelin (CHEBI:5520) has role antineoplastic agent (CHEBI:35610) |
| gonadorelin acetate (CHEBI:749265) has role antineoplastic agent (CHEBI:35610) |
| gonadotropin, chorionic (CHEBI:749576) has role antineoplastic agent (CHEBI:35610) |
| Goserelin (CHEBI:5523) has role antineoplastic agent (CHEBI:35610) |
| goserelin acetate (CHEBI:749262) has role antineoplastic agent (CHEBI:35610) |
| gossypol (CHEBI:28584) has role antineoplastic agent (CHEBI:35610) |
| gossypol acetic acid (CHEBI:749016) has role antineoplastic agent (CHEBI:35610) |
| gotistobart (CHEBI:759677) has role antineoplastic agent (CHEBI:35610) |
| gozetotide (CHEBI:755642) has role antineoplastic agent (CHEBI:35610) |
| gozetotide alf-18 (CHEBI:758250) has role antineoplastic agent (CHEBI:35610) |
| gp-100 antigen (CHEBI:757393) has role antineoplastic agent (CHEBI:35610) |
| gpi-0100 (CHEBI:758286) has role antineoplastic agent (CHEBI:35610) |
| granaticin (CHEBI:5533) has role antineoplastic agent (CHEBI:35610) |
| granaticin b (CHEBI:755324) has role antineoplastic agent (CHEBI:35610) |
| grapiprant (CHEBI:755055) has role antineoplastic agent (CHEBI:35610) |
| grassypeptolide (CHEBI:65980) has role antineoplastic agent (CHEBI:35610) |
| gridegalutamide (CHEBI:760325) has role antineoplastic agent (CHEBI:35610) |
| griffithane A (CHEBI:69700) has role antineoplastic agent (CHEBI:35610) |
| griffithane B (CHEBI:69701) has role antineoplastic agent (CHEBI:35610) |
| griffithane D (CHEBI:69703) has role antineoplastic agent (CHEBI:35610) |
| gs-9901 (CHEBI:755989) has role antineoplastic agent (CHEBI:35610) |
| gsk-1059615 (CHEBI:755394) has role antineoplastic agent (CHEBI:35610) |
| gsk-1795091 (CHEBI:758519) has role antineoplastic agent (CHEBI:35610) |
| gsk-2256098 (CHEBI:758420) has role antineoplastic agent (CHEBI:35610) |
| gsk-2636771 (CHEBI:755218) has role antineoplastic agent (CHEBI:35610) |
| gsk-3174998 (CHEBI:757398) has role antineoplastic agent (CHEBI:35610) |
| GSK-923295 (CHEBI:234356) has role antineoplastic agent (CHEBI:35610) |
| GSK-J1 (CHEBI:131152) has role antineoplastic agent (CHEBI:35610) |
| GSK-J4 (CHEBI:95077) has role antineoplastic agent (CHEBI:35610) |
| GSK046 (CHEBI:231669) has role antineoplastic agent (CHEBI:35610) |
| GSK1059615 (CHEBI:71955) has role antineoplastic agent (CHEBI:35610) |
| GSK126 (CHEBI:124921) has role antineoplastic agent (CHEBI:35610) |
| GSK2656157 (CHEBI:139047) has role antineoplastic agent (CHEBI:35610) |
| GSK2879552 (CHEBI:176334) has role antineoplastic agent (CHEBI:35610) |
| GSK343 (CHEBI:167693) has role antineoplastic agent (CHEBI:35610) |
| GSK461364 (CHEBI:91333) has role antineoplastic agent (CHEBI:35610) |
| GSK690693 (CHEBI:90677) has role antineoplastic agent (CHEBI:35610) |
| gti-2040 (CHEBI:757212) has role antineoplastic agent (CHEBI:35610) |
| gtx-758 (CHEBI:755420) has role antineoplastic agent (CHEBI:35610) |
| guadecitabine (CHEBI:231603) has role antineoplastic agent (CHEBI:35610) |
| guanazole (CHEBI:75425) has role antineoplastic agent (CHEBI:35610) |
| guanidine (CHEBI:42820) has role antineoplastic agent (CHEBI:35610) |
| guanidine hydrochloride (CHEBI:749309) has role antineoplastic agent (CHEBI:35610) |
| guanine (CHEBI:16235) has role antineoplastic agent (CHEBI:35610) |
| gumarontinib (CHEBI:757889) has role antineoplastic agent (CHEBI:35610) |
| gumelutamide (CHEBI:759172) has role antineoplastic agent (CHEBI:35610) |
| gummiferaoside A (CHEBI:65986) has role antineoplastic agent (CHEBI:35610) |
| gummiferaoside B (CHEBI:65987) has role antineoplastic agent (CHEBI:35610) |
| gummiferaoside C (CHEBI:65988) has role antineoplastic agent (CHEBI:35610) |
| guretolimod (CHEBI:759254) has role antineoplastic agent (CHEBI:35610) |
| gusacitinib (CHEBI:757778) has role antineoplastic agent (CHEBI:35610) |
| gusacitinib hydrochloride (CHEBI:757779) has role antineoplastic agent (CHEBI:35610) |
| GW843682X (CHEBI:91334) has role antineoplastic agent (CHEBI:35610) |
| gwn-323 (CHEBI:757402) has role antineoplastic agent (CHEBI:35610) |
| GYS32661 (CHEBI:197341) has role antineoplastic agent (CHEBI:35610) |
| H-Ala-Val-Pro-Ile-NH2 (CHEBI:234235) has role antineoplastic agent (CHEBI:35610) |
| h3b-6545 (CHEBI:760423) has role antineoplastic agent (CHEBI:35610) |
| HA15 (CHEBI:132781) has role antineoplastic agent (CHEBI:35610) |
| hadacidin (CHEBI:43040) has role antineoplastic agent (CHEBI:35610) |
| hafnium oxide (CHEBI:757474) has role antineoplastic agent (CHEBI:35610) |
| halofuginone hydrobromide (CHEBI:749041) has role antineoplastic agent (CHEBI:35610) |
| HC toxin (CHEBI:48028) has role antineoplastic agent (CHEBI:35610) |
| hcbe-11 (CHEBI:754288) has role antineoplastic agent (CHEBI:35610) |
| he3235 (CHEBI:755532) has role antineoplastic agent (CHEBI:35610) |
| hedychilactone D (CHEBI:66009) has role antineoplastic agent (CHEBI:35610) |
| hefi-1 (CHEBI:754122) has role antineoplastic agent (CHEBI:35610) |
| helenalin (CHEBI:5635) has role antineoplastic agent (CHEBI:35610) |
| heliangin (CHEBI:5638) has role antineoplastic agent (CHEBI:35610) |
| helioxanthin (CHEBI:191856) has role antineoplastic agent (CHEBI:35610) |
| hellebrigenin (CHEBI:38344) has role antineoplastic agent (CHEBI:35610) |
| helveticoside (CHEBI:5650) has role antineoplastic agent (CHEBI:35610) |
| hemay-022 (CHEBI:755466) has role antineoplastic agent (CHEBI:35610) |
| hemin (CHEBI:50385) has role antineoplastic agent (CHEBI:35610) |
| henatinib (CHEBI:749751) has role antineoplastic agent (CHEBI:35610) |
| heparin (CHEBI:28304) has role antineoplastic agent (CHEBI:35610) |
| heparin sodium (CHEBI:230519) has role antineoplastic agent (CHEBI:35610) |
| hepatitis b virus hbsag surface protein antigen (CHEBI:757403) has role antineoplastic agent (CHEBI:35610) |
| herbacetin (CHEBI:27673) has role antineoplastic agent (CHEBI:35610) |
| hesperetin (CHEBI:28230) has role antineoplastic agent (CHEBI:35610) |
| hexamethylmelamine (CHEBI:24564) has role antineoplastic agent (CHEBI:35610) |
| hexaminolevulinate hydrochloride (CHEBI:749596) has role antineoplastic agent (CHEBI:35610) |
| HG-9-91-01 (CHEBI:133818) has role antineoplastic agent (CHEBI:35610) |
| hiltonol (CHEBI:757034) has role antineoplastic agent (CHEBI:35610) |
| himastatin (CHEBI:190009) has role antineoplastic agent (CHEBI:35610) |
| hinokiflavone (CHEBI:5721) has role antineoplastic agent (CHEBI:35610) |
| hippeastrine (CHEBI:5724) has role antineoplastic agent (CHEBI:35610) |
| hispidulin (CHEBI:75902) has role antineoplastic agent (CHEBI:35610) |
| histamine (CHEBI:18295) has role antineoplastic agent (CHEBI:35610) |
| histamine dihydrochloride (CHEBI:749857) has role antineoplastic agent (CHEBI:35610) |
| histrelin (CHEBI:5739) has role antineoplastic agent (CHEBI:35610) |
| histrelin acetate (CHEBI:63530) has role antineoplastic agent (CHEBI:35610) |
| HMN-214 (CHEBI:91440) has role antineoplastic agent (CHEBI:35610) |
| hmpl-453 (CHEBI:758199) has role antineoplastic agent (CHEBI:35610) |
| holomycin (CHEBI:156451) has role antineoplastic agent (CHEBI:35610) |
| holothurin A3 (CHEBI:66018) has role antineoplastic agent (CHEBI:35610) |
| holothurin A4 (CHEBI:66019) has role antineoplastic agent (CHEBI:35610) |
| honey (CHEBI:753365) has role antineoplastic agent (CHEBI:35610) |
| horminone (CHEBI:73128) has role antineoplastic agent (CHEBI:35610) |
| HPI-1 (CHEBI:231759) has role antineoplastic agent (CHEBI:35610) |
| hpn-424 (CHEBI:758353) has role antineoplastic agent (CHEBI:35610) |
| hpph (CHEBI:749014) has role antineoplastic agent (CHEBI:35610) |
| hro-761 (CHEBI:760462) has role antineoplastic agent (CHEBI:35610) |
| hu3s193 (CHEBI:754286) has role antineoplastic agent (CHEBI:35610) |
| hua33 (CHEBI:754229) has role antineoplastic agent (CHEBI:35610) |
| huhmfg1 (CHEBI:754374) has role antineoplastic agent (CHEBI:35610) |
| huj591 111in (CHEBI:754391) has role antineoplastic agent (CHEBI:35610) |
| huj591 177lu (CHEBI:754392) has role antineoplastic agent (CHEBI:35610) |
| human immunoglobulin g (CHEBI:749498) has role antineoplastic agent (CHEBI:35610) |
| human recombinant bone morphogenetic protein 4 (CHEBI:758024) has role antineoplastic agent (CHEBI:35610) |
| humik-beta-1 (CHEBI:754358) has role antineoplastic agent (CHEBI:35610) |
| hyaluronic acid (CHEBI:16336) has role antineoplastic agent (CHEBI:35610) |
| Hyaluronidase (CHEBI:231673) has role antineoplastic agent (CHEBI:35610) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role antineoplastic agent (CHEBI:35610) |
| hydralazine (CHEBI:5775) has role antineoplastic agent (CHEBI:35610) |
| hydrazinocurcumin (CHEBI:84340) has role antineoplastic agent (CHEBI:35610) |
| Hydrocortisone Sodium Succinate (CHEBI:5782) has role antineoplastic agent (CHEBI:35610) |
| hydrogen (CHEBI:757215) has role antineoplastic agent (CHEBI:35610) |
| hydroxocobalamin (CHEBI:27786) has role antineoplastic agent (CHEBI:35610) |
| hydroxychloroquine (CHEBI:5801) has role antineoplastic agent (CHEBI:35610) |
| hydroxychloroquine sulfate (CHEBI:749017) has role antineoplastic agent (CHEBI:35610) |
| hydroxysafflor yellow A (CHEBI:139030) has role antineoplastic agent (CHEBI:35610) |
| hydroxytyrosol (CHEBI:68889) has role antineoplastic agent (CHEBI:35610) |
| hydroxyurea (CHEBI:44423) has role antineoplastic agent (CHEBI:35610) |
| hygrolidin (CHEBI:83959) has role antineoplastic agent (CHEBI:35610) |
| hyperforin (CHEBI:5834) has role antineoplastic agent (CHEBI:35610) |
| hypericin (CHEBI:5835) has role antineoplastic agent (CHEBI:35610) |
| hypericin sodium (CHEBI:759299) has role antineoplastic agent (CHEBI:35610) |
| hyperxanthone C (CHEBI:66057) has role antineoplastic agent (CHEBI:35610) |
| hyperxanthone E (CHEBI:66058) has role antineoplastic agent (CHEBI:35610) |
| hypocrellin D (CHEBI:66059) has role antineoplastic agent (CHEBI:35610) |
| hypothemycin (CHEBI:83275) has role antineoplastic agent (CHEBI:35610) |
| I-BET151 (CHEBI:95083) has role antineoplastic agent (CHEBI:35610) |
| iacs-010759 (CHEBI:758380) has role antineoplastic agent (CHEBI:35610) |
| Iadademstat (CHEBI:234592) has role antineoplastic agent (CHEBI:35610) |
| ianalumab (CHEBI:757852) has role antineoplastic agent (CHEBI:35610) |
| IBANDRONATE (CHEBI:41060) has role antineoplastic agent (CHEBI:35610) |
| ibandronate sodium (CHEBI:756152) has role antineoplastic agent (CHEBI:35610) |
| ibcasertib (CHEBI:758619) has role antineoplastic agent (CHEBI:35610) |
| ibentatug (CHEBI:759532) has role antineoplastic agent (CHEBI:35610) |
| iberdomide (CHEBI:756418) has role antineoplastic agent (CHEBI:35610) |
| iberdomide hydrochloride (CHEBI:756406) has role antineoplastic agent (CHEBI:35610) |
| ibi-188 (CHEBI:758026) has role antineoplastic agent (CHEBI:35610) |
| ibi-939 (CHEBI:758355) has role antineoplastic agent (CHEBI:35610) |
| iboctadekin (CHEBI:753050) has role antineoplastic agent (CHEBI:35610) |
| ibrilatazar (CHEBI:759934) has role antineoplastic agent (CHEBI:35610) |
| ibritumomab tiuxetan (CHEBI:749464) has role antineoplastic agent (CHEBI:35610) |
| ibrutinib (CHEBI:76612) has role antineoplastic agent (CHEBI:35610) |
| Ibudilast (CHEBI:31684) has role antineoplastic agent (CHEBI:35610) |
| ibuprofen (CHEBI:5855) has role antineoplastic agent (CHEBI:35610) |
| icapamespib (CHEBI:758217) has role antineoplastic agent (CHEBI:35610) |
| icariside II (CHEBI:82619) has role antineoplastic agent (CHEBI:35610) |
| icaritin (CHEBI:201674) has role antineoplastic agent (CHEBI:35610) |
| ICI D1694 (CHEBI:5847) has role antineoplastic agent (CHEBI:35610) |
| ICI-164384 (CHEBI:40710) has role antineoplastic agent (CHEBI:35610) |
| icotinib (CHEBI:750435) has role antineoplastic agent (CHEBI:35610) |
| icovamenib (CHEBI:760305) has role antineoplastic agent (CHEBI:35610) |
| ICRF-193 (CHEBI:93771) has role antineoplastic agent (CHEBI:35610) |
| icrucumab (CHEBI:750108) has role antineoplastic agent (CHEBI:35610) |
| idarubicin (CHEBI:42068) has role antineoplastic agent (CHEBI:35610) |
| idec-159 (CHEBI:754336) has role antineoplastic agent (CHEBI:35610) |
| idec-159 111in (CHEBI:754393) has role antineoplastic agent (CHEBI:35610) |
| idec-159 90y (CHEBI:754394) has role antineoplastic agent (CHEBI:35610) |
| idecabtagene vicleucel (CHEBI:757606) has role antineoplastic agent (CHEBI:35610) |
| idelalisib (CHEBI:82701) has role antineoplastic agent (CHEBI:35610) |
| idh305 (CHEBI:756623) has role antineoplastic agent (CHEBI:35610) |
| idronoxil (CHEBI:750316) has role antineoplastic agent (CHEBI:35610) |
| idroxioleate sodium (CHEBI:760391) has role antineoplastic agent (CHEBI:35610) |
| idroxioleic acid (CHEBI:759918) has role antineoplastic agent (CHEBI:35610) |
| ieramilimab (CHEBI:757434) has role antineoplastic agent (CHEBI:35610) |
| ifebemtinib (CHEBI:755684) has role antineoplastic agent (CHEBI:35610) |
| ifetroban sodium (CHEBI:755308) has role antineoplastic agent (CHEBI:35610) |
| ifinatamab (CHEBI:758708) has role antineoplastic agent (CHEBI:35610) |
| ifinatamab deruxtecan (CHEBI:758901) has role antineoplastic agent (CHEBI:35610) |
| ifosfamide (CHEBI:5864) has role antineoplastic agent (CHEBI:35610) |
| iFSP1 (CHEBI:176501) has role antineoplastic agent (CHEBI:35610) |
| igalan (CHEBI:66068) has role antineoplastic agent (CHEBI:35610) |
| igermetostat (CHEBI:759224) has role antineoplastic agent (CHEBI:35610) |
| ign-002 (CHEBI:757858) has role antineoplastic agent (CHEBI:35610) |
| ign-523 (CHEBI:758029) has role antineoplastic agent (CHEBI:35610) |
| igovomab (CHEBI:753937) has role antineoplastic agent (CHEBI:35610) |
| igrelimogene litadenorepvec (CHEBI:759377) has role antineoplastic agent (CHEBI:35610) |
| ikarugamycin (CHEBI:75276) has role antineoplastic agent (CHEBI:35610) |
| ikt-001pro (CHEBI:759610) has role antineoplastic agent (CHEBI:35610) |
| ilomastat (CHEBI:137236) has role antineoplastic agent (CHEBI:35610) |
| iloprost (CHEBI:63916) has role antineoplastic agent (CHEBI:35610) |
| ilorasertib (CHEBI:750338) has role antineoplastic agent (CHEBI:35610) |
| imaradenant (CHEBI:757928) has role antineoplastic agent (CHEBI:35610) |
| imatinib (CHEBI:45783) has role antineoplastic agent (CHEBI:35610) |
| imatinib methanesulfonate (CHEBI:31690) has role antineoplastic agent (CHEBI:35610) |
| imc-3c5 (CHEBI:754353) has role antineoplastic agent (CHEBI:35610) |
| imc-cs4 (CHEBI:754159) has role antineoplastic agent (CHEBI:35610) |
| imc-eb10 (CHEBI:754162) has role antineoplastic agent (CHEBI:35610) |
| imcnyeso (CHEBI:757218) has role antineoplastic agent (CHEBI:35610) |
| imdatifan (CHEBI:759225) has role antineoplastic agent (CHEBI:35610) |
| imetelstat (CHEBI:752899) has role antineoplastic agent (CHEBI:35610) |
| imetelstat sodium (CHEBI:753646) has role antineoplastic agent (CHEBI:35610) |
| imexon (CHEBI:748595) has role antineoplastic agent (CHEBI:35610) |
| imgatuzumab (CHEBI:754205) has role antineoplastic agent (CHEBI:35610) |
| imgn-388 (CHEBI:754370) has role antineoplastic agent (CHEBI:35610) |
| imgn-779 (CHEBI:757419) has role antineoplastic agent (CHEBI:35610) |
| IMID-2 (CHEBI:177369) has role antineoplastic agent (CHEBI:35610) |
| imifoplatin (CHEBI:758555) has role antineoplastic agent (CHEBI:35610) |
| imipramine (CHEBI:47499) has role antineoplastic agent (CHEBI:35610) |
| imiquimod (CHEBI:36704) has role antineoplastic agent (CHEBI:35610) |
| imlunestrant (CHEBI:747442) has role antineoplastic agent (CHEBI:35610) |
| imlunestrant tosylate (CHEBI:758962) has role antineoplastic agent (CHEBI:35610) |
| imm-0306 (CHEBI:758357) has role antineoplastic agent (CHEBI:35610) |
| immh-010 (CHEBI:758765) has role antineoplastic agent (CHEBI:35610) |
| immucillin H (CHEBI:43362) has role antineoplastic agent (CHEBI:35610) |
| immunocytokine nhs-il12 (CHEBI:757479) has role antineoplastic agent (CHEBI:35610) |
| imneskibart (CHEBI:760364) has role antineoplastic agent (CHEBI:35610) |
| imsamotide (CHEBI:759439) has role antineoplastic agent (CHEBI:35610) |
| imsapepimut (CHEBI:760313) has role antineoplastic agent (CHEBI:35610) |
| imvotamab (CHEBI:757955) has role antineoplastic agent (CHEBI:35610) |
| imzokitug (CHEBI:760365) has role antineoplastic agent (CHEBI:35610) |
| inaleucel (CHEBI:759378) has role antineoplastic agent (CHEBI:35610) |
| inalimarev (cea, muc-1, vaccinia virus) (CHEBI:753562) has role antineoplastic agent (CHEBI:35610) |
| inaticabtagene autoleucel (CHEBI:759440) has role antineoplastic agent (CHEBI:35610) |
| inavolisib (CHEBI:758122) has role antineoplastic agent (CHEBI:35610) |
| inbakicept (CHEBI:757817) has role antineoplastic agent (CHEBI:35610) |
| incb-047986 (CHEBI:755527) has role antineoplastic agent (CHEBI:35610) |
| incb-057643 (CHEBI:757900) has role antineoplastic agent (CHEBI:35610) |
| incb-059872 (CHEBI:758820) has role antineoplastic agent (CHEBI:35610) |
| incb-086550 (CHEBI:758521) has role antineoplastic agent (CHEBI:35610) |
| incb-40093 (CHEBI:755435) has role antineoplastic agent (CHEBI:35610) |
| incomplete freund's adjuvant (CHEBI:758289) has role antineoplastic agent (CHEBI:35610) |
| incyclinide (CHEBI:751144) has role antineoplastic agent (CHEBI:35610) |
| indanomycin (CHEBI:141380) has role antineoplastic agent (CHEBI:35610) |
| indatuximab ravtansine (CHEBI:750109) has role antineoplastic agent (CHEBI:35610) |
| indibulin (CHEBI:748217) has role antineoplastic agent (CHEBI:35610) |
| indigo (CHEBI:749117) has role antineoplastic agent (CHEBI:35610) |
| indigo carmine (acid form) (CHEBI:90117) has role antineoplastic agent (CHEBI:35610) |
| indinavir sulfate (CHEBI:5899) has role antineoplastic agent (CHEBI:35610) |
| indirubin (CHEBI:183083) has role antineoplastic agent (CHEBI:35610) |
| indisulam (CHEBI:145431) has role antineoplastic agent (CHEBI:35610) |
| indium in 111 ibritumomab tiuxetan (CHEBI:753563) has role antineoplastic agent (CHEBI:35610) |
| indole-3-methanol (CHEBI:24814) has role antineoplastic agent (CHEBI:35610) |
| indometacin (CHEBI:49662) has role antineoplastic agent (CHEBI:35610) |
| Indoximod (CHEBI:230682) has role antineoplastic agent (CHEBI:35610) |
| indusatumab vedotin (CHEBI:757468) has role antineoplastic agent (CHEBI:35610) |
| INDY (CHEBI:195332) has role antineoplastic agent (CHEBI:35610) |
| inebilizumab (CHEBI:754166) has role antineoplastic agent (CHEBI:35610) |
| inecalcitol (CHEBI:751219) has role antineoplastic agent (CHEBI:35610) |
| inezetamab (CHEBI:758709) has role antineoplastic agent (CHEBI:35610) |
| infigratinib phosphate (CHEBI:750218) has role antineoplastic agent (CHEBI:35610) |
| infliximab (CHEBI:749571) has role antineoplastic agent (CHEBI:35610) |
| influenza virus vaccine (CHEBI:753942) has role antineoplastic agent (CHEBI:35610) |
| ing-1 (CHEBI:754127) has role antineoplastic agent (CHEBI:35610) |
| ingenol mebutate (CHEBI:66913) has role antineoplastic agent (CHEBI:35610) |
| ingitamig (CHEBI:760380) has role antineoplastic agent (CHEBI:35610) |
| inixaciclib (CHEBI:758685) has role antineoplastic agent (CHEBI:35610) |
| inlexisertib (CHEBI:759936) has role antineoplastic agent (CHEBI:35610) |
| inobrodib (CHEBI:758440) has role antineoplastic agent (CHEBI:35610) |
| inodiftagene vixteplasmid (CHEBI:757957) has role antineoplastic agent (CHEBI:35610) |
| inotuzumab (CHEBI:757033) has role antineoplastic agent (CHEBI:35610) |
| inotuzumab ozogamicin (CHEBI:753564) has role antineoplastic agent (CHEBI:35610) |
| insulin aspart (CHEBI:749465) has role antineoplastic agent (CHEBI:35610) |
| insulin glargine (CHEBI:749436) has role antineoplastic agent (CHEBI:35610) |
| interferon (CHEBI:52999) has role antineoplastic agent (CHEBI:35610) |
| interferon alfa (CHEBI:753470) has role antineoplastic agent (CHEBI:35610) |
| Interferon alfa-2a (CHEBI:5937) has role antineoplastic agent (CHEBI:35610) |
| interferon alfa-2b (CHEBI:749428) has role antineoplastic agent (CHEBI:35610) |
| interferon alfa-n1 (CHEBI:753472) has role antineoplastic agent (CHEBI:35610) |
| interferon alfacon-1 (CHEBI:749570) has role antineoplastic agent (CHEBI:35610) |
| interferon beta (CHEBI:753473) has role antineoplastic agent (CHEBI:35610) |
| interferon beta-1a (CHEBI:749518) has role antineoplastic agent (CHEBI:35610) |
| Interferon beta-1b (CHEBI:5938) has role antineoplastic agent (CHEBI:35610) |
| Interferon gamma-1b (CHEBI:5939) has role antineoplastic agent (CHEBI:35610) |
| interleukin 15, recombinant non-glycosylated (CHEBI:757416) has role antineoplastic agent (CHEBI:35610) |
| interleukin-12 human recombinant (CHEBI:758911) has role antineoplastic agent (CHEBI:35610) |
| interleukin-7 (CHEBI:757221) has role antineoplastic agent (CHEBI:35610) |
| intetumumab (CHEBI:750110) has role antineoplastic agent (CHEBI:35610) |
| intismeran autogene (CHEBI:760172) has role antineoplastic agent (CHEBI:35610) |
| intoplicine (CHEBI:135474) has role antineoplastic agent (CHEBI:35610) |
| inupadenant (CHEBI:758229) has role antineoplastic agent (CHEBI:35610) |
| inupadenant hydrochloride (CHEBI:758134) has role antineoplastic agent (CHEBI:35610) |
| invac-1, a double stranded dna plasmid vaccine construct encoding ubiquitin-human telomerase reverse transcriptase (htert) fusion protein (CHEBI:758034) has role antineoplastic agent (CHEBI:35610) |
| invikafusp alfa (CHEBI:760043) has role antineoplastic agent (CHEBI:35610) |
| iobenguane (CHEBI:748159) has role antineoplastic agent (CHEBI:35610) |
| iobenguane (131I) (CHEBI:135997) has role antineoplastic agent (CHEBI:35610) |
| iodine (131i) metuximab (CHEBI:758923) has role antineoplastic agent (CHEBI:35610) |
| iodine i 131 apamistamab (CHEBI:757423) has role antineoplastic agent (CHEBI:35610) |
| iodofalan i-131 (CHEBI:759937) has role antineoplastic agent (CHEBI:35610) |
| iohexol (CHEBI:31709) has role antineoplastic agent (CHEBI:35610) |
| iopamidol (CHEBI:31711) has role antineoplastic agent (CHEBI:35610) |
| iopofosine i 131 (CHEBI:756981) has role antineoplastic agent (CHEBI:35610) |
| ipafricept (CHEBI:755261) has role antineoplastic agent (CHEBI:35610) |
| iph-2101 (CHEBI:754280) has role antineoplastic agent (CHEBI:35610) |
| ipilimumab (CHEBI:231679) has role antineoplastic agent (CHEBI:35610) |
| ipn-60090 (CHEBI:758419) has role antineoplastic agent (CHEBI:35610) |
| iratumumab (CHEBI:753565) has role antineoplastic agent (CHEBI:35610) |
| irgd (CHEBI:757856) has role antineoplastic agent (CHEBI:35610) |
| irilone (CHEBI:5970) has role antineoplastic agent (CHEBI:35610) |
| irinotecan (CHEBI:80630) has role antineoplastic agent (CHEBI:35610) |
| irinotecan hydrochloride (anhydrous) (CHEBI:5971) has role antineoplastic agent (CHEBI:35610) |
| irinotecan hydrochloride hydrate (CHEBI:90881) has role antineoplastic agent (CHEBI:35610) |
| irinotecan sucrosofate (CHEBI:759096) has role antineoplastic agent (CHEBI:35610) |
| irofulven (CHEBI:135002) has role antineoplastic agent (CHEBI:35610) |
| iron isomaltoside 1000 (CHEBI:757469) has role antineoplastic agent (CHEBI:35610) |
| iron sucrose (CHEBI:749322) has role antineoplastic agent (CHEBI:35610) |
| irosustat (CHEBI:748076) has role antineoplastic agent (CHEBI:35610) |
| iruplinalkib (CHEBI:758652) has role antineoplastic agent (CHEBI:35610) |
| irx-2 (CHEBI:757958) has role antineoplastic agent (CHEBI:35610) |
| irx-4204 (CHEBI:748338) has role antineoplastic agent (CHEBI:35610) |
| isariotin F (CHEBI:66086) has role antineoplastic agent (CHEBI:35610) |
| isatuximab (CHEBI:755476) has role antineoplastic agent (CHEBI:35610) |
| isavuconazole (CHEBI:85979) has role antineoplastic agent (CHEBI:35610) |
| isavuconazonium sulfate (CHEBI:85977) has role antineoplastic agent (CHEBI:35610) |
| isis-2503 (CHEBI:758035) has role antineoplastic agent (CHEBI:35610) |
| ismidenon (CHEBI:756925) has role antineoplastic agent (CHEBI:35610) |
| isobrucein A (CHEBI:5987) has role antineoplastic agent (CHEBI:35610) |
| isochamuvaritin (CHEBI:66092) has role antineoplastic agent (CHEBI:35610) |
| isoflavipucine (CHEBI:156435) has role antineoplastic agent (CHEBI:35610) |
| isoflavone (CHEBI:18220) has role antineoplastic agent (CHEBI:35610) |
| isoginkgetin (CHEBI:79087) has role antineoplastic agent (CHEBI:35610) |
| isoiguesterin (CHEBI:66094) has role antineoplastic agent (CHEBI:35610) |
| isoliquiritigenin (CHEBI:310312) has role antineoplastic agent (CHEBI:35610) |
| isoliquiritin (CHEBI:80839) has role antineoplastic agent (CHEBI:35610) |
| isoniazide (CHEBI:6030) has role antineoplastic agent (CHEBI:35610) |
| isoorientin (CHEBI:17965) has role antineoplastic agent (CHEBI:35610) |
| isophenoxodiol (CHEBI:748713) has role antineoplastic agent (CHEBI:35610) |
| Isophosphamide mustard (CHEBI:80566) has role antineoplastic agent (CHEBI:35610) |
| isoproterenol (CHEBI:747921) has role antineoplastic agent (CHEBI:35610) |
| isorhapontigenin (CHEBI:167830) has role antineoplastic agent (CHEBI:35610) |
| Isosorbide (CHEBI:6060) has role antineoplastic agent (CHEBI:35610) |
| isostrychnine (CHEBI:132659) has role antineoplastic agent (CHEBI:35610) |
| isosulfan blue (CHEBI:749330) has role antineoplastic agent (CHEBI:35610) |
| isotretinoin (CHEBI:6067) has role antineoplastic agent (CHEBI:35610) |
| isowigtheone hydrate (CHEBI:66099) has role antineoplastic agent (CHEBI:35610) |
| ispectamab debotansine (CHEBI:758710) has role antineoplastic agent (CHEBI:35610) |
| ispectamab tazide (CHEBI:759379) has role antineoplastic agent (CHEBI:35610) |
| istiratumab (CHEBI:756473) has role antineoplastic agent (CHEBI:35610) |
| istisociclib (CHEBI:759068) has role antineoplastic agent (CHEBI:35610) |
| isunakinra (CHEBI:755505) has role antineoplastic agent (CHEBI:35610) |
| it-139 (CHEBI:756899) has role antineoplastic agent (CHEBI:35610) |
| itacitinib (CHEBI:755660) has role antineoplastic agent (CHEBI:35610) |
| itanistomig (CHEBI:760173) has role antineoplastic agent (CHEBI:35610) |
| itarnafloxin (CHEBI:177533) has role antineoplastic agent (CHEBI:35610) |
| itraconazole (CHEBI:6076) has role antineoplastic agent (CHEBI:35610) |
| iturin A (CHEBI:31737) has role antineoplastic agent (CHEBI:35610) |
| ivabradine (CHEBI:85966) has role antineoplastic agent (CHEBI:35610) |
| ivarmacitinib sulfate (CHEBI:758964) has role antineoplastic agent (CHEBI:35610) |
| ivermectin (CHEBI:6078) has role antineoplastic agent (CHEBI:35610) |
| ivonescimab (CHEBI:760362) has role antineoplastic agent (CHEBI:35610) |
| ivosidenib (CHEBI:145430) has role antineoplastic agent (CHEBI:35610) |
| ivospemin (CHEBI:748348) has role antineoplastic agent (CHEBI:35610) |
| ivospemin hydrochloride (CHEBI:758984) has role antineoplastic agent (CHEBI:35610) |
| ivuxolimab (CHEBI:757321) has role antineoplastic agent (CHEBI:35610) |
| ixabepilone (CHEBI:63605) has role antineoplastic agent (CHEBI:35610) |
| ixazomib (CHEBI:90942) has role antineoplastic agent (CHEBI:35610) |
| ixazomib citrate (CHEBI:90939) has role antineoplastic agent (CHEBI:35610) |
| ixerochinolide (CHEBI:66100) has role antineoplastic agent (CHEBI:35610) |
| izalontamab (CHEBI:758950) has role antineoplastic agent (CHEBI:35610) |
| izalontamab brengitecan (CHEBI:759534) has role antineoplastic agent (CHEBI:35610) |
| izastobart (CHEBI:759535) has role antineoplastic agent (CHEBI:35610) |
| izeltabart (CHEBI:759380) has role antineoplastic agent (CHEBI:35610) |
| izeltabart tapatansine (CHEBI:758914) has role antineoplastic agent (CHEBI:35610) |
| izorlisib (CHEBI:749964) has role antineoplastic agent (CHEBI:35610) |
| izuralimab (CHEBI:758576) has role antineoplastic agent (CHEBI:35610) |
| j591 (CHEBI:754316) has role antineoplastic agent (CHEBI:35610) |
| j591 177lu (CHEBI:754323) has role antineoplastic agent (CHEBI:35610) |
| jacarelhyperol A (CHEBI:66101) has role antineoplastic agent (CHEBI:35610) |
| jaceosidin (CHEBI:66103) has role antineoplastic agent (CHEBI:35610) |
| jadomycin B (CHEBI:31738) has role antineoplastic agent (CHEBI:35610) |
| jaspamide (CHEBI:66104) has role antineoplastic agent (CHEBI:35610) |
| jaspamide B (CHEBI:66105) has role antineoplastic agent (CHEBI:35610) |
| jaspamide C (CHEBI:66106) has role antineoplastic agent (CHEBI:35610) |
| jaspamide D (CHEBI:66107) has role antineoplastic agent (CHEBI:35610) |
| jaspamide E (CHEBI:66108) has role antineoplastic agent (CHEBI:35610) |
| jaspamide F (CHEBI:66109) has role antineoplastic agent (CHEBI:35610) |
| jaspamide G (CHEBI:66110) has role antineoplastic agent (CHEBI:35610) |
| jaspamide H (CHEBI:66111) has role antineoplastic agent (CHEBI:35610) |
| jaspamide J (CHEBI:66114) has role antineoplastic agent (CHEBI:35610) |
| jaspamide K (CHEBI:66112) has role antineoplastic agent (CHEBI:35610) |
| jaspamide L (CHEBI:66113) has role antineoplastic agent (CHEBI:35610) |
| jaspamide M (CHEBI:66115) has role antineoplastic agent (CHEBI:35610) |
| jaspamide N (CHEBI:66116) has role antineoplastic agent (CHEBI:35610) |
| jaspamide O (CHEBI:66117) has role antineoplastic agent (CHEBI:35610) |
| jaspamide P (CHEBI:66118) has role antineoplastic agent (CHEBI:35610) |
| jasplakinolide D (CHEBI:68271) has role antineoplastic agent (CHEBI:35610) |
| jasplakinolide Q (CHEBI:68272) has role antineoplastic agent (CHEBI:35610) |
| jasplakinolide R1 (CHEBI:68273) has role antineoplastic agent (CHEBI:35610) |
| jbi-802 (CHEBI:759611) has role antineoplastic agent (CHEBI:35610) |
| jerantinine A (CHEBI:66119) has role antineoplastic agent (CHEBI:35610) |
| jerantinine B (CHEBI:66120) has role antineoplastic agent (CHEBI:35610) |
| jerantinine C (CHEBI:66121) has role antineoplastic agent (CHEBI:35610) |
| jerantinine D (CHEBI:66122) has role antineoplastic agent (CHEBI:35610) |
| jerantinine E (CHEBI:66123) has role antineoplastic agent (CHEBI:35610) |
| jerantinine F (CHEBI:66124) has role antineoplastic agent (CHEBI:35610) |
| jervine (CHEBI:6088) has role antineoplastic agent (CHEBI:35610) |
| JHU083 (CHEBI:232049) has role antineoplastic agent (CHEBI:35610) |
| ji-101 (CHEBI:755488) has role antineoplastic agent (CHEBI:35610) |
| jineol (CHEBI:66125) has role antineoplastic agent (CHEBI:35610) |
| JM335 (CHEBI:85610) has role antineoplastic agent (CHEBI:35610) |
| jnj-26483327 (CHEBI:755119) has role antineoplastic agent (CHEBI:35610) |
| jnj-27548547 (CHEBI:756982) has role antineoplastic agent (CHEBI:35610) |
| jnj-38877618 (CHEBI:758832) has role antineoplastic agent (CHEBI:35610) |
| JP-8g (CHEBI:74654) has role antineoplastic agent (CHEBI:35610) |
| JQ1 (CHEBI:137113) has role antineoplastic agent (CHEBI:35610) |
| JS-K (CHEBI:232953) has role antineoplastic agent (CHEBI:35610) |
| JTE-013 (CHEBI:195541) has role antineoplastic agent (CHEBI:35610) |
| JTE-607 dihydrochloride (CHEBI:167629) has role antineoplastic agent (CHEBI:35610) |
| JTE-607 free base (CHEBI:167630) has role antineoplastic agent (CHEBI:35610) |
| juglanin A (CHEBI:66126) has role antineoplastic agent (CHEBI:35610) |
| juglanin B (CHEBI:66127) has role antineoplastic agent (CHEBI:35610) |
| JWH-133 (CHEBI:146243) has role antineoplastic agent (CHEBI:35610) |
| ka-2507 (CHEBI:758823) has role antineoplastic agent (CHEBI:35610) |
| kadlongilactone A (CHEBI:66128) has role antineoplastic agent (CHEBI:35610) |
| kadlongilactone B (CHEBI:66129) has role antineoplastic agent (CHEBI:35610) |
| kaempferol 3-O-(5-O-acetyl-α-D-apiofuranosyl)-7-O-α-L-rhamnopyranoside (CHEBI:68877) has role antineoplastic agent (CHEBI:35610) |
| kaempferol 3,7-di-O-α-L-rhamnoside (CHEBI:68883) has role antineoplastic agent (CHEBI:35610) |
| kaempferol 7-O-(2-E-p-coumaroyl-α-L-rhamnopyranoside) (CHEBI:66134) has role antineoplastic agent (CHEBI:35610) |
| kaempferol 7-O-(2,3-di-E-p-coumaroyl-α-L-rhamnopyranoside) (CHEBI:66133) has role antineoplastic agent (CHEBI:35610) |
| kahweol (CHEBI:138308) has role antineoplastic agent (CHEBI:35610) |
| kanamycin A sulfate (CHEBI:6109) has role antineoplastic agent (CHEBI:35610) |
| kansuiphorin A (CHEBI:66138) has role antineoplastic agent (CHEBI:35610) |
| kansuiphorin B (CHEBI:66139) has role antineoplastic agent (CHEBI:35610) |
| karenitecin (CHEBI:750168) has role antineoplastic agent (CHEBI:35610) |
| kb-004 (CHEBI:754209) has role antineoplastic agent (CHEBI:35610) |
| kbp5209 (CHEBI:758192) has role antineoplastic agent (CHEBI:35610) |
| ketamine (CHEBI:6121) has role antineoplastic agent (CHEBI:35610) |
| ketamine hydrochloride (CHEBI:650657) has role antineoplastic agent (CHEBI:35610) |
| ketoconazole (CHEBI:47519) has role antineoplastic agent (CHEBI:35610) |
| ketoprofen (CHEBI:6128) has role antineoplastic agent (CHEBI:35610) |
| ketorolac (CHEBI:6129) has role antineoplastic agent (CHEBI:35610) |
| ketorolac tromethamine (CHEBI:6130) has role antineoplastic agent (CHEBI:35610) |
| keyhole limpet hemocyanin (CHEBI:759678) has role antineoplastic agent (CHEBI:35610) |
| khk-2866 (CHEBI:754230) has role antineoplastic agent (CHEBI:35610) |
| Ki11502 (CHEBI:133397) has role antineoplastic agent (CHEBI:35610) |
| kidjoranin-3-O-α-diginopyranosyl-(1→4)-β-cymaropyranoside (CHEBI:66144) has role antineoplastic agent (CHEBI:35610) |
| kidjoranin-3-O-β-digitoxopyranoside (CHEBI:66145) has role antineoplastic agent (CHEBI:35610) |
| kievitone (CHEBI:16832) has role antineoplastic agent (CHEBI:35610) |
| kinanthraquinone (CHEBI:167575) has role antineoplastic agent (CHEBI:35610) |
| kitastatin 1 (CHEBI:66146) has role antineoplastic agent (CHEBI:35610) |
| kn-026 (CHEBI:758041) has role antineoplastic agent (CHEBI:35610) |
| knipholone (CHEBI:6141) has role antineoplastic agent (CHEBI:35610) |
| ko-947 (CHEBI:758189) has role antineoplastic agent (CHEBI:35610) |
| kos-1584 (CHEBI:756796) has role antineoplastic agent (CHEBI:35610) |
| koshikamide A2 (CHEBI:66149) has role antineoplastic agent (CHEBI:35610) |
| kosn-1724 (CHEBI:756884) has role antineoplastic agent (CHEBI:35610) |
| KP1019 (CHEBI:77760) has role antineoplastic agent (CHEBI:35610) |
| KP1339 (CHEBI:176975) has role antineoplastic agent (CHEBI:35610) |
| KRIBB11 (CHEBI:228800) has role antineoplastic agent (CHEBI:35610) |
| krn-330 (CHEBI:754142) has role antineoplastic agent (CHEBI:35610) |
| krn5500 (CHEBI:750428) has role antineoplastic agent (CHEBI:35610) |
| Ku-0063794 (CHEBI:85572) has role antineoplastic agent (CHEBI:35610) |
| KU-55933 (CHEBI:228209) has role antineoplastic agent (CHEBI:35610) |
| KU-60019 (CHEBI:228206) has role antineoplastic agent (CHEBI:35610) |
| kw-2449 (CHEBI:750265) has role antineoplastic agent (CHEBI:35610) |
| kw-2450 (CHEBI:759080) has role antineoplastic agent (CHEBI:35610) |
| kw-2478 (CHEBI:756798) has role antineoplastic agent (CHEBI:35610) |
| kweichowenol B (CHEBI:66152) has role antineoplastic agent (CHEBI:35610) |
| kx2-361 (CHEBI:756799) has role antineoplastic agent (CHEBI:35610) |
| l-377202 (CHEBI:755115) has role antineoplastic agent (CHEBI:35610) |
| L-744,832 (CHEBI:183636) has role antineoplastic agent (CHEBI:35610) |
| L-778,123 (free base) (CHEBI:180478) has role antineoplastic agent (CHEBI:35610) |
| L-778,123 hydrochloride (CHEBI:177371) has role antineoplastic agent (CHEBI:35610) |
| l-dos47 (CHEBI:757959) has role antineoplastic agent (CHEBI:35610) |
| l19il2 (CHEBI:754357) has role antineoplastic agent (CHEBI:35610) |
| l19sip 131i (CHEBI:754215) has role antineoplastic agent (CHEBI:35610) |
| l19tnfa (CHEBI:754346) has role antineoplastic agent (CHEBI:35610) |
| labetuzumab (CHEBI:753465) has role antineoplastic agent (CHEBI:35610) |
| labradimil (CHEBI:751656) has role antineoplastic agent (CHEBI:35610) |
| lacosamide (CHEBI:135939) has role antineoplastic agent (CHEBI:35610) |
| lactobacillus acidophilus (CHEBI:753965) has role antineoplastic agent (CHEBI:35610) |
| lacutamab (CHEBI:757424) has role antineoplastic agent (CHEBI:35610) |
| lacutoclax (CHEBI:759227) has role antineoplastic agent (CHEBI:35610) |
| ladarixin (CHEBI:748706) has role antineoplastic agent (CHEBI:35610) |
| ladiratuzumab vedotin (CHEBI:757520) has role antineoplastic agent (CHEBI:35610) |
| lalikinogene sifuplasmid (CHEBI:760381) has role antineoplastic agent (CHEBI:35610) |
| lamivudine (CHEBI:63577) has role antineoplastic agent (CHEBI:35610) |
| lancastotug (CHEBI:759536) has role antineoplastic agent (CHEBI:35610) |
| landogrozumab (CHEBI:755447) has role antineoplastic agent (CHEBI:35610) |
| lanerkitug (CHEBI:760044) has role antineoplastic agent (CHEBI:35610) |
| laniquidar (CHEBI:749050) has role antineoplastic agent (CHEBI:35610) |
| lanperisone (CHEBI:176339) has role antineoplastic agent (CHEBI:35610) |
| lanperisone hydrochloride (CHEBI:31762) has role antineoplastic agent (CHEBI:35610) |
| lanraplenib (CHEBI:756027) has role antineoplastic agent (CHEBI:35610) |
| lanreotide acetate (CHEBI:749391) has role antineoplastic agent (CHEBI:35610) |
| lansoprazole (CHEBI:6375) has role antineoplastic agent (CHEBI:35610) |
| lanthanum trichloride (CHEBI:231515) has role antineoplastic agent (CHEBI:35610) |
| lapachol (CHEBI:6377) has role antineoplastic agent (CHEBI:35610) |
| lapatinib (CHEBI:49603) has role antineoplastic agent (CHEBI:35610) |
| Lapatinib ditosylate monohydrate (CHEBI:192581) has role antineoplastic agent (CHEBI:35610) |
| laporolimus (CHEBI:760388) has role antineoplastic agent (CHEBI:35610) |
| lapuleucel-t (CHEBI:753568) has role antineoplastic agent (CHEBI:35610) |
| larnefpendekin alfa (CHEBI:760174) has role antineoplastic agent (CHEBI:35610) |
| laromustine (CHEBI:748656) has role antineoplastic agent (CHEBI:35610) |
| larotaxel (CHEBI:756659) has role antineoplastic agent (CHEBI:35610) |
| larotrectinib (CHEBI:755964) has role antineoplastic agent (CHEBI:35610) |
| larotrectinib sulfate (CHEBI:756427) has role antineoplastic agent (CHEBI:35610) |
| lartesertib (CHEBI:759126) has role antineoplastic agent (CHEBI:35610) |
| lasmecabtagene timgedleucel (CHEBI:760175) has role antineoplastic agent (CHEBI:35610) |
| lasofoxifene (CHEBI:135938) has role antineoplastic agent (CHEBI:35610) |
| latikafusp (CHEBI:758712) has role antineoplastic agent (CHEBI:35610) |
| laulimalide (CHEBI:69134) has role antineoplastic agent (CHEBI:35610) |
| laurebiphenyl (CHEBI:66554) has role antineoplastic agent (CHEBI:35610) |
| lazertinib (CHEBI:757712) has role antineoplastic agent (CHEBI:35610) |
| lazertinib mesylate (CHEBI:760389) has role antineoplastic agent (CHEBI:35610) |
| lb-100 (CHEBI:756800) has role antineoplastic agent (CHEBI:35610) |
| LB42908 (CHEBI:167660) has role antineoplastic agent (CHEBI:35610) |
| lcl-161 (CHEBI:755042) has role antineoplastic agent (CHEBI:35610) |
| LCL161 (CHEBI:193137) has role antineoplastic agent (CHEBI:35610) |
| LDC4297 (CHEBI:144671) has role antineoplastic agent (CHEBI:35610) |
| LDN-212854 (CHEBI:229962) has role antineoplastic agent (CHEBI:35610) |
| leachianone A (CHEBI:66559) has role antineoplastic agent (CHEBI:35610) |
| lead (212pb) bamzireotide navoxetan (CHEBI:759985) has role antineoplastic agent (CHEBI:35610) |
| lead (212pb) lapemelanotide zapixetan (CHEBI:759986) has role antineoplastic agent (CHEBI:35610) |
| lebrikizumab (CHEBI:750113) has role antineoplastic agent (CHEBI:35610) |
| leflunomide (CHEBI:6402) has role antineoplastic agent (CHEBI:35610) |
| lehualide F (CHEBI:68006) has role antineoplastic agent (CHEBI:35610) |
| lehualide G (CHEBI:68007) has role antineoplastic agent (CHEBI:35610) |
| lehualide H (CHEBI:68008) has role antineoplastic agent (CHEBI:35610) |
| lehualide I (CHEBI:68009) has role antineoplastic agent (CHEBI:35610) |
| lejimalide A (CHEBI:77757) has role antineoplastic agent (CHEBI:35610) |
| lejimalide B (CHEBI:77759) has role antineoplastic agent (CHEBI:35610) |
| lemzoparlimab (CHEBI:758397) has role antineoplastic agent (CHEBI:35610) |
| lenalidomide (CHEBI:63791) has role antineoplastic agent (CHEBI:35610) |
| lenalidomide hydrochloride monohydrate (CHEBI:760251) has role antineoplastic agent (CHEBI:35610) |
| leniolisib (CHEBI:229649) has role antineoplastic agent (CHEBI:35610) |
| lenograstim (CHEBI:754020) has role antineoplastic agent (CHEBI:35610) |
| lentinan (CHEBI:31770) has role antineoplastic agent (CHEBI:35610) |
| lenvatinib (CHEBI:85994) has role antineoplastic agent (CHEBI:35610) |
| lenvatinib mesylate (CHEBI:85995) has role antineoplastic agent (CHEBI:35610) |
| lenzilumab (CHEBI:755801) has role antineoplastic agent (CHEBI:35610) |
| lepirudin (CHEBI:142437) has role antineoplastic agent (CHEBI:35610) |
| leq506 (CHEBI:755136) has role antineoplastic agent (CHEBI:35610) |
| lerociclib (CHEBI:755970) has role antineoplastic agent (CHEBI:35610) |
| leronlimab (CHEBI:754173) has role antineoplastic agent (CHEBI:35610) |
| lerzeparib (CHEBI:759229) has role antineoplastic agent (CHEBI:35610) |
| lesabelimab (CHEBI:758714) has role antineoplastic agent (CHEBI:35610) |
| lestaurtinib (CHEBI:749110) has role antineoplastic agent (CHEBI:35610) |
| letetresgene autoleucel (CHEBI:758144) has role antineoplastic agent (CHEBI:35610) |
| letrozole (CHEBI:6413) has role antineoplastic agent (CHEBI:35610) |
| leucospiroside A (CHEBI:66574) has role antineoplastic agent (CHEBI:35610) |
| leucovorin (CHEBI:748997) has role antineoplastic agent (CHEBI:35610) |
| leucovorin calcium (CHEBI:749381) has role antineoplastic agent (CHEBI:35610) |
| leucovorin sodium (CHEBI:755758) has role antineoplastic agent (CHEBI:35610) |
| leuprolide (CHEBI:6427) has role antineoplastic agent (CHEBI:35610) |
| leuprolide acetate (CHEBI:63597) has role antineoplastic agent (CHEBI:35610) |
| leuprolide mesylate (CHEBI:758534) has role antineoplastic agent (CHEBI:35610) |
| Levamisole hydrochloride (CHEBI:6433) has role antineoplastic agent (CHEBI:35610) |
| levetiracetam (CHEBI:6437) has role antineoplastic agent (CHEBI:35610) |
| levobupivacaine (CHEBI:6149) has role antineoplastic agent (CHEBI:35610) |
| levoleucovorin (CHEBI:750266) has role antineoplastic agent (CHEBI:35610) |
| levoleucovorin calcium (CHEBI:750263) has role antineoplastic agent (CHEBI:35610) |
| levonorgestrel (CHEBI:6443) has role antineoplastic agent (CHEBI:35610) |
| levothyroxine sodium hydrate (CHEBI:6447) has role antineoplastic agent (CHEBI:35610) |
| lexatumumab (CHEBI:750114) has role antineoplastic agent (CHEBI:35610) |
| lfb-r603 (CHEBI:754176) has role antineoplastic agent (CHEBI:35610) |
| LFM-A13 (CHEBI:183517) has role antineoplastic agent (CHEBI:35610) |
| lgh-447 (CHEBI:755678) has role antineoplastic agent (CHEBI:35610) |
| LGK974 (CHEBI:78030) has role antineoplastic agent (CHEBI:35610) |
| lhc-165 (CHEBI:758043) has role antineoplastic agent (CHEBI:35610) |
| licofelone (CHEBI:47532) has role antineoplastic agent (CHEBI:35610) |
| lidocaine (CHEBI:6456) has role antineoplastic agent (CHEBI:35610) |
| lifastuzumab vedotin (CHEBI:757369) has role antineoplastic agent (CHEBI:35610) |
| lificiguat (CHEBI:142430) has role antineoplastic agent (CHEBI:35610) |
| lifileucel (CHEBI:757607) has role antineoplastic agent (CHEBI:35610) |
| lifirafenib (CHEBI:756640) has role antineoplastic agent (CHEBI:35610) |
| lifirafenib maleate (CHEBI:757556) has role antineoplastic agent (CHEBI:35610) |
| ligstroside (CHEBI:149585) has role antineoplastic agent (CHEBI:35610) |
| lilotomab (CHEBI:758567) has role antineoplastic agent (CHEBI:35610) |
| limaresiquimod (CHEBI:759538) has role antineoplastic agent (CHEBI:35610) |
| linaclotide acetate (CHEBI:755309) has role antineoplastic agent (CHEBI:35610) |
| linagliptin (CHEBI:68610) has role antineoplastic agent (CHEBI:35610) |
| linavonkibart (CHEBI:759381) has role antineoplastic agent (CHEBI:35610) |
| linclatamig (CHEBI:760047) has role antineoplastic agent (CHEBI:35610) |
| linezolid (CHEBI:63607) has role antineoplastic agent (CHEBI:35610) |
| linifanib (CHEBI:91435) has role antineoplastic agent (CHEBI:35610) |
| linoleic acid (CHEBI:17351) has role antineoplastic agent (CHEBI:35610) |
| linoserpaturev (CHEBI:760176) has role antineoplastic agent (CHEBI:35610) |
| linperlisib (CHEBI:757724) has role antineoplastic agent (CHEBI:35610) |
| linrodostat (CHEBI:757072) has role antineoplastic agent (CHEBI:35610) |
| linrodostat mesylate (CHEBI:757557) has role antineoplastic agent (CHEBI:35610) |
| linsitinib (CHEBI:91402) has role antineoplastic agent (CHEBI:35610) |
| lintuzumab (CHEBI:754042) has role antineoplastic agent (CHEBI:35610) |
| linvoseltamab (CHEBI:758940) has role antineoplastic agent (CHEBI:35610) |
| linzagolix (CHEBI:755689) has role antineoplastic agent (CHEBI:35610) |
| linzagolix choline (CHEBI:757580) has role antineoplastic agent (CHEBI:35610) |
| liothyronine sodium (CHEBI:6484) has role antineoplastic agent (CHEBI:35610) |
| lipegfilgrastim (CHEBI:757744) has role antineoplastic agent (CHEBI:35610) |
| lipoic acid, alpha (CHEBI:748116) has role antineoplastic agent (CHEBI:35610) |
| lipustobart (CHEBI:759383) has role antineoplastic agent (CHEBI:35610) |
| lirafugratinib (CHEBI:759255) has role antineoplastic agent (CHEBI:35610) |
| lirafugratinib hydrochloride (CHEBI:759256) has role antineoplastic agent (CHEBI:35610) |
| lirilumab (CHEBI:754281) has role antineoplastic agent (CHEBI:35610) |
| liriodenine (CHEBI:70649) has role antineoplastic agent (CHEBI:35610) |
| lirodegimod (CHEBI:759939) has role antineoplastic agent (CHEBI:35610) |
| lisavanbulin (CHEBI:757070) has role antineoplastic agent (CHEBI:35610) |
| lisinopril (CHEBI:43755) has role antineoplastic agent (CHEBI:35610) |
| lisocabtagene maraleucel (CHEBI:756742) has role antineoplastic agent (CHEBI:35610) |
| lissoclibadin 1 (CHEBI:66579) has role antineoplastic agent (CHEBI:35610) |
| lissoclibadin 2 (CHEBI:66580) has role antineoplastic agent (CHEBI:35610) |
| lissoclibadin 3 (CHEBI:66581) has role antineoplastic agent (CHEBI:35610) |
| litgenprostucel-l (CHEBI:753571) has role antineoplastic agent (CHEBI:35610) |
| lithium carbonate (CHEBI:6504) has role antineoplastic agent (CHEBI:35610) |
| litronesib (CHEBI:751559) has role antineoplastic agent (CHEBI:35610) |
| livmoniplimab (CHEBI:759679) has role antineoplastic agent (CHEBI:35610) |
| lixumistat acetate (CHEBI:758210) has role antineoplastic agent (CHEBI:35610) |
| LLP-3 (CHEBI:78766) has role antineoplastic agent (CHEBI:35610) |
| lmb-100 (CHEBI:757225) has role antineoplastic agent (CHEBI:35610) |
| lmb-2 (CHEBI:754190) has role antineoplastic agent (CHEBI:35610) |
| lmb-7 (CHEBI:754150) has role antineoplastic agent (CHEBI:35610) |
| lmb-9 (CHEBI:754284) has role antineoplastic agent (CHEBI:35610) |
| lmp-744 (CHEBI:748506) has role antineoplastic agent (CHEBI:35610) |
| lobaplatin (CHEBI:192744) has role antineoplastic agent (CHEBI:35610) |
| lodapolimab (CHEBI:757444) has role antineoplastic agent (CHEBI:35610) |
| lometrexol (CHEBI:748132) has role antineoplastic agent (CHEBI:35610) |
| lomustine (CHEBI:6520) has role antineoplastic agent (CHEBI:35610) |
| lomvastomig (CHEBI:758074) has role antineoplastic agent (CHEBI:35610) |
| lonafarnib (CHEBI:47097) has role antineoplastic agent (CHEBI:35610) |
| lonaprisan (CHEBI:748586) has role antineoplastic agent (CHEBI:35610) |
| lonazolac (CHEBI:76164) has role antineoplastic agent (CHEBI:35610) |
| lonazolac calcium (CHEBI:76167) has role antineoplastic agent (CHEBI:35610) |
| loncastuximab tesirine (CHEBI:757226) has role antineoplastic agent (CHEBI:35610) |
| longicalycinin A (CHEBI:66590) has role antineoplastic agent (CHEBI:35610) |
| longirostrerone A (CHEBI:68980) has role antineoplastic agent (CHEBI:35610) |
| longirostrerone B (CHEBI:68981) has role antineoplastic agent (CHEBI:35610) |
| longirostrerone C (CHEBI:68982) has role antineoplastic agent (CHEBI:35610) |
| longirostrerone D (CHEBI:68774) has role antineoplastic agent (CHEBI:35610) |
| lonidamine (CHEBI:50138) has role antineoplastic agent (CHEBI:35610) |
| Lonsurf (CHEBI:90876) has role antineoplastic agent (CHEBI:35610) |
| loperamide (CHEBI:6532) has role antineoplastic agent (CHEBI:35610) |
| lopinavir (CHEBI:31781) has role antineoplastic agent (CHEBI:35610) |
| loratadine (CHEBI:6538) has role antineoplastic agent (CHEBI:35610) |
| lorigerlimab (CHEBI:758854) has role antineoplastic agent (CHEBI:35610) |
| lorlatinib (CHEBI:143117) has role antineoplastic agent (CHEBI:35610) |
| lorvotuzumab mertansine (CHEBI:750115) has role antineoplastic agent (CHEBI:35610) |
| losartan (CHEBI:6541) has role antineoplastic agent (CHEBI:35610) |
| lovastatin (CHEBI:40303) has role antineoplastic agent (CHEBI:35610) |
| lp-184 (CHEBI:755880) has role antineoplastic agent (CHEBI:35610) |
| LRRK2-IN-1 (CHEBI:78413) has role antineoplastic agent (CHEBI:35610) |
| LSM-1131 (CHEBI:91398) has role antineoplastic agent (CHEBI:35610) |
| lsz-102 (CHEBI:756578) has role antineoplastic agent (CHEBI:35610) |
| lucanthone (CHEBI:51052) has role antineoplastic agent (CHEBI:35610) |
| lucanthone hydrochloride (CHEBI:750361) has role antineoplastic agent (CHEBI:35610) |
| lucatumumab (CHEBI:750116) has role antineoplastic agent (CHEBI:35610) |
| lucialdehyde B (CHEBI:66593) has role antineoplastic agent (CHEBI:35610) |
| lucialdehyde C (CHEBI:66594) has role antineoplastic agent (CHEBI:35610) |
| lucicebtide (CHEBI:759539) has role antineoplastic agent (CHEBI:35610) |
| lucidenic acid N (CHEBI:66595) has role antineoplastic agent (CHEBI:35610) |
| lucorafusp alfa (CHEBI:760051) has role antineoplastic agent (CHEBI:35610) |
| lumiliximab (CHEBI:754043) has role antineoplastic agent (CHEBI:35610) |
| luminespib (CHEBI:83656) has role antineoplastic agent (CHEBI:35610) |
| lumistobart (CHEBI:760052) has role antineoplastic agent (CHEBI:35610) |
| lumretuzumab (CHEBI:755855) has role antineoplastic agent (CHEBI:35610) |
| lumrotatug (CHEBI:759540) has role antineoplastic agent (CHEBI:35610) |
| lunasine (CHEBI:233245) has role antineoplastic agent (CHEBI:35610) |
| lunaxafusp (CHEBI:759384) has role antineoplastic agent (CHEBI:35610) |
| lunbotinib (CHEBI:760053) has role antineoplastic agent (CHEBI:35610) |
| lupulone (CHEBI:6574) has role antineoplastic agent (CHEBI:35610) |
| lurbinectedin (CHEBI:746908) has role antineoplastic agent (CHEBI:35610) |
| lurtotecan (CHEBI:748323) has role antineoplastic agent (CHEBI:35610) |
| luspatercept (CHEBI:755086) has role antineoplastic agent (CHEBI:35610) |
| lutadenovec autogene (CHEBI:760179) has role antineoplastic agent (CHEBI:35610) |
| luteolin (CHEBI:15864) has role antineoplastic agent (CHEBI:35610) |
| lutetium (lu177) lilotomab satetraxetan (CHEBI:758568) has role antineoplastic agent (CHEBI:35610) |
| lutetium (lu177) rofapitide tetraxetan (CHEBI:759174) has role antineoplastic agent (CHEBI:35610) |
| lutetium (lu177) rosopatamab tetraxetan (CHEBI:760054) has role antineoplastic agent (CHEBI:35610) |
| lutetium lu 177 zadavotide guraxetan (CHEBI:759628) has role antineoplastic agent (CHEBI:35610) |
| lutetium lu-177 psma-r2 (CHEBI:760439) has role antineoplastic agent (CHEBI:35610) |
| lutetium lu-177 vipivotide tetraxetan (CHEBI:757895) has role antineoplastic agent (CHEBI:35610) |
| lutetium lu177 edotreotide (CHEBI:758987) has role antineoplastic agent (CHEBI:35610) |
| lutetium oxodotreotide lu-177 (CHEBI:757020) has role antineoplastic agent (CHEBI:35610) |
| luveltamab tazevibulin (CHEBI:758716) has role antineoplastic agent (CHEBI:35610) |
| luveltamab tazide (CHEBI:758717) has role antineoplastic agent (CHEBI:35610) |
| luvixasertib (CHEBI:757690) has role antineoplastic agent (CHEBI:35610) |
| luvometinib (CHEBI:759977) has role antineoplastic agent (CHEBI:35610) |
| luxdegalutamide (CHEBI:759231) has role antineoplastic agent (CHEBI:35610) |
| luxeptinib (CHEBI:757908) has role antineoplastic agent (CHEBI:35610) |
| luzonial A (CHEBI:66598) has role antineoplastic agent (CHEBI:35610) |
| luzonial B (CHEBI:66599) has role antineoplastic agent (CHEBI:35610) |
| luzonidial B (CHEBI:66600) has role antineoplastic agent (CHEBI:35610) |
| LY-2090314 (CHEBI:167661) has role antineoplastic agent (CHEBI:35610) |
| LY-2157299 (CHEBI:137064) has role antineoplastic agent (CHEBI:35610) |
| ly-2334737 (CHEBI:749080) has role antineoplastic agent (CHEBI:35610) |
| ly-2584702 (CHEBI:755450) has role antineoplastic agent (CHEBI:35610) |
| ly-2780301 (CHEBI:755478) has role antineoplastic agent (CHEBI:35610) |
| ly-295501 (CHEBI:748342) has role antineoplastic agent (CHEBI:35610) |
| ly-3076226 (CHEBI:757441) has role antineoplastic agent (CHEBI:35610) |
| ly-3164530 (CHEBI:757442) has role antineoplastic agent (CHEBI:35610) |
| ly-3200882 (CHEBI:757920) has role antineoplastic agent (CHEBI:35610) |
| ly-3321367 (CHEBI:757446) has role antineoplastic agent (CHEBI:35610) |
| ly-3415244 (CHEBI:758047) has role antineoplastic agent (CHEBI:35610) |
| ly-3475070 (CHEBI:758448) has role antineoplastic agent (CHEBI:35610) |
| ly2452473 (CHEBI:755365) has role antineoplastic agent (CHEBI:35610) |
| LY293111 (CHEBI:187612) has role antineoplastic agent (CHEBI:35610) |
| LY3009120 (CHEBI:167662) has role antineoplastic agent (CHEBI:35610) |
| lychnostatin 1 (CHEBI:66601) has role antineoplastic agent (CHEBI:35610) |
| lychnostatin 2 (CHEBI:66602) has role antineoplastic agent (CHEBI:35610) |
| lycopene (CHEBI:15948) has role antineoplastic agent (CHEBI:35610) |
| lym-1 (CHEBI:754239) has role antineoplastic agent (CHEBI:35610) |
| lymphocyte activation gene 3 protein (CHEBI:757433) has role antineoplastic agent (CHEBI:35610) |
| lyratol C (CHEBI:66607) has role antineoplastic agent (CHEBI:35610) |
| lyratol D (CHEBI:66608) has role antineoplastic agent (CHEBI:35610) |
| lysikokianoside 1 (CHEBI:69611) has role antineoplastic agent (CHEBI:35610) |
| m170 (CHEBI:754298) has role antineoplastic agent (CHEBI:35610) |
| maackiaflavanone A (CHEBI:66643) has role antineoplastic agent (CHEBI:35610) |
| maackiaflavanone B (CHEBI:66644) has role antineoplastic agent (CHEBI:35610) |
| maackiapterocarpan A (CHEBI:66645) has role antineoplastic agent (CHEBI:35610) |
| mab-425 (CHEBI:754206) has role antineoplastic agent (CHEBI:35610) |
| macaflavanone G (CHEBI:66647) has role antineoplastic agent (CHEBI:35610) |
| macaranone A (CHEBI:66648) has role antineoplastic agent (CHEBI:35610) |
| macitegtagene autoleucel (CHEBI:760180) has role antineoplastic agent (CHEBI:35610) |
| macitentan (CHEBI:76607) has role antineoplastic agent (CHEBI:35610) |
| macluraxanthone B (CHEBI:66649) has role antineoplastic agent (CHEBI:35610) |
| macluraxanthone C (CHEBI:66650) has role antineoplastic agent (CHEBI:35610) |
| madecassic acid (CHEBI:73058) has role antineoplastic agent (CHEBI:35610) |
| mafosfamide (CHEBI:748286) has role antineoplastic agent (CHEBI:35610) |
| magnesium atom (CHEBI:25107) has role antineoplastic agent (CHEBI:35610) |
| magnesium dichloride hexahydrate (CHEBI:86345) has role antineoplastic agent (CHEBI:35610) |
| magnesium sulfate (CHEBI:32599) has role antineoplastic agent (CHEBI:35610) |
| magnesium valproate (CHEBI:754941) has role antineoplastic agent (CHEBI:35610) |
| magrolimab (CHEBI:757412) has role antineoplastic agent (CHEBI:35610) |
| mak-683 (CHEBI:758370) has role antineoplastic agent (CHEBI:35610) |
| manassantin A (CHEBI:66663) has role antineoplastic agent (CHEBI:35610) |
| manassantin B (CHEBI:66664) has role antineoplastic agent (CHEBI:35610) |
| mangafodipir (CHEBI:749406) has role antineoplastic agent (CHEBI:35610) |
| manganese chloride (CHEBI:759091) has role antineoplastic agent (CHEBI:35610) |
| mannosulfan (CHEBI:136005) has role antineoplastic agent (CHEBI:35610) |
| manool (CHEBI:76945) has role antineoplastic agent (CHEBI:35610) |
| manumycin A (CHEBI:29623) has role antineoplastic agent (CHEBI:35610) |
| manzamine A (CHEBI:66667) has role antineoplastic agent (CHEBI:35610) |
| maoecrystal Z (CHEBI:66670) has role antineoplastic agent (CHEBI:35610) |
| mapatumumab (CHEBI:753574) has role antineoplastic agent (CHEBI:35610) |
| maplirpacept (CHEBI:758504) has role antineoplastic agent (CHEBI:35610) |
| Maprotiline (CHEBI:6690) has role antineoplastic agent (CHEBI:35610) |
| margetuximab (CHEBI:754997) has role antineoplastic agent (CHEBI:35610) |
| marimastat (CHEBI:50662) has role antineoplastic agent (CHEBI:35610) |
| marineosin A (CHEBI:66676) has role antineoplastic agent (CHEBI:35610) |
| marineosin B (CHEBI:66677) has role antineoplastic agent (CHEBI:35610) |
| marlumotide (CHEBI:759446) has role antineoplastic agent (CHEBI:35610) |
| masitinib (CHEBI:63450) has role antineoplastic agent (CHEBI:35610) |
| maslinic acid (CHEBI:66682) has role antineoplastic agent (CHEBI:35610) |
| masofaniten (CHEBI:758689) has role antineoplastic agent (CHEBI:35610) |
| masoprocol (CHEBI:73468) has role antineoplastic agent (CHEBI:35610) |
| matuzumab (CHEBI:753054) has role antineoplastic agent (CHEBI:35610) |
| mavelertinib (CHEBI:756454) has role antineoplastic agent (CHEBI:35610) |
| maveropepimut-s (CHEBI:757818) has role antineoplastic agent (CHEBI:35610) |
| mavrostobart (CHEBI:760181) has role antineoplastic agent (CHEBI:35610) |
| max-10181 (CHEBI:758768) has role antineoplastic agent (CHEBI:35610) |
| maytansine (CHEBI:6701) has role antineoplastic agent (CHEBI:35610) |
| maytenfolone A (CHEBI:66686) has role antineoplastic agent (CHEBI:35610) |
| mbc-11 (CHEBI:758465) has role antineoplastic agent (CHEBI:35610) |
| mbq-167 (CHEBI:759081) has role antineoplastic agent (CHEBI:35610) |
| MCB-613 (CHEBI:90954) has role antineoplastic agent (CHEBI:35610) |
| mcs-110 (CHEBI:754290) has role antineoplastic agent (CHEBI:35610) |
| mdx-1342 (CHEBI:754169) has role antineoplastic agent (CHEBI:35610) |
| mdx-1411 (CHEBI:754276) has role antineoplastic agent (CHEBI:35610) |
| mdx-447 (CHEBI:754207) has role antineoplastic agent (CHEBI:35610) |
| me-344 (CHEBI:759101) has role antineoplastic agent (CHEBI:35610) |
| me1-14 f(ab')2 (CHEBI:754314) has role antineoplastic agent (CHEBI:35610) |
| mebendazole (CHEBI:6704) has role antineoplastic agent (CHEBI:35610) |
| mecapegfilgrastim (CHEBI:758855) has role antineoplastic agent (CHEBI:35610) |
| mecbotamab (CHEBI:758991) has role antineoplastic agent (CHEBI:35610) |
| mecbotamab vedotin (CHEBI:758885) has role antineoplastic agent (CHEBI:35610) |
| mechlorethamine (CHEBI:28925) has role antineoplastic agent (CHEBI:35610) |
| mechlorethamine hydrochloride (CHEBI:55368) has role antineoplastic agent (CHEBI:35610) |
| Meclizine (CHEBI:6709) has role antineoplastic agent (CHEBI:35610) |
| meclofenamic acid (CHEBI:6710) has role antineoplastic agent (CHEBI:35610) |
| medi-0639 (CHEBI:757453) has role antineoplastic agent (CHEBI:35610) |
| medi-3617 (CHEBI:754144) has role antineoplastic agent (CHEBI:35610) |
| medi-547 (CHEBI:757960) has role antineoplastic agent (CHEBI:35610) |
| medi-565 (CHEBI:754193) has role antineoplastic agent (CHEBI:35610) |
| medi-6469 (CHEBI:754304) has role antineoplastic agent (CHEBI:35610) |
| medroxyprogesterone acetate (CHEBI:6716) has role antineoplastic agent (CHEBI:35610) |
| mefloquine (CHEBI:63609) has role antineoplastic agent (CHEBI:35610) |
| mefuparib (CHEBI:167905) has role antineoplastic agent (CHEBI:35610) |
| mefuparib hydrochloride (CHEBI:167899) has role antineoplastic agent (CHEBI:35610) |
| megathyrin A (CHEBI:66689) has role antineoplastic agent (CHEBI:35610) |
| megestrol (CHEBI:6722) has role antineoplastic agent (CHEBI:35610) |
| megestrol acetate (CHEBI:6723) has role antineoplastic agent (CHEBI:35610) |
| melanoma-associated antigen 3 (CHEBI:758928) has role antineoplastic agent (CHEBI:35610) |
| melatonin (CHEBI:16796) has role antineoplastic agent (CHEBI:35610) |
| melittin (CHEBI:6736) has role antineoplastic agent (CHEBI:35610) |
| melophlin P (CHEBI:66691) has role antineoplastic agent (CHEBI:35610) |
| melophlin Q (CHEBI:66692) has role antineoplastic agent (CHEBI:35610) |
| melophlin R (CHEBI:66693) has role antineoplastic agent (CHEBI:35610) |
| melophlin S (CHEBI:66694) has role antineoplastic agent (CHEBI:35610) |
| meloxicam (CHEBI:6741) has role antineoplastic agent (CHEBI:35610) |
| melphalan (CHEBI:28876) has role antineoplastic agent (CHEBI:35610) |
| melphalan flufenamide (CHEBI:757647) has role antineoplastic agent (CHEBI:35610) |
| melphalan flufenamide hydrochloride (CHEBI:756892) has role antineoplastic agent (CHEBI:35610) |
| melphalan hydrochloride (CHEBI:749331) has role antineoplastic agent (CHEBI:35610) |
| memantine (CHEBI:64312) has role antineoplastic agent (CHEBI:35610) |
| memantine hydrochloride (CHEBI:64323) has role antineoplastic agent (CHEBI:35610) |
| menadione (CHEBI:28869) has role antineoplastic agent (CHEBI:35610) |
| menaquinone-4 (CHEBI:78277) has role antineoplastic agent (CHEBI:35610) |
| menthol (CHEBI:748835) has role antineoplastic agent (CHEBI:35610) |
| meprednisone (CHEBI:135573) has role antineoplastic agent (CHEBI:35610) |
| mercaptopurine (CHEBI:50667) has role antineoplastic agent (CHEBI:35610) |
| merestinib (CHEBI:755566) has role antineoplastic agent (CHEBI:35610) |
| meropenem (CHEBI:43968) has role antineoplastic agent (CHEBI:35610) |
| mertansine (CHEBI:82755) has role antineoplastic agent (CHEBI:35610) |
| mesalamine (CHEBI:6775) has role antineoplastic agent (CHEBI:35610) |
| mesmulogene ancovacivec (CHEBI:758394) has role antineoplastic agent (CHEBI:35610) |
| Mesna (CHEBI:31824) has role antineoplastic agent (CHEBI:35610) |
| Met-enkephalin (CHEBI:6618) has role antineoplastic agent (CHEBI:35610) |
| metachromin S (CHEBI:66695) has role antineoplastic agent (CHEBI:35610) |
| metachromin T (CHEBI:66696) has role antineoplastic agent (CHEBI:35610) |
| metenkefalin (CHEBI:753282) has role antineoplastic agent (CHEBI:35610) |
| metformin (CHEBI:6801) has role antineoplastic agent (CHEBI:35610) |
| metformin hydrochloride (CHEBI:6802) has role antineoplastic agent (CHEBI:35610) |
| methadone (CHEBI:6807) has role antineoplastic agent (CHEBI:35610) |
| Methazolamide (CHEBI:6822) has role antineoplastic agent (CHEBI:35610) |
| metholone (CHEBI:34838) has role antineoplastic agent (CHEBI:35610) |
| methotrexate (CHEBI:44185) has role antineoplastic agent (CHEBI:35610) |
| methotrexate disodium (CHEBI:50679) has role antineoplastic agent (CHEBI:35610) |
| methoxsalen (CHEBI:18358) has role antineoplastic agent (CHEBI:35610) |
| methoxyacetic acid (CHEBI:132098) has role antineoplastic agent (CHEBI:35610) |
| Methoxyamine (CHEBI:192842) has role antineoplastic agent (CHEBI:35610) |
| methoxyflurane (CHEBI:6843) has role antineoplastic agent (CHEBI:35610) |
| methyl (indol-3-yl)acetate (CHEBI:72782) has role antineoplastic agent (CHEBI:35610) |
| methyl 5-aminolevulinate (CHEBI:724125) has role antineoplastic agent (CHEBI:35610) |
| methyl 5-aminolevulinate hydrochloride (CHEBI:60641) has role antineoplastic agent (CHEBI:35610) |
| methyl aminolevulinate hydrochloride (CHEBI:749373) has role antineoplastic agent (CHEBI:35610) |
| Methyl violet 2B (CHEBI:90108) has role antineoplastic agent (CHEBI:35610) |
| Methyl violet 2B free base (CHEBI:90110) has role antineoplastic agent (CHEBI:35610) |
| methyl γ-linolenate (CHEBI:144354) has role antineoplastic agent (CHEBI:35610) |
| methylene blue (CHEBI:6872) has role antineoplastic agent (CHEBI:35610) |
| methyllinderone (CHEBI:233555) has role antineoplastic agent (CHEBI:35610) |
| methylnaltrexone bromide (CHEBI:749594) has role antineoplastic agent (CHEBI:35610) |
| methylphenidate (CHEBI:6887) has role antineoplastic agent (CHEBI:35610) |
| methylphenidate hydrochloride (CHEBI:31836) has role antineoplastic agent (CHEBI:35610) |
| methylprednisolone acetate (CHEBI:6889) has role antineoplastic agent (CHEBI:35610) |
| Methylprednisolone sodium succinate (CHEBI:6890) has role antineoplastic agent (CHEBI:35610) |
| methylseleninic acid (CHEBI:77012) has role antineoplastic agent (CHEBI:35610) |
| methylselenol (CHEBI:64685) has role antineoplastic agent (CHEBI:35610) |
| methylstat (CHEBI:95078) has role antineoplastic agent (CHEBI:35610) |
| methyltestosterone (CHEBI:27436) has role antineoplastic agent (CHEBI:35610) |
| methylthioadenosine-DADMe immucillin-A (CHEBI:234322) has role antineoplastic agent (CHEBI:35610) |
| metoclopramide (CHEBI:107736) has role antineoplastic agent (CHEBI:35610) |
| metoclopramide hydrochloride (CHEBI:6899) has role antineoplastic agent (CHEBI:35610) |
| metoprolol (CHEBI:6904) has role antineoplastic agent (CHEBI:35610) |
| metronidazole (CHEBI:6909) has role antineoplastic agent (CHEBI:35610) |
| metronidazole hydrochloride (CHEBI:50687) has role antineoplastic agent (CHEBI:35610) |
| mevrometostat (CHEBI:756584) has role antineoplastic agent (CHEBI:35610) |
| mezagitamab (CHEBI:757277) has role antineoplastic agent (CHEBI:35610) |
| mezigdomide (CHEBI:758118) has role antineoplastic agent (CHEBI:35610) |
| mgd-007 (CHEBI:757461) has role antineoplastic agent (CHEBI:35610) |
| mgd-009 (CHEBI:758050) has role antineoplastic agent (CHEBI:35610) |
| Mibefradil (CHEBI:6920) has role antineoplastic agent (CHEBI:35610) |
| miboplatin (CHEBI:36143) has role antineoplastic agent (CHEBI:35610) |
| michaolide A (CHEBI:66374) has role antineoplastic agent (CHEBI:35610) |
| michaolide B (CHEBI:66375) has role antineoplastic agent (CHEBI:35610) |
| michaolide C (CHEBI:66376) has role antineoplastic agent (CHEBI:35610) |
| michaolide D (CHEBI:66377) has role antineoplastic agent (CHEBI:35610) |
| michaolide E (CHEBI:66378) has role antineoplastic agent (CHEBI:35610) |
| michaolide F (CHEBI:66379) has role antineoplastic agent (CHEBI:35610) |
| michaolide G (CHEBI:66380) has role antineoplastic agent (CHEBI:35610) |
| michaolide H (CHEBI:66381) has role antineoplastic agent (CHEBI:35610) |
| michaolide I (CHEBI:66382) has role antineoplastic agent (CHEBI:35610) |
| michaolide J (CHEBI:66383) has role antineoplastic agent (CHEBI:35610) |
| michaolide K (CHEBI:66384) has role antineoplastic agent (CHEBI:35610) |
| miconazole (CHEBI:6923) has role antineoplastic agent (CHEBI:35610) |
| miconazole nitrate (CHEBI:6924) has role antineoplastic agent (CHEBI:35610) |
| microclavatin (CHEBI:66387) has role antineoplastic agent (CHEBI:35610) |
| microcrystalline cellulose (CHEBI:757032) has role antineoplastic agent (CHEBI:35610) |
| micvotabart (CHEBI:760057) has role antineoplastic agent (CHEBI:35610) |
| micvotabart pelidotin (CHEBI:760058) has role antineoplastic agent (CHEBI:35610) |
| midazolam (CHEBI:6931) has role antineoplastic agent (CHEBI:35610) |
| midazolam hydrochloride (CHEBI:6932) has role antineoplastic agent (CHEBI:35610) |
| midostaurin (CHEBI:63452) has role antineoplastic agent (CHEBI:35610) |
| mifamurtide (CHEBI:135906) has role antineoplastic agent (CHEBI:35610) |
| mifanertinib (CHEBI:759176) has role antineoplastic agent (CHEBI:35610) |
| mifepristone (CHEBI:50692) has role antineoplastic agent (CHEBI:35610) |
| migoprotafib (CHEBI:759177) has role antineoplastic agent (CHEBI:35610) |
| migrastatin (CHEBI:66389) has role antineoplastic agent (CHEBI:35610) |
| mik-665 (CHEBI:757515) has role antineoplastic agent (CHEBI:35610) |
| mik-beta-1 (CHEBI:754160) has role antineoplastic agent (CHEBI:35610) |
| milademetan (CHEBI:756667) has role antineoplastic agent (CHEBI:35610) |
| milademetan tosylate (CHEBI:756866) has role antineoplastic agent (CHEBI:35610) |
| milataxel (CHEBI:752843) has role antineoplastic agent (CHEBI:35610) |
| milatuzumab (CHEBI:750118) has role antineoplastic agent (CHEBI:35610) |
| milciclib (CHEBI:749060) has role antineoplastic agent (CHEBI:35610) |
| milciclib maleate (CHEBI:757129) has role antineoplastic agent (CHEBI:35610) |
| milk thistle (CHEBI:753575) has role antineoplastic agent (CHEBI:35610) |
| milrebrutinib (CHEBI:758600) has role antineoplastic agent (CHEBI:35610) |
| miltefosine (CHEBI:75283) has role antineoplastic agent (CHEBI:35610) |
| minabeolide 1 (CHEBI:67566) has role antineoplastic agent (CHEBI:35610) |
| minheryin G (CHEBI:66394) has role antineoplastic agent (CHEBI:35610) |
| minnelide (CHEBI:755869) has role antineoplastic agent (CHEBI:35610) |
| minocycline (CHEBI:50694) has role antineoplastic agent (CHEBI:35610) |
| minoxidil (CHEBI:6942) has role antineoplastic agent (CHEBI:35610) |
| minquartynoic acid (CHEBI:542606) has role antineoplastic agent (CHEBI:35610) |
| minretumomab (CHEBI:753723) has role antineoplastic agent (CHEBI:35610) |
| mint-1526a (CHEBI:757467) has role antineoplastic agent (CHEBI:35610) |
| mip-1095 i-131 (CHEBI:757295) has role antineoplastic agent (CHEBI:35610) |
| mipasetamab (CHEBI:759009) has role antineoplastic agent (CHEBI:35610) |
| mipasetamab uzoptirine (CHEBI:758873) has role antineoplastic agent (CHEBI:35610) |
| mipletamig (CHEBI:760060) has role antineoplastic agent (CHEBI:35610) |
| mipsagargin (CHEBI:756372) has role antineoplastic agent (CHEBI:35610) |
| miransertib (CHEBI:756706) has role antineoplastic agent (CHEBI:35610) |
| miransertib mesylate (CHEBI:757561) has role antineoplastic agent (CHEBI:35610) |
| mirtazapine (CHEBI:6950) has role antineoplastic agent (CHEBI:35610) |
| mirvetuximab soravtansine (CHEBI:755477) has role antineoplastic agent (CHEBI:35610) |
| mirzotamab (CHEBI:758572) has role antineoplastic agent (CHEBI:35610) |
| mirzotamab clezutoclax (CHEBI:757988) has role antineoplastic agent (CHEBI:35610) |
| misetionamide (CHEBI:759136) has role antineoplastic agent (CHEBI:35610) |
| misitatug (CHEBI:760061) has role antineoplastic agent (CHEBI:35610) |
| misitatug blivedotin (CHEBI:760062) has role antineoplastic agent (CHEBI:35610) |
| misoprostol (CHEBI:63610) has role antineoplastic agent (CHEBI:35610) |
| mitazalimab (CHEBI:757309) has role antineoplastic agent (CHEBI:35610) |
| mithramycin (CHEBI:31856) has role antineoplastic agent (CHEBI:35610) |
| Mitobronitol (CHEBI:34853) has role antineoplastic agent (CHEBI:35610) |
| mitoguazone (CHEBI:43996) has role antineoplastic agent (CHEBI:35610) |
| mitoguazone hydrochloride (CHEBI:78028) has role antineoplastic agent (CHEBI:35610) |
| mitoguazone hydrochloride hydrate (CHEBI:78032) has role antineoplastic agent (CHEBI:35610) |
| mitolactol (CHEBI:135311) has role antineoplastic agent (CHEBI:35610) |
| mitomycin A (CHEBI:85412) has role antineoplastic agent (CHEBI:35610) |
| mitomycin B (CHEBI:85416) has role antineoplastic agent (CHEBI:35610) |
| mitomycin C (CHEBI:27504) has role antineoplastic agent (CHEBI:35610) |
| Mitotane (CHEBI:6954) has role antineoplastic agent (CHEBI:35610) |
| mitoxantrone (CHEBI:50729) has role antineoplastic agent (CHEBI:35610) |
| mitoxantrone dihydrochloride (CHEBI:50727) has role antineoplastic agent (CHEBI:35610) |
| mitumomab (CHEBI:753412) has role antineoplastic agent (CHEBI:35610) |
| mivavotinib (CHEBI:756023) has role antineoplastic agent (CHEBI:35610) |
| mivavotinib citrate (CHEBI:757760) has role antineoplastic agent (CHEBI:35610) |
| mk-0752 (CHEBI:756630) has role antineoplastic agent (CHEBI:35610) |
| mk-1496 (CHEBI:759102) has role antineoplastic agent (CHEBI:35610) |
| MK-2206 (CHEBI:67271) has role antineoplastic agent (CHEBI:35610) |
| MK-2461 (CHEBI:230540) has role antineoplastic agent (CHEBI:35610) |
| mk-4721 (CHEBI:754315) has role antineoplastic agent (CHEBI:35610) |
| mk-5108 (CHEBI:755654) has role antineoplastic agent (CHEBI:35610) |
| mk-6592 (CHEBI:755606) has role antineoplastic agent (CHEBI:35610) |
| mk-8033 (CHEBI:754943) has role antineoplastic agent (CHEBI:35610) |
| MK-8353 (CHEBI:167664) has role antineoplastic agent (CHEBI:35610) |
| ML-210 (CHEBI:176502) has role antineoplastic agent (CHEBI:35610) |
| ML240 (CHEBI:143014) has role antineoplastic agent (CHEBI:35610) |
| mln-2704 (CHEBI:754320) has role antineoplastic agent (CHEBI:35610) |
| mm-111 (CHEBI:757031) has role antineoplastic agent (CHEBI:35610) |
| MMP-9-IN-1 (CHEBI:156264) has role antineoplastic agent (CHEBI:35610) |
| mobinitinib (CHEBI:754849) has role antineoplastic agent (CHEBI:35610) |
| mobocertinib (CHEBI:758219) has role antineoplastic agent (CHEBI:35610) |
| mobocertinib succinate (CHEBI:758547) has role antineoplastic agent (CHEBI:35610) |
| moc31-pe (CHEBI:754129) has role antineoplastic agent (CHEBI:35610) |
| mocaciclib (CHEBI:759978) has role antineoplastic agent (CHEBI:35610) |
| mocetinostat (CHEBI:197437) has role antineoplastic agent (CHEBI:35610) |
| mocravimod (CHEBI:754771) has role antineoplastic agent (CHEBI:35610) |
| mocravimod hydrochloride (CHEBI:760307) has role antineoplastic agent (CHEBI:35610) |
| modafinil (CHEBI:31859) has role antineoplastic agent (CHEBI:35610) |
| modakafusp alfa (CHEBI:757279) has role antineoplastic agent (CHEBI:35610) |
| modotuximab (CHEBI:756471) has role antineoplastic agent (CHEBI:35610) |
| mogamulizumab (CHEBI:750119) has role antineoplastic agent (CHEBI:35610) |
| mogrol (CHEBI:138974) has role antineoplastic agent (CHEBI:35610) |
| mol-4239 (CHEBI:757922) has role antineoplastic agent (CHEBI:35610) |
| molgramostim (CHEBI:754026) has role antineoplastic agent (CHEBI:35610) |
| molibresib (CHEBI:95082) has role antineoplastic agent (CHEBI:35610) |
| mollicellin B (CHEBI:68801) has role antineoplastic agent (CHEBI:35610) |
| mollicellin C (CHEBI:68802) has role antineoplastic agent (CHEBI:35610) |
| mollicellin E (CHEBI:68803) has role antineoplastic agent (CHEBI:35610) |
| mollicellin F (CHEBI:68721) has role antineoplastic agent (CHEBI:35610) |
| mollicellin H (CHEBI:68722) has role antineoplastic agent (CHEBI:35610) |
| mollicellin J (CHEBI:68723) has role antineoplastic agent (CHEBI:35610) |
| mollicellin K (CHEBI:68724) has role antineoplastic agent (CHEBI:35610) |
| mollicellin L (CHEBI:68725) has role antineoplastic agent (CHEBI:35610) |
| mollicellin M (CHEBI:68726) has role antineoplastic agent (CHEBI:35610) |
| mollicellin N (CHEBI:68727) has role antineoplastic agent (CHEBI:35610) |
| momelotinib (CHEBI:91407) has role antineoplastic agent (CHEBI:35610) |
| momelotinib dihydrochloride monohydrate (CHEBI:760250) has role antineoplastic agent (CHEBI:35610) |
| mometasone furoate (CHEBI:47564) has role antineoplastic agent (CHEBI:35610) |
| monalizumab (CHEBI:757233) has role antineoplastic agent (CHEBI:35610) |
| monascin (CHEBI:82621) has role antineoplastic agent (CHEBI:35610) |
| monascorubrin (CHEBI:156408) has role antineoplastic agent (CHEBI:35610) |
| monastrol (CHEBI:75382) has role antineoplastic agent (CHEBI:35610) |
| mono-dga-rfb4 (CHEBI:754179) has role antineoplastic agent (CHEBI:35610) |
| monodictyochromone A (CHEBI:66396) has role antineoplastic agent (CHEBI:35610) |
| monodictyochromone B (CHEBI:66397) has role antineoplastic agent (CHEBI:35610) |
| monodictysin B (CHEBI:66398) has role antineoplastic agent (CHEBI:35610) |
| monodictysin C (CHEBI:66399) has role antineoplastic agent (CHEBI:35610) |
| Monomethyl auristatin E (vedotin) (CHEBI:747132) has role antineoplastic agent (CHEBI:35610) |
| monosialotetrahexosylganglioside sodium (CHEBI:758856) has role antineoplastic agent (CHEBI:35610) |
| montelukast (CHEBI:50730) has role antineoplastic agent (CHEBI:35610) |
| montmorillonite (CHEBI:133353) has role antineoplastic agent (CHEBI:35610) |
| monzosertib (CHEBI:758592) has role antineoplastic agent (CHEBI:35610) |
| morab-028 (CHEBI:754217) has role antineoplastic agent (CHEBI:35610) |
| morellic acid (CHEBI:66401) has role antineoplastic agent (CHEBI:35610) |
| morellin (CHEBI:6995) has role antineoplastic agent (CHEBI:35610) |
| morin (CHEBI:75092) has role antineoplastic agent (CHEBI:35610) |
| moromycin A (CHEBI:66403) has role antineoplastic agent (CHEBI:35610) |
| moromycin B (CHEBI:66404) has role antineoplastic agent (CHEBI:35610) |
| morusin (CHEBI:7005) has role antineoplastic agent (CHEBI:35610) |
| mosedipimod (CHEBI:748634) has role antineoplastic agent (CHEBI:35610) |
| mosperafenib (CHEBI:759979) has role antineoplastic agent (CHEBI:35610) |
| mosunetuzumab (CHEBI:757234) has role antineoplastic agent (CHEBI:35610) |
| motesanib (CHEBI:51098) has role antineoplastic agent (CHEBI:35610) |
| motesanib diphosphate (CHEBI:752587) has role antineoplastic agent (CHEBI:35610) |
| motexafin (CHEBI:750823) has role antineoplastic agent (CHEBI:35610) |
| motexafin gadolinium (CHEBI:50161) has role antineoplastic agent (CHEBI:35610) |
| motixafortide (CHEBI:145536) has role antineoplastic agent (CHEBI:35610) |
| motixafortide acetate (CHEBI:229224) has role antineoplastic agent (CHEBI:35610) |
| motolimod (CHEBI:755299) has role antineoplastic agent (CHEBI:35610) |
| moxetumomab pasudotox (CHEBI:750121) has role antineoplastic agent (CHEBI:35610) |
| moxifloxacin (CHEBI:63611) has role antineoplastic agent (CHEBI:35610) |
| moxifloxacin hydrochloride (CHEBI:7008) has role antineoplastic agent (CHEBI:35610) |
| mozistobart (CHEBI:760063) has role antineoplastic agent (CHEBI:35610) |
| mozistobart zoratolimod (CHEBI:760064) has role antineoplastic agent (CHEBI:35610) |
| mp-0250 (CHEBI:757471) has role antineoplastic agent (CHEBI:35610) |
| MP-A08 (CHEBI:167665) has role antineoplastic agent (CHEBI:35610) |
| MRTX1133 (CHEBI:746962) has role antineoplastic agent (CHEBI:35610) |
| mrx-2843 (CHEBI:758297) has role antineoplastic agent (CHEBI:35610) |
| MST-312 (CHEBI:95003) has role antineoplastic agent (CHEBI:35610) |
| msx-122 (CHEBI:755580) has role antineoplastic agent (CHEBI:35610) |
| mt-3724 (CHEBI:757235) has role antineoplastic agent (CHEBI:35610) |
| mti-31 (CHEBI:757919) has role antineoplastic agent (CHEBI:35610) |
| MTIC (CHEBI:72568) has role antineoplastic agent (CHEBI:35610) |
| mu-j591 (CHEBI:754322) has role antineoplastic agent (CHEBI:35610) |
| mucronulatol (CHEBI:7014) has role antineoplastic agent (CHEBI:35610) |
| mulnitorsen (CHEBI:758718) has role antineoplastic agent (CHEBI:35610) |
| mupadolimab (CHEBI:758513) has role antineoplastic agent (CHEBI:35610) |
| muparfostat (CHEBI:756699) has role antineoplastic agent (CHEBI:35610) |
| murcidencel (CHEBI:759447) has role antineoplastic agent (CHEBI:35610) |
| mureletecan (CHEBI:753438) has role antineoplastic agent (CHEBI:35610) |
| murizatoclax (CHEBI:758131) has role antineoplastic agent (CHEBI:35610) |
| murlentamab (CHEBI:758908) has role antineoplastic agent (CHEBI:35610) |
| muromonab-cd3 (CHEBI:749554) has role antineoplastic agent (CHEBI:35610) |
| muvadenant (CHEBI:759853) has role antineoplastic agent (CHEBI:35610) |
| muzastotug (CHEBI:759448) has role antineoplastic agent (CHEBI:35610) |
| mvt-1075 (CHEBI:757236) has role antineoplastic agent (CHEBI:35610) |
| mvt-5873 (CHEBI:757237) has role antineoplastic agent (CHEBI:35610) |
| mycophenolate mofetil (CHEBI:8764) has role antineoplastic agent (CHEBI:35610) |
| mycophenolic acid (CHEBI:168396) has role antineoplastic agent (CHEBI:35610) |
| myriaporone 3 (CHEBI:66422) has role antineoplastic agent (CHEBI:35610) |
| Myricanone (CHEBI:141540) has role antineoplastic agent (CHEBI:35610) |
| myricetin (CHEBI:18152) has role antineoplastic agent (CHEBI:35610) |
| myriocin (CHEBI:582124) has role antineoplastic agent (CHEBI:35610) |
| myrsinoic acid A (CHEBI:66426) has role antineoplastic agent (CHEBI:35610) |
| N-(1,3-benzodioxol-5-ylmethyl)-4-(4-benzofuro[3,2-d]pyrimidinyl)-1-piperazinecarbothioamide (CHEBI:91389) has role antineoplastic agent (CHEBI:35610) |
| N-(3-aminopropyl)-N-[(1R)-1-[7-chloro-4-oxo-3-(phenylmethyl)-2-quinazolinyl]-2-methylpropyl]-4-methylbenzamide (CHEBI:94692) has role antineoplastic agent (CHEBI:35610) |
| N-[(1-methyl-4-piperidinyl)methyl]-3-[3-(trifluoromethoxy)phenyl]-6-imidazo[1,2-b]pyridazinamine (CHEBI:95061) has role antineoplastic agent (CHEBI:35610) |
| N-[2-(4-hydroxyanilino)-3-pyridinyl]-4-methoxybenzenesulfonamide (CHEBI:95043) has role antineoplastic agent (CHEBI:35610) |
| N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxo-3-pyridinecarboxamide (CHEBI:91409) has role antineoplastic agent (CHEBI:35610) |
| N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide (CHEBI:91336) has role antineoplastic agent (CHEBI:35610) |
| N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-quinazolinyl]-2-propenamide (CHEBI:91467) has role antineoplastic agent (CHEBI:35610) |
| N-[6,6-dimethyl-5-[(1-methyl-4-piperidinyl)-oxomethyl]-1,4-dihydropyrrolo[3,4-c]pyrazol-3-yl]-3-methylbutanamide (CHEBI:91371) has role antineoplastic agent (CHEBI:35610) |
| N-tert-butyl-3-[[5-methyl-2-[4-[2-(1-pyrrolidinyl)ethoxy]anilino]-4-pyrimidinyl]amino]benzenesulfonamide (CHEBI:91408) has role antineoplastic agent (CHEBI:35610) |
| N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (CHEBI:93414) has role antineoplastic agent (CHEBI:35610) |
| N4-(3-chloro-4-fluorophenyl)-N6-(1-methyl-4-piperidinyl)pyrimido[5,4-d]pyrimidine-4,6-diamine (CHEBI:93243) has role antineoplastic agent (CHEBI:35610) |
| nabilone (CHEBI:135574) has role antineoplastic agent (CHEBI:35610) |
| nabiximols (CHEBI:755928) has role antineoplastic agent (CHEBI:35610) |
| nadofaragene firadenovec (CHEBI:756521) has role antineoplastic agent (CHEBI:35610) |
| nadolol (CHEBI:7444) has role antineoplastic agent (CHEBI:35610) |
| nadravaleucel (CHEBI:759388) has role antineoplastic agent (CHEBI:35610) |
| nadroparin calcium (CHEBI:754093) has role antineoplastic agent (CHEBI:35610) |
| nalotimagene carmaleucel (CHEBI:756520) has role antineoplastic agent (CHEBI:35610) |
| nanatinostat (CHEBI:750200) has role antineoplastic agent (CHEBI:35610) |
| nanrilkefusp alfa (CHEBI:758951) has role antineoplastic agent (CHEBI:35610) |
| napabucasin (CHEBI:748285) has role antineoplastic agent (CHEBI:35610) |
| naphthazarin (CHEBI:28849) has role antineoplastic agent (CHEBI:35610) |
| Naporafenib (CHEBI:747299) has role antineoplastic agent (CHEBI:35610) |
| naproxen (CHEBI:7476) has role antineoplastic agent (CHEBI:35610) |
| naptumomab estafenatox (CHEBI:750123) has role antineoplastic agent (CHEBI:35610) |
| naquotinib (CHEBI:755687) has role antineoplastic agent (CHEBI:35610) |
| naquotinib mesylate (CHEBI:755817) has role antineoplastic agent (CHEBI:35610) |
| naratuximab emtansine (CHEBI:754132) has role antineoplastic agent (CHEBI:35610) |
| narazaciclib (CHEBI:755127) has role antineoplastic agent (CHEBI:35610) |
| naringin (CHEBI:28819) has role antineoplastic agent (CHEBI:35610) |
| narlumosbart (CHEBI:759683) has role antineoplastic agent (CHEBI:35610) |
| narmafotinib (CHEBI:755705) has role antineoplastic agent (CHEBI:35610) |
| narnatumab (CHEBI:750124) has role antineoplastic agent (CHEBI:35610) |
| nastorazepide calcium (CHEBI:757547) has role antineoplastic agent (CHEBI:35610) |
| natalizumab (CHEBI:749500) has role antineoplastic agent (CHEBI:35610) |
| nataloe-emodin (CHEBI:152054) has role antineoplastic agent (CHEBI:35610) |
| navepegritide (CHEBI:757982) has role antineoplastic agent (CHEBI:35610) |
| navicixizumab (CHEBI:756467) has role antineoplastic agent (CHEBI:35610) |
| navitoclax (CHEBI:131174) has role antineoplastic agent (CHEBI:35610) |
| navoximod (CHEBI:756437) has role antineoplastic agent (CHEBI:35610) |
| navtemadlin (CHEBI:755133) has role antineoplastic agent (CHEBI:35610) |
| naxitamab (CHEBI:757411) has role antineoplastic agent (CHEBI:35610) |
| naxtarubicin (CHEBI:760320) has role antineoplastic agent (CHEBI:35610) |
| nazartinib (CHEBI:755884) has role antineoplastic agent (CHEBI:35610) |
| nbl-015 (CHEBI:759684) has role antineoplastic agent (CHEBI:35610) |
| NCX-4040 (CHEBI:233566) has role antineoplastic agent (CHEBI:35610) |
| nebentan (CHEBI:752844) has role antineoplastic agent (CHEBI:35610) |
| nebratamig (CHEBI:759449) has role antineoplastic agent (CHEBI:35610) |
| necitumumab (CHEBI:750125) has role antineoplastic agent (CHEBI:35610) |
| necuparanib (CHEBI:755254) has role antineoplastic agent (CHEBI:35610) |
| nedaplatin (CHEBI:31898) has role antineoplastic agent (CHEBI:35610) |
| nedisertib (CHEBI:757098) has role antineoplastic agent (CHEBI:35610) |
| nedometinib (CHEBI:759893) has role antineoplastic agent (CHEBI:35610) |
| nefextinib (CHEBI:756956) has role antineoplastic agent (CHEBI:35610) |
| nefopam (CHEBI:88316) has role antineoplastic agent (CHEBI:35610) |
| negalstobart (CHEBI:759545) has role antineoplastic agent (CHEBI:35610) |
| neladalkib (CHEBI:759941) has role antineoplastic agent (CHEBI:35610) |
| nelarabine (CHEBI:63612) has role antineoplastic agent (CHEBI:35610) |
| neldaleucel (CHEBI:760367) has role antineoplastic agent (CHEBI:35610) |
| nelfinavir (CHEBI:7496) has role antineoplastic agent (CHEBI:35610) |
| nelfinavir mesylate (CHEBI:7497) has role antineoplastic agent (CHEBI:35610) |
| Nelipepimut-S (CHEBI:230310) has role antineoplastic agent (CHEBI:35610) |
| nelistotug (CHEBI:759712) has role antineoplastic agent (CHEBI:35610) |
| nelitolimod (CHEBI:760368) has role antineoplastic agent (CHEBI:35610) |
| nelitolimod sodium (CHEBI:760369) has role antineoplastic agent (CHEBI:35610) |
| nelmastobart (CHEBI:760517) has role antineoplastic agent (CHEBI:35610) |
| nemtabrutinib (CHEBI:758429) has role antineoplastic agent (CHEBI:35610) |
| nemvaleukin alfa (CHEBI:758857) has role antineoplastic agent (CHEBI:35610) |
| nendocabtagene onogedleucel (CHEBI:760066) has role antineoplastic agent (CHEBI:35610) |
| nendratareotide uzatansine (CHEBI:758233) has role antineoplastic agent (CHEBI:35610) |
| Neoandrographolide (CHEBI:228890) has role antineoplastic agent (CHEBI:35610) |
| neobavaisoflavone (CHEBI:66614) has role antineoplastic agent (CHEBI:35610) |
| neocarzinostatin chromophore (CHEBI:29655) has role antineoplastic agent (CHEBI:35610) |
| neohesperidin (CHEBI:59016) has role antineoplastic agent (CHEBI:35610) |
| neomycin (CHEBI:7507) has role antineoplastic agent (CHEBI:35610) |
| neostigmine (CHEBI:7514) has role antineoplastic agent (CHEBI:35610) |
| neotetrazolium chloride (CHEBI:748374) has role antineoplastic agent (CHEBI:35610) |
| nepidermin (CHEBI:753302) has role antineoplastic agent (CHEBI:35610) |
| neratinib (CHEBI:61397) has role antineoplastic agent (CHEBI:35610) |
| neratinib maleate (CHEBI:756414) has role antineoplastic agent (CHEBI:35610) |
| nerofe (CHEBI:756807) has role antineoplastic agent (CHEBI:35610) |
| nesiritide (CHEBI:135919) has role antineoplastic agent (CHEBI:35610) |
| nespecabtagene autoleucel (CHEBI:760186) has role antineoplastic agent (CHEBI:35610) |
| nesuparib (CHEBI:758822) has role antineoplastic agent (CHEBI:35610) |
| nesvacumab (CHEBI:753626) has role antineoplastic agent (CHEBI:35610) |
| netazepide (CHEBI:748477) has role antineoplastic agent (CHEBI:35610) |
| netupitant (CHEBI:85155) has role antineoplastic agent (CHEBI:35610) |
| nezastomig (CHEBI:758069) has role antineoplastic agent (CHEBI:35610) |
| nezutatug (CHEBI:759713) has role antineoplastic agent (CHEBI:35610) |
| ng-641 (CHEBI:758858) has role antineoplastic agent (CHEBI:35610) |
| nibrozetone (CHEBI:755362) has role antineoplastic agent (CHEBI:35610) |
| nicardipine (CHEBI:7550) has role antineoplastic agent (CHEBI:35610) |
| nicotinamide (CHEBI:17154) has role antineoplastic agent (CHEBI:35610) |
| nicotinic acid (CHEBI:15940) has role antineoplastic agent (CHEBI:35610) |
| nidanilimab (CHEBI:758932) has role antineoplastic agent (CHEBI:35610) |
| nidulalin A (CHEBI:66625) has role antineoplastic agent (CHEBI:35610) |
| Nifurtimox (CHEBI:7566) has role antineoplastic agent (CHEBI:35610) |
| nigerapyrone B (CHEBI:69257) has role antineoplastic agent (CHEBI:35610) |
| nigerapyrone D (CHEBI:69259) has role antineoplastic agent (CHEBI:35610) |
| nigerapyrone E (CHEBI:69260) has role antineoplastic agent (CHEBI:35610) |
| nigranoic acid (CHEBI:66626) has role antineoplastic agent (CHEBI:35610) |
| nilotinib (CHEBI:52172) has role antineoplastic agent (CHEBI:35610) |
| nilotinib hydrochloride monohydrate (CHEBI:749589) has role antineoplastic agent (CHEBI:35610) |
| nilotinib laurylsulfate (CHEBI:760321) has role antineoplastic agent (CHEBI:35610) |
| nilutamide (CHEBI:7573) has role antineoplastic agent (CHEBI:35610) |
| nimesulide (CHEBI:44445) has role antineoplastic agent (CHEBI:35610) |
| nimodipine (CHEBI:7575) has role antineoplastic agent (CHEBI:35610) |
| nimorazole (CHEBI:134929) has role antineoplastic agent (CHEBI:35610) |
| nimotuzumab (CHEBI:753337) has role antineoplastic agent (CHEBI:35610) |
| nimustine (CHEBI:75270) has role antineoplastic agent (CHEBI:35610) |
| nimustine hydrochloride (CHEBI:7576) has role antineoplastic agent (CHEBI:35610) |
| ningetinib (CHEBI:756026) has role antineoplastic agent (CHEBI:35610) |
| ninsipapogene sibamarepvec (CHEBI:759392) has role antineoplastic agent (CHEBI:35610) |
| ninsipapogene sibarnarepvec (CHEBI:760358) has role antineoplastic agent (CHEBI:35610) |
| nintedanib (CHEBI:85164) has role antineoplastic agent (CHEBI:35610) |
| nintedanib esylate (CHEBI:85170) has role antineoplastic agent (CHEBI:35610) |
| niraparib (CHEBI:176844) has role antineoplastic agent (CHEBI:35610) |
| niraparib tosylate monohydrate (CHEBI:756415) has role antineoplastic agent (CHEBI:35610) |
| nirogacestat (CHEBI:229217) has role antineoplastic agent (CHEBI:35610) |
| nirogacestat dihydrobromide (CHEBI:229218) has role antineoplastic agent (CHEBI:35610) |
| nisevokitug (CHEBI:757480) has role antineoplastic agent (CHEBI:35610) |
| nitensidine E (CHEBI:66628) has role antineoplastic agent (CHEBI:35610) |
| nitric acid (CHEBI:48107) has role antineoplastic agent (CHEBI:35610) |
| nitric oxide (CHEBI:16480) has role antineoplastic agent (CHEBI:35610) |
| nitroglycerin (CHEBI:28787) has role antineoplastic agent (CHEBI:35610) |
| nitrosulindac (CHEBI:75321) has role antineoplastic agent (CHEBI:35610) |
| nitrous oxide (CHEBI:749671) has role antineoplastic agent (CHEBI:35610) |
| nivatrotamab (CHEBI:758298) has role antineoplastic agent (CHEBI:35610) |
| Nivolumab (CHEBI:231614) has role antineoplastic agent (CHEBI:35610) |
| njh-395 (CHEBI:758053) has role antineoplastic agent (CHEBI:35610) |
| NK154183A (CHEBI:66629) has role antineoplastic agent (CHEBI:35610) |
| NK154183B (CHEBI:66630) has role antineoplastic agent (CHEBI:35610) |
| nlg-802 (CHEBI:758375) has role antineoplastic agent (CHEBI:35610) |
| nm-21-1480 (CHEBI:758377) has role antineoplastic agent (CHEBI:35610) |
| nms-1116354 (CHEBI:755576) has role antineoplastic agent (CHEBI:35610) |
| NNC 55-0396 (free base) (CHEBI:194337) has role antineoplastic agent (CHEBI:35610) |
| NNC 55-0396 dihydrochloride (CHEBI:194301) has role antineoplastic agent (CHEBI:35610) |
| nobiletin (CHEBI:7602) has role antineoplastic agent (CHEBI:35610) |
| nocodazole (CHEBI:34892) has role antineoplastic agent (CHEBI:35610) |
| nogalamycin (CHEBI:44504) has role antineoplastic agent (CHEBI:35610) |
| nogapendekin alfa (CHEBI:757146) has role antineoplastic agent (CHEBI:35610) |
| nolatrexed (CHEBI:748463) has role antineoplastic agent (CHEBI:35610) |
| nomilin (CHEBI:7609) has role antineoplastic agent (CHEBI:35610) |
| nonanedioic acid (CHEBI:48131) has role antineoplastic agent (CHEBI:35610) |
| noraramtide (CHEBI:760310) has role antineoplastic agent (CHEBI:35610) |
| norathyriol (CHEBI:7622) has role antineoplastic agent (CHEBI:35610) |
| norethandrolone (CHEBI:135282) has role antineoplastic agent (CHEBI:35610) |
| norethisterone (CHEBI:7627) has role antineoplastic agent (CHEBI:35610) |
| norethisterone acetate (CHEBI:7628) has role antineoplastic agent (CHEBI:35610) |
| norgestrel (CHEBI:7630) has role antineoplastic agent (CHEBI:35610) |
| nortriptyline (CHEBI:7640) has role antineoplastic agent (CHEBI:35610) |
| Nortriptyline hydrochloride (CHEBI:7641) has role antineoplastic agent (CHEBI:35610) |
| novaferon (CHEBI:758299) has role antineoplastic agent (CHEBI:35610) |
| Novobiocin sodium (CHEBI:31924) has role antineoplastic agent (CHEBI:35610) |
| np-g2-044 (CHEBI:756959) has role antineoplastic agent (CHEBI:35610) |
| nrx195183 (CHEBI:748449) has role antineoplastic agent (CHEBI:35610) |
| NS-398 (CHEBI:73458) has role antineoplastic agent (CHEBI:35610) |
| numidargistat (CHEBI:195556) has role antineoplastic agent (CHEBI:35610) |
| nurulimab (CHEBI:758003) has role antineoplastic agent (CHEBI:35610) |
| Nutlin (CHEBI:46741) has role antineoplastic agent (CHEBI:35610) |
| nuvisertib (CHEBI:756018) has role antineoplastic agent (CHEBI:35610) |
| nuvustotug (CHEBI:760189) has role antineoplastic agent (CHEBI:35610) |
| ny-eso-1 (CHEBI:757962) has role antineoplastic agent (CHEBI:35610) |
| nystatin (CHEBI:7660) has role antineoplastic agent (CHEBI:35610) |
| nzv-930 (CHEBI:758055) has role antineoplastic agent (CHEBI:35610) |
| o-chloroacetylcarbamoylfumagillol (CHEBI:748550) has role antineoplastic agent (CHEBI:35610) |
| obatoclax mesylate (CHEBI:752588) has role antineoplastic agent (CHEBI:35610) |
| obecabtagene autoleucel (CHEBI:759002) has role antineoplastic agent (CHEBI:35610) |
| oberotatug (CHEBI:759450) has role antineoplastic agent (CHEBI:35610) |
| oberotatug ravtansine (CHEBI:759451) has role antineoplastic agent (CHEBI:35610) |
| obertamig (CHEBI:759452) has role antineoplastic agent (CHEBI:35610) |
| obi-3424 (CHEBI:756960) has role antineoplastic agent (CHEBI:35610) |
| obi-888 (CHEBI:757963) has role antineoplastic agent (CHEBI:35610) |
| obinutuzumab (CHEBI:750126) has role antineoplastic agent (CHEBI:35610) |
| oblimersen (CHEBI:753308) has role antineoplastic agent (CHEBI:35610) |
| oblimersen sodium (CHEBI:754116) has role antineoplastic agent (CHEBI:35610) |
| obochalcolactone (CHEBI:66802) has role antineoplastic agent (CHEBI:35610) |
| obolactone (CHEBI:66803) has role antineoplastic agent (CHEBI:35610) |
| obp-801 (CHEBI:755135) has role antineoplastic agent (CHEBI:35610) |
| obrixtamig (CHEBI:760068) has role antineoplastic agent (CHEBI:35610) |
| obyanamide (CHEBI:66805) has role antineoplastic agent (CHEBI:35610) |
| ocaratuzumab (CHEBI:754388) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpin A (CHEBI:66811) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpin B (CHEBI:66812) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpin C (CHEBI:66813) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpin D (CHEBI:66814) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpin E (CHEBI:66815) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpin F (CHEBI:66816) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpin G (CHEBI:66817) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpinone A (CHEBI:66808) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpinone B (CHEBI:66809) has role antineoplastic agent (CHEBI:35610) |
| ocifisertib (CHEBI:755352) has role antineoplastic agent (CHEBI:35610) |
| ociperlimab (CHEBI:758300) has role antineoplastic agent (CHEBI:35610) |
| ocrelizumab (CHEBI:753057) has role antineoplastic agent (CHEBI:35610) |
| octafluoropropane (CHEBI:31980) has role antineoplastic agent (CHEBI:35610) |
| octanoic acid (CHEBI:28837) has role antineoplastic agent (CHEBI:35610) |
| octinoxate (CHEBI:134750) has role antineoplastic agent (CHEBI:35610) |
| octreotide acetate (CHEBI:749258) has role antineoplastic agent (CHEBI:35610) |
| octreotide hydrochloride (CHEBI:755442) has role antineoplastic agent (CHEBI:35610) |
| octreotide pamoate (CHEBI:751645) has role antineoplastic agent (CHEBI:35610) |
| odanacatib (CHEBI:748946) has role antineoplastic agent (CHEBI:35610) |
| odm-204 (CHEBI:760425) has role antineoplastic agent (CHEBI:35610) |
| odm-207 (CHEBI:758770) has role antineoplastic agent (CHEBI:35610) |
| odronextamab (CHEBI:757503) has role antineoplastic agent (CHEBI:35610) |
| ofatumumab (CHEBI:749610) has role antineoplastic agent (CHEBI:35610) |
| ofranergene obadenovec (CHEBI:755837) has role antineoplastic agent (CHEBI:35610) |
| oglufanide disodium (CHEBI:752444) has role antineoplastic agent (CHEBI:35610) |
| olanzapine (CHEBI:7735) has role antineoplastic agent (CHEBI:35610) |
| olaparib (CHEBI:83766) has role antineoplastic agent (CHEBI:35610) |
| olaptesed pegol (CHEBI:757964) has role antineoplastic agent (CHEBI:35610) |
| olaratumab (CHEBI:231681) has role antineoplastic agent (CHEBI:35610) |
| oleanolic acid 3-O-[O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→3)-O-α-L-rhamnopyranosyl-(1→2)-α-L-arabinopyranoside] (CHEBI:66818) has role antineoplastic agent (CHEBI:35610) |
| oleclumab (CHEBI:756498) has role antineoplastic agent (CHEBI:35610) |
| oleic acid (CHEBI:16196) has role antineoplastic agent (CHEBI:35610) |
| oleocanthal (CHEBI:85673) has role antineoplastic agent (CHEBI:35610) |
| oleuropein (CHEBI:7747) has role antineoplastic agent (CHEBI:35610) |
| oligomycin A (CHEBI:28285) has role antineoplastic agent (CHEBI:35610) |
| oligomycin D (CHEBI:7753) has role antineoplastic agent (CHEBI:35610) |
| olintatug (CHEBI:760071) has role antineoplastic agent (CHEBI:35610) |
| olintatug tesirine (CHEBI:760072) has role antineoplastic agent (CHEBI:35610) |
| olinvacimab (CHEBI:757534) has role antineoplastic agent (CHEBI:35610) |
| olmutinib (CHEBI:755885) has role antineoplastic agent (CHEBI:35610) |
| olomorasib (CHEBI:760322) has role antineoplastic agent (CHEBI:35610) |
| olorofim (CHEBI:757081) has role antineoplastic agent (CHEBI:35610) |
| oltipraz (CHEBI:77319) has role antineoplastic agent (CHEBI:35610) |
| olutasidenib (CHEBI:757082) has role antineoplastic agent (CHEBI:35610) |
| olverembatinib (CHEBI:754942) has role antineoplastic agent (CHEBI:35610) |
| olvimulogene nanivacirepvec (CHEBI:757807) has role antineoplastic agent (CHEBI:35610) |
| omacetaxine mepesuccinate (CHEBI:71019) has role antineoplastic agent (CHEBI:35610) |
| omalizumab (CHEBI:749497) has role antineoplastic agent (CHEBI:35610) |
| omaveloxolone (CHEBI:229661) has role antineoplastic agent (CHEBI:35610) |
| ombipepimut-s (CHEBI:756741) has role antineoplastic agent (CHEBI:35610) |
| ombrabulin (CHEBI:749087) has role antineoplastic agent (CHEBI:35610) |
| omburtamab (CHEBI:756739) has role antineoplastic agent (CHEBI:35610) |
| omectatug (CHEBI:760190) has role antineoplastic agent (CHEBI:35610) |
| omega-3 fatty acids (CHEBI:757488) has role antineoplastic agent (CHEBI:35610) |
| omega-3-acid ethyl esters (CHEBI:749306) has role antineoplastic agent (CHEBI:35610) |
| omeprazole (CHEBI:7772) has role antineoplastic agent (CHEBI:35610) |
| omidubicel (CHEBI:757597) has role antineoplastic agent (CHEBI:35610) |
| omidubicel non-cultured fraction (CHEBI:760407) has role antineoplastic agent (CHEBI:35610) |
| omiganan (CHEBI:749905) has role antineoplastic agent (CHEBI:35610) |
| omipalisib (CHEBI:95093) has role antineoplastic agent (CHEBI:35610) |
| ompenaclid succinate (CHEBI:760314) has role antineoplastic agent (CHEBI:35610) |
| omramotide (CHEBI:759548) has role antineoplastic agent (CHEBI:35610) |
| onabotulinumtoxina (CHEBI:749424) has role antineoplastic agent (CHEBI:35610) |
| onacrisantaspase (CHEBI:759549) has role antineoplastic agent (CHEBI:35610) |
| onalespib (CHEBI:140592) has role antineoplastic agent (CHEBI:35610) |
| onalespib lactate (CHEBI:755282) has role antineoplastic agent (CHEBI:35610) |
| onamelatucel-l (CHEBI:753577) has role antineoplastic agent (CHEBI:35610) |
| onartuzumab (CHEBI:750128) has role antineoplastic agent (CHEBI:35610) |
| onatasertib (CHEBI:755645) has role antineoplastic agent (CHEBI:35610) |
| onc-392 (CHEBI:757965) has role antineoplastic agent (CHEBI:35610) |
| oncrasin-1 (CHEBI:178196) has role antineoplastic agent (CHEBI:35610) |
| Ondansetron (CHEBI:7773) has role antineoplastic agent (CHEBI:35610) |
| Ondansetron hydrochloride (CHEBI:7774) has role antineoplastic agent (CHEBI:35610) |
| onfekafusp alfa (CHEBI:757432) has role antineoplastic agent (CHEBI:35610) |
| ongericimab (CHEBI:758039) has role antineoplastic agent (CHEBI:35610) |
| ono-7579 (CHEBI:755965) has role antineoplastic agent (CHEBI:35610) |
| ontasameran (CHEBI:759050) has role antineoplastic agent (CHEBI:35610) |
| ontorpacept (CHEBI:759686) has role antineoplastic agent (CHEBI:35610) |
| ontuxizumab (CHEBI:755003) has role antineoplastic agent (CHEBI:35610) |
| onvansertib (CHEBI:749996) has role antineoplastic agent (CHEBI:35610) |
| onvansertib fumarate (CHEBI:757567) has role antineoplastic agent (CHEBI:35610) |
| onvapegleukin alfa (CHEBI:759550) has role antineoplastic agent (CHEBI:35610) |
| onvatilimab (CHEBI:757426) has role antineoplastic agent (CHEBI:35610) |
| onvitrelin ucalontide (CHEBI:757199) has role antineoplastic agent (CHEBI:35610) |
| onzigolide (CHEBI:758239) has role antineoplastic agent (CHEBI:35610) |
| opadotin (CHEBI:759285) has role antineoplastic agent (CHEBI:35610) |
| opelkibart (CHEBI:759551) has role antineoplastic agent (CHEBI:35610) |
| opelkibart elmanitin (CHEBI:759552) has role antineoplastic agent (CHEBI:35610) |
| opevesostat (CHEBI:759234) has role antineoplastic agent (CHEBI:35610) |
| ophiobolin C (CHEBI:167548) has role antineoplastic agent (CHEBI:35610) |
| opilrelagene atradenorepvec (CHEBI:758720) has role antineoplastic agent (CHEBI:35610) |
| opnurasib (CHEBI:758599) has role antineoplastic agent (CHEBI:35610) |
| opolimogene capmilisbac (CHEBI:756748) has role antineoplastic agent (CHEBI:35610) |
| oportuzumab monatox (CHEBI:750129) has role antineoplastic agent (CHEBI:35610) |
| oprelvekin (CHEBI:749532) has role antineoplastic agent (CHEBI:35610) |
| oprozomib (CHEBI:747352) has role antineoplastic agent (CHEBI:35610) |
| opugotamig olatansine (CHEBI:760074) has role antineoplastic agent (CHEBI:35610) |
| orantinib (CHEBI:91088) has role antineoplastic agent (CHEBI:35610) |
| orbiculin A (CHEBI:66824) has role antineoplastic agent (CHEBI:35610) |
| orbiculin E (CHEBI:66826) has role antineoplastic agent (CHEBI:35610) |
| orbiculin F (CHEBI:66827) has role antineoplastic agent (CHEBI:35610) |
| orbiculin G (CHEBI:66828) has role antineoplastic agent (CHEBI:35610) |
| oregovomab (CHEBI:752951) has role antineoplastic agent (CHEBI:35610) |
| orelabrutinib (CHEBI:758220) has role antineoplastic agent (CHEBI:35610) |
| orenasitecan (CHEBI:759982) has role antineoplastic agent (CHEBI:35610) |
| oric-101 (CHEBI:758497) has role antineoplastic agent (CHEBI:35610) |
| oridonin (CHEBI:138236) has role antineoplastic agent (CHEBI:35610) |
| oritinib (CHEBI:760468) has role antineoplastic agent (CHEBI:35610) |
| ormaplatin (CHEBI:85577) has role antineoplastic agent (CHEBI:35610) |
| ornidazole (CHEBI:75176) has role antineoplastic agent (CHEBI:35610) |
| oroxylin A (CHEBI:61668) has role antineoplastic agent (CHEBI:35610) |
| oroxylin A(1−) (CHEBI:77939) has role antineoplastic agent (CHEBI:35610) |
| ortataxel (CHEBI:748727) has role antineoplastic agent (CHEBI:35610) |
| orteronel (CHEBI:231353) has role antineoplastic agent (CHEBI:35610) |
| orvacabtagene autoleucel (CHEBI:757808) has role antineoplastic agent (CHEBI:35610) |
| Osalmid (CHEBI:31938) has role antineoplastic agent (CHEBI:35610) |
| osanetant (CHEBI:748617) has role antineoplastic agent (CHEBI:35610) |
| osemitamab (CHEBI:758954) has role antineoplastic agent (CHEBI:35610) |
| osencabtagene autoleucel (CHEBI:760075) has role antineoplastic agent (CHEBI:35610) |
| osi-027 (CHEBI:755128) has role antineoplastic agent (CHEBI:35610) |
| osi-632 (CHEBI:748833) has role antineoplastic agent (CHEBI:35610) |
| osi-7904 (CHEBI:748662) has role antineoplastic agent (CHEBI:35610) |
| osimertinib (CHEBI:90943) has role antineoplastic agent (CHEBI:35610) |
| osimertinib mesylate (CHEBI:90948) has role antineoplastic agent (CHEBI:35610) |
| ospemifene (CHEBI:73275) has role antineoplastic agent (CHEBI:35610) |
| ossamycin (CHEBI:77735) has role antineoplastic agent (CHEBI:35610) |
| OSU-03012 (CHEBI:131196) has role antineoplastic agent (CHEBI:35610) |
| osunprotafib (CHEBI:758747) has role antineoplastic agent (CHEBI:35610) |
| otekinogene vusaplasmid (CHEBI:760192) has role antineoplastic agent (CHEBI:35610) |
| otlertuzumab (CHEBI:755081) has role antineoplastic agent (CHEBI:35610) |
| otx-008 (CHEBI:748760) has role antineoplastic agent (CHEBI:35610) |
| ovemotide (CHEBI:748499) has role antineoplastic agent (CHEBI:35610) |
| oviedomycin (CHEBI:156291) has role antineoplastic agent (CHEBI:35610) |
| oxaline (CHEBI:70400) has role antineoplastic agent (CHEBI:35610) |
| oxaliplatin (CHEBI:31941) has role antineoplastic agent (CHEBI:35610) |
| oxandrolone (CHEBI:7820) has role antineoplastic agent (CHEBI:35610) |
| oxcarbazepine (CHEBI:7824) has role antineoplastic agent (CHEBI:35610) |
| oxi-4503 (CHEBI:749621) has role antineoplastic agent (CHEBI:35610) |
| oximbomotide (CHEBI:759554) has role antineoplastic agent (CHEBI:35610) |
| oxybutynin (CHEBI:7856) has role antineoplastic agent (CHEBI:35610) |
| oxybutynin chloride (CHEBI:7857) has role antineoplastic agent (CHEBI:35610) |
| oxypeucedanin hydrate acetonide (CHEBI:66843) has role antineoplastic agent (CHEBI:35610) |
| oxyphenbutazone (CHEBI:76258) has role antineoplastic agent (CHEBI:35610) |
| oxyphenbutazone hydrate (CHEBI:76259) has role antineoplastic agent (CHEBI:35610) |
| oxytocin (CHEBI:7872) has role antineoplastic agent (CHEBI:35610) |
| ozarelix (CHEBI:753300) has role antineoplastic agent (CHEBI:35610) |
| ozekibart (CHEBI:759310) has role antineoplastic agent (CHEBI:35610) |
| ozuriftamab (CHEBI:758994) has role antineoplastic agent (CHEBI:35610) |
| ozuriftamab vedotin (CHEBI:758860) has role antineoplastic agent (CHEBI:35610) |
| p-276-00 (CHEBI:754940) has role antineoplastic agent (CHEBI:35610) |
| PABA/NO (CHEBI:195533) has role antineoplastic agent (CHEBI:35610) |
| pacanalotamab (CHEBI:758160) has role antineoplastic agent (CHEBI:35610) |
| paclitaxel (CHEBI:45863) has role antineoplastic agent (CHEBI:35610) |
| paclitaxel docosahexaenoic acid (CHEBI:756929) has role antineoplastic agent (CHEBI:35610) |
| paclitaxel obaluronate (CHEBI:758721) has role antineoplastic agent (CHEBI:35610) |
| paclitaxel poliglumex (CHEBI:753579) has role antineoplastic agent (CHEBI:35610) |
| pacmilimab (CHEBI:757038) has role antineoplastic agent (CHEBI:35610) |
| pacritinib (CHEBI:231350) has role antineoplastic agent (CHEBI:35610) |
| pacritinib citrate (CHEBI:231412) has role antineoplastic agent (CHEBI:35610) |
| padeliporfin (CHEBI:757787) has role antineoplastic agent (CHEBI:35610) |
| padeliporfin potassium (CHEBI:757788) has role antineoplastic agent (CHEBI:35610) |
| padnarsertib (CHEBI:756953) has role antineoplastic agent (CHEBI:35610) |
| padoporfin (CHEBI:756713) has role antineoplastic agent (CHEBI:35610) |
| pafolacianine (CHEBI:756901) has role antineoplastic agent (CHEBI:35610) |
| pafolacianine sodium (CHEBI:757872) has role antineoplastic agent (CHEBI:35610) |
| palau'amide (CHEBI:66721) has role antineoplastic agent (CHEBI:35610) |
| palazestrant (CHEBI:759181) has role antineoplastic agent (CHEBI:35610) |
| palbociclib (CHEBI:85993) has role antineoplastic agent (CHEBI:35610) |
| palbociclib isethionate (CHEBI:754982) has role antineoplastic agent (CHEBI:35610) |
| palifermin (CHEBI:749597) has role antineoplastic agent (CHEBI:35610) |
| palonosetron (CHEBI:85161) has role antineoplastic agent (CHEBI:35610) |
| palonosetron hydrochloride (CHEBI:85157) has role antineoplastic agent (CHEBI:35610) |
| paltimatrectinib (CHEBI:758660) has role antineoplastic agent (CHEBI:35610) |
| paltusotine (CHEBI:759077) has role antineoplastic agent (CHEBI:35610) |
| paltusotine hydrochloride (CHEBI:759258) has role antineoplastic agent (CHEBI:35610) |
| paluratide (CHEBI:760078) has role antineoplastic agent (CHEBI:35610) |
| palverafusp alfa (CHEBI:760079) has role antineoplastic agent (CHEBI:35610) |
| pamidronate (CHEBI:7903) has role antineoplastic agent (CHEBI:35610) |
| Pamidronate disodium (CHEBI:7904) has role antineoplastic agent (CHEBI:35610) |
| pamiparib (CHEBI:756607) has role antineoplastic agent (CHEBI:35610) |
| pamirtecan (CHEBI:760392) has role antineoplastic agent (CHEBI:35610) |
| pamlectabart (CHEBI:760193) has role antineoplastic agent (CHEBI:35610) |
| pamlectabart tismanitin (CHEBI:760194) has role antineoplastic agent (CHEBI:35610) |
| pamrevlumab (CHEBI:754196) has role antineoplastic agent (CHEBI:35610) |
| pamvatamig (CHEBI:759555) has role antineoplastic agent (CHEBI:35610) |
| pancrelipase (CHEBI:753090) has role antineoplastic agent (CHEBI:35610) |
| panitumumab (CHEBI:749603) has role antineoplastic agent (CHEBI:35610) |
| pannarin (CHEBI:144185) has role antineoplastic agent (CHEBI:35610) |
| panobinostat (CHEBI:85990) has role antineoplastic agent (CHEBI:35610) |
| panobinostat lactate (CHEBI:85991) has role antineoplastic agent (CHEBI:35610) |
| pantoprazole (CHEBI:7915) has role antineoplastic agent (CHEBI:35610) |
| pantoprazole sodium (CHEBI:50270) has role antineoplastic agent (CHEBI:35610) |
| panulisib (CHEBI:758612) has role antineoplastic agent (CHEBI:35610) |
| papaverine (CHEBI:28241) has role antineoplastic agent (CHEBI:35610) |
| papaverine hydrochloride (CHEBI:748411) has role antineoplastic agent (CHEBI:35610) |
| papuamide B (CHEBI:83265) has role antineoplastic agent (CHEBI:35610) |
| paracetamol (CHEBI:46195) has role antineoplastic agent (CHEBI:35610) |
| paraminabeolide A (CHEBI:67560) has role antineoplastic agent (CHEBI:35610) |
| parbendazole (CHEBI:94267) has role antineoplastic agent (CHEBI:35610) |
| paricalcitol (CHEBI:7931) has role antineoplastic agent (CHEBI:35610) |
| parpi (CHEBI:758246) has role antineoplastic agent (CHEBI:35610) |
| parsaclisib (CHEBI:757085) has role antineoplastic agent (CHEBI:35610) |
| parsaclisib hydrochloride (CHEBI:757564) has role antineoplastic agent (CHEBI:35610) |
| parsatuzumab (CHEBI:754203) has role antineoplastic agent (CHEBI:35610) |
| pasifolate exatecan (CHEBI:760374) has role antineoplastic agent (CHEBI:35610) |
| pasireotide (CHEBI:72312) has role antineoplastic agent (CHEBI:35610) |
| pasireotide aspartate (CHEBI:72313) has role antineoplastic agent (CHEBI:35610) |
| pasritamig (CHEBI:760196) has role antineoplastic agent (CHEBI:35610) |
| pateamine (CHEBI:134184) has role antineoplastic agent (CHEBI:35610) |
| Patidegib (CHEBI:177425) has role antineoplastic agent (CHEBI:35610) |
| patidegib hydrochloride (CHEBI:751613) has role antineoplastic agent (CHEBI:35610) |
| patritumab (CHEBI:754211) has role antineoplastic agent (CHEBI:35610) |
| patritumab deruxtecan (CHEBI:758083) has role antineoplastic agent (CHEBI:35610) |
| patupilone (CHEBI:748408) has role antineoplastic agent (CHEBI:35610) |
| pavurutamab (CHEBI:758161) has role antineoplastic agent (CHEBI:35610) |
| paxalisib (CHEBI:755893) has role antineoplastic agent (CHEBI:35610) |
| pazopanib (CHEBI:71219) has role antineoplastic agent (CHEBI:35610) |
| pazopanib hydrochloride (CHEBI:71217) has role antineoplastic agent (CHEBI:35610) |
| PB28 (CHEBI:189648) has role antineoplastic agent (CHEBI:35610) |
| pbf-509 (CHEBI:755709) has role antineoplastic agent (CHEBI:35610) |
| pbf-999 (CHEBI:756001) has role antineoplastic agent (CHEBI:35610) |
| pci-27483 (CHEBI:756812) has role antineoplastic agent (CHEBI:35610) |
| PD 0325901 (CHEBI:88249) has role antineoplastic agent (CHEBI:35610) |
| PD-166866 (CHEBI:156259) has role antineoplastic agent (CHEBI:35610) |
| pd-360324 (CHEBI:754291) has role antineoplastic agent (CHEBI:35610) |
| PD158780 (CHEBI:92843) has role antineoplastic agent (CHEBI:35610) |
| PD173074 (CHEBI:63448) has role antineoplastic agent (CHEBI:35610) |
| pebezertinib (CHEBI:760324) has role antineoplastic agent (CHEBI:35610) |
| pectin (CHEBI:17309) has role antineoplastic agent (CHEBI:35610) |
| pectolinarin (CHEBI:156327) has role antineoplastic agent (CHEBI:35610) |
| pederin (CHEBI:78591) has role antineoplastic agent (CHEBI:35610) |
| pegademase bovine (CHEBI:749443) has role antineoplastic agent (CHEBI:35610) |
| pegamotecan (CHEBI:756088) has role antineoplastic agent (CHEBI:35610) |
| pegargiminase (CHEBI:755172) has role antineoplastic agent (CHEBI:35610) |
| pegaspargase (CHEBI:753505) has role antineoplastic agent (CHEBI:35610) |
| pegdinetanib (CHEBI:753334) has role antineoplastic agent (CHEBI:35610) |
| pegenzileukin (CHEBI:758314) has role antineoplastic agent (CHEBI:35610) |
| pegfilgrastim (CHEBI:749426) has role antineoplastic agent (CHEBI:35610) |
| pegilodecakin (CHEBI:756475) has role antineoplastic agent (CHEBI:35610) |
| peginterferon alfa-2a (CHEBI:749533) has role antineoplastic agent (CHEBI:35610) |
| peginterferon alfa-2b (CHEBI:63615) has role antineoplastic agent (CHEBI:35610) |
| peginterferon alfacon-2 (CHEBI:760000) has role antineoplastic agent (CHEBI:35610) |
| peginterferon beta-1a (CHEBI:753625) has role antineoplastic agent (CHEBI:35610) |
| pegipanermin (CHEBI:758520) has role antineoplastic agent (CHEBI:35610) |
| pegloprastide (CHEBI:758883) has role antineoplastic agent (CHEBI:35610) |
| pegsitacianine (CHEBI:758378) has role antineoplastic agent (CHEBI:35610) |
| pegteograstim (CHEBI:757246) has role antineoplastic agent (CHEBI:35610) |
| pegulicianine acetate (CHEBI:757843) has role antineoplastic agent (CHEBI:35610) |
| pegvisomant (CHEBI:749488) has role antineoplastic agent (CHEBI:35610) |
| pegvorhyaluronidase alfa (CHEBI:756459) has role antineoplastic agent (CHEBI:35610) |
| pegzilarginase (CHEBI:757248) has role antineoplastic agent (CHEBI:35610) |
| pelabresib (CHEBI:189653) has role antineoplastic agent (CHEBI:35610) |
| pelareorep (CHEBI:755444) has role antineoplastic agent (CHEBI:35610) |
| pelcitoclax (CHEBI:758473) has role antineoplastic agent (CHEBI:35610) |
| pelgifatamab (CHEBI:758724) has role antineoplastic agent (CHEBI:35610) |
| pelitinib (CHEBI:38927) has role antineoplastic agent (CHEBI:35610) |
| pelitrexol (CHEBI:752590) has role antineoplastic agent (CHEBI:35610) |
| peloruside A (CHEBI:77692) has role antineoplastic agent (CHEBI:35610) |
| peltopepimut-s (CHEBI:759038) has role antineoplastic agent (CHEBI:35610) |
| peluntamig (CHEBI:760197) has role antineoplastic agent (CHEBI:35610) |
| Pembrolizumab (CHEBI:82976) has role antineoplastic agent (CHEBI:35610) |
| pemetrexed (CHEBI:63616) has role antineoplastic agent (CHEBI:35610) |
| pemetrexed dipotassium (CHEBI:760244) has role antineoplastic agent (CHEBI:35610) |
| pemetrexed disodium (CHEBI:63722) has role antineoplastic agent (CHEBI:35610) |
| pemetrexed disodium hemipentahydrate (CHEBI:760249) has role antineoplastic agent (CHEBI:35610) |
| pemetrexed disodium heptahydrate (CHEBI:63723) has role antineoplastic agent (CHEBI:35610) |
| pemetrexed monohydrate (CHEBI:759739) has role antineoplastic agent (CHEBI:35610) |
| pemetrexed tromethamine (CHEBI:756446) has role antineoplastic agent (CHEBI:35610) |
| pemigatinib (CHEBI:757002) has role antineoplastic agent (CHEBI:35610) |
| pemlimogene merolisbac (CHEBI:756747) has role antineoplastic agent (CHEBI:35610) |
| pemrametostat (CHEBI:757685) has role antineoplastic agent (CHEBI:35610) |
| pemvidutide (CHEBI:758725) has role antineoplastic agent (CHEBI:35610) |
| penclomedine (CHEBI:747954) has role antineoplastic agent (CHEBI:35610) |
| penpulimab (CHEBI:757046) has role antineoplastic agent (CHEBI:35610) |
| pentamidine (CHEBI:45081) has role antineoplastic agent (CHEBI:35610) |
| pentamidine isethionate (CHEBI:7977) has role antineoplastic agent (CHEBI:35610) |
| pentetate calcium trisodium (CHEBI:749345) has role antineoplastic agent (CHEBI:35610) |
| pentetic acid (CHEBI:35739) has role antineoplastic agent (CHEBI:35610) |
| Pentetreotide (CHEBI:31975) has role antineoplastic agent (CHEBI:35610) |
| pentostatin (CHEBI:27834) has role antineoplastic agent (CHEBI:35610) |
| Pentoxifylline (CHEBI:7986) has role antineoplastic agent (CHEBI:35610) |
| peonidin (CHEBI:75314) has role antineoplastic agent (CHEBI:35610) |
| peonidin chloride (CHEBI:75033) has role antineoplastic agent (CHEBI:35610) |
| pepinemab (CHEBI:757322) has role antineoplastic agent (CHEBI:35610) |
| perenostobart (CHEBI:759393) has role antineoplastic agent (CHEBI:35610) |
| peretinoin (CHEBI:757651) has role antineoplastic agent (CHEBI:35610) |
| perflubutane (CHEBI:134964) has role antineoplastic agent (CHEBI:35610) |
| perfluoropentane (CHEBI:39428) has role antineoplastic agent (CHEBI:35610) |
| perfosfamide (CHEBI:135223) has role antineoplastic agent (CHEBI:35610) |
| perifosine (CHEBI:67272) has role antineoplastic agent (CHEBI:35610) |
| perillic acid (CHEBI:36999) has role antineoplastic agent (CHEBI:35610) |
| perindopril (CHEBI:8024) has role antineoplastic agent (CHEBI:35610) |
| persicabtagene lemgedleucel (CHEBI:760198) has role antineoplastic agent (CHEBI:35610) |
| pertussis vaccine adsorbed (CHEBI:754107) has role antineoplastic agent (CHEBI:35610) |
| pertuzumab (CHEBI:750362) has role antineoplastic agent (CHEBI:35610) |
| pertuzumab zuvotolimod (CHEBI:758726) has role antineoplastic agent (CHEBI:35610) |
| petosemtamab (CHEBI:757228) has role antineoplastic agent (CHEBI:35610) |
| pevonedistat (CHEBI:145535) has role antineoplastic agent (CHEBI:35610) |
| pexastimogene devacirepvec (CHEBI:755087) has role antineoplastic agent (CHEBI:35610) |
| pexidartinib (CHEBI:145373) has role antineoplastic agent (CHEBI:35610) |
| pexipepimut-s (CHEBI:759040) has role antineoplastic agent (CHEBI:35610) |
| pexmetinib (CHEBI:756558) has role antineoplastic agent (CHEBI:35610) |
| pf-00337210 (CHEBI:749994) has role antineoplastic agent (CHEBI:35610) |
| PF-00477736 (CHEBI:91385) has role antineoplastic agent (CHEBI:35610) |
| pf-03732010 (CHEBI:754306) has role antineoplastic agent (CHEBI:35610) |
| pf-04605412 (CHEBI:754363) has role antineoplastic agent (CHEBI:35610) |
| pf-05019702 (CHEBI:755534) has role antineoplastic agent (CHEBI:35610) |
| PF-06409577 (CHEBI:231658) has role antineoplastic agent (CHEBI:35610) |
| pf-06459988 (CHEBI:755881) has role antineoplastic agent (CHEBI:35610) |
| pf-06671008 (CHEBI:757250) has role antineoplastic agent (CHEBI:35610) |
| pf-06688992 (CHEBI:757966) has role antineoplastic agent (CHEBI:35610) |
| pf-06747143 (CHEBI:757251) has role antineoplastic agent (CHEBI:35610) |
| Pf-06840003 (CHEBI:233415) has role antineoplastic agent (CHEBI:35610) |
| pf-07265807 (CHEBI:759880) has role antineoplastic agent (CHEBI:35610) |
| pf-07284892 (CHEBI:759848) has role antineoplastic agent (CHEBI:35610) |
| PF-3758309 (CHEBI:93751) has role antineoplastic agent (CHEBI:35610) |
| pf-4136309 (CHEBI:750383) has role antineoplastic agent (CHEBI:35610) |
| PF-573228 (CHEBI:91446) has role antineoplastic agent (CHEBI:35610) |
| pfk-158 (CHEBI:757663) has role antineoplastic agent (CHEBI:35610) |
| PHA-533533 (CHEBI:132239) has role antineoplastic agent (CHEBI:35610) |
| PHA-665752 (CHEBI:90197) has role antineoplastic agent (CHEBI:35610) |
| phantomolin (CHEBI:8041) has role antineoplastic agent (CHEBI:35610) |
| phaseolotoxin (CHEBI:8047) has role antineoplastic agent (CHEBI:35610) |
| Phenelzine sulfate (CHEBI:8061) has role antineoplastic agent (CHEBI:35610) |
| phenethyl caffeate (CHEBI:8062) has role antineoplastic agent (CHEBI:35610) |
| phenethyl isothiocyanate (CHEBI:351346) has role antineoplastic agent (CHEBI:35610) |
| phenformin (CHEBI:8064) has role antineoplastic agent (CHEBI:35610) |
| phenobarbital (CHEBI:8069) has role antineoplastic agent (CHEBI:35610) |
| Phenoxybenzamine (CHEBI:8077) has role antineoplastic agent (CHEBI:35610) |
| Phenoxybenzamine hydrochloride (CHEBI:8078) has role antineoplastic agent (CHEBI:35610) |
| phenprocoumon (CHEBI:50438) has role antineoplastic agent (CHEBI:35610) |
| phentolamine mesylate (CHEBI:749332) has role antineoplastic agent (CHEBI:35610) |
| phenylarsine oxide (CHEBI:75253) has role antineoplastic agent (CHEBI:35610) |
| phenylephrine (CHEBI:8093) has role antineoplastic agent (CHEBI:35610) |
| phenytoin (CHEBI:8107) has role antineoplastic agent (CHEBI:35610) |
| phi-101 (CHEBI:758458) has role antineoplastic agent (CHEBI:35610) |
| phleomycin (CHEBI:75044) has role antineoplastic agent (CHEBI:35610) |
| phleomycin D1 (CHEBI:75046) has role antineoplastic agent (CHEBI:35610) |
| phloretin (CHEBI:17276) has role antineoplastic agent (CHEBI:35610) |
| phomacin A (CHEBI:66746) has role antineoplastic agent (CHEBI:35610) |
| phomacin B (CHEBI:66747) has role antineoplastic agent (CHEBI:35610) |
| phomacin C (CHEBI:66748) has role antineoplastic agent (CHEBI:35610) |
| phomoxanthone A (CHEBI:66749) has role antineoplastic agent (CHEBI:35610) |
| phomoxanthone B (CHEBI:66750) has role antineoplastic agent (CHEBI:35610) |
| phorbol 13-acetate 12-myristate (CHEBI:37537) has role antineoplastic agent (CHEBI:35610) |
| phthalocyanine (CHEBI:34921) has role antineoplastic agent (CHEBI:35610) |
| phylloquinone (CHEBI:18067) has role antineoplastic agent (CHEBI:35610) |
| physalin B (CHEBI:69017) has role antineoplastic agent (CHEBI:35610) |
| physalin D (CHEBI:69018) has role antineoplastic agent (CHEBI:35610) |
| physalin F (CHEBI:69019) has role antineoplastic agent (CHEBI:35610) |
| physcion (CHEBI:38167) has role antineoplastic agent (CHEBI:35610) |
| PI-103 (CHEBI:90524) has role antineoplastic agent (CHEBI:35610) |
| piceatannol (CHEBI:28814) has role antineoplastic agent (CHEBI:35610) |
| picoplatin (CHEBI:755367) has role antineoplastic agent (CHEBI:35610) |
| picropodophyllotoxin (CHEBI:75251) has role antineoplastic agent (CHEBI:35610) |
| pictrelisib (CHEBI:65326) has role antineoplastic agent (CHEBI:35610) |
| pidilizumab (CHEBI:753628) has role antineoplastic agent (CHEBI:35610) |
| pierreione A (CHEBI:68047) has role antineoplastic agent (CHEBI:35610) |
| pierreione B (CHEBI:68048) has role antineoplastic agent (CHEBI:35610) |
| piflufolastat (CHEBI:757621) has role antineoplastic agent (CHEBI:35610) |
| piflufolastat f18 (CHEBI:756830) has role antineoplastic agent (CHEBI:35610) |
| pifusertib (CHEBI:756826) has role antineoplastic agent (CHEBI:35610) |
| pilaralisib (CHEBI:755344) has role antineoplastic agent (CHEBI:35610) |
| pilocarpine hydrochloride (CHEBI:141029) has role antineoplastic agent (CHEBI:35610) |
| pimasertib (CHEBI:94793) has role antineoplastic agent (CHEBI:35610) |
| pimasertib hydrochloride (CHEBI:757134) has role antineoplastic agent (CHEBI:35610) |
| pimicotinib (CHEBI:759236) has role antineoplastic agent (CHEBI:35610) |
| pimicotinib hydrochloride (CHEBI:760344) has role antineoplastic agent (CHEBI:35610) |
| pimivalimab (CHEBI:758364) has role antineoplastic agent (CHEBI:35610) |
| Pimonidazole (CHEBI:230386) has role antineoplastic agent (CHEBI:35610) |
| pimurutamab (CHEBI:758022) has role antineoplastic agent (CHEBI:35610) |
| pinatuzumab vedotin (CHEBI:755268) has role antineoplastic agent (CHEBI:35610) |
| pinocembrin (CHEBI:28157) has role antineoplastic agent (CHEBI:35610) |
| pinometostat (CHEBI:230493) has role antineoplastic agent (CHEBI:35610) |
| pioglitazone (CHEBI:8228) has role antineoplastic agent (CHEBI:35610) |
| Pioglitazone hydrochloride (CHEBI:8229) has role antineoplastic agent (CHEBI:35610) |
| pipendoxifene (CHEBI:748195) has role antineoplastic agent (CHEBI:35610) |
| piperacillin (CHEBI:8232) has role antineoplastic agent (CHEBI:35610) |
| pipobroman (CHEBI:8242) has role antineoplastic agent (CHEBI:35610) |
| pirarubicin (CHEBI:94770) has role antineoplastic agent (CHEBI:35610) |
| pirazofurin (CHEBI:90284) has role antineoplastic agent (CHEBI:35610) |
| pirfenidone (CHEBI:32016) has role antineoplastic agent (CHEBI:35610) |
| piritrexim (CHEBI:747920) has role antineoplastic agent (CHEBI:35610) |
| pirtobrutinib (CHEBI:229212) has role antineoplastic agent (CHEBI:35610) |
| pitavastatin (CHEBI:32020) has role antineoplastic agent (CHEBI:35610) |
| pitavastatin calcium (CHEBI:71258) has role antineoplastic agent (CHEBI:35610) |
| pivekimab (CHEBI:759013) has role antineoplastic agent (CHEBI:35610) |
| pivekimab sunirine (CHEBI:757418) has role antineoplastic agent (CHEBI:35610) |
| pixantrone (CHEBI:135945) has role antineoplastic agent (CHEBI:35610) |
| pixantrone dimaleate (CHEBI:750493) has role antineoplastic agent (CHEBI:35610) |
| PJ34 (CHEBI:167900) has role antineoplastic agent (CHEBI:35610) |
| PJ34 hydrochloride (CHEBI:167904) has role antineoplastic agent (CHEBI:35610) |
| PK-11195 (CHEBI:73290) has role antineoplastic agent (CHEBI:35610) |
| pki-179 (CHEBI:749738) has role antineoplastic agent (CHEBI:35610) |
| pl-225b (CHEBI:755415) has role antineoplastic agent (CHEBI:35610) |
| plamotamab (CHEBI:757542) has role antineoplastic agent (CHEBI:35610) |
| platelet concentrate (CHEBI:753704) has role antineoplastic agent (CHEBI:35610) |
| platinum (CHEBI:33364) has role antineoplastic agent (CHEBI:35610) |
| plaunotol (CHEBI:32023) has role antineoplastic agent (CHEBI:35610) |
| plb1003 (CHEBI:758200) has role antineoplastic agent (CHEBI:35610) |
| pleosporone (CHEBI:66765) has role antineoplastic agent (CHEBI:35610) |
| plerixafor (CHEBI:125354) has role antineoplastic agent (CHEBI:35610) |
| plevitrexed (CHEBI:748519) has role antineoplastic agent (CHEBI:35610) |
| plinabulin (CHEBI:177413) has role antineoplastic agent (CHEBI:35610) |
| plitidepsin (CHEBI:90205) has role antineoplastic agent (CHEBI:35610) |
| plixacabtagene autoleucel (CHEBI:758728) has role antineoplastic agent (CHEBI:35610) |
| plixorafenib (CHEBI:757666) has role antineoplastic agent (CHEBI:35610) |
| plocabulin (CHEBI:757105) has role antineoplastic agent (CHEBI:35610) |
| plogosertib (CHEBI:759147) has role antineoplastic agent (CHEBI:35610) |
| plozalizumab (CHEBI:755741) has role antineoplastic agent (CHEBI:35610) |
| PLS-123 (CHEBI:230531) has role antineoplastic agent (CHEBI:35610) |
| plumbagin (CHEBI:8273) has role antineoplastic agent (CHEBI:35610) |
| PLX-4720 (CHEBI:90295) has role antineoplastic agent (CHEBI:35610) |
| PM-94128 (CHEBI:66766) has role antineoplastic agent (CHEBI:35610) |
| PM00104 (CHEBI:235523) has role antineoplastic agent (CHEBI:35610) |
| pobrolitide (CHEBI:759558) has role antineoplastic agent (CHEBI:35610) |
| pocenbrodib (CHEBI:759182) has role antineoplastic agent (CHEBI:35610) |
| pocenbrodib hydrochloride (CHEBI:760345) has role antineoplastic agent (CHEBI:35610) |
| podentamig (CHEBI:760080) has role antineoplastic agent (CHEBI:35610) |
| podophyllotoxin (CHEBI:50305) has role antineoplastic agent (CHEBI:35610) |
| polatuzumab vedotin (CHEBI:755266) has role antineoplastic agent (CHEBI:35610) |
| polidocanol (CHEBI:46859) has role antineoplastic agent (CHEBI:35610) |
| polifeprosan 20 (CHEBI:753492) has role antineoplastic agent (CHEBI:35610) |
| poliglusam (CHEBI:753144) has role antineoplastic agent (CHEBI:35610) |
| poly (adp-ribose) polymerase 1 (CHEBI:757491) has role antineoplastic agent (CHEBI:35610) |
| polyestradiol phosphate (CHEBI:749485) has role antineoplastic agent (CHEBI:35610) |
| polyethylene glycol (CHEBI:749470) has role antineoplastic agent (CHEBI:35610) |
| polyethylene glycol 3350 (CHEBI:749517) has role antineoplastic agent (CHEBI:35610) |
| polyketomycin (CHEBI:66771) has role antineoplastic agent (CHEBI:35610) |
| polzastobart (CHEBI:758921) has role antineoplastic agent (CHEBI:35610) |
| pomalidomide (CHEBI:72690) has role antineoplastic agent (CHEBI:35610) |
| pomlucabtagene autoleucel (CHEBI:759395) has role antineoplastic agent (CHEBI:35610) |
| ponatinib (CHEBI:78543) has role antineoplastic agent (CHEBI:35610) |
| ponatinib hydrochloride (CHEBI:191940) has role antineoplastic agent (CHEBI:35610) |
| porfimer (CHEBI:60652) has role antineoplastic agent (CHEBI:35610) |
| porfimer sodium (CHEBI:60773) has role antineoplastic agent (CHEBI:35610) |
| porustobart (CHEBI:758910) has role antineoplastic agent (CHEBI:35610) |
| posaconazole (CHEBI:64355) has role antineoplastic agent (CHEBI:35610) |
| potassium chloride (CHEBI:32588) has role antineoplastic agent (CHEBI:35610) |
| potassium iodide (CHEBI:8346) has role antineoplastic agent (CHEBI:35610) |
| potrasertib (CHEBI:759945) has role antineoplastic agent (CHEBI:35610) |
| Povidone-iodine (CHEBI:8347) has role antineoplastic agent (CHEBI:35610) |
| poziotinib (CHEBI:195559) has role antineoplastic agent (CHEBI:35610) |
| poziotinib hydrochloride (CHEBI:758966) has role antineoplastic agent (CHEBI:35610) |
| pp-f11n lutetium lu-177 (CHEBI:758207) has role antineoplastic agent (CHEBI:35610) |
| PP121 (CHEBI:50915) has role antineoplastic agent (CHEBI:35610) |
| ppi-2458 (CHEBI:755364) has role antineoplastic agent (CHEBI:35610) |
| pr-104 (CHEBI:756818) has role antineoplastic agent (CHEBI:35610) |
| pr1 leukemia peptide vaccine (CHEBI:757256) has role antineoplastic agent (CHEBI:35610) |
| pracinostat (CHEBI:95071) has role antineoplastic agent (CHEBI:35610) |
| pradusinstobart (CHEBI:759396) has role antineoplastic agent (CHEBI:35610) |
| pralatrexate (CHEBI:71223) has role antineoplastic agent (CHEBI:35610) |
| pralsetinib (CHEBI:757728) has role antineoplastic agent (CHEBI:35610) |
| praluzatamab (CHEBI:758157) has role antineoplastic agent (CHEBI:35610) |
| praluzatamab ravtansine (CHEBI:757188) has role antineoplastic agent (CHEBI:35610) |
| pravastatin (CHEBI:63618) has role antineoplastic agent (CHEBI:35610) |
| pravastatin sodium (CHEBI:8361) has role antineoplastic agent (CHEBI:35610) |
| precemtabart (CHEBI:760081) has role antineoplastic agent (CHEBI:35610) |
| precemtabart tocentecan (CHEBI:760082) has role antineoplastic agent (CHEBI:35610) |
| Prednimustine (CHEBI:82524) has role antineoplastic agent (CHEBI:35610) |
| prednisolone (CHEBI:8378) has role antineoplastic agent (CHEBI:35610) |
| prednisolone phosphate (CHEBI:145705) has role antineoplastic agent (CHEBI:35610) |
| prednisolone sodium phosphate (CHEBI:8379) has role antineoplastic agent (CHEBI:35610) |
| prednisone (CHEBI:8382) has role antineoplastic agent (CHEBI:35610) |
| pregabalin (CHEBI:64356) has role antineoplastic agent (CHEBI:35610) |
| preladenant (CHEBI:748815) has role antineoplastic agent (CHEBI:35610) |
| prenylcandidusin A (CHEBI:67530) has role antineoplastic agent (CHEBI:35610) |
| prenylcandidusin B (CHEBI:67531) has role antineoplastic agent (CHEBI:35610) |
| prenylcandidusin C (CHEBI:67532) has role antineoplastic agent (CHEBI:35610) |
| prenylterphenyllin (CHEBI:67533) has role antineoplastic agent (CHEBI:35610) |
| prenylterphenyllin A (CHEBI:67526) has role antineoplastic agent (CHEBI:35610) |
| prenylterphenyllin B (CHEBI:67527) has role antineoplastic agent (CHEBI:35610) |
| prenylterphenyllin C (CHEBI:67528) has role antineoplastic agent (CHEBI:35610) |
| Prexasertib (CHEBI:747627) has role antineoplastic agent (CHEBI:35610) |
| prexigebersen (CHEBI:756461) has role antineoplastic agent (CHEBI:35610) |
| pri-724 (CHEBI:757258) has role antineoplastic agent (CHEBI:35610) |
| prifetrastat (CHEBI:760526) has role antineoplastic agent (CHEBI:35610) |
| prilocaine (CHEBI:8404) has role antineoplastic agent (CHEBI:35610) |
| prinomastat (CHEBI:138885) has role antineoplastic agent (CHEBI:35610) |
| prinomastat hydrochloride (CHEBI:138841) has role antineoplastic agent (CHEBI:35610) |
| prizloncabtagene autoleucel (CHEBI:759458) has role antineoplastic agent (CHEBI:35610) |
| prn-1371 (CHEBI:756566) has role antineoplastic agent (CHEBI:35610) |
| probenecid (CHEBI:8426) has role antineoplastic agent (CHEBI:35610) |
| procarbazine (CHEBI:71417) has role antineoplastic agent (CHEBI:35610) |
| procarbazine hydrochloride (CHEBI:71428) has role antineoplastic agent (CHEBI:35610) |
| prochlorperazine (CHEBI:8435) has role antineoplastic agent (CHEBI:35610) |
| procyanidin B4 (CHEBI:27589) has role antineoplastic agent (CHEBI:35610) |
| prodigiosin (CHEBI:82758) has role antineoplastic agent (CHEBI:35610) |
| progesterone (CHEBI:17026) has role antineoplastic agent (CHEBI:35610) |
| proglumide (CHEBI:32058) has role antineoplastic agent (CHEBI:35610) |
| programmed cell death 1 ligand 1 (CHEBI:757492) has role antineoplastic agent (CHEBI:35610) |
| proINDY (CHEBI:195315) has role antineoplastic agent (CHEBI:35610) |
| prolgolimab (CHEBI:759688) has role antineoplastic agent (CHEBI:35610) |
| promegestone (CHEBI:73390) has role antineoplastic agent (CHEBI:35610) |
| propan-2-ol (CHEBI:17824) has role antineoplastic agent (CHEBI:35610) |
| propofol (CHEBI:44915) has role antineoplastic agent (CHEBI:35610) |
| propranolol (CHEBI:8499) has role antineoplastic agent (CHEBI:35610) |
| propranolol hydrochloride (CHEBI:8500) has role antineoplastic agent (CHEBI:35610) |
| prostaglandin E1 (CHEBI:15544) has role antineoplastic agent (CHEBI:35610) |
| prostaglandin E2 (CHEBI:15551) has role antineoplastic agent (CHEBI:35610) |
| prostaglandin J3 (CHEBI:140267) has role antineoplastic agent (CHEBI:35610) |
| protirelin (CHEBI:35940) has role antineoplastic agent (CHEBI:35610) |
| protodioscin (CHEBI:8588) has role antineoplastic agent (CHEBI:35610) |
| protopanaxadiol (CHEBI:76238) has role antineoplastic agent (CHEBI:35610) |
| pruxelutamide (CHEBI:757905) has role antineoplastic agent (CHEBI:35610) |
| PS-1145 (CHEBI:94801) has role antineoplastic agent (CHEBI:35610) |
| pseudolaric acid B (CHEBI:189471) has role antineoplastic agent (CHEBI:35610) |
| psilocybin (CHEBI:8614) has role antineoplastic agent (CHEBI:35610) |
| psoralen (CHEBI:27616) has role antineoplastic agent (CHEBI:35610) |
| psorospermin (CHEBI:8617) has role antineoplastic agent (CHEBI:35610) |
| pterostilbene (CHEBI:8630) has role antineoplastic agent (CHEBI:35610) |
| pti-6d2 (CHEBI:754292) has role antineoplastic agent (CHEBI:35610) |
| pti-6d2 188re (CHEBI:754390) has role antineoplastic agent (CHEBI:35610) |
| pucotenlimab (CHEBI:758354) has role antineoplastic agent (CHEBI:35610) |
| pulocimab (CHEBI:758506) has role antineoplastic agent (CHEBI:35610) |
| pulrodemstat besilate (CHEBI:758255) has role antineoplastic agent (CHEBI:35610) |
| punicalagin (CHEBI:167695) has role antineoplastic agent (CHEBI:35610) |
| purine-6-thiol (CHEBI:2208) has role antineoplastic agent (CHEBI:35610) |
| puromycin (CHEBI:17939) has role antineoplastic agent (CHEBI:35610) |
| puxitatug (CHEBI:759459) has role antineoplastic agent (CHEBI:35610) |
| puxitatug samrotecan (CHEBI:759460) has role antineoplastic agent (CHEBI:35610) |
| px-12 (CHEBI:748839) has role antineoplastic agent (CHEBI:35610) |
| px-478 (CHEBI:756561) has role antineoplastic agent (CHEBI:35610) |
| pxs-5505 (CHEBI:758306) has role antineoplastic agent (CHEBI:35610) |
| PYR-41 (CHEBI:192973) has role antineoplastic agent (CHEBI:35610) |
| pyrazoloacridine (CHEBI:748494) has role antineoplastic agent (CHEBI:35610) |
| pyridoxatin (CHEBI:84035) has role antineoplastic agent (CHEBI:35610) |
| pyridoxine (CHEBI:16709) has role antineoplastic agent (CHEBI:35610) |
| pyrimethamine (CHEBI:8673) has role antineoplastic agent (CHEBI:35610) |
| pyrimidine (CHEBI:16898) has role antineoplastic agent (CHEBI:35610) |
| pyronaridine tetraphosphate (CHEBI:750440) has role antineoplastic agent (CHEBI:35610) |
| pyrotinib (CHEBI:755675) has role antineoplastic agent (CHEBI:35610) |
| pyrrolidine dithiocarbamate (CHEBI:78782) has role antineoplastic agent (CHEBI:35610) |
| pyrvinium (CHEBI:8687) has role antineoplastic agent (CHEBI:35610) |
| Pyrvinium pamoate (CHEBI:8688) has role antineoplastic agent (CHEBI:35610) |
| qn-302 (CHEBI:758113) has role antineoplastic agent (CHEBI:35610) |
| qs-21 (CHEBI:757261) has role antineoplastic agent (CHEBI:35610) |
| quaratusugene ozeplasmid (CHEBI:757879) has role antineoplastic agent (CHEBI:35610) |
| quassimarin (CHEBI:8691) has role antineoplastic agent (CHEBI:35610) |
| quavonlimab (CHEBI:758307) has role antineoplastic agent (CHEBI:35610) |
| quazomotide (CHEBI:759461) has role antineoplastic agent (CHEBI:35610) |
| quemliclustat (CHEBI:757692) has role antineoplastic agent (CHEBI:35610) |
| quercetin (CHEBI:16243) has role antineoplastic agent (CHEBI:35610) |
| quercetin 3-O-β-D-glucopyranoside (CHEBI:68352) has role antineoplastic agent (CHEBI:35610) |
| quercetin 3,4'-dimethyl ether (CHEBI:70008) has role antineoplastic agent (CHEBI:35610) |
| quercetin 4'-O-β-D-glucopyranoside (CHEBI:75839) has role antineoplastic agent (CHEBI:35610) |
| quinacrine (CHEBI:8711) has role antineoplastic agent (CHEBI:35610) |
| quisinostat (CHEBI:94771) has role antineoplastic agent (CHEBI:35610) |
| quizartinib (CHEBI:90217) has role antineoplastic agent (CHEBI:35610) |
| quizartinib dihydrochloride (CHEBI:751588) has role antineoplastic agent (CHEBI:35610) |
| r-306465 (CHEBI:749101) has role antineoplastic agent (CHEBI:35610) |
| r(+)xk469 (CHEBI:750003) has role antineoplastic agent (CHEBI:35610) |
| rabeprazole (CHEBI:8768) has role antineoplastic agent (CHEBI:35610) |
| racemetirosine (CHEBI:232408) has role antineoplastic agent (CHEBI:35610) |
| racotumomab (CHEBI:750136) has role antineoplastic agent (CHEBI:35610) |
| rad-140 (CHEBI:749958) has role antineoplastic agent (CHEBI:35610) |
| radium dichloride (CHEBI:754767) has role antineoplastic agent (CHEBI:35610) |
| radium ra-223 (CHEBI:756909) has role antineoplastic agent (CHEBI:35610) |
| radotinib (CHEBI:757004) has role antineoplastic agent (CHEBI:35610) |
| rafoxanide (CHEBI:234200) has role antineoplastic agent (CHEBI:35610) |
| rafutrombopag (CHEBI:757890) has role antineoplastic agent (CHEBI:35610) |
| ragifilimab (CHEBI:758031) has role antineoplastic agent (CHEBI:35610) |
| ragistomig (CHEBI:759560) has role antineoplastic agent (CHEBI:35610) |
| ralimetinib (CHEBI:754987) has role antineoplastic agent (CHEBI:35610) |
| raloxifene (CHEBI:8772) has role antineoplastic agent (CHEBI:35610) |
| raloxifene hydrochloride (CHEBI:50740) has role antineoplastic agent (CHEBI:35610) |
| raltegravir (CHEBI:82960) has role antineoplastic agent (CHEBI:35610) |
| raludotatug (CHEBI:759397) has role antineoplastic agent (CHEBI:35610) |
| raludotatug deruxtecan (CHEBI:758899) has role antineoplastic agent (CHEBI:35610) |
| ralzapastotug (CHEBI:758872) has role antineoplastic agent (CHEBI:35610) |
| ramosetron (CHEBI:135156) has role antineoplastic agent (CHEBI:35610) |
| ramucirumab (CHEBI:750139) has role antineoplastic agent (CHEBI:35610) |
| ranibizumab (CHEBI:749601) has role antineoplastic agent (CHEBI:35610) |
| Ranimustine (CHEBI:32089) has role antineoplastic agent (CHEBI:35610) |
| ranosidenib (CHEBI:759987) has role antineoplastic agent (CHEBI:35610) |
| ranpirnase (CHEBI:753445) has role antineoplastic agent (CHEBI:35610) |
| rapcabtagene autoleucel (CHEBI:758730) has role antineoplastic agent (CHEBI:35610) |
| rasburicase (CHEBI:749439) has role antineoplastic agent (CHEBI:35610) |
| rasdegafusp alfa (CHEBI:757357) has role antineoplastic agent (CHEBI:35610) |
| rav-12 (CHEBI:754325) has role antineoplastic agent (CHEBI:35610) |
| ravidomycin (CHEBI:84037) has role antineoplastic agent (CHEBI:35610) |
| ravoxertinib (CHEBI:755393) has role antineoplastic agent (CHEBI:35610) |
| raxorulimogene belzovacirepvec (CHEBI:759398) has role antineoplastic agent (CHEBI:35610) |
| rebamipide (CHEBI:32090) has role antineoplastic agent (CHEBI:35610) |
| rebimastat (CHEBI:748339) has role antineoplastic agent (CHEBI:35610) |
| recombinant human interleukin-15 (CHEBI:758309) has role antineoplastic agent (CHEBI:35610) |
| recombinant human thrombopoietin (CHEBI:758500) has role antineoplastic agent (CHEBI:35610) |
| rediocide G (CHEBI:66296) has role antineoplastic agent (CHEBI:35610) |
| regn-1400 (CHEBI:758063) has role antineoplastic agent (CHEBI:35610) |
| regn-4659 (CHEBI:758068) has role antineoplastic agent (CHEBI:35610) |
| regorafenib (CHEBI:68647) has role antineoplastic agent (CHEBI:35610) |
| regorafenib hydrate (CHEBI:68646) has role antineoplastic agent (CHEBI:35610) |
| regramostim (CHEBI:752923) has role antineoplastic agent (CHEBI:35610) |
| relacorilant (CHEBI:756567) has role antineoplastic agent (CHEBI:35610) |
| relatlimab (CHEBI:756524) has role antineoplastic agent (CHEBI:35610) |
| relebactam (CHEBI:755288) has role antineoplastic agent (CHEBI:35610) |
| relmapirazin (CHEBI:750303) has role antineoplastic agent (CHEBI:35610) |
| relugolix (CHEBI:750198) has role antineoplastic agent (CHEBI:35610) |
| remetinostat (CHEBI:755733) has role antineoplastic agent (CHEBI:35610) |
| remifentanil (CHEBI:8802) has role antineoplastic agent (CHEBI:35610) |
| remimazolam (CHEBI:757006) has role antineoplastic agent (CHEBI:35610) |
| remvulimorgene autoleucel (CHEBI:760084) has role antineoplastic agent (CHEBI:35610) |
| remzistotug (CHEBI:759990) has role antineoplastic agent (CHEBI:35610) |
| rencofilstat (CHEBI:756973) has role antineoplastic agent (CHEBI:35610) |
| renvistobart (CHEBI:757161) has role antineoplastic agent (CHEBI:35610) |
| reozalimab (CHEBI:758926) has role antineoplastic agent (CHEBI:35610) |
| Repaglinide (CHEBI:8805) has role antineoplastic agent (CHEBI:35610) |
| reparixin (CHEBI:177765) has role antineoplastic agent (CHEBI:35610) |
| repicericel (CHEBI:759563) has role antineoplastic agent (CHEBI:35610) |
| repotrectinib (CHEBI:229220) has role antineoplastic agent (CHEBI:35610) |
| RepSox (CHEBI:190969) has role antineoplastic agent (CHEBI:35610) |
| resencatinib (CHEBI:759186) has role antineoplastic agent (CHEBI:35610) |
| resigratinib (CHEBI:759238) has role antineoplastic agent (CHEBI:35610) |
| resimmune (CHEBI:757030) has role antineoplastic agent (CHEBI:35610) |
| resiquimod (CHEBI:36706) has role antineoplastic agent (CHEBI:35610) |
| resminostat (CHEBI:231352) has role antineoplastic agent (CHEBI:35610) |
| respirantin (CHEBI:66299) has role antineoplastic agent (CHEBI:35610) |
| retaspimycin (CHEBI:71975) has role antineoplastic agent (CHEBI:35610) |
| retaspimycin hydrochloride (CHEBI:71956) has role antineoplastic agent (CHEBI:35610) |
| retifanlimab (CHEBI:757460) has role antineoplastic agent (CHEBI:35610) |
| retlirafusp alfa (CHEBI:758949) has role antineoplastic agent (CHEBI:35610) |
| reumycin (CHEBI:121196) has role antineoplastic agent (CHEBI:35610) |
| revdofilimab (CHEBI:757990) has role antineoplastic agent (CHEBI:35610) |
| reversine (CHEBI:70723) has role antineoplastic agent (CHEBI:35610) |
| revumenib (CHEBI:758410) has role antineoplastic agent (CHEBI:35610) |
| revumenib citrate (CHEBI:760308) has role antineoplastic agent (CHEBI:35610) |
| revumenib sesquifumarate (CHEBI:758184) has role antineoplastic agent (CHEBI:35610) |
| rezatapopt (CHEBI:759239) has role antineoplastic agent (CHEBI:35610) |
| rezetamig (CHEBI:759564) has role antineoplastic agent (CHEBI:35610) |
| rezivertinib (CHEBI:759643) has role antineoplastic agent (CHEBI:35610) |
| rezorstobart (CHEBI:759565) has role antineoplastic agent (CHEBI:35610) |
| rezvilutamide (CHEBI:758182) has role antineoplastic agent (CHEBI:35610) |
| rg-1530 (CHEBI:750339) has role antineoplastic agent (CHEBI:35610) |
| RG-2833 (CHEBI:233052) has role antineoplastic agent (CHEBI:35610) |
| rg-547 (CHEBI:748756) has role antineoplastic agent (CHEBI:35610) |
| rg-7602 (CHEBI:759103) has role antineoplastic agent (CHEBI:35610) |
| rg-7603 (CHEBI:754948) has role antineoplastic agent (CHEBI:35610) |
| rg-7741 (CHEBI:755510) has role antineoplastic agent (CHEBI:35610) |
| rg-7841 (CHEBI:757366) has role antineoplastic agent (CHEBI:35610) |
| rgb-286638 (CHEBI:755453) has role antineoplastic agent (CHEBI:35610) |
| RGRN-305 (CHEBI:232048) has role antineoplastic agent (CHEBI:35610) |
| rhamnacene (CHEBI:133721) has role antineoplastic agent (CHEBI:35610) |
| rhapontigenin (CHEBI:174376) has role antineoplastic agent (CHEBI:35610) |
| rhigm12b7 (CHEBI:754152) has role antineoplastic agent (CHEBI:35610) |
| rhinacanthin C (CHEBI:66303) has role antineoplastic agent (CHEBI:35610) |
| rhizoxin (CHEBI:72590) has role antineoplastic agent (CHEBI:35610) |
| rhosin (CHEBI:137693) has role antineoplastic agent (CHEBI:35610) |
| ribavirin (CHEBI:63580) has role antineoplastic agent (CHEBI:35610) |
| Ribociclib (CHEBI:230905) has role antineoplastic agent (CHEBI:35610) |
| ribociclib succinate (CHEBI:755762) has role antineoplastic agent (CHEBI:35610) |
| riboflavin (CHEBI:17015) has role antineoplastic agent (CHEBI:35610) |
| ribrecabtagene autoleucel (CHEBI:759566) has role antineoplastic agent (CHEBI:35610) |
| ricolinostat (CHEBI:95073) has role antineoplastic agent (CHEBI:35610) |
| ridaforolimus (CHEBI:82677) has role antineoplastic agent (CHEBI:35610) |
| rifampicin (CHEBI:28077) has role antineoplastic agent (CHEBI:35610) |
| rifaximin (CHEBI:75246) has role antineoplastic agent (CHEBI:35610) |
| rigosertib (CHEBI:145417) has role antineoplastic agent (CHEBI:35610) |
| rigosertib sodium (CHEBI:145421) has role antineoplastic agent (CHEBI:35610) |
| rilimogene galvacirepvec (CHEBI:755088) has role antineoplastic agent (CHEBI:35610) |
| rilotumumab (CHEBI:750140) has role antineoplastic agent (CHEBI:35610) |
| rilunermin alfa (CHEBI:758733) has role antineoplastic agent (CHEBI:35610) |
| Riluzole (CHEBI:8863) has role antineoplastic agent (CHEBI:35610) |
| rilvegostomig (CHEBI:759401) has role antineoplastic agent (CHEBI:35610) |
| rimiducid (CHEBI:748450) has role antineoplastic agent (CHEBI:35610) |
| rinatabart (CHEBI:760085) has role antineoplastic agent (CHEBI:35610) |
| rinatabart sesutecan (CHEBI:760086) has role antineoplastic agent (CHEBI:35610) |
| rindopepimut (CHEBI:752906) has role antineoplastic agent (CHEBI:35610) |
| rintatolimod (CHEBI:752905) has role antineoplastic agent (CHEBI:35610) |
| rintodestrant (CHEBI:756559) has role antineoplastic agent (CHEBI:35610) |
| ripertamab (CHEBI:758076) has role antineoplastic agent (CHEBI:35610) |
| ripretinib (CHEBI:756647) has role antineoplastic agent (CHEBI:35610) |
| Risedronate sodium (CHEBI:8868) has role antineoplastic agent (CHEBI:35610) |
| Risedronic acid (CHEBI:8869) has role antineoplastic agent (CHEBI:35610) |
| risovalisib (CHEBI:758451) has role antineoplastic agent (CHEBI:35610) |
| ritlecitinib (CHEBI:229233) has role antineoplastic agent (CHEBI:35610) |
| ritonavir (CHEBI:45409) has role antineoplastic agent (CHEBI:35610) |
| rituximab (CHEBI:64357) has role antineoplastic agent (CHEBI:35610) |
| rivaroxaban (CHEBI:68579) has role antineoplastic agent (CHEBI:35610) |
| riviciclib (CHEBI:231364) has role antineoplastic agent (CHEBI:35610) |
| rivoceranib (CHEBI:755209) has role antineoplastic agent (CHEBI:35610) |
| rivoceranib mesylate (CHEBI:755629) has role antineoplastic agent (CHEBI:35610) |
| rivogenlecleucel (CHEBI:756462) has role antineoplastic agent (CHEBI:35610) |
| rizedisben (CHEBI:759189) has role antineoplastic agent (CHEBI:35610) |
| rm-2 ga-68 (CHEBI:756836) has role antineoplastic agent (CHEBI:35610) |
| rmc-5552 (CHEBI:759618) has role antineoplastic agent (CHEBI:35610) |
| Ro 48-8071 (CHEBI:101064) has role antineoplastic agent (CHEBI:35610) |
| Ro 48-8071 fumarate (CHEBI:101097) has role antineoplastic agent (CHEBI:35610) |
| Ro 5-3335 (CHEBI:131785) has role antineoplastic agent (CHEBI:35610) |
| ro-4987655 (CHEBI:749897) has role antineoplastic agent (CHEBI:35610) |
| ro-5045337 (CHEBI:755026) has role antineoplastic agent (CHEBI:35610) |
| ro-5429083 (CHEBI:758073) has role antineoplastic agent (CHEBI:35610) |
| ro-5458640 (CHEBI:754352) has role antineoplastic agent (CHEBI:35610) |
| ro-6870810 (CHEBI:756911) has role antineoplastic agent (CHEBI:35610) |
| RO4929097 (CHEBI:86474) has role antineoplastic agent (CHEBI:35610) |
| robatumumab (CHEBI:750141) has role antineoplastic agent (CHEBI:35610) |
| robustaflavone (CHEBI:8881) has role antineoplastic agent (CHEBI:35610) |
| robustaflavone 7,4',7''-trimethyl ether (CHEBI:66308) has role antineoplastic agent (CHEBI:35610) |
| rocaglamide (CHEBI:66309) has role antineoplastic agent (CHEBI:35610) |
| rocakinogene sifuplasmid (CHEBI:758033) has role antineoplastic agent (CHEBI:35610) |
| rocapuldencel-t (CHEBI:755473) has role antineoplastic agent (CHEBI:35610) |
| rocbrutinib (CHEBI:759240) has role antineoplastic agent (CHEBI:35610) |
| rociletinib (CHEBI:755567) has role antineoplastic agent (CHEBI:35610) |
| rocuronium (CHEBI:8884) has role antineoplastic agent (CHEBI:35610) |
| roducitabine (CHEBI:147412) has role antineoplastic agent (CHEBI:35610) |
| rofecoxib (CHEBI:8887) has role antineoplastic agent (CHEBI:35610) |
| roflumilast (CHEBI:47657) has role antineoplastic agent (CHEBI:35610) |
| rogaratinib (CHEBI:756014) has role antineoplastic agent (CHEBI:35610) |
| roginolisib (CHEBI:755702) has role antineoplastic agent (CHEBI:35610) |
| rogocekib (CHEBI:759072) has role antineoplastic agent (CHEBI:35610) |
| rohitukine (CHEBI:156498) has role antineoplastic agent (CHEBI:35610) |
| rolapitant hydrochloride hydrate (CHEBI:90911) has role antineoplastic agent (CHEBI:35610) |
| rolistobart (CHEBI:759464) has role antineoplastic agent (CHEBI:35610) |
| romidepsin (CHEBI:61080) has role antineoplastic agent (CHEBI:35610) |
| romiplostim (CHEBI:749606) has role antineoplastic agent (CHEBI:35610) |
| romyelocel-l (CHEBI:755166) has role antineoplastic agent (CHEBI:35610) |
| roneparstat (CHEBI:758107) has role antineoplastic agent (CHEBI:35610) |
| roniciclib (CHEBI:757674) has role antineoplastic agent (CHEBI:35610) |
| ropeginterferon alfa-2b (CHEBI:757263) has role antineoplastic agent (CHEBI:35610) |
| ropidoxuridine (CHEBI:750481) has role antineoplastic agent (CHEBI:35610) |
| ropivacaine hydrochloride (CHEBI:750246) has role antineoplastic agent (CHEBI:35610) |
| rosabulin (CHEBI:748858) has role antineoplastic agent (CHEBI:35610) |
| rose bengal free acid (CHEBI:87202) has role antineoplastic agent (CHEBI:35610) |
| rosiglitazone (CHEBI:50122) has role antineoplastic agent (CHEBI:35610) |
| rosiglitazone maleate (CHEBI:8892) has role antineoplastic agent (CHEBI:35610) |
| rosmantuzumab (CHEBI:756512) has role antineoplastic agent (CHEBI:35610) |
| rostratin A (CHEBI:66310) has role antineoplastic agent (CHEBI:35610) |
| rostratin B (CHEBI:66311) has role antineoplastic agent (CHEBI:35610) |
| rostratin C (CHEBI:66312) has role antineoplastic agent (CHEBI:35610) |
| rostratin D (CHEBI:66313) has role antineoplastic agent (CHEBI:35610) |
| rosuvastatin (CHEBI:38545) has role antineoplastic agent (CHEBI:35610) |
| rosuvastatin calcium (CHEBI:77249) has role antineoplastic agent (CHEBI:35610) |
| rotenone (CHEBI:28201) has role antineoplastic agent (CHEBI:35610) |
| rottlerin (CHEBI:8899) has role antineoplastic agent (CHEBI:35610) |
| rotundifolioside A (CHEBI:66314) has role antineoplastic agent (CHEBI:35610) |
| rotundifolioside H (CHEBI:66315) has role antineoplastic agent (CHEBI:35610) |
| rotundifolioside I (CHEBI:66316) has role antineoplastic agent (CHEBI:35610) |
| rotundifolioside J (CHEBI:66317) has role antineoplastic agent (CHEBI:35610) |
| rotundifuran (CHEBI:91265) has role antineoplastic agent (CHEBI:35610) |
| rovalpituzumab tesirine (CHEBI:756493) has role antineoplastic agent (CHEBI:35610) |
| roxadustat (CHEBI:132774) has role antineoplastic agent (CHEBI:35610) |
| RP-6306 (CHEBI:747624) has role antineoplastic agent (CHEBI:35610) |
| RSL3 (CHEBI:173109) has role antineoplastic agent (CHEBI:35610) |
| RSL5 (CHEBI:176418) has role antineoplastic agent (CHEBI:35610) |
| rsm-932a (CHEBI:748715) has role antineoplastic agent (CHEBI:35610) |
| RU 58668 (CHEBI:90223) has role antineoplastic agent (CHEBI:35610) |
| rubiarbonol G (CHEBI:69518) has role antineoplastic agent (CHEBI:35610) |
| rubiarbonone E 19-acetate (CHEBI:69505) has role antineoplastic agent (CHEBI:35610) |
| rubiarboside G 28-acetate (CHEBI:69508) has role antineoplastic agent (CHEBI:35610) |
| rubimaillin (CHEBI:141063) has role antineoplastic agent (CHEBI:35610) |
| rubitecan (CHEBI:90225) has role antineoplastic agent (CHEBI:35610) |
| rubiyunnanol A (CHEBI:69501) has role antineoplastic agent (CHEBI:35610) |
| rubiyunnanol B (CHEBI:69502) has role antineoplastic agent (CHEBI:35610) |
| rubraxanthone (CHEBI:66318) has role antineoplastic agent (CHEBI:35610) |
| rucaparib (CHEBI:134689) has role antineoplastic agent (CHEBI:35610) |
| rucaparib phosphate (CHEBI:751597) has role antineoplastic agent (CHEBI:35610) |
| rucosopasem manganese (CHEBI:758208) has role antineoplastic agent (CHEBI:35610) |
| runimotamab (CHEBI:758341) has role antineoplastic agent (CHEBI:35610) |
| rupitasertib (CHEBI:758593) has role antineoplastic agent (CHEBI:35610) |
| ruserontinib (CHEBI:755697) has role antineoplastic agent (CHEBI:35610) |
| rutin (CHEBI:28527) has role antineoplastic agent (CHEBI:35610) |
| ruxolitinib (CHEBI:66919) has role antineoplastic agent (CHEBI:35610) |
| ruxolitinib phosphate (CHEBI:66917) has role antineoplastic agent (CHEBI:35610) |
| ruxotemitide (CHEBI:757097) has role antineoplastic agent (CHEBI:35610) |
| ryuvidine (CHEBI:92119) has role antineoplastic agent (CHEBI:35610) |
| s-3304 (CHEBI:748223) has role antineoplastic agent (CHEBI:35610) |
| s-55746 (CHEBI:758332) has role antineoplastic agent (CHEBI:35610) |
| sabarubicin (CHEBI:749650) has role antineoplastic agent (CHEBI:35610) |
| sabatolimab (CHEBI:758048) has role antineoplastic agent (CHEBI:35610) |
| sabestomig (CHEBI:759465) has role antineoplastic agent (CHEBI:35610) |
| sabizabulin (CHEBI:754821) has role antineoplastic agent (CHEBI:35610) |
| sabizabulin hydrochloride (CHEBI:759267) has role antineoplastic agent (CHEBI:35610) |
| sacibertinib (CHEBI:759150) has role antineoplastic agent (CHEBI:35610) |
| sacituzumab govitecan (CHEBI:755547) has role antineoplastic agent (CHEBI:35610) |
| sacituzumab tirumotecan (CHEBI:759568) has role antineoplastic agent (CHEBI:35610) |
| safimaltib (CHEBI:758821) has role antineoplastic agent (CHEBI:35610) |
| safimestomig (CHEBI:760206) has role antineoplastic agent (CHEBI:35610) |
| Safingol ( L-threo-sphinganine) (CHEBI:179060) has role antineoplastic agent (CHEBI:35610) |
| safranal (CHEBI:53169) has role antineoplastic agent (CHEBI:35610) |
| safusidenib (CHEBI:758414) has role antineoplastic agent (CHEBI:35610) |
| Sagopilone (CHEBI:177512) has role antineoplastic agent (CHEBI:35610) |
| saintopin (CHEBI:91276) has role antineoplastic agent (CHEBI:35610) |
| salicylic acid (CHEBI:16914) has role antineoplastic agent (CHEBI:35610) |
| salinosporamide A (CHEBI:48045) has role antineoplastic agent (CHEBI:35610) |
| salsalate (CHEBI:9014) has role antineoplastic agent (CHEBI:35610) |
| salvianolic acid B (CHEBI:134301) has role antineoplastic agent (CHEBI:35610) |
| salvigenin (CHEBI:192703) has role antineoplastic agent (CHEBI:35610) |
| salvileucalin B (CHEBI:66154) has role antineoplastic agent (CHEBI:35610) |
| samaderine B (CHEBI:66159) has role antineoplastic agent (CHEBI:35610) |
| samaderine C (CHEBI:66160) has role antineoplastic agent (CHEBI:35610) |
| samaderine E (CHEBI:66161) has role antineoplastic agent (CHEBI:35610) |
| samaderine X (CHEBI:66162) has role antineoplastic agent (CHEBI:35610) |
| samaderine Y (CHEBI:66163) has role antineoplastic agent (CHEBI:35610) |
| samaderine Z (CHEBI:66164) has role antineoplastic agent (CHEBI:35610) |
| samalizumab (CHEBI:750144) has role antineoplastic agent (CHEBI:35610) |
| samarium (CHEBI:757625) has role antineoplastic agent (CHEBI:35610) |
| samarium sm-153 (CHEBI:756914) has role antineoplastic agent (CHEBI:35610) |
| samatatug (CHEBI:760087) has role antineoplastic agent (CHEBI:35610) |
| samatatug zovodotin (CHEBI:760088) has role antineoplastic agent (CHEBI:35610) |
| samotolisib (CHEBI:756701) has role antineoplastic agent (CHEBI:35610) |
| samrotamab vedotin (CHEBI:757987) has role antineoplastic agent (CHEBI:35610) |
| samrotecan (CHEBI:760382) has role antineoplastic agent (CHEBI:35610) |
| sapacitabine (CHEBI:145429) has role antineoplastic agent (CHEBI:35610) |
| sapanisertib (CHEBI:91450) has role antineoplastic agent (CHEBI:35610) |
| sapecmeran autogene (CHEBI:760207) has role antineoplastic agent (CHEBI:35610) |
| sapitinib (CHEBI:132986) has role antineoplastic agent (CHEBI:35610) |
| saposin c (non-glycosylated) (CHEBI:757855) has role antineoplastic agent (CHEBI:35610) |
| sapropterin dihydrochloride (CHEBI:32120) has role antineoplastic agent (CHEBI:35610) |
| Saquinavir mesylate (CHEBI:32121) has role antineoplastic agent (CHEBI:35610) |
| sar-103168 (CHEBI:755620) has role antineoplastic agent (CHEBI:35610) |
| sar-125844 (CHEBI:757684) has role antineoplastic agent (CHEBI:35610) |
| sar-260301 (CHEBI:755122) has role antineoplastic agent (CHEBI:35610) |
| sar-405838 (CHEBI:755024) has role antineoplastic agent (CHEBI:35610) |
| sar-439459 (CHEBI:757518) has role antineoplastic agent (CHEBI:35610) |
| sar-566658 (CHEBI:754372) has role antineoplastic agent (CHEBI:35610) |
| sar-bbn cu-64 (CHEBI:759634) has role antineoplastic agent (CHEBI:35610) |
| saracatinib (CHEBI:47458) has role antineoplastic agent (CHEBI:35610) |
| sarcnu (CHEBI:748660) has role antineoplastic agent (CHEBI:35610) |
| sargramostim (CHEBI:749544) has role antineoplastic agent (CHEBI:35610) |
| sarilumab (CHEBI:753668) has role antineoplastic agent (CHEBI:35610) |
| saruparib (CHEBI:758797) has role antineoplastic agent (CHEBI:35610) |
| sasanlimab (CHEBI:757598) has role antineoplastic agent (CHEBI:35610) |
| satoreotide tetraxetan (CHEBI:757009) has role antineoplastic agent (CHEBI:35610) |
| satoreotide trizoxetan (CHEBI:757010) has role antineoplastic agent (CHEBI:35610) |
| satraplatin (CHEBI:85609) has role antineoplastic agent (CHEBI:35610) |
| satricabtagene autoleucel (CHEBI:759403) has role antineoplastic agent (CHEBI:35610) |
| savolitinib (CHEBI:231369) has role antineoplastic agent (CHEBI:35610) |
| saw palmetto (CHEBI:753699) has role antineoplastic agent (CHEBI:35610) |
| SB-743921 (CHEBI:231716) has role antineoplastic agent (CHEBI:35610) |
| SB225002 (CHEBI:93074) has role antineoplastic agent (CHEBI:35610) |
| sc-004 (CHEBI:757267) has role antineoplastic agent (CHEBI:35610) |
| sc-005 (CHEBI:757972) has role antineoplastic agent (CHEBI:35610) |
| sc-006 (CHEBI:757973) has role antineoplastic agent (CHEBI:35610) |
| sc-0191 (CHEBI:760467) has role antineoplastic agent (CHEBI:35610) |
| sc-43 (CHEBI:750412) has role antineoplastic agent (CHEBI:35610) |
| SC-58125 (CHEBI:8983) has role antineoplastic agent (CHEBI:35610) |
| SC560 (CHEBI:76274) has role antineoplastic agent (CHEBI:35610) |
| sch-900776 (CHEBI:755029) has role antineoplastic agent (CHEBI:35610) |
| SCH51344 (CHEBI:77556) has role antineoplastic agent (CHEBI:35610) |
| SCH772984 (CHEBI:167670) has role antineoplastic agent (CHEBI:35610) |
| schiprolactone A (CHEBI:66430) has role antineoplastic agent (CHEBI:35610) |
| schizolaenone A (CHEBI:66433) has role antineoplastic agent (CHEBI:35610) |
| schizolaenone B (CHEBI:66434) has role antineoplastic agent (CHEBI:35610) |
| schweinfurthin G (CHEBI:66437) has role antineoplastic agent (CHEBI:35610) |
| schweinfurthin H (CHEBI:66438) has role antineoplastic agent (CHEBI:35610) |
| sciscllascilloside E-1 (CHEBI:66439) has role antineoplastic agent (CHEBI:35610) |
| scutebarbatine C (CHEBI:66443) has role antineoplastic agent (CHEBI:35610) |
| scutebarbatine D (CHEBI:66444) has role antineoplastic agent (CHEBI:35610) |
| scutebarbatine E (CHEBI:66445) has role antineoplastic agent (CHEBI:35610) |
| scutebarbatine F (CHEBI:66446) has role antineoplastic agent (CHEBI:35610) |
| scutebarbatine G (CHEBI:66447) has role antineoplastic agent (CHEBI:35610) |
| scutellarin (CHEBI:61278) has role antineoplastic agent (CHEBI:35610) |
| scutianthraquinone A (CHEBI:66453) has role antineoplastic agent (CHEBI:35610) |
| scutianthraquinone B (CHEBI:66454) has role antineoplastic agent (CHEBI:35610) |
| scutianthraquinone C (CHEBI:66455) has role antineoplastic agent (CHEBI:35610) |
| scytalidamide A (CHEBI:66456) has role antineoplastic agent (CHEBI:35610) |
| scytalidamide B (CHEBI:66457) has role antineoplastic agent (CHEBI:35610) |
| SDZ PSC 833 (CHEBI:8985) has role antineoplastic agent (CHEBI:35610) |
| sea-bcma (CHEBI:757974) has role antineoplastic agent (CHEBI:35610) |
| seclidemstat (CHEBI:757109) has role antineoplastic agent (CHEBI:35610) |
| seclidemstat mesylate (CHEBI:759290) has role antineoplastic agent (CHEBI:35610) |
| secoaggregatalactone A (CHEBI:66458) has role antineoplastic agent (CHEBI:35610) |
| segigratinib (CHEBI:759078) has role antineoplastic agent (CHEBI:35610) |
| selenium atom (CHEBI:27568) has role antineoplastic agent (CHEBI:35610) |
| selenomethionine (CHEBI:27585) has role antineoplastic agent (CHEBI:35610) |
| seliciclib (CHEBI:45307) has role antineoplastic agent (CHEBI:35610) |
| selicrelumab (CHEBI:754263) has role antineoplastic agent (CHEBI:35610) |
| selinexor (CHEBI:229764) has role antineoplastic agent (CHEBI:35610) |
| selitrectinib (CHEBI:757096) has role antineoplastic agent (CHEBI:35610) |
| selpercatinib (CHEBI:757714) has role antineoplastic agent (CHEBI:35610) |
| selumetinib (CHEBI:90227) has role antineoplastic agent (CHEBI:35610) |
| selumetinib sulfate (CHEBI:751573) has role antineoplastic agent (CHEBI:35610) |
| selvigaltin (CHEBI:759064) has role antineoplastic agent (CHEBI:35610) |
| semaxanib (CHEBI:91083) has role antineoplastic agent (CHEBI:35610) |
| semustine (CHEBI:6863) has role antineoplastic agent (CHEBI:35610) |
| senacnagene enfaleucel (CHEBI:760208) has role antineoplastic agent (CHEBI:35610) |
| senaparib (CHEBI:758474) has role antineoplastic agent (CHEBI:35610) |
| sendegobresib (CHEBI:758805) has role antineoplastic agent (CHEBI:35610) |
| senexin b (CHEBI:756580) has role antineoplastic agent (CHEBI:35610) |
| sennosides (CHEBI:84154) has role antineoplastic agent (CHEBI:35610) |
| sepantronium bromide (CHEBI:139608) has role antineoplastic agent (CHEBI:35610) |
| sephb4-hsa (CHEBI:757499) has role antineoplastic agent (CHEBI:35610) |
| serabelisib (CHEBI:755995) has role antineoplastic agent (CHEBI:35610) |
| serclutamab (CHEBI:757880) has role antineoplastic agent (CHEBI:35610) |
| serclutamab talirine (CHEBI:757881) has role antineoplastic agent (CHEBI:35610) |
| seribantumab (CHEBI:755446) has role antineoplastic agent (CHEBI:35610) |
| serplulimab (CHEBI:758023) has role antineoplastic agent (CHEBI:35610) |
| sesame oil (CHEBI:753125) has role antineoplastic agent (CHEBI:35610) |
| sesterstatin 1 (CHEBI:66475) has role antineoplastic agent (CHEBI:35610) |
| sesterstatin 2 (CHEBI:66476) has role antineoplastic agent (CHEBI:35610) |
| sesterstatin 3 (CHEBI:66477) has role antineoplastic agent (CHEBI:35610) |
| setanaxib (CHEBI:757649) has role antineoplastic agent (CHEBI:35610) |
| setidegrasib (CHEBI:760090) has role antineoplastic agent (CHEBI:35610) |
| sevabertinib (CHEBI:759992) has role antineoplastic agent (CHEBI:35610) |
| seviprotimut-l (CHEBI:755168) has role antineoplastic agent (CHEBI:35610) |
| seviteronel (CHEBI:755245) has role antineoplastic agent (CHEBI:35610) |
| sevoflurane (CHEBI:9130) has role antineoplastic agent (CHEBI:35610) |
| sf-1126 (CHEBI:754947) has role antineoplastic agent (CHEBI:35610) |
| SF2523 (CHEBI:231676) has role antineoplastic agent (CHEBI:35610) |
| Sg17-1-4 (CHEBI:66478) has role antineoplastic agent (CHEBI:35610) |
| sgn-1 (CHEBI:759725) has role antineoplastic agent (CHEBI:35610) |
| sgn-15 (CHEBI:754283) has role antineoplastic agent (CHEBI:35610) |
| sgn-30 (CHEBI:754123) has role antineoplastic agent (CHEBI:35610) |
| sgn-cd123a (CHEBI:757270) has role antineoplastic agent (CHEBI:35610) |
| sgn-cd352a (CHEBI:757271) has role antineoplastic agent (CHEBI:35610) |
| SGX-523 (CHEBI:90624) has role antineoplastic agent (CHEBI:35610) |
| SH-1242 (CHEBI:231663) has role antineoplastic agent (CHEBI:35610) |
| SHP099 (CHEBI:234265) has role antineoplastic agent (CHEBI:35610) |
| shr-1501 (CHEBI:760495) has role antineoplastic agent (CHEBI:35610) |
| sibiromycin (CHEBI:90941) has role antineoplastic agent (CHEBI:35610) |
| sibrotuzumab (CHEBI:753803) has role antineoplastic agent (CHEBI:35610) |
| sig12d loder (CHEBI:757977) has role antineoplastic agent (CHEBI:35610) |
| sigvotatug (CHEBI:759571) has role antineoplastic agent (CHEBI:35610) |
| sigvotatug vedotin (CHEBI:759572) has role antineoplastic agent (CHEBI:35610) |
| sildenafil (CHEBI:9139) has role antineoplastic agent (CHEBI:35610) |
| sildenafil citrate (CHEBI:58987) has role antineoplastic agent (CHEBI:35610) |
| silibinin (CHEBI:9144) has role antineoplastic agent (CHEBI:35610) |
| silodosin (CHEBI:135929) has role antineoplastic agent (CHEBI:35610) |
| siltuximab (CHEBI:750147) has role antineoplastic agent (CHEBI:35610) |
| silvestrol (CHEBI:66484) has role antineoplastic agent (CHEBI:35610) |
| silybin a (CHEBI:748120) has role antineoplastic agent (CHEBI:35610) |
| simalikalactone D (CHEBI:66486) has role antineoplastic agent (CHEBI:35610) |
| simethicone (CHEBI:756708) has role antineoplastic agent (CHEBI:35610) |
| simlukafusp alfa (CHEBI:757509) has role antineoplastic agent (CHEBI:35610) |
| simmitecan (CHEBI:756822) has role antineoplastic agent (CHEBI:35610) |
| simotaxel (CHEBI:752596) has role antineoplastic agent (CHEBI:35610) |
| simotinib (CHEBI:755530) has role antineoplastic agent (CHEBI:35610) |
| simtuzumab (CHEBI:754389) has role antineoplastic agent (CHEBI:35610) |
| simufilam (CHEBI:758136) has role antineoplastic agent (CHEBI:35610) |
| simufilam hydrochloride (CHEBI:758137) has role antineoplastic agent (CHEBI:35610) |
| simvastatin (CHEBI:9150) has role antineoplastic agent (CHEBI:35610) |
| sinecatechins (CHEBI:749579) has role antineoplastic agent (CHEBI:35610) |
| singlet dioxygen (CHEBI:26689) has role antineoplastic agent (CHEBI:35610) |
| sintilimab (CHEBI:757273) has role antineoplastic agent (CHEBI:35610) |
| sinularolide B (CHEBI:66507) has role antineoplastic agent (CHEBI:35610) |
| sinularolide C (CHEBI:66508) has role antineoplastic agent (CHEBI:35610) |
| sinularolide D (CHEBI:66509) has role antineoplastic agent (CHEBI:35610) |
| sinularolide E (CHEBI:66510) has role antineoplastic agent (CHEBI:35610) |
| siplizumab (CHEBI:753678) has role antineoplastic agent (CHEBI:35610) |
| siponimod (CHEBI:754951) has role antineoplastic agent (CHEBI:35610) |
| sipuleucel-t (CHEBI:749682) has role antineoplastic agent (CHEBI:35610) |
| siremadlin (CHEBI:755680) has role antineoplastic agent (CHEBI:35610) |
| siremadlin succinate (CHEBI:758986) has role antineoplastic agent (CHEBI:35610) |
| sirolimus (CHEBI:9168) has role antineoplastic agent (CHEBI:35610) |
| sirpiglenastat (CHEBI:758261) has role antineoplastic agent (CHEBI:35610) |
| sitagliptin (CHEBI:40237) has role antineoplastic agent (CHEBI:35610) |
| sitocabnagene loxiveleucel (CHEBI:760359) has role antineoplastic agent (CHEBI:35610) |
| sitoindoside IX (CHEBI:69119) has role antineoplastic agent (CHEBI:35610) |
| sitravatinib (CHEBI:756417) has role antineoplastic agent (CHEBI:35610) |
| sitravatinib malate (CHEBI:757573) has role antineoplastic agent (CHEBI:35610) |
| sivifene (CHEBI:748316) has role antineoplastic agent (CHEBI:35610) |
| sizofiran (CHEBI:753019) has role antineoplastic agent (CHEBI:35610) |
| sjg-136 (CHEBI:747990) has role antineoplastic agent (CHEBI:35610) |
| SKF-96365 hydrochloride (CHEBI:145121) has role antineoplastic agent (CHEBI:35610) |
| skl-27969 (CHEBI:759729) has role antineoplastic agent (CHEBI:35610) |
| SLC-0111 (CHEBI:232342) has role antineoplastic agent (CHEBI:35610) |
| slc-391 (CHEBI:758775) has role antineoplastic agent (CHEBI:35610) |
| SM-164 (CHEBI:192710) has role antineoplastic agent (CHEBI:35610) |
| SMIP004 (CHEBI:230532) has role antineoplastic agent (CHEBI:35610) |
| SN-38 (CHEBI:8988) has role antineoplastic agent (CHEBI:35610) |
| SNC-80 (CHEBI:231727) has role antineoplastic agent (CHEBI:35610) |
| snx 5422 (CHEBI:749214) has role antineoplastic agent (CHEBI:35610) |
| soblidotin (CHEBI:32135) has role antineoplastic agent (CHEBI:35610) |
| socazolimab (CHEBI:758532) has role antineoplastic agent (CHEBI:35610) |
| sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate (CHEBI:73280) has role antineoplastic agent (CHEBI:35610) |
| sodium acetate (CHEBI:32954) has role antineoplastic agent (CHEBI:35610) |
| sodium arsenite (CHEBI:29678) has role antineoplastic agent (CHEBI:35610) |
| sodium ascorbate (CHEBI:113451) has role antineoplastic agent (CHEBI:35610) |
| sodium chloride (CHEBI:26710) has role antineoplastic agent (CHEBI:35610) |
| sodium dichloroacetate (CHEBI:748334) has role antineoplastic agent (CHEBI:35610) |
| sodium fluoride (CHEBI:28741) has role antineoplastic agent (CHEBI:35610) |
| sodium fluoride f 18 (CHEBI:749312) has role antineoplastic agent (CHEBI:35610) |
| sodium gallate (CHEBI:115197) has role antineoplastic agent (CHEBI:35610) |
| sodium globostellatate A (CHEBI:65969) has role antineoplastic agent (CHEBI:35610) |
| sodium globostellatate B (CHEBI:65970) has role antineoplastic agent (CHEBI:35610) |
| sodium globostellatate C (CHEBI:65971) has role antineoplastic agent (CHEBI:35610) |
| sodium globostellatate D (CHEBI:65972) has role antineoplastic agent (CHEBI:35610) |
| sodium hydrogencarbonate (CHEBI:32139) has role antineoplastic agent (CHEBI:35610) |
| sodium iodide i 131 (CHEBI:749371) has role antineoplastic agent (CHEBI:35610) |
| sodium lactate (CHEBI:75228) has role antineoplastic agent (CHEBI:35610) |
| sodium meclofenamate monohydrate (CHEBI:76232) has role antineoplastic agent (CHEBI:35610) |
| sodium methoxyacetate (CHEBI:132096) has role antineoplastic agent (CHEBI:35610) |
| sodium pentaborate (CHEBI:759689) has role antineoplastic agent (CHEBI:35610) |
| sodium phenylacetate (CHEBI:749228) has role antineoplastic agent (CHEBI:35610) |
| sodium phenylbutyrate (CHEBI:75316) has role antineoplastic agent (CHEBI:35610) |
| Sodium salicylate (CHEBI:9180) has role antineoplastic agent (CHEBI:35610) |
| sodium stibogluconate (CHEBI:28148) has role antineoplastic agent (CHEBI:35610) |
| sodium valproate (CHEBI:9925) has role antineoplastic agent (CHEBI:35610) |
| sofituzumab vedotin (CHEBI:755602) has role antineoplastic agent (CHEBI:35610) |
| sofnobrutinib (CHEBI:756641) has role antineoplastic agent (CHEBI:35610) |
| sofosbuvir (CHEBI:85083) has role antineoplastic agent (CHEBI:35610) |
| solabafusp alfa (CHEBI:760210) has role antineoplastic agent (CHEBI:35610) |
| solanine (CHEBI:9188) has role antineoplastic agent (CHEBI:35610) |
| solasodine(1+) (CHEBI:145043) has role antineoplastic agent (CHEBI:35610) |
| solnerstotug (CHEBI:760211) has role antineoplastic agent (CHEBI:35610) |
| somocystinamide A (CHEBI:66512) has role antineoplastic agent (CHEBI:35610) |
| sonepcizumab (CHEBI:754331) has role antineoplastic agent (CHEBI:35610) |
| sonesitatug (CHEBI:760212) has role antineoplastic agent (CHEBI:35610) |
| sonesitatug vedotin (CHEBI:760213) has role antineoplastic agent (CHEBI:35610) |
| sonidegib (CHEBI:90863) has role antineoplastic agent (CHEBI:35610) |
| sonidegib phosphate (CHEBI:90864) has role antineoplastic agent (CHEBI:35610) |
| sonrotoclax (CHEBI:759642) has role antineoplastic agent (CHEBI:35610) |
| sontigidomide (CHEBI:759241) has role antineoplastic agent (CHEBI:35610) |
| sophoraflavanone A (CHEBI:70023) has role antineoplastic agent (CHEBI:35610) |
| sophoraflavanone L (CHEBI:66513) has role antineoplastic agent (CHEBI:35610) |
| soquelitinib (CHEBI:759864) has role antineoplastic agent (CHEBI:35610) |
| sor-c13 (CHEBI:756653) has role antineoplastic agent (CHEBI:35610) |
| sorafenib (CHEBI:50924) has role antineoplastic agent (CHEBI:35610) |
| sorafenib tosylate (CHEBI:50928) has role antineoplastic agent (CHEBI:35610) |
| sotatercept (CHEBI:750150) has role antineoplastic agent (CHEBI:35610) |
| sotiburafusp alfa (CHEBI:759468) has role antineoplastic agent (CHEBI:35610) |
| sotigalimab (CHEBI:757326) has role antineoplastic agent (CHEBI:35610) |
| sotorasib (CHEBI:178199) has role antineoplastic agent (CHEBI:35610) |
| sotrastaurin (CHEBI:90531) has role antineoplastic agent (CHEBI:35610) |
| sovatelitide (CHEBI:755217) has role antineoplastic agent (CHEBI:35610) |
| sovipostobart (CHEBI:759469) has role antineoplastic agent (CHEBI:35610) |
| sovipostobart beta (CHEBI:760215) has role antineoplastic agent (CHEBI:35610) |
| sovleplenib (CHEBI:758620) has role antineoplastic agent (CHEBI:35610) |
| sovleplenib acetate (CHEBI:760340) has role antineoplastic agent (CHEBI:35610) |
| soxataltinib (CHEBI:759993) has role antineoplastic agent (CHEBI:35610) |
| soybean oil (CHEBI:166975) has role antineoplastic agent (CHEBI:35610) |
| spartalizumab (CHEBI:757275) has role antineoplastic agent (CHEBI:35610) |
| spebrutinib (CHEBI:755302) has role antineoplastic agent (CHEBI:35610) |
| spebrutinib besylate (CHEBI:755283) has role antineoplastic agent (CHEBI:35610) |
| spevatamig (CHEBI:760216) has role antineoplastic agent (CHEBI:35610) |
| sph-5030 (CHEBI:760469) has role antineoplastic agent (CHEBI:35610) |
| spiculoic acid A (CHEBI:66520) has role antineoplastic agent (CHEBI:35610) |
| spironolactone (CHEBI:9241) has role antineoplastic agent (CHEBI:35610) |
| spiruchostatin B (CHEBI:90235) has role antineoplastic agent (CHEBI:35610) |
| spongotine A (CHEBI:144086) has role antineoplastic agent (CHEBI:35610) |
| spx-101 (CHEBI:760433) has role antineoplastic agent (CHEBI:35610) |
| squalamine lactate (CHEBI:756250) has role antineoplastic agent (CHEBI:35610) |
| squaric acid dibutyl ester (CHEBI:53612) has role antineoplastic agent (CHEBI:35610) |
| SR11302 (CHEBI:197438) has role antineoplastic agent (CHEBI:35610) |
| SR9243 (CHEBI:90842) has role antineoplastic agent (CHEBI:35610) |
| sra-737 (CHEBI:756624) has role antineoplastic agent (CHEBI:35610) |
| ss1(dsfv)-pe38 (CHEBI:754293) has role antineoplastic agent (CHEBI:35610) |
| SSTC3 (CHEBI:232382) has role antineoplastic agent (CHEBI:35610) |
| st. john's wort (CHEBI:753115) has role antineoplastic agent (CHEBI:35610) |
| stachsterol (CHEBI:66521) has role antineoplastic agent (CHEBI:35610) |
| stanozolol (CHEBI:9249) has role antineoplastic agent (CHEBI:35610) |
| stapuldencel (CHEBI:755411) has role antineoplastic agent (CHEBI:35610) |
| starch (CHEBI:28017) has role antineoplastic agent (CHEBI:35610) |
| stattic (CHEBI:86989) has role antineoplastic agent (CHEBI:35610) |
| steffimycin D (CHEBI:156294) has role antineoplastic agent (CHEBI:35610) |
| stem bromelain (CHEBI:757477) has role antineoplastic agent (CHEBI:35610) |
| steviol (CHEBI:145024) has role antineoplastic agent (CHEBI:35610) |
| stevioside (CHEBI:9271) has role antineoplastic agent (CHEBI:35610) |
| sti-6643 (CHEBI:758501) has role antineoplastic agent (CHEBI:35610) |
| STM2457 (CHEBI:172325) has role antineoplastic agent (CHEBI:35610) |
| streptokordin (CHEBI:66524) has role antineoplastic agent (CHEBI:35610) |
| streptonigrin (CHEBI:9287) has role antineoplastic agent (CHEBI:35610) |
| streptozocin (CHEBI:9288) has role antineoplastic agent (CHEBI:35610) |
| strongylin A (CHEBI:66526) has role antineoplastic agent (CHEBI:35610) |
| strongylophorine-26 (CHEBI:66527) has role antineoplastic agent (CHEBI:35610) |
| strontium chloride sr 89 (CHEBI:749288) has role antineoplastic agent (CHEBI:35610) |
| su-014813 (CHEBI:749989) has role antineoplastic agent (CHEBI:35610) |
| SU11274 (CHEBI:190974) has role antineoplastic agent (CHEBI:35610) |
| SU4312 (CHEBI:92369) has role antineoplastic agent (CHEBI:35610) |
| SU6656 (CHEBI:91462) has role antineoplastic agent (CHEBI:35610) |
| subasumstat (CHEBI:758630) has role antineoplastic agent (CHEBI:35610) |
| sucantomotide (CHEBI:759576) has role antineoplastic agent (CHEBI:35610) |
| succimer (CHEBI:63623) has role antineoplastic agent (CHEBI:35610) |
| sudocetaxel (CHEBI:759291) has role antineoplastic agent (CHEBI:35610) |
| sudocetaxel zendusortide (CHEBI:758736) has role antineoplastic agent (CHEBI:35610) |
| sugammadex (CHEBI:90953) has role antineoplastic agent (CHEBI:35610) |
| sugemalimab (CHEBI:758009) has role antineoplastic agent (CHEBI:35610) |
| sugiol (CHEBI:138961) has role antineoplastic agent (CHEBI:35610) |
| sulanemadlin (CHEBI:758787) has role antineoplastic agent (CHEBI:35610) |
| sulfamethoxazole (CHEBI:9332) has role antineoplastic agent (CHEBI:35610) |
| sulfasalazine (CHEBI:9334) has role antineoplastic agent (CHEBI:35610) |
| sulfopin (CHEBI:231413) has role antineoplastic agent (CHEBI:35610) |
| sulforaphane (CHEBI:47807) has role antineoplastic agent (CHEBI:35610) |
| sulfur hexafluoride (CHEBI:30496) has role antineoplastic agent (CHEBI:35610) |
| sulindac (CHEBI:9352) has role antineoplastic agent (CHEBI:35610) |
| sulindac sulfide (CHEBI:75408) has role antineoplastic agent (CHEBI:35610) |
| sulindac sulfone (CHEBI:64212) has role antineoplastic agent (CHEBI:35610) |
| sumecigrel (CHEBI:750395) has role antineoplastic agent (CHEBI:35610) |
| sunirine (CHEBI:758976) has role antineoplastic agent (CHEBI:35610) |
| sunitinib (CHEBI:38940) has role antineoplastic agent (CHEBI:35610) |
| sunitinib malate (CHEBI:232546) has role antineoplastic agent (CHEBI:35610) |
| sunvozertinib (CHEBI:759262) has role antineoplastic agent (CHEBI:35610) |
| supinoxin (CHEBI:749752) has role antineoplastic agent (CHEBI:35610) |
| suramin (CHEBI:45906) has role antineoplastic agent (CHEBI:35610) |
| suramin sodium (CHEBI:9364) has role antineoplastic agent (CHEBI:35610) |
| suratadenoturev (CHEBI:759337) has role antineoplastic agent (CHEBI:35610) |
| surfactin (CHEBI:29681) has role antineoplastic agent (CHEBI:35610) |
| surfactin A (CHEBI:71976) has role antineoplastic agent (CHEBI:35610) |
| surfactin B (CHEBI:71977) has role antineoplastic agent (CHEBI:35610) |
| surfactin C (CHEBI:71978) has role antineoplastic agent (CHEBI:35610) |
| surfactin D (CHEBI:71979) has role antineoplastic agent (CHEBI:35610) |
| surovatamig (CHEBI:760217) has role antineoplastic agent (CHEBI:35610) |
| surufatinib (CHEBI:756707) has role antineoplastic agent (CHEBI:35610) |
| surzebiclimab (CHEBI:757945) has role antineoplastic agent (CHEBI:35610) |
| surzetoclax (CHEBI:759950) has role antineoplastic agent (CHEBI:35610) |
| sutidiazine (CHEBI:756662) has role antineoplastic agent (CHEBI:35610) |
| suvemcitug (CHEBI:759727) has role antineoplastic agent (CHEBI:35610) |
| suvutresgene autoleucel (CHEBI:759471) has role antineoplastic agent (CHEBI:35610) |
| svn53-67/m57-klh peptide vaccine (CHEBI:758312) has role antineoplastic agent (CHEBI:35610) |
| swainsonine (CHEBI:9367) has role antineoplastic agent (CHEBI:35610) |
| sx-682 (CHEBI:756966) has role antineoplastic agent (CHEBI:35610) |
| sy-5609 (CHEBI:758607) has role antineoplastic agent (CHEBI:35610) |
| SYC-435 (CHEBI:189826) has role antineoplastic agent (CHEBI:35610) |
| sym-021 (CHEBI:757529) has role antineoplastic agent (CHEBI:35610) |
| sym-023 (CHEBI:757531) has role antineoplastic agent (CHEBI:35610) |
| SZL-P1-41 (CHEBI:75919) has role antineoplastic agent (CHEBI:35610) |
| t-900607 (CHEBI:756928) has role antineoplastic agent (CHEBI:35610) |
| tabalumab (CHEBI:750152) has role antineoplastic agent (CHEBI:35610) |
| tabelecleucel (CHEBI:756490) has role antineoplastic agent (CHEBI:35610) |
| tabernaemontanine (CHEBI:142075) has role antineoplastic agent (CHEBI:35610) |
| tabersonine (CHEBI:16776) has role antineoplastic agent (CHEBI:35610) |
| tacaciclib (CHEBI:759242) has role antineoplastic agent (CHEBI:35610) |
| tacalcitol (CHEBI:32176) has role antineoplastic agent (CHEBI:35610) |
| tacedinaline (CHEBI:90195) has role antineoplastic agent (CHEBI:35610) |
| tacrolimus (CHEBI:756389) has role antineoplastic agent (CHEBI:35610) |
| tacrolimus anhydrous (CHEBI:747917) has role antineoplastic agent (CHEBI:35610) |
| tadalafil (CHEBI:71940) has role antineoplastic agent (CHEBI:35610) |
| tafasitamab (CHEBI:757470) has role antineoplastic agent (CHEBI:35610) |
| tafetinib (CHEBI:754838) has role antineoplastic agent (CHEBI:35610) |
| tafolecimab (CHEBI:758027) has role antineoplastic agent (CHEBI:35610) |
| tagraxofusp (CHEBI:757048) has role antineoplastic agent (CHEBI:35610) |
| taiwanhomoflavone A (CHEBI:66182) has role antineoplastic agent (CHEBI:35610) |
| taiwanhomoflavone-B (CHEBI:66183) has role antineoplastic agent (CHEBI:35610) |
| taiwanin C (CHEBI:191411) has role antineoplastic agent (CHEBI:35610) |
| tak-243 (CHEBI:756894) has role antineoplastic agent (CHEBI:35610) |
| tak-285 (CHEBI:749896) has role antineoplastic agent (CHEBI:35610) |
| tak-441 (CHEBI:754846) has role antineoplastic agent (CHEBI:35610) |
| tak-448 (CHEBI:755988) has role antineoplastic agent (CHEBI:35610) |
| TAK-580 (CHEBI:167672) has role antineoplastic agent (CHEBI:35610) |
| tak-593 (CHEBI:754839) has role antineoplastic agent (CHEBI:35610) |
| TAK-632 (CHEBI:167673) has role antineoplastic agent (CHEBI:35610) |
| TAK-733 (CHEBI:231366) has role antineoplastic agent (CHEBI:35610) |
| tak-960 (CHEBI:755033) has role antineoplastic agent (CHEBI:35610) |
| talabostat (CHEBI:748301) has role antineoplastic agent (CHEBI:35610) |
| talabostat mesylate (CHEBI:755440) has role antineoplastic agent (CHEBI:35610) |
| talacotuzumab (CHEBI:757280) has role antineoplastic agent (CHEBI:35610) |
| talactoferrin alfa (CHEBI:753601) has role antineoplastic agent (CHEBI:35610) |
| taladegib (CHEBI:754776) has role antineoplastic agent (CHEBI:35610) |
| Talampanel (CHEBI:34992) has role antineoplastic agent (CHEBI:35610) |
| talaporfin sodium (CHEBI:752873) has role antineoplastic agent (CHEBI:35610) |
| talaroconvolutin A (CHEBI:173105) has role antineoplastic agent (CHEBI:35610) |
| talazoparib (CHEBI:231344) has role antineoplastic agent (CHEBI:35610) |
| talazoparib tosylate (CHEBI:755149) has role antineoplastic agent (CHEBI:35610) |
| taletrectinib (CHEBI:758413) has role antineoplastic agent (CHEBI:35610) |
| taletrectinib adipate (CHEBI:758256) has role antineoplastic agent (CHEBI:35610) |
| talfirastide (CHEBI:755587) has role antineoplastic agent (CHEBI:35610) |
| talimogene laherparepvec (CHEBI:753665) has role antineoplastic agent (CHEBI:35610) |
| talmapimod (CHEBI:90683) has role antineoplastic agent (CHEBI:35610) |
| talogreptide mesaroxetan (CHEBI:760094) has role antineoplastic agent (CHEBI:35610) |
| talorasib (CHEBI:759952) has role antineoplastic agent (CHEBI:35610) |
| talotrexin ammonium (CHEBI:751152) has role antineoplastic agent (CHEBI:35610) |
| talquetamab (CHEBI:757979) has role antineoplastic agent (CHEBI:35610) |
| tambiciclib (CHEBI:756666) has role antineoplastic agent (CHEBI:35610) |
| tamibarotene (CHEBI:32181) has role antineoplastic agent (CHEBI:35610) |
| tamnorzatinib (CHEBI:759140) has role antineoplastic agent (CHEBI:35610) |
| tamoxifen (CHEBI:41774) has role antineoplastic agent (CHEBI:35610) |
| tamsulosin (CHEBI:9398) has role antineoplastic agent (CHEBI:35610) |
| tamsulosin hydrochloride (CHEBI:9399) has role antineoplastic agent (CHEBI:35610) |
| tanariflavanone D (CHEBI:66191) has role antineoplastic agent (CHEBI:35610) |
| tandutinib (CHEBI:90237) has role antineoplastic agent (CHEBI:35610) |
| tanespimycin (CHEBI:64153) has role antineoplastic agent (CHEBI:35610) |
| tangeretin (CHEBI:9400) has role antineoplastic agent (CHEBI:35610) |
| tanghinigenin (CHEBI:74633) has role antineoplastic agent (CHEBI:35610) |
| tanghinin (CHEBI:66192) has role antineoplastic agent (CHEBI:35610) |
| taniraleucel (CHEBI:759316) has role antineoplastic agent (CHEBI:35610) |
| tapentadol (CHEBI:135935) has role antineoplastic agent (CHEBI:35610) |
| tapotoclax (CHEBI:757677) has role antineoplastic agent (CHEBI:35610) |
| taragarestrant (CHEBI:758604) has role antineoplastic agent (CHEBI:35610) |
| tarextumab (CHEBI:755271) has role antineoplastic agent (CHEBI:35610) |
| Tariquidar (CHEBI:177609) has role antineoplastic agent (CHEBI:35610) |
| tarlatamab (CHEBI:758866) has role antineoplastic agent (CHEBI:35610) |
| tarloxotinib (CHEBI:757123) has role antineoplastic agent (CHEBI:35610) |
| tarloxotinib bromide (CHEBI:757124) has role antineoplastic agent (CHEBI:35610) |
| tas-108 (CHEBI:755517) has role antineoplastic agent (CHEBI:35610) |
| Tas-116 (CHEBI:233475) has role antineoplastic agent (CHEBI:35610) |
| tas-119 (CHEBI:755706) has role antineoplastic agent (CHEBI:35610) |
| tas-266 (CHEBI:758530) has role antineoplastic agent (CHEBI:35610) |
| tas0612 (CHEBI:758183) has role antineoplastic agent (CHEBI:35610) |
| tasadenoturev (CHEBI:756525) has role antineoplastic agent (CHEBI:35610) |
| taselisib (CHEBI:755030) has role antineoplastic agent (CHEBI:35610) |
| tasidotin hydrochloride (CHEBI:752599) has role antineoplastic agent (CHEBI:35610) |
| tasisulam (CHEBI:231621) has role antineoplastic agent (CHEBI:35610) |
| tasisulam sodium (CHEBI:750482) has role antineoplastic agent (CHEBI:35610) |
| tasonermin (CHEBI:752933) has role antineoplastic agent (CHEBI:35610) |
| tasquinimod (CHEBI:231355) has role antineoplastic agent (CHEBI:35610) |
| tasumatrol E (CHEBI:66194) has role antineoplastic agent (CHEBI:35610) |
| tasumatrol F (CHEBI:66195) has role antineoplastic agent (CHEBI:35610) |
| taurine (CHEBI:15891) has role antineoplastic agent (CHEBI:35610) |
| taurolidine (CHEBI:135173) has role antineoplastic agent (CHEBI:35610) |
| tavokinogene telseplasmid (CHEBI:757613) has role antineoplastic agent (CHEBI:35610) |
| tavolimab (CHEBI:757452) has role antineoplastic agent (CHEBI:35610) |
| tazarotene (CHEBI:32184) has role antineoplastic agent (CHEBI:35610) |
| tazemetostat hydrobromide (CHEBI:757766) has role antineoplastic agent (CHEBI:35610) |
| tazlestobart (CHEBI:760095) has role antineoplastic agent (CHEBI:35610) |
| tazobactam (CHEBI:9421) has role antineoplastic agent (CHEBI:35610) |
| tb-403 (CHEBI:754312) has role antineoplastic agent (CHEBI:35610) |
| TDZD-8 (CHEBI:147411) has role antineoplastic agent (CHEBI:35610) |
| tebentafusp (CHEBI:757417) has role antineoplastic agent (CHEBI:35610) |
| tebotelimab (CHEBI:758051) has role antineoplastic agent (CHEBI:35610) |
| tecemotide (CHEBI:755085) has role antineoplastic agent (CHEBI:35610) |
| technetium tc 99m pentetate (CHEBI:750452) has role antineoplastic agent (CHEBI:35610) |
| Technetium tc 99m sestamibi (CHEBI:9423) has role antineoplastic agent (CHEBI:35610) |
| technetium tc 99m sulfur colloid (CHEBI:749474) has role antineoplastic agent (CHEBI:35610) |
| technetium tc 99m tilmanocept (CHEBI:753664) has role antineoplastic agent (CHEBI:35610) |
| teclistamab (CHEBI:757981) has role antineoplastic agent (CHEBI:35610) |
| tecotabart (CHEBI:760096) has role antineoplastic agent (CHEBI:35610) |
| tecotabart vedotin (CHEBI:760097) has role antineoplastic agent (CHEBI:35610) |
| tectochrysin (CHEBI:9426) has role antineoplastic agent (CHEBI:35610) |
| tefinostat (CHEBI:757057) has role antineoplastic agent (CHEBI:35610) |
| Tegafur (CHEBI:32188) has role antineoplastic agent (CHEBI:35610) |
| tegavivint (CHEBI:755656) has role antineoplastic agent (CHEBI:35610) |
| tegeprotafib (CHEBI:759244) has role antineoplastic agent (CHEBI:35610) |
| teglarinad chloride (CHEBI:748704) has role antineoplastic agent (CHEBI:35610) |
| tegtociclib (CHEBI:759071) has role antineoplastic agent (CHEBI:35610) |
| telaglenastat (CHEBI:231605) has role antineoplastic agent (CHEBI:35610) |
| telaglenastat hydrochloride (CHEBI:757789) has role antineoplastic agent (CHEBI:35610) |
| Telapristone acetate (CHEBI:188804) has role antineoplastic agent (CHEBI:35610) |
| telatinib (CHEBI:231351) has role antineoplastic agent (CHEBI:35610) |
| telisotuzumab (CHEBI:755631) has role antineoplastic agent (CHEBI:35610) |
| telisotuzumab adizutecan (CHEBI:760098) has role antineoplastic agent (CHEBI:35610) |
| telisotuzumab vedotin (CHEBI:756513) has role antineoplastic agent (CHEBI:35610) |
| telmisartan (CHEBI:9434) has role antineoplastic agent (CHEBI:35610) |
| Telotristat (CHEBI:177736) has role antineoplastic agent (CHEBI:35610) |
| telotristat ethyl (CHEBI:751580) has role antineoplastic agent (CHEBI:35610) |
| telotristat etiprate (CHEBI:755333) has role antineoplastic agent (CHEBI:35610) |
| telratolimod (CHEBI:757100) has role antineoplastic agent (CHEBI:35610) |
| temozolomide (CHEBI:72564) has role antineoplastic agent (CHEBI:35610) |
| temuterkib (CHEBI:758190) has role antineoplastic agent (CHEBI:35610) |
| temuterkib mesylate (CHEBI:758550) has role antineoplastic agent (CHEBI:35610) |
| tenalisib (CHEBI:757059) has role antineoplastic agent (CHEBI:35610) |
| tenifatecan (CHEBI:751561) has role antineoplastic agent (CHEBI:35610) |
| teniposide (CHEBI:75988) has role antineoplastic agent (CHEBI:35610) |
| tenofovir (anhydrous) (CHEBI:63625) has role antineoplastic agent (CHEBI:35610) |
| tenofovir disoproxil fumarate (CHEBI:63718) has role antineoplastic agent (CHEBI:35610) |
| tenovin-6 (CHEBI:77729) has role antineoplastic agent (CHEBI:35610) |
| tephrosin (CHEBI:9442) has role antineoplastic agent (CHEBI:35610) |
| tepotinib (CHEBI:755350) has role antineoplastic agent (CHEBI:35610) |
| tepotinib hydrochloride (CHEBI:757794) has role antineoplastic agent (CHEBI:35610) |
| teprosulvose (CHEBI:759060) has role antineoplastic agent (CHEBI:35610) |
| teprosulvose calcium (CHEBI:760330) has role antineoplastic agent (CHEBI:35610) |
| teprotumumab (CHEBI:750156) has role antineoplastic agent (CHEBI:35610) |
| terameprocol (CHEBI:177824) has role antineoplastic agent (CHEBI:35610) |
| terazosin (CHEBI:9445) has role antineoplastic agent (CHEBI:35610) |
| Terfenadine (CHEBI:9453) has role antineoplastic agent (CHEBI:35610) |
| tergenpumatucel-l (CHEBI:753630) has role antineoplastic agent (CHEBI:35610) |
| terreic acid (CHEBI:156546) has role antineoplastic agent (CHEBI:35610) |
| terrequinone A (CHEBI:64534) has role antineoplastic agent (CHEBI:35610) |
| tertomotide (CHEBI:753296) has role antineoplastic agent (CHEBI:35610) |
| tesetaxel (CHEBI:752861) has role antineoplastic agent (CHEBI:35610) |
| tesevatinib (CHEBI:167674) has role antineoplastic agent (CHEBI:35610) |
| testosterone (CHEBI:17347) has role antineoplastic agent (CHEBI:35610) |
| testosterone cypionate (CHEBI:9463) has role antineoplastic agent (CHEBI:35610) |
| testosterone enanthate (CHEBI:9464) has role antineoplastic agent (CHEBI:35610) |
| testosterone undecanoate (CHEBI:135741) has role antineoplastic agent (CHEBI:35610) |
| tetanus toxoid (CHEBI:753796) has role antineoplastic agent (CHEBI:35610) |
| tetanus toxoid adsorbed (CHEBI:753797) has role antineoplastic agent (CHEBI:35610) |
| tetracycline (CHEBI:27902) has role antineoplastic agent (CHEBI:35610) |
| TETRAHYDROURIDINE (CHEBI:46208) has role antineoplastic agent (CHEBI:35610) |
| tetramethylpyrazine (CHEBI:133246) has role antineoplastic agent (CHEBI:35610) |
| tetrazolium violet (CHEBI:75193) has role antineoplastic agent (CHEBI:35610) |
| tetulomab tetraxetan lu-177 (CHEBI:757344) has role antineoplastic agent (CHEBI:35610) |
| tezemlimogene daxadenorepvec (CHEBI:758898) has role antineoplastic agent (CHEBI:35610) |
| TG101209 (CHEBI:90304) has role antineoplastic agent (CHEBI:35610) |
| tgn-1412 (CHEBI:754120) has role antineoplastic agent (CHEBI:35610) |
| thalidomide (CHEBI:9513) has role antineoplastic agent (CHEBI:35610) |
| theliatinib (CHEBI:759123) has role antineoplastic agent (CHEBI:35610) |
| thiarabine (CHEBI:749936) has role antineoplastic agent (CHEBI:35610) |
| thiodiglycol (CHEBI:75184) has role antineoplastic agent (CHEBI:35610) |
| thiolutin (CHEBI:156450) has role antineoplastic agent (CHEBI:35610) |
| thioridazine (CHEBI:9566) has role antineoplastic agent (CHEBI:35610) |
| thiostrepton (CHEBI:29693) has role antineoplastic agent (CHEBI:35610) |
| Thiotepa (CHEBI:9570) has role antineoplastic agent (CHEBI:35610) |
| thiourea, n-(5-bromo-2-pyridinyl)-n'-(2-(2-chloro-3-ethoxy-6-fluorophenyl)ethyl)- (CHEBI:748826) has role antineoplastic agent (CHEBI:35610) |
| Thrombin (CHEBI:9574) has role antineoplastic agent (CHEBI:35610) |
| thrombomodulin alfa (CHEBI:753603) has role antineoplastic agent (CHEBI:35610) |
| thymalfasin (CHEBI:135915) has role antineoplastic agent (CHEBI:35610) |
| thymidine (CHEBI:17748) has role antineoplastic agent (CHEBI:35610) |
| thymoquinone (CHEBI:113532) has role antineoplastic agent (CHEBI:35610) |
| thymosin (CHEBI:748163) has role antineoplastic agent (CHEBI:35610) |
| thyroglobulin (CHEBI:749525) has role antineoplastic agent (CHEBI:35610) |
| thyroid (CHEBI:753799) has role antineoplastic agent (CHEBI:35610) |
| thyrotropin (CHEBI:749528) has role antineoplastic agent (CHEBI:35610) |
| thyrotropin alfa (CHEBI:749567) has role antineoplastic agent (CHEBI:35610) |
| THZ1 (CHEBI:230500) has role antineoplastic agent (CHEBI:35610) |
| THZ531 (CHEBI:143122) has role antineoplastic agent (CHEBI:35610) |
| tiazofurine (CHEBI:90239) has role antineoplastic agent (CHEBI:35610) |
| tibolone (CHEBI:32223) has role antineoplastic agent (CHEBI:35610) |
| tibremciclib (CHEBI:759246) has role antineoplastic agent (CHEBI:35610) |
| tidutamab (CHEBI:757544) has role antineoplastic agent (CHEBI:35610) |
| tifcemalimab (CHEBI:758920) has role antineoplastic agent (CHEBI:35610) |
| tigapotide triflutate (CHEBI:755017) has role antineoplastic agent (CHEBI:35610) |
| tigatuzumab (CHEBI:750157) has role antineoplastic agent (CHEBI:35610) |
| tigecycline (CHEBI:149836) has role antineoplastic agent (CHEBI:35610) |
| tigilanol tiglate (CHEBI:194146) has role antineoplastic agent (CHEBI:35610) |
| tigozertinib (CHEBI:758752) has role antineoplastic agent (CHEBI:35610) |
| tilatamig (CHEBI:760099) has role antineoplastic agent (CHEBI:35610) |
| tilatamig samrotecan (CHEBI:760100) has role antineoplastic agent (CHEBI:35610) |
| tildrakizumab (CHEBI:753629) has role antineoplastic agent (CHEBI:35610) |
| tilmanocept (CHEBI:759760) has role antineoplastic agent (CHEBI:35610) |
| tilorone (CHEBI:147347) has role antineoplastic agent (CHEBI:35610) |
| tilorone dihydrochloride (CHEBI:147356) has role antineoplastic agent (CHEBI:35610) |
| tilsotolimod (CHEBI:757281) has role antineoplastic agent (CHEBI:35610) |
| tilsotolimod sodium (CHEBI:757421) has role antineoplastic agent (CHEBI:35610) |
| tilvestamab (CHEBI:758004) has role antineoplastic agent (CHEBI:35610) |
| timcodar (CHEBI:750403) has role antineoplastic agent (CHEBI:35610) |
| timdarpacept (CHEBI:759473) has role antineoplastic agent (CHEBI:35610) |
| tinengotinib (CHEBI:759141) has role antineoplastic agent (CHEBI:35610) |
| tinidazole (CHEBI:63627) has role antineoplastic agent (CHEBI:35610) |
| tinlorafenib (CHEBI:758833) has role antineoplastic agent (CHEBI:35610) |
| tinocabtagene autoleucel (CHEBI:759474) has role antineoplastic agent (CHEBI:35610) |
| tinodasertib (CHEBI:756644) has role antineoplastic agent (CHEBI:35610) |
| tinostamustine (CHEBI:756429) has role antineoplastic agent (CHEBI:35610) |
| tinzaparin (CHEBI:760498) has role antineoplastic agent (CHEBI:35610) |
| tinzaparin sodium (CHEBI:749522) has role antineoplastic agent (CHEBI:35610) |
| tioguanine (CHEBI:9555) has role antineoplastic agent (CHEBI:35610) |
| tiomolibdate choline (CHEBI:757765) has role antineoplastic agent (CHEBI:35610) |
| tiomolibdate diammonium (CHEBI:755878) has role antineoplastic agent (CHEBI:35610) |
| tiomolibdate ion (CHEBI:749652) has role antineoplastic agent (CHEBI:35610) |
| tipifarnib (CHEBI:141969) has role antineoplastic agent (CHEBI:35610) |
| tipiracil (CHEBI:90879) has role antineoplastic agent (CHEBI:35610) |
| tipiracil hydrochloride (CHEBI:90877) has role antineoplastic agent (CHEBI:35610) |
| tirabrutinib hydrochloride (CHEBI:759297) has role antineoplastic agent (CHEBI:35610) |
| tiragolumab (CHEBI:757473) has role antineoplastic agent (CHEBI:35610) |
| tirapazamine (CHEBI:78887) has role antineoplastic agent (CHEBI:35610) |
| tirbanibulin (CHEBI:231702) has role antineoplastic agent (CHEBI:35610) |
| tirbanibulin mesylate (CHEBI:757782) has role antineoplastic agent (CHEBI:35610) |
| tisagenlecleucel (CHEBI:755258) has role antineoplastic agent (CHEBI:35610) |
| tislelizumab (CHEBI:757282) has role antineoplastic agent (CHEBI:35610) |
| tisotumab (CHEBI:757842) has role antineoplastic agent (CHEBI:35610) |
| tisotumab vedotin (CHEBI:757283) has role antineoplastic agent (CHEBI:35610) |
| titanium dioxide (CHEBI:32234) has role antineoplastic agent (CHEBI:35610) |
| tivozanib (CHEBI:91327) has role antineoplastic agent (CHEBI:35610) |
| tivozanib hydrochloride (CHEBI:751609) has role antineoplastic agent (CHEBI:35610) |
| tivumecirnon (CHEBI:759195) has role antineoplastic agent (CHEBI:35610) |
| tivumecirnon besylate (CHEBI:760327) has role antineoplastic agent (CHEBI:35610) |
| tizanidine (CHEBI:63629) has role antineoplastic agent (CHEBI:35610) |
| tizaterkib (CHEBI:757697) has role antineoplastic agent (CHEBI:35610) |
| tizetatug (CHEBI:760222) has role antineoplastic agent (CHEBI:35610) |
| tizetatug rezetecan (CHEBI:760223) has role antineoplastic agent (CHEBI:35610) |
| tlc-388 (CHEBI:757848) has role antineoplastic agent (CHEBI:35610) |
| TMC-135A (CHEBI:66232) has role antineoplastic agent (CHEBI:35610) |
| TMC-135B (CHEBI:66233) has role antineoplastic agent (CHEBI:35610) |
| TMC-1A (CHEBI:66234) has role antineoplastic agent (CHEBI:35610) |
| TMC-1B (CHEBI:66235) has role antineoplastic agent (CHEBI:35610) |
| TMC-1C (CHEBI:66236) has role antineoplastic agent (CHEBI:35610) |
| TMC-1D (CHEBI:66237) has role antineoplastic agent (CHEBI:35610) |
| TMC-86A (CHEBI:66242) has role antineoplastic agent (CHEBI:35610) |
| TMC-86B (CHEBI:66243) has role antineoplastic agent (CHEBI:35610) |
| TMC-95A (CHEBI:40322) has role antineoplastic agent (CHEBI:35610) |
| TMC-95B (CHEBI:66246) has role antineoplastic agent (CHEBI:35610) |
| TMC-95C (CHEBI:66247) has role antineoplastic agent (CHEBI:35610) |
| TMC-95D (CHEBI:66248) has role antineoplastic agent (CHEBI:35610) |
| TMC-96 (CHEBI:66244) has role antineoplastic agent (CHEBI:35610) |
| tnt-1b (CHEBI:754379) has role antineoplastic agent (CHEBI:35610) |
| tobemstomig (CHEBI:759691) has role antineoplastic agent (CHEBI:35610) |
| tocilizumab (CHEBI:64360) has role antineoplastic agent (CHEBI:35610) |
| tocladesine (CHEBI:752426) has role antineoplastic agent (CHEBI:35610) |
| tocotrienol (CHEBI:33235) has role antineoplastic agent (CHEBI:35610) |
| tofacitinib (CHEBI:71200) has role antineoplastic agent (CHEBI:35610) |
| tolbutamide (CHEBI:27999) has role antineoplastic agent (CHEBI:35610) |
| tolcapone (CHEBI:63630) has role antineoplastic agent (CHEBI:35610) |
| tolfenamic acid (CHEBI:32243) has role antineoplastic agent (CHEBI:35610) |
| toll-like receptor 9 (CHEBI:758315) has role antineoplastic agent (CHEBI:35610) |
| toluene-4-sulfonamide (CHEBI:34435) has role antineoplastic agent (CHEBI:35610) |
| tolvaptan (CHEBI:32246) has role antineoplastic agent (CHEBI:35610) |
| tomaralimab (CHEBI:757489) has role antineoplastic agent (CHEBI:35610) |
| tomaymycin (CHEBI:157681) has role antineoplastic agent (CHEBI:35610) |
| tomivosertib (CHEBI:756577) has role antineoplastic agent (CHEBI:35610) |
| tomivosertib hydrochloride (CHEBI:757550) has role antineoplastic agent (CHEBI:35610) |
| tomuzotuximab (CHEBI:757284) has role antineoplastic agent (CHEBI:35610) |
| TOP-53 (CHEBI:134547) has role antineoplastic agent (CHEBI:35610) |
| topopyrone A (CHEBI:66252) has role antineoplastic agent (CHEBI:35610) |
| topopyrone B (CHEBI:66253) has role antineoplastic agent (CHEBI:35610) |
| topopyrone C (CHEBI:66254) has role antineoplastic agent (CHEBI:35610) |
| topopyrone D (CHEBI:66255) has role antineoplastic agent (CHEBI:35610) |
| topotecan (CHEBI:63632) has role antineoplastic agent (CHEBI:35610) |
| topotecan hydrochloride (CHEBI:232548) has role antineoplastic agent (CHEBI:35610) |
| topsalysin (CHEBI:755002) has role antineoplastic agent (CHEBI:35610) |
| toremifene (CHEBI:9635) has role antineoplastic agent (CHEBI:35610) |
| Toremifene citrate (CHEBI:9636) has role antineoplastic agent (CHEBI:35610) |
| torin 1 (CHEBI:84327) has role antineoplastic agent (CHEBI:35610) |
| torin 2 (CHEBI:90682) has role antineoplastic agent (CHEBI:35610) |
| toripalimab (CHEBI:757285) has role antineoplastic agent (CHEBI:35610) |
| torkinib (CHEBI:90679) has role antineoplastic agent (CHEBI:35610) |
| torulimogene lonferencel (CHEBI:759406) has role antineoplastic agent (CHEBI:35610) |
| tositumomab (CHEBI:749499) has role antineoplastic agent (CHEBI:35610) |
| tositumomab 131i (CHEBI:755905) has role antineoplastic agent (CHEBI:35610) |
| tovecimig (CHEBI:760224) has role antineoplastic agent (CHEBI:35610) |
| tovetumab (CHEBI:754998) has role antineoplastic agent (CHEBI:35610) |
| toxoflavin (CHEBI:80729) has role antineoplastic agent (CHEBI:35610) |
| toyocamycin (CHEBI:134606) has role antineoplastic agent (CHEBI:35610) |
| tozinameran (CHEBI:758316) has role antineoplastic agent (CHEBI:35610) |
| tozuleristide (CHEBI:756505) has role antineoplastic agent (CHEBI:35610) |
| tp-1287 (CHEBI:757911) has role antineoplastic agent (CHEBI:35610) |
| tpx-4589 (CHEBI:759715) has role antineoplastic agent (CHEBI:35610) |
| trabectedin (CHEBI:84050) has role antineoplastic agent (CHEBI:35610) |
| trabedersen (CHEBI:753325) has role antineoplastic agent (CHEBI:35610) |
| tralokinumab (CHEBI:750158) has role antineoplastic agent (CHEBI:35610) |
| tramadol (CHEBI:9648) has role antineoplastic agent (CHEBI:35610) |
| tramadol hydrochloride (CHEBI:32250) has role antineoplastic agent (CHEBI:35610) |
| trametinib (CHEBI:75998) has role antineoplastic agent (CHEBI:35610) |
| trametinib dimethyl sulfoxide (CHEBI:75991) has role antineoplastic agent (CHEBI:35610) |
| tranexamic acid (CHEBI:48669) has role antineoplastic agent (CHEBI:35610) |
| tranilast (CHEBI:77572) has role antineoplastic agent (CHEBI:35610) |
| transcrocetinate sodium (CHEBI:755162) has role antineoplastic agent (CHEBI:35610) |
| transplatin (CHEBI:35852) has role antineoplastic agent (CHEBI:35610) |
| tranylcypromine (CHEBI:9652) has role antineoplastic agent (CHEBI:35610) |
| trapoxin A (CHEBI:84057) has role antineoplastic agent (CHEBI:35610) |
| trastuzumab (CHEBI:231601) has role antineoplastic agent (CHEBI:35610) |
| trastuzumab botidotin (CHEBI:759476) has role antineoplastic agent (CHEBI:35610) |
| trastuzumab brengitecan (CHEBI:759579) has role antineoplastic agent (CHEBI:35610) |
| trastuzumab corixetan (CHEBI:758738) has role antineoplastic agent (CHEBI:35610) |
| trastuzumab deruxtecan (CHEBI:757286) has role antineoplastic agent (CHEBI:35610) |
| trastuzumab duocarmazine (CHEBI:757585) has role antineoplastic agent (CHEBI:35610) |
| trastuzumab emtansine (CHEBI:750159) has role antineoplastic agent (CHEBI:35610) |
| trastuzumab envedotin (CHEBI:760101) has role antineoplastic agent (CHEBI:35610) |
| trastuzumab imbotolimod (CHEBI:758888) has role antineoplastic agent (CHEBI:35610) |
| trastuzumab pamirtecan (CHEBI:760225) has role antineoplastic agent (CHEBI:35610) |
| trastuzumab rezetecan (CHEBI:759407) has role antineoplastic agent (CHEBI:35610) |
| trastuzumab vedotin (CHEBI:759720) has role antineoplastic agent (CHEBI:35610) |
| trc-093 (CHEBI:754195) has role antineoplastic agent (CHEBI:35610) |
| trc-253 (CHEBI:758587) has role antineoplastic agent (CHEBI:35610) |
| tre-515 (CHEBI:759624) has role antineoplastic agent (CHEBI:35610) |
| trebananib (CHEBI:753522) has role antineoplastic agent (CHEBI:35610) |
| trehalose 6,6'-dimycolate (CHEBI:82624) has role antineoplastic agent (CHEBI:35610) |
| tremelimumab (CHEBI:753608) has role antineoplastic agent (CHEBI:35610) |
| tremtelectogene empogeditemcel (CHEBI:759408) has role antineoplastic agent (CHEBI:35610) |
| Treosulfan (CHEBI:82557) has role antineoplastic agent (CHEBI:35610) |
| tretazicar (CHEBI:748040) has role antineoplastic agent (CHEBI:35610) |
| trevotamig (CHEBI:760226) has role antineoplastic agent (CHEBI:35610) |
| triamcinolone (CHEBI:9667) has role antineoplastic agent (CHEBI:35610) |
| triapine (CHEBI:231347) has role antineoplastic agent (CHEBI:35610) |
| triaziquone (CHEBI:27090) has role antineoplastic agent (CHEBI:35610) |
| tributyrin (CHEBI:35020) has role antineoplastic agent (CHEBI:35610) |
| tricetin (CHEBI:507499) has role antineoplastic agent (CHEBI:35610) |
| trichodermin (CHEBI:9688) has role antineoplastic agent (CHEBI:35610) |
| trichodimerol (CHEBI:66261) has role antineoplastic agent (CHEBI:35610) |
| trichothecin (CHEBI:69621) has role antineoplastic agent (CHEBI:35610) |
| triciribine phosphate (CHEBI:748887) has role antineoplastic agent (CHEBI:35610) |
| trierixin (CHEBI:66262) has role antineoplastic agent (CHEBI:35610) |
| trifarotene (CHEBI:755791) has role antineoplastic agent (CHEBI:35610) |
| trifluridine (CHEBI:75179) has role antineoplastic agent (CHEBI:35610) |
| Trilaciclib (CHEBI:231087) has role antineoplastic agent (CHEBI:35610) |
| trilaciclib dihydrochloride (CHEBI:758178) has role antineoplastic agent (CHEBI:35610) |
| trilobacin (CHEBI:66270) has role antineoplastic agent (CHEBI:35610) |
| trilostane (CHEBI:32260) has role antineoplastic agent (CHEBI:35610) |
| Trimetazidine hydrochloride (CHEBI:32262) has role antineoplastic agent (CHEBI:35610) |
| trimethoprim (CHEBI:45924) has role antineoplastic agent (CHEBI:35610) |
| trimetrexate glucuronate (CHEBI:754867) has role antineoplastic agent (CHEBI:35610) |
| trimix (CHEBI:758503) has role antineoplastic agent (CHEBI:35610) |
| triphosphoric acid (CHEBI:39949) has role antineoplastic agent (CHEBI:35610) |
| triplatin tetranitrate (CHEBI:85611) has role antineoplastic agent (CHEBI:35610) |
| triplatin(4+) (CHEBI:85612) has role antineoplastic agent (CHEBI:35610) |
| triptonide (CHEBI:132267) has role antineoplastic agent (CHEBI:35610) |
| triptorelin (CHEBI:63633) has role antineoplastic agent (CHEBI:35610) |
| triptorelin acetate (CHEBI:759756) has role antineoplastic agent (CHEBI:35610) |
| triptorelin pamoate (CHEBI:749274) has role antineoplastic agent (CHEBI:35610) |
| tris (CHEBI:9754) has role antineoplastic agent (CHEBI:35610) |
| tris(8-hydroxyquinolinato)gallium (CHEBI:757998) has role antineoplastic agent (CHEBI:35610) |
| trisodium vanadate (CHEBI:35607) has role antineoplastic agent (CHEBI:35610) |
| trk-950 (CHEBI:757853) has role antineoplastic agent (CHEBI:35610) |
| troculeucel (CHEBI:759581) has role antineoplastic agent (CHEBI:35610) |
| trofosfamide (CHEBI:135381) has role antineoplastic agent (CHEBI:35610) |
| troglitazone (CHEBI:9753) has role antineoplastic agent (CHEBI:35610) |
| troriluzole (CHEBI:757061) has role antineoplastic agent (CHEBI:35610) |
| trotabresib (CHEBI:758260) has role antineoplastic agent (CHEBI:35610) |
| trovocabtagene autoleucel (CHEBI:759477) has role antineoplastic agent (CHEBI:35610) |
| trph-222 (CHEBI:757983) has role antineoplastic agent (CHEBI:35610) |
| tru-015 (CHEBI:757287) has role antineoplastic agent (CHEBI:35610) |
| trx-518 (CHEBI:754225) has role antineoplastic agent (CHEBI:35610) |
| tschimganine (CHEBI:142517) has role antineoplastic agent (CHEBI:35610) |
| tsn-084 (CHEBI:759659) has role antineoplastic agent (CHEBI:35610) |
| tsugarioside C (CHEBI:66278) has role antineoplastic agent (CHEBI:35610) |
| tt-232 (CHEBI:748996) has role antineoplastic agent (CHEBI:35610) |
| ttc-352 (CHEBI:755874) has role antineoplastic agent (CHEBI:35610) |
| ttp-607 (CHEBI:755578) has role antineoplastic agent (CHEBI:35610) |
| TTT-3002 (CHEBI:88219) has role antineoplastic agent (CHEBI:35610) |
| tubercidin (CHEBI:48267) has role antineoplastic agent (CHEBI:35610) |
| tubocapsanolide A (CHEBI:66325) has role antineoplastic agent (CHEBI:35610) |
| tubocapsanolide F (CHEBI:66328) has role antineoplastic agent (CHEBI:35610) |
| tubulozole (CHEBI:83928) has role antineoplastic agent (CHEBI:35610) |
| tucatinib (CHEBI:756373) has role antineoplastic agent (CHEBI:35610) |
| tucotuzumab celmoleukin (CHEBI:753610) has role antineoplastic agent (CHEBI:35610) |
| tulmimetostat (CHEBI:758808) has role antineoplastic agent (CHEBI:35610) |
| tumor necrosis factor receptor superfamily member 9 (CHEBI:757356) has role antineoplastic agent (CHEBI:35610) |
| tunlametinib (CHEBI:758818) has role antineoplastic agent (CHEBI:35610) |
| tuparstobart (CHEBI:758032) has role antineoplastic agent (CHEBI:35610) |
| tusamitamab (CHEBI:759021) has role antineoplastic agent (CHEBI:35610) |
| tusamitamab ravtansine (CHEBI:757517) has role antineoplastic agent (CHEBI:35610) |
| tuspetinib (CHEBI:759131) has role antineoplastic agent (CHEBI:35610) |
| tuvusertib (CHEBI:759625) has role antineoplastic agent (CHEBI:35610) |
| tuxobertinib (CHEBI:758185) has role antineoplastic agent (CHEBI:35610) |
| TW-37 (CHEBI:95008) has role antineoplastic agent (CHEBI:35610) |
| tyrosinase (CHEBI:758913) has role antineoplastic agent (CHEBI:35610) |
| tyrphostin AG 1478 (CHEBI:75404) has role antineoplastic agent (CHEBI:35610) |
| U0126 (CHEBI:90693) has role antineoplastic agent (CHEBI:35610) |
| U0126.EtOH (CHEBI:90692) has role antineoplastic agent (CHEBI:35610) |
| uab-30 (CHEBI:755116) has role antineoplastic agent (CHEBI:35610) |
| ubamatamab (CHEBI:758067) has role antineoplastic agent (CHEBI:35610) |
| ubiquinol-8 (CHEBI:61682) has role antineoplastic agent (CHEBI:35610) |
| ublituximab (CHEBI:753332) has role antineoplastic agent (CHEBI:35610) |
| ucasareotide dasaroxetan (CHEBI:759582) has role antineoplastic agent (CHEBI:35610) |
| ucb-6114 (CHEBI:758400) has role antineoplastic agent (CHEBI:35610) |
| UCS1025 A (CHEBI:66338) has role antineoplastic agent (CHEBI:35610) |
| ulecaciclib (CHEBI:756564) has role antineoplastic agent (CHEBI:35610) |
| ulevostinag (CHEBI:758779) has role antineoplastic agent (CHEBI:35610) |
| uliledlimab (CHEBI:758396) has role antineoplastic agent (CHEBI:35610) |
| ulintoclax pegondrimer (CHEBI:760103) has role antineoplastic agent (CHEBI:35610) |
| Ulipristal (CHEBI:177631) has role antineoplastic agent (CHEBI:35610) |
| ulipristal acetate (CHEBI:71025) has role antineoplastic agent (CHEBI:35610) |
| ulixertinib (CHEBI:755648) has role antineoplastic agent (CHEBI:35610) |
| ulocuplumab (CHEBI:755084) has role antineoplastic agent (CHEBI:35610) |
| ulviprubart (CHEBI:758319) has role antineoplastic agent (CHEBI:35610) |
| umbralisib (CHEBI:756005) has role antineoplastic agent (CHEBI:35610) |
| umbralisib tosylate (CHEBI:756374) has role antineoplastic agent (CHEBI:35610) |
| umikibart (CHEBI:760104) has role antineoplastic agent (CHEBI:35610) |
| umitrelimorgene autodencel (CHEBI:759409) has role antineoplastic agent (CHEBI:35610) |
| umizortamig (CHEBI:759410) has role antineoplastic agent (CHEBI:35610) |
| UNC0638 (CHEBI:95074) has role antineoplastic agent (CHEBI:35610) |
| UNC0642 (CHEBI:233643) has role antineoplastic agent (CHEBI:35610) |
| undecylprodigiosin (CHEBI:29702) has role antineoplastic agent (CHEBI:35610) |
| unecritinib (CHEBI:759658) has role antineoplastic agent (CHEBI:35610) |
| unesbulin (CHEBI:757849) has role antineoplastic agent (CHEBI:35610) |
| upamostat (CHEBI:756633) has role antineoplastic agent (CHEBI:35610) |
| uplarafenib (CHEBI:759248) has role antineoplastic agent (CHEBI:35610) |
| uprevstobart (CHEBI:759583) has role antineoplastic agent (CHEBI:35610) |
| uproleselan (CHEBI:756455) has role antineoplastic agent (CHEBI:35610) |
| uprosertib (CHEBI:755163) has role antineoplastic agent (CHEBI:35610) |
| urabrelimab (CHEBI:758082) has role antineoplastic agent (CHEBI:35610) |
| uracil (CHEBI:17568) has role antineoplastic agent (CHEBI:35610) |
| uracil mustard (CHEBI:748819) has role antineoplastic agent (CHEBI:35610) |
| urdamycin A (CHEBI:32279) has role antineoplastic agent (CHEBI:35610) |
| urea (CHEBI:16199) has role antineoplastic agent (CHEBI:35610) |
| urelumab (CHEBI:750161) has role antineoplastic agent (CHEBI:35610) |
| uridine (CHEBI:16704) has role antineoplastic agent (CHEBI:35610) |
| uridine triacetate (CHEBI:90914) has role antineoplastic agent (CHEBI:35610) |
| ursodeoxycholic acid (CHEBI:9907) has role antineoplastic agent (CHEBI:35610) |
| ursolic acid (CHEBI:9908) has role antineoplastic agent (CHEBI:35610) |
| usl-311 (CHEBI:756937) has role antineoplastic agent (CHEBI:35610) |
| ustekinumab (CHEBI:749609) has role antineoplastic agent (CHEBI:35610) |
| utomilumab (CHEBI:755800) has role antineoplastic agent (CHEBI:35610) |
| uvaretin (CHEBI:9915) has role antineoplastic agent (CHEBI:35610) |
| uzatresgene autoleucel (CHEBI:760376) has role antineoplastic agent (CHEBI:35610) |
| uzoptirine (CHEBI:758971) has role antineoplastic agent (CHEBI:35610) |
| vabametkib (CHEBI:756006) has role antineoplastic agent (CHEBI:35610) |
| vactosertib (CHEBI:755241) has role antineoplastic agent (CHEBI:35610) |
| vadacabtagene leraleucel (CHEBI:756502) has role antineoplastic agent (CHEBI:35610) |
| vadastuximab talirine (CHEBI:756503) has role antineoplastic agent (CHEBI:35610) |
| vadimezan (CHEBI:75934) has role antineoplastic agent (CHEBI:35610) |
| valacyclovir (CHEBI:35854) has role antineoplastic agent (CHEBI:35610) |
| valemetostat (CHEBI:758103) has role antineoplastic agent (CHEBI:35610) |
| valemetostat tosylate (CHEBI:757894) has role antineoplastic agent (CHEBI:35610) |
| valganciclovir (CHEBI:63635) has role antineoplastic agent (CHEBI:35610) |
| valproate semisodium (CHEBI:4667) has role antineoplastic agent (CHEBI:35610) |
| valproic acid (CHEBI:39867) has role antineoplastic agent (CHEBI:35610) |
| valrubicin (CHEBI:135876) has role antineoplastic agent (CHEBI:35610) |
| vamotinib (CHEBI:756964) has role antineoplastic agent (CHEBI:35610) |
| vandetanib (CHEBI:49960) has role antineoplastic agent (CHEBI:35610) |
| vandortuzumab vedotin (CHEBI:755906) has role antineoplastic agent (CHEBI:35610) |
| vangatalcite (CHEBI:753752) has role antineoplastic agent (CHEBI:35610) |
| vantictumab (CHEBI:754999) has role antineoplastic agent (CHEBI:35610) |
| vanucizumab (CHEBI:755544) has role antineoplastic agent (CHEBI:35610) |
| varegacestat (CHEBI:755976) has role antineoplastic agent (CHEBI:35610) |
| variecolorquinone A (CHEBI:66350) has role antineoplastic agent (CHEBI:35610) |
| variecolorquinone B (CHEBI:66351) has role antineoplastic agent (CHEBI:35610) |
| varlilumab (CHEBI:755173) has role antineoplastic agent (CHEBI:35610) |
| varlitinib (CHEBI:231356) has role antineoplastic agent (CHEBI:35610) |
| varnimcabtagene autoleucel (CHEBI:759411) has role antineoplastic agent (CHEBI:35610) |
| vatalanib (CHEBI:90620) has role antineoplastic agent (CHEBI:35610) |
| vatalanib succinate (CHEBI:90623) has role antineoplastic agent (CHEBI:35610) |
| vebreltinib (CHEBI:758329) has role antineoplastic agent (CHEBI:35610) |
| vecabrutinib (CHEBI:757108) has role antineoplastic agent (CHEBI:35610) |
| vecabrutinib succinate (CHEBI:757558) has role antineoplastic agent (CHEBI:35610) |
| vedelianin (CHEBI:66352) has role antineoplastic agent (CHEBI:35610) |
| vedolizumab (CHEBI:750163) has role antineoplastic agent (CHEBI:35610) |
| veledimex (CHEBI:755070) has role antineoplastic agent (CHEBI:35610) |
| veligrotug (CHEBI:754182) has role antineoplastic agent (CHEBI:35610) |
| velimogene aliplasmid (CHEBI:753611) has role antineoplastic agent (CHEBI:35610) |
| velinotamig (CHEBI:760229) has role antineoplastic agent (CHEBI:35610) |
| veliparib (CHEBI:62880) has role antineoplastic agent (CHEBI:35610) |
| veltuzumab (CHEBI:750164) has role antineoplastic agent (CHEBI:35610) |
| vemurafenib (CHEBI:63637) has role antineoplastic agent (CHEBI:35610) |
| venetoclax (CHEBI:133021) has role antineoplastic agent (CHEBI:35610) |
| venlafaxine hydrochloride (CHEBI:9944) has role antineoplastic agent (CHEBI:35610) |
| veonetinib (CHEBI:759996) has role antineoplastic agent (CHEBI:35610) |
| verapamil (CHEBI:9948) has role antineoplastic agent (CHEBI:35610) |
| verapamil hydrochloride (CHEBI:53188) has role antineoplastic agent (CHEBI:35610) |
| verpasep caltespen (CHEBI:753612) has role antineoplastic agent (CHEBI:35610) |
| verteporfin (CHEBI:32293) has role antineoplastic agent (CHEBI:35610) |
| verubulin (CHEBI:748950) has role antineoplastic agent (CHEBI:35610) |
| verzistobart (CHEBI:759480) has role antineoplastic agent (CHEBI:35610) |
| vesencumab (CHEBI:750165) has role antineoplastic agent (CHEBI:35610) |
| vesigenurtucel-l (CHEBI:755255) has role antineoplastic agent (CHEBI:35610) |
| vevoctadekin (CHEBI:759585) has role antineoplastic agent (CHEBI:35610) |
| vevorisertib (CHEBI:758478) has role antineoplastic agent (CHEBI:35610) |
| vgx-100 (CHEBI:757289) has role antineoplastic agent (CHEBI:35610) |
| viagenpumatucel-l (CHEBI:755167) has role antineoplastic agent (CHEBI:35610) |
| vibecotamab (CHEBI:757543) has role antineoplastic agent (CHEBI:35610) |
| vibosameran (CHEBI:759048) has role antineoplastic agent (CHEBI:35610) |
| vibostolimab (CHEBI:757231) has role antineoplastic agent (CHEBI:35610) |
| vididencel (CHEBI:759481) has role antineoplastic agent (CHEBI:35610) |
| vidutolimod (CHEBI:759693) has role antineoplastic agent (CHEBI:35610) |
| vilamakitug (CHEBI:759025) has role antineoplastic agent (CHEBI:35610) |
| vilaprisan (CHEBI:756425) has role antineoplastic agent (CHEBI:35610) |
| vilastobart (CHEBI:759587) has role antineoplastic agent (CHEBI:35610) |
| vildagliptin (CHEBI:135285) has role antineoplastic agent (CHEBI:35610) |
| vilobelimab (CHEBI:754373) has role antineoplastic agent (CHEBI:35610) |
| vilzemetkib (CHEBI:759954) has role antineoplastic agent (CHEBI:35610) |
| vimseltinib (CHEBI:758781) has role antineoplastic agent (CHEBI:35610) |
| vinblastine (CHEBI:748218) has role antineoplastic agent (CHEBI:35610) |
| vinblastine sulfate (CHEBI:748751) has role antineoplastic agent (CHEBI:35610) |
| vincaleukoblastine (CHEBI:27375) has role antineoplastic agent (CHEBI:35610) |
| vincristine (CHEBI:28445) has role antineoplastic agent (CHEBI:35610) |
| vincristine sulfate (CHEBI:79401) has role antineoplastic agent (CHEBI:35610) |
| vincristine(2+) (CHEBI:143658) has role antineoplastic agent (CHEBI:35610) |
| vindesine (CHEBI:36373) has role antineoplastic agent (CHEBI:35610) |
| vindesine sulfate (CHEBI:32295) has role antineoplastic agent (CHEBI:35610) |
| vinflunine (CHEBI:90241) has role antineoplastic agent (CHEBI:35610) |
| vinflunine ditartrate (CHEBI:751532) has role antineoplastic agent (CHEBI:35610) |
| vinorelbine (CHEBI:480999) has role antineoplastic agent (CHEBI:35610) |
| vinorelbine D-tartrate (CHEBI:53750) has role antineoplastic agent (CHEBI:35610) |
| vinorelbine L-tartrate (CHEBI:32296) has role antineoplastic agent (CHEBI:35610) |
| vinorelbine tartrate (CHEBI:749064) has role antineoplastic agent (CHEBI:35610) |
| violacein (CHEBI:131914) has role antineoplastic agent (CHEBI:35610) |
| vipivotide tetraxetan (CHEBI:757783) has role antineoplastic agent (CHEBI:35610) |
| vipivotide tetraxetan gallium ga-68 (CHEBI:758252) has role antineoplastic agent (CHEBI:35610) |
| viridicatumtoxin (CHEBI:85616) has role antineoplastic agent (CHEBI:35610) |
| visilizumab (CHEBI:753738) has role antineoplastic agent (CHEBI:35610) |
| vislarafusp alfa (CHEBI:760106) has role antineoplastic agent (CHEBI:35610) |
| vismodegib (CHEBI:66903) has role antineoplastic agent (CHEBI:35610) |
| vispacabtagene regedleucel (CHEBI:760232) has role antineoplastic agent (CHEBI:35610) |
| vistusertib (CHEBI:754952) has role antineoplastic agent (CHEBI:35610) |
| visugromab (CHEBI:758897) has role antineoplastic agent (CHEBI:35610) |
| vitamin D2 (CHEBI:28934) has role antineoplastic agent (CHEBI:35610) |
| vitamin E (CHEBI:33234) has role antineoplastic agent (CHEBI:35610) |
| vitamin K (CHEBI:28384) has role antineoplastic agent (CHEBI:35610) |
| vitekwangin B (CHEBI:231954) has role antineoplastic agent (CHEBI:35610) |
| vitespen (CHEBI:753076) has role antineoplastic agent (CHEBI:35610) |
| vitetrifolin D (CHEBI:91266) has role antineoplastic agent (CHEBI:35610) |
| vitexilactone (CHEBI:91267) has role antineoplastic agent (CHEBI:35610) |
| vitexin (CHEBI:16954) has role antineoplastic agent (CHEBI:35610) |
| vobramitamab (CHEBI:758740) has role antineoplastic agent (CHEBI:35610) |
| vobramitamab duocarmazine (CHEBI:758049) has role antineoplastic agent (CHEBI:35610) |
| vocimagene amiretrorepvec (CHEBI:753578) has role antineoplastic agent (CHEBI:35610) |
| vociprotafib (CHEBI:759138) has role antineoplastic agent (CHEBI:35610) |
| vodobatinib (CHEBI:756619) has role antineoplastic agent (CHEBI:35610) |
| vofatamab (CHEBI:757290) has role antineoplastic agent (CHEBI:35610) |
| volamcabtagene durzigedleucel (CHEBI:758741) has role antineoplastic agent (CHEBI:35610) |
| volasertib (CHEBI:231358) has role antineoplastic agent (CHEBI:35610) |
| volociximab (CHEBI:753077) has role antineoplastic agent (CHEBI:35610) |
| volrustomig (CHEBI:758929) has role antineoplastic agent (CHEBI:35610) |
| vonlerolizumab (CHEBI:756504) has role antineoplastic agent (CHEBI:35610) |
| vonsetamig (CHEBI:759482) has role antineoplastic agent (CHEBI:35610) |
| vopikitug (CHEBI:758389) has role antineoplastic agent (CHEBI:35610) |
| vopratelimab (CHEBI:757429) has role antineoplastic agent (CHEBI:35610) |
| vorasidenib (CHEBI:756658) has role antineoplastic agent (CHEBI:35610) |
| vorasidenib citrate (CHEBI:757868) has role antineoplastic agent (CHEBI:35610) |
| vorbipiprant (CHEBI:759912) has role antineoplastic agent (CHEBI:35610) |
| vorbipiprant sodium (CHEBI:760393) has role antineoplastic agent (CHEBI:35610) |
| voriconazole (CHEBI:10023) has role antineoplastic agent (CHEBI:35610) |
| vorinostat (CHEBI:45716) has role antineoplastic agent (CHEBI:35610) |
| vorolanib (CHEBI:757062) has role antineoplastic agent (CHEBI:35610) |
| vorsetuzumab mafodotin (CHEBI:753620) has role antineoplastic agent (CHEBI:35610) |
| voruciclib (CHEBI:755971) has role antineoplastic agent (CHEBI:35610) |
| vorumotide (CHEBI:759483) has role antineoplastic agent (CHEBI:35610) |
| vosaroxin (CHEBI:231651) has role antineoplastic agent (CHEBI:35610) |
| votumumab (CHEBI:753167) has role antineoplastic agent (CHEBI:35610) |
| vs-4718 (CHEBI:755099) has role antineoplastic agent (CHEBI:35610) |
| vs-5584 (CHEBI:755348) has role antineoplastic agent (CHEBI:35610) |
| VTP-50469 (CHEBI:232861) has role antineoplastic agent (CHEBI:35610) |
| vudalimab (CHEBI:758089) has role antineoplastic agent (CHEBI:35610) |
| vulinacimab (CHEBI:758021) has role antineoplastic agent (CHEBI:35610) |
| vulolisib (CHEBI:759156) has role antineoplastic agent (CHEBI:35610) |
| vusolimogene oderparepvec (CHEBI:758177) has role antineoplastic agent (CHEBI:35610) |
| warfarin (CHEBI:10033) has role antineoplastic agent (CHEBI:35610) |
| wedelolactone (CHEBI:10037) has role antineoplastic agent (CHEBI:35610) |
| withaferin A (CHEBI:69120) has role antineoplastic agent (CHEBI:35610) |
| withalongolide A (CHEBI:69106) has role antineoplastic agent (CHEBI:35610) |
| withalongolide B (CHEBI:69107) has role antineoplastic agent (CHEBI:35610) |
| withalongolide C (CHEBI:69108) has role antineoplastic agent (CHEBI:35610) |
| withalongolide G (CHEBI:69126) has role antineoplastic agent (CHEBI:35610) |
| withalongolide H (CHEBI:69112) has role antineoplastic agent (CHEBI:35610) |
| withanolide D (CHEBI:10041) has role antineoplastic agent (CHEBI:35610) |
| Wnt-C59 (CHEBI:235513) has role antineoplastic agent (CHEBI:35610) |
| wogonin (CHEBI:10043) has role antineoplastic agent (CHEBI:35610) |
| wortmannin (CHEBI:52289) has role antineoplastic agent (CHEBI:35610) |
| wrightiamine A (CHEBI:66330) has role antineoplastic agent (CHEBI:35610) |
| wx-037 (CHEBI:755610) has role antineoplastic agent (CHEBI:35610) |
| wx-554 (CHEBI:755483) has role antineoplastic agent (CHEBI:35610) |
| WYE-28 (CHEBI:234113) has role antineoplastic agent (CHEBI:35610) |
| WZ4002 (CHEBI:61400) has role antineoplastic agent (CHEBI:35610) |
| WZB-117 (CHEBI:229781) has role antineoplastic agent (CHEBI:35610) |
| x-82 (CHEBI:755621) has role antineoplastic agent (CHEBI:35610) |
| xaliproden (CHEBI:48520) has role antineoplastic agent (CHEBI:35610) |
| xanthohumol (CHEBI:66331) has role antineoplastic agent (CHEBI:35610) |
| xanthomicrol (CHEBI:35047) has role antineoplastic agent (CHEBI:35610) |
| xentuzumab (CHEBI:757292) has role antineoplastic agent (CHEBI:35610) |
| xestospongin C (CHEBI:131784) has role antineoplastic agent (CHEBI:35610) |
| xirestomig (CHEBI:759589) has role antineoplastic agent (CHEBI:35610) |
| xl-019 (CHEBI:755579) has role antineoplastic agent (CHEBI:35610) |
| xl-228 (CHEBI:755454) has role antineoplastic agent (CHEBI:35610) |
| xl-281 (CHEBI:755422) has role antineoplastic agent (CHEBI:35610) |
| xl-418 (CHEBI:750372) has role antineoplastic agent (CHEBI:35610) |
| xl-820 (CHEBI:755622) has role antineoplastic agent (CHEBI:35610) |
| xl-844 (CHEBI:755381) has role antineoplastic agent (CHEBI:35610) |
| xl-888 (CHEBI:756938) has role antineoplastic agent (CHEBI:35610) |
| xl-999 (CHEBI:759105) has role antineoplastic agent (CHEBI:35610) |
| XL147 (CHEBI:71957) has role antineoplastic agent (CHEBI:35610) |
| XL413 (CHEBI:189662) has role antineoplastic agent (CHEBI:35610) |
| XL765 (CHEBI:71958) has role antineoplastic agent (CHEBI:35610) |
| XMD-17-51 (CHEBI:234455) has role antineoplastic agent (CHEBI:35610) |
| xmt-1536 (CHEBI:757293) has role antineoplastic agent (CHEBI:35610) |
| XPO1-IN-1 (CHEBI:229765) has role antineoplastic agent (CHEBI:35610) |
| xylocarpin J (CHEBI:66337) has role antineoplastic agent (CHEBI:35610) |
| yadanziolide B (CHEBI:68932) has role antineoplastic agent (CHEBI:35610) |
| yadanziolide T (CHEBI:68928) has role antineoplastic agent (CHEBI:35610) |
| yahyaxanthone (CHEBI:66491) has role antineoplastic agent (CHEBI:35610) |
| yh-001 (CHEBI:758956) has role antineoplastic agent (CHEBI:35610) |
| yh-003 (CHEBI:758957) has role antineoplastic agent (CHEBI:35610) |
| YK-4-279 (CHEBI:94301) has role antineoplastic agent (CHEBI:35610) |
| YM-216391 (CHEBI:169951) has role antineoplastic agent (CHEBI:35610) |
| yttrium y 90 clivatuzumab tetraxetan (CHEBI:753651) has role antineoplastic agent (CHEBI:35610) |
| yttrium y 90 epratuzumab tetraxetan (CHEBI:753614) has role antineoplastic agent (CHEBI:35610) |
| yttrium y 90 ibritumomab tiuxetan (CHEBI:753615) has role antineoplastic agent (CHEBI:35610) |
| yttrium y-90 (CHEBI:758259) has role antineoplastic agent (CHEBI:35610) |
| YXG-158 (CHEBI:228303) has role antineoplastic agent (CHEBI:35610) |
| zabadinostat (CHEBI:756975) has role antineoplastic agent (CHEBI:35610) |
| zabilugene almadenorepvec (CHEBI:760235) has role antineoplastic agent (CHEBI:35610) |
| zafirlukast (CHEBI:10100) has role antineoplastic agent (CHEBI:35610) |
| zalifrelimab (CHEBI:757314) has role antineoplastic agent (CHEBI:35610) |
| zalutumumab (CHEBI:752904) has role antineoplastic agent (CHEBI:35610) |
| zamaporvint (CHEBI:759142) has role antineoplastic agent (CHEBI:35610) |
| zamzetoclax (CHEBI:759955) has role antineoplastic agent (CHEBI:35610) |
| zandelisib (CHEBI:758121) has role antineoplastic agent (CHEBI:35610) |
| zanidatamab (CHEBI:758162) has role antineoplastic agent (CHEBI:35610) |
| zanolimumab (CHEBI:753079) has role antineoplastic agent (CHEBI:35610) |
| zansecimab (CHEBI:758367) has role antineoplastic agent (CHEBI:35610) |
| zanubrutinib (CHEBI:755996) has role antineoplastic agent (CHEBI:35610) |
| zanzalintinib (CHEBI:759139) has role antineoplastic agent (CHEBI:35610) |
| zanzalintinib fumarate (CHEBI:759302) has role antineoplastic agent (CHEBI:35610) |
| zarzissine (CHEBI:66501) has role antineoplastic agent (CHEBI:35610) |
| zavondemstat (CHEBI:759199) has role antineoplastic agent (CHEBI:35610) |
| zb-716 (CHEBI:757702) has role antineoplastic agent (CHEBI:35610) |
| zd-6126 (CHEBI:748865) has role antineoplastic agent (CHEBI:35610) |
| zeaxanthin (CHEBI:27547) has role antineoplastic agent (CHEBI:35610) |
| zedenoleucel (CHEBI:758374) has role antineoplastic agent (CHEBI:35610) |
| zelebrudomide (CHEBI:759840) has role antineoplastic agent (CHEBI:35610) |
| zelenectide (CHEBI:759595) has role antineoplastic agent (CHEBI:35610) |
| zelenectide pevedotin (CHEBI:759596) has role antineoplastic agent (CHEBI:35610) |
| zelenirstat (CHEBI:755341) has role antineoplastic agent (CHEBI:35610) |
| zen-3694 (CHEBI:760506) has role antineoplastic agent (CHEBI:35610) |
| zendusortide (CHEBI:758745) has role antineoplastic agent (CHEBI:35610) |
| zenocutuzumab (CHEBI:757449) has role antineoplastic agent (CHEBI:35610) |
| zeprumetostat (CHEBI:759871) has role antineoplastic agent (CHEBI:35610) |
| zeripatamig (CHEBI:758313) has role antineoplastic agent (CHEBI:35610) |
| zeteletinib (CHEBI:759053) has role antineoplastic agent (CHEBI:35610) |
| zeteletinib adipate (CHEBI:758627) has role antineoplastic agent (CHEBI:35610) |
| zetomipzomib (CHEBI:756954) has role antineoplastic agent (CHEBI:35610) |
| zevorcabtagene autoleucel (CHEBI:758172) has role antineoplastic agent (CHEBI:35610) |
| zhankuic acid A (CHEBI:66503) has role antineoplastic agent (CHEBI:35610) |
| zhankuic acid B (CHEBI:66504) has role antineoplastic agent (CHEBI:35610) |
| zhankuic acid C (CHEBI:66505) has role antineoplastic agent (CHEBI:35610) |
| zibotentan (CHEBI:94573) has role antineoplastic agent (CHEBI:35610) |
| zidesamtinib (CHEBI:747901) has role antineoplastic agent (CHEBI:35610) |
| zidovudine (CHEBI:10110) has role antineoplastic agent (CHEBI:35610) |
| zifcasiran (CHEBI:759026) has role antineoplastic agent (CHEBI:35610) |
| zifcasiran sodium (CHEBI:759027) has role antineoplastic agent (CHEBI:35610) |
| ziftomenib (CHEBI:758624) has role antineoplastic agent (CHEBI:35610) |
| zigakibart (CHEBI:758889) has role antineoplastic agent (CHEBI:35610) |
| zileuton (CHEBI:10112) has role antineoplastic agent (CHEBI:35610) |
| zimberelimab (CHEBI:757298) has role antineoplastic agent (CHEBI:35610) |
| zimistobart (CHEBI:760378) has role antineoplastic agent (CHEBI:35610) |
| zipalertinib (CHEBI:233402) has role antineoplastic agent (CHEBI:35610) |
| zirconium zr-89-desferrioxamine-iab22m2c (CHEBI:758318) has role antineoplastic agent (CHEBI:35610) |
| ZM447439 (CHEBI:91376) has role antineoplastic agent (CHEBI:35610) |
| zolacabtagene autoleucel (CHEBI:760386) has role antineoplastic agent (CHEBI:35610) |
| zolbetuximab (CHEBI:754224) has role antineoplastic agent (CHEBI:35610) |
| zoledronic acid (CHEBI:46557) has role antineoplastic agent (CHEBI:35610) |
| zolpidem (CHEBI:10125) has role antineoplastic agent (CHEBI:35610) |
| zomiradomide (CHEBI:759850) has role antineoplastic agent (CHEBI:35610) |
| zongertinib (CHEBI:759202) has role antineoplastic agent (CHEBI:35610) |
| zoptarelin doxorubicin (CHEBI:755389) has role antineoplastic agent (CHEBI:35610) |
| zosuquidar (CHEBI:749003) has role antineoplastic agent (CHEBI:35610) |
| zosuquidar trihydrochloride (CHEBI:750426) has role antineoplastic agent (CHEBI:35610) |
| zotatifin (CHEBI:757667) has role antineoplastic agent (CHEBI:35610) |
| zotiraciclib citrate (CHEBI:757581) has role antineoplastic agent (CHEBI:35610) |
| zotizalkib (CHEBI:759125) has role antineoplastic agent (CHEBI:35610) |
| zovostotug (CHEBI:759484) has role antineoplastic agent (CHEBI:35610) |
| ZSTK-474 (CHEBI:90545) has role antineoplastic agent (CHEBI:35610) |
| zubotamig (CHEBI:760112) has role antineoplastic agent (CHEBI:35610) |
| zurletrectinib (CHEBI:758988) has role antineoplastic agent (CHEBI:35610) |
| α-(4-hydroxyphenyl)-N-tert-butylnitrone (CHEBI:77433) has role antineoplastic agent (CHEBI:35610) |
| α-mangostin (CHEBI:67547) has role antineoplastic agent (CHEBI:35610) |
| α-methyl-L-tyrosine (CHEBI:6912) has role antineoplastic agent (CHEBI:35610) |
| α-peltatin (CHEBI:10324) has role antineoplastic agent (CHEBI:35610) |
| α-tocopheryloxyacetic acid (CHEBI:194185) has role antineoplastic agent (CHEBI:35610) |
| β-D-ribopyranose (CHEBI:27476) has role antineoplastic agent (CHEBI:35610) |
| β-aminopropionitrile (CHEBI:27413) has role antineoplastic agent (CHEBI:35610) |
| β-aminopropionitrile hemifumarate (CHEBI:91084) has role antineoplastic agent (CHEBI:35610) |
| β-dihydroartemisinin (CHEBI:135921) has role antineoplastic agent (CHEBI:35610) |
| β-elemene (CHEBI:62854) has role antineoplastic agent (CHEBI:35610) |
| β-lapachone (CHEBI:10429) has role antineoplastic agent (CHEBI:35610) |
| β-peltatin (CHEBI:74867) has role antineoplastic agent (CHEBI:35610) |
| β-thujaplicin (CHEBI:10447) has role antineoplastic agent (CHEBI:35610) |
| β-tocotrienol (CHEBI:33275) has role antineoplastic agent (CHEBI:35610) |
| γ-glutamyl-Se-methylselenocysteine (CHEBI:28776) has role antineoplastic agent (CHEBI:35610) |
| γ-mangostin (CHEBI:67548) has role antineoplastic agent (CHEBI:35610) |
| γ-tocotrienol (CHEBI:33277) has role antineoplastic agent (CHEBI:35610) |
| δ-tocotrienol (CHEBI:33276) has role antineoplastic agent (CHEBI:35610) |
| Δ12-prostaglandin J3 (CHEBI:140274) has role antineoplastic agent (CHEBI:35610) |
| Δ9-tetrahydrocannabinol (CHEBI:66964) has role antineoplastic agent (CHEBI:35610) |
